<SEC-DOCUMENT>0001477932-25-007949.txt : 20251106
<SEC-HEADER>0001477932-25-007949.hdr.sgml : 20251106
<ACCEPTANCE-DATETIME>20251106170114
ACCESSION NUMBER:		0001477932-25-007949
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		58
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20251106
DATE AS OF CHANGE:		20251106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGHTBRIDGE Corp
		CENTRAL INDEX KEY:			0001084554
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INORGANIC CHEMICALS [2810]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				911975651
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34487
		FILM NUMBER:		251459400

	BUSINESS ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190
		BUSINESS PHONE:		571 730 1200

	MAIL ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thorium Power, Ltd
		DATE OF NAME CHANGE:	20061011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD.
		DATE OF NAME CHANGE:	20051011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD
		DATE OF NAME CHANGE:	20050829
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ltbr_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:ltbr="http://ltbr.com/20250930"><head><title>ltbr_10q.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-01-01to2025-09-30" id="ixv-8665">0001084554</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-01-01to2025-09-30" format="ixt:booleanfalse" id="ixv-8666">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2025-01-01to2025-09-30" id="ixv-8667">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2025-01-01to2025-09-30" id="ixv-8668">Q3</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2025-01-01to2025-09-30" id="ixv-8669">2025</ix:nonNumeric><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-8670">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8671">10000000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-09-30" unitRef="Shares" decimals="0" id="ixv-8672">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8673">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8674">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-09-30" unitRef="Shares" decimals="0" id="ixv-8675">0</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-8676">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8677">100000000</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8678">18783912</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-09-30" unitRef="Shares" decimals="0" id="ixv-8679">30384981</ix:nonFraction><ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-09-30" id="ixv-8680">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-09-30" id="ixv-8681">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-09-30" id="ixv-8682">false</ix:nonNumeric><ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-09-30" id="ixv-8683">true</ix:nonNumeric><ix:nonNumeric name="ltbr:Rule10b51ArrAdoptedFlagSecond" contextRef="From2025-01-01to2025-09-30" id="ixv-8684">true</ix:nonNumeric><ix:nonNumeric name="ltbr:Rule10b51ArrAdoptedFlagThird" contextRef="From2025-01-01to2025-09-30" id="ixv-8685">true</ix:nonNumeric><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2025-07-01to2025-09-30" unitRef="Shares" decimals="0" id="ixv-8686">263630</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2024-07-01to2024-09-30" unitRef="Shares" decimals="0" id="ixv-8687">547362</ix:nonFraction><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2025-07-01to2025-09-30" unitRef="Shares" decimals="0" id="ixv-8688">2113036</ix:nonFraction><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2024-07-01to2024-09-30" unitRef="Shares" decimals="0" id="ixv-8689">545992</ix:nonFraction><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2025-07-01to2025-09-30" unitRef="Shares" decimals="0" id="ixv-8690">2376666</ix:nonFraction><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-07-01to2024-09-30" unitRef="Shares" decimals="0" id="ixv-8691">1093354</ix:nonFraction><ix:nonFraction name="ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" contextRef="From2024-07-01to2024-09-30_ltbr_CANDUMember" unitRef="USD" decimals="0" id="ixv-8692">0</ix:nonFraction><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-07-01to2025-09-30_ltbr_FEEdMember" unitRef="USD" decimals="0" id="ixv-8693">0</ix:nonFraction><ix:nonFraction name="ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" contextRef="From2025-07-01to2025-09-30_ltbr_CANDUMember" unitRef="USD" decimals="0" id="ixv-8694">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" unitRef="Shares" decimals="0" id="ixv-8695">57940</ix:nonFraction><ix:nonFraction name="ltbr:CommonStockShareOutstanding" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember" unitRef="Shares" decimals="0" id="ixv-8696">781864</ix:nonFraction><ix:nonFraction name="ltbr:CommonStockShareOutstanding" contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember" unitRef="Shares" decimals="0" id="ixv-8697">2113036</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ltbr-20250930.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-01-01to2025-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-10-01to2025-10-27_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_CODMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-03-01to2024-03-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-11-01to2024-11-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-09-01to2025-09-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-01</xbrli:startDate><xbrli:endDate>2025-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-06-01to2025-06-05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-05-01to2025-05-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-01</xbrli:startDate><xbrli:endDate>2025-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2019-05-01to2019-05-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-01</xbrli:startDate><xbrli:endDate>2024-12-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-03</xbrli:startDate><xbrli:endDate>2025-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-08-01to2025-08-28_ltbr_SecondTrancheMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:SecondTrancheMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:FirstTrancheMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-18_ltbr_StrategicPartnershipProjectAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-03-01to2025-03-18_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-01-16_ltbr_CRADAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CRADAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_FEEdMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-12-01to2024-12-31_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-10-16_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_CANDUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-01-16_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-01-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_ltbr_INLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-06-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-07-01to2024-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-07-01to2025-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-10-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>WASHINGTON, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="font-size:18pt"><strong>FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2025-01-01to2025-09-30" id="ixv-9824">10-Q</ix:nonNumeric></strong>&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Mark One)&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:DocumentQuarterlyReport" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:boolballotbox" id="ixv-9825">&#9746;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the quarterly period ended: <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2025-01-01to2025-09-30" format="ixt:datemonthdayyearen" id="ixv-9826">September 30, 2025</ix:nonNumeric></span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:DocumentTransitionReport" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:boolballotbox" id="ixv-9827">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the transition period from _____________ to _____________</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Commission File Number: <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2025-01-01to2025-09-30" id="ixv-9828">001-34487</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2025-01-01to2025-09-30" id="ixv-9829">LIGHTBRIDGE CORPORATION</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:stateprovnameen" id="ixv-9830">Nevada</ix:nonNumeric></strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2025-01-01to2025-09-30" id="ixv-9831">91-1975651</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(State or other jurisdiction of </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>incorporation or organization)</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(I.R.S. Employer </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>Identification No.)</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2025-01-01to2025-09-30" id="ixv-9832">11710 Plaza America Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2025-01-01to2025-09-30" id="ixv-9833">Suite 2000</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2025-01-01to2025-09-30" id="ixv-9834">Reston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2025-01-01to2025-09-30" id="ixv-9835">VA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2025-01-01to2025-09-30" id="ixv-9836">20190</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Address of principal executive offices) (Zip Code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2025-01-01to2025-09-30" id="ixv-9837">571</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2025-01-01to2025-09-30" id="ixv-9838">730-1200</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Registrant&#8217;s telephone number, including area code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of Each Class:</p></td><td style="width:3%; background-color:#ffffff;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s):</p></td><td style="width:3%; background-color:#ffffff;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of Each Exchange on Which Registered:</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2025-01-01to2025-09-30" id="ixv-9839">Common Stock, $0.001 par value</ix:nonNumeric></strong></p></td><td style="width:3%; background-color:#ffffff;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2025-01-01to2025-09-30" id="ixv-9840">LTBR</ix:nonNumeric></strong></p></td><td style="width:3%; background-color:#ffffff;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The <ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:exchnameen" id="ixv-9841">Nasdaq</ix:nonNumeric> Capital Market</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" contextRef="From2025-01-01to2025-09-30" id="ixv-9842">Yes</ix:nonNumeric> &#9746;&#160;&#160; &#160;No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" contextRef="From2025-01-01to2025-09-30" id="ixv-9843">Yes</ix:nonNumeric> &#9746;&#160;&#160; &#160;No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Large Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:entityfilercategoryen" id="ixv-9844">Non- accelerated Filer</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9746;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Smaller reporting company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:boolballotbox" id="ixv-9845">&#9746;</ix:nonNumeric></p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:boolballotbox" id="ixv-9846">&#9744;</ix:nonNumeric></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric name="dei:EntityShellCompany" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:boolballotbox" id="ixv-9847">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No &#9746;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The number of shares outstanding of the issuer&#8217;s common stock, as of October 31, 2025 is as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Class of Securities</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Shares Outstanding</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock, $0.001 par value</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-10-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="INF" id="ixv-9848">32,371,338</ix:nonFraction></strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="toc">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM 10-Q</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SEPTEMBER 30, 2025</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"/><td/><td style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Page</strong></p></td></tr><tr style="height:15px"><td/><td/><td/></tr><tr style="height:15px"><td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><a href="#p1">PART I - FINANCIAL INFORMATION</a></strong></p></td><td/></tr><tr style="height:15px"><td/><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1">Item 1.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1">Condensed Consolidated Financial Statements (unaudited)</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#bs">Unaudited Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td></tr><tr style="height:15px;background-color:#cceeff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#op">Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#eq1">Unaudited Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity for the Three and Nine Months Ended September 30, 2025 and 2024</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5</p></td></tr><tr style="height:15px;background-color:#cceeff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#cf">Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">7</p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#fs">Notes to Condensed Consolidated Financial Statements (unaudited)</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">8</p></td></tr><tr style="height:15px;background-color:#cceeff"><td/><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#fo">Forward-Looking Statements</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">19</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2">Item 2.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">21</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3">Item 3.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3">Quantitative and Qualitative Disclosures About Market Risk</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4">Item 4.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4">Controls and Procedures</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">30</p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td/><td/></tr><tr style="height:15px;background-color:#ffffff"><td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><a href="#p2">PART II - OTHER INFORMATION</a></strong></p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td/><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii1">Item 1.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii1">Legal Proceedings</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">31</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii1a">Item 1A.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii1a">Risk Factors</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">31</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii2">Item 2.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii2">Unregistered Sales of Equity Securities and Use of Proceeds</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">31</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii3">Item 3.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii3">Defaults Upon Senior Securities</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">31</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii4">Item 4.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii4">Mine Safety Disclosures</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">31</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii5">Item 5.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii5">Other Information</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">32</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii6">Item 6.</a></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#ii6">Exhibits</a></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">32</p></td></tr><tr style="height:15px;background-color:#ffffff"><td/><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#sig">SIGNATURES</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">33</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p1">PART I-FINANCIAL INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i1">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="bs">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="8" style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ASSETS</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_808" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">153,330,134</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_809" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">39,990,827</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_810" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,293,501</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_811" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">324,378</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_812" name="us-gaap:AssetsCurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">154,623,635</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_813" name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,315,205</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_815" name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">327,148</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_816" name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">528,805</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Trademarks</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_817" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">114,982</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_818" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">108,865</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_819" name="us-gaap:Assets" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">155,065,765</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_820" name="us-gaap:Assets" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,952,875</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</strong></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_822" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,560,097</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_823" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">424,585</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_824" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,560,097</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_825" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">424,585</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Commitments and contingencies - Note 5</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Preferred stock, $<ix:nonFraction id="fid_35" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_37" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">10,000,000</ix:nonFraction> authorized shares, no shares issued and outstanding at September 30, 2025 and December 31, 2024 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_828" name="us-gaap:PreferredStockValue" contextRef="AsOf2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_829" name="us-gaap:PreferredStockValue" contextRef="AsOf2024-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Common stock, $<ix:nonFraction id="fid_43" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_45" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">100,000,000</ix:nonFraction> authorized, <ix:nonFraction id="fid_48" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">30,384,981</ix:nonFraction> shares and <ix:nonFraction id="fid_47" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">18,783,912</ix:nonFraction> shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_830" name="us-gaap:CommonStockValue" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,385</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_831" name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">18,784</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_832" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">330,050,816</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_833" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,694,348</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accumulated deficit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_834" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">176,575,533</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_835" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">164,184,842</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_836" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">153,505,668</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_837" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,528,290</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Liabilities and Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_838" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">155,065,765</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_839" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,952,875</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="op">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_841" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,164,343</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_842" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,676,209</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_843" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">9,146,989</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_844" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,626,567</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_845" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,039,857</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_846" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,298,601</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_847" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,345,635</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_848" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,232,036</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_849" name="us-gaap:OperatingExpenses" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,204,200</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_850" name="us-gaap:OperatingExpenses" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,974,810</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_851" name="us-gaap:OperatingExpenses" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,492,624</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_852" name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,858,603</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_853" name="us-gaap:OperatingIncomeLoss" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">5,204,200</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_854" name="us-gaap:OperatingIncomeLoss" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,974,810</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_855" name="us-gaap:OperatingIncomeLoss" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">14,492,624</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_856" name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">8,858,603</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_858" name="us-gaap:InterestIncomeOther" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,104,955</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_859" name="us-gaap:InterestIncomeOther" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">318,649</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_860" name="us-gaap:InterestIncomeOther" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,101,933</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_861" name="us-gaap:InterestIncomeOther" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,008,224</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_862" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,104,955</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_863" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">318,649</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_864" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,101,933</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_865" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,008,224</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_866" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,099,245</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_867" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,656,161</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_868" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">12,390,691</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_869" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">7,850,379</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_870" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2025-07-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_871" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_872" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_873" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_874" name="us-gaap:NetIncomeLoss" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,099,245</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_875" name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,656,161</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_876" name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">12,390,691</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_877" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">7,850,379</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Per Common Share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Basic and diluted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_879" name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.16</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_880" name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.19</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_881" name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.55</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_882" name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.57</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted Average Number of Common Shares Outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Basic and diluted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_884" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">25,624,598</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_885" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,189,787</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_886" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">22,498,638</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_887" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,871,756</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="17" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="eq1">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance &#8211; June 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_888" name="us-gaap:SharesIssued" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">25,545,488</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_889" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">25,545</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_890" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">270,225,336</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_891" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">172,476,288</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_892" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">97,774,593</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of restricted share awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_893" name="ltbr:IssuanceOfRestrictedShareAwardsShares" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,110,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_894" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,110</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_895" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,110</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_896" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_897" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-07-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs and commissions of $1,986,689</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_898" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,612,403</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_899" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,613</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_900" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">57,324,913</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_901" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_902" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">57,328,526</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultants and directors for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_903" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">20,949</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_904" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">21</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_905" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">314,979</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_906" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_907" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">315,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued through the exercise of options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_908" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">96,141</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_909" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">96</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_910" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">610,323</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_911" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_912" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">610,419</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_913" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_914" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,576,375</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_915" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_916" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,576,375</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_917" name="us-gaap:NetIncomeLoss" contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_918" name="us-gaap:NetIncomeLoss" contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1387" name="us-gaap:NetIncomeLoss" contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,099,245</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_920" name="us-gaap:NetIncomeLoss" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,099,245</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance &#8211; September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_921" name="us-gaap:SharesIssued" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">30,384,981</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_922" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,385</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_923" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">330,050,816</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_924" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">176,575,533</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_925" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">153,505,668</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_926" name="us-gaap:SharesIssued" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">18,783,912</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_927" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">18,784</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_928" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,694,348</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_929" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">164,184,842</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_930" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,528,290</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of restricted share awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_931" name="ltbr:IssuanceOfRestrictedShareAwardsShares" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,467,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_932" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,468</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_933" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,468</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_934" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_935" name="ltbr:IssuanceOfRestrictedShareAwardsAmount" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net share settlement for withholding taxes paid upon vesting of restricted stock awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_936" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0" sign="-">29,440</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_937" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">29</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1388" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">234,592</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_939" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_940" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">234,621</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs and commissions of $4,207,920</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_941" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">9,854,669</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_942" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">9,854</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_943" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">120,441,594</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_944" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_945" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">120,451,448</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultants and directors for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_946" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">112,045</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_947" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">112</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_948" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">344,888</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_949" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_950" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">345,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued through the exercise of options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_951" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">195,855</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_952" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">196</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_953" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,243,598</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_954" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_955" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,243,794</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_956" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_957" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,562,448</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_958" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_959" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,562,448</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the nine months ended September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_960" name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_961" name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_962" name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">12,390,691</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_963" name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">12,390,691</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance &#8211; September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_964" name="us-gaap:SharesIssued" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">30,384,981</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_965" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,385</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_966" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">330,050,816</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_967" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">176,575,533</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_968" name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">153,505,668</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIGHTBRIDGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - June 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_969" name="us-gaap:SharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,591,477</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_970" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,591</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_971" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">184,599,393</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_972" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">157,591,994</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_973" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">27,021,990</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs and commissions of $123,694</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_974" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">608,690</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_975" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">609</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_976" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,511,132</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_977" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_978" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,511,741</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultants for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_979" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">76,164</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_980" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">76</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_981" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">194,924</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_982" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_983" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">195,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_984" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_985" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">388,477</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_986" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_987" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">388,477</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_988" name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_989" name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_990" name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,656,161</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_991" name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,656,161</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance &#8211; September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_992" name="us-gaap:SharesIssued" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">15,276,331</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_993" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,276</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_994" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">186,693,926</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_995" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">160,248,155</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_996" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">26,461,047</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_997" name="us-gaap:SharesIssued" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,698,274</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_998" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">13,698</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_999" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">181,295,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1000" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">152,397,776</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1001" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,911,047</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs and commissions of $421,657</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1002" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,436,821</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1003" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,437</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1004" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,714,928</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1005" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1006" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,716,365</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultants and directors for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1007" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">145,370</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1008" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">145</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1009" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">464,855</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1010" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1011" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">465,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net share settlement for withholding taxes paid upon vesting of restricted stock awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1012" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0" sign="-">4,134</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1013" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1014" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">10,579</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1015" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1016" name="ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">10,583</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1017" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1018" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,229,597</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1019" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1020" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,229,597</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the nine months ended September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1021" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1022" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1023" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">7,850,379</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1024" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">7,850,379</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance &#8211; September 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1025" name="us-gaap:SharesIssued" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">15,276,331</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1026" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,276</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1027" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">186,693,926</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1028" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">160,248,155</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1029" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">26,461,047</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="cf">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1031" name="ltbr:ProfitAndLoss" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,390,691</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1032" name="ltbr:ProfitAndLoss" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">7,850,379</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adjustments to reconcile net loss to net cash used in operating activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1034" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,746,642</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1035" name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,280,403</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in operating assets and liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1037" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">808,317</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1038" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">37,665</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1039" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">201,657</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1040" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">10,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1041" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,135,512</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1042" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">928,240</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1043" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">8,115,197</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1044" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">5,669,276</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Trademarks</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1046" name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,117</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1047" name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1048" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">6,117</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1049" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Gross proceeds from the issuances of common stock under the ATM program</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1051" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">124,659,368</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1052" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,138,022</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payment of offering costs and commissions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1053" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,207,920</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1054" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">421,657</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net proceeds from the exercise of stock options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1055" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,243,794</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1056" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payments for taxes related to net share settlement of equity awards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1057" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">234,621</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1058" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,583</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1059" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">121,460,621</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1060" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,705,782</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Increase (Decrease) in Cash and Cash Equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1061" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">113,339,307</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1062" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,963,494</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, Beginning of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1063" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">39,990,827</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1064" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,598,445</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, End of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1065" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">153,330,134</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1066" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">26,634,951</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Supplemental Disclosure of Cash Flow Information</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid during the period:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1068" name="us-gaap:InterestPaidNet" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1069" name="us-gaap:InterestPaidNet" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1070" name="us-gaap:IncomeTaxesPaidNet" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1071" name="us-gaap:IncomeTaxesPaidNet" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-Cash Financing Activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payment of accrued liabilities with common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1073" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1074" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Common stock issued for prepaid consulting services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1075" name="ltbr:CommonStockIssuedForConsultingServices" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">300,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1076" name="ltbr:CommonStockIssuedForConsultingServices" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">180,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="fs">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_191" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true" continuedAt="cont_66e90a"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#8217;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine-month periods have been made. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_202" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="From2025-01-01to2025-09-30" escape="true" continuedAt="cont_bb1904"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_66e90a" continuedAt="cont_349a57"><ix:continuation id="cont_bb1904"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At period-end, the Company evaluates U.S. Treasury instruments held to determine whether they are:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;On-the-run&#8221;: Securities from the most recent auction with active market pricing, classified as Level 1</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;Off-the-run&#8221;: Securities from prior auctions with observable inputs but less liquidity, classified as Level 2</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although U.S. Treasury instruments held as cash equivalents have short maturities (typically 30&#8211;90 days) and cost closely approximates fair value, fair value disclosures are presented in accordance with ASC 820 and ASC 320 guidance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of U.S. Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $<ix:nonFraction id="fid_1180" name="ltbr:InvestmentsInDebtSecuritiesPurchased" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">116.7</ix:nonFraction> million of U.S. Treasury instruments during the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at September 30, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_213" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true" continuedAt="cont_d93c3c"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1167" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">56.6</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1169" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">96.7</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1170" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1173" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.6</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1174" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1175" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_d93c3c"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1168" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">40.0</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1171" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1172" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1176" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1177" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1178" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:continuation></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_203" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s cash and cash equivalents are sufficient to pay for the Company&#8217;s research and development (R&amp;D) and operations for the next year. However, given the long-term nature of the R&amp;D activities that are expected to be necessary prior to commercialization, the Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future R&amp;D activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant R&amp;D activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three and nine months ended September 30, 2025, R&amp;D expenses associated with activities conducted at INL accounted for <ix:nonFraction id="fid_1383" name="ltbr:ResearchAndDevelopmentPercentage" contextRef="From2025-07-01to2025-09-30_ltbr_INLMember" unitRef="Pure" decimals="2" scale="-2">41</ix:nonFraction>% and <ix:nonFraction id="fid_1179" name="ltbr:ResearchAndDevelopmentPercentage" contextRef="From2025-01-01to2025-09-30_ltbr_INLMember" unitRef="Pure" decimals="2" scale="-2">45</ix:nonFraction>% of the Company&#8217;s total R&amp;D expenditure, respectively. For the three and nine months ended September 30, 2024, R&amp;D expenses associated with activities conducted at the INL accounted for <ix:nonFraction id="fid_1382" name="ltbr:ResearchAndDevelopmentPercentage" contextRef="From2024-07-01to2024-09-30_ltbr_INLMember" unitRef="Pure" decimals="2" scale="-2">32</ix:nonFraction>% and <ix:nonFraction id="fid_1381" name="ltbr:ResearchAndDevelopmentPercentage" contextRef="From2024-01-01to2024-09-30_ltbr_INLMember" unitRef="Pure" decimals="2" scale="-2">36</ix:nonFraction>% of the Company&#8217;s total R&amp;D expenditure, respectively. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_349a57"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Accounting Pronouncements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_212" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Update (ASU) No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the Financial Accounting Standards Board (FASB) in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (ASU 2024-03), which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_192" name="us-gaap:EarningsPerShareTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three and nine months ended September 30, 2025 and 2024, as they would have been anti-dilutive due to the Company&#8217;s losses at September 30, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_214" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three and Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1077" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">263,630</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1080" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">547,362</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards (RSAs) outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1078" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,113,036</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1081" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">545,992</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1079" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,376,666</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1082" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,093,354</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_193" name="ltbr:PrepaidProjectCostsDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-Term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with INL, in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advance payments for future project work totaling $<ix:nonFraction id="fid_1089" name="ltbr:ProjectAbandonmentCosts" contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million to Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $<ix:nonFraction id="fid_1091" name="ltbr:ProjectAbandonmentCosts" contextRef="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_TopMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million to a total of $<ix:nonFraction id="fid_1090" name="ltbr:ProjectAbandonmentCosts" contextRef="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_BottomMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, and December 31, 2024, the Company&#8217;s prepaid project costs were $<ix:nonFraction id="fid_1092" name="ltbr:ProjectAbandonmentCosts" contextRef="AsOf2025-09-30_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction> million and $<ix:nonFraction id="fid_1093" name="ltbr:ProjectAbandonmentCosts" contextRef="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_194" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consist of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_215" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1181" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1186" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1182" name="ltbr:AccruedResearchAndDevelopmentExpensesCurrent" contextRef="AsOf2025-09-30" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1187" name="ltbr:AccruedResearchAndDevelopmentExpensesCurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1183" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.9</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1188" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2024-12-31" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued professional and consulting fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1185" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1189" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1184" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1190" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_195" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Operating Leases</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a <ix:nonNumeric id="fid_1195" name="ltbr:LesseeOperatingLeaseTerm" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:durmonth">12</ix:nonNumeric>-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $<ix:nonFraction id="fid_1193" name="us-gaap:OperatingLeasePayments" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,000</ix:nonFraction>. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $<ix:nonFraction id="fid_1194" name="ltbr:LeasePaymentUnderNonCancellableOperatingLeases" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction>. Total rent expense for the three and nine months ended September 30, 2025 was approximately $<ix:nonFraction id="fid_1196" name="us-gaap:OperatingLeaseExpense" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">25,000</ix:nonFraction> and $<ix:nonFraction id="fid_1192" name="us-gaap:OperatingLeaseExpense" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">75,000</ix:nonFraction>, respectively. Total rent expense for the three and nine months ended September 30, 2024 was approximately $<ix:nonFraction id="fid_1191" name="us-gaap:OperatingLeaseExpense" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction> and $<ix:nonFraction id="fid_1197" name="us-gaap:OperatingLeaseExpense" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">73,000</ix:nonFraction>, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_196" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true" continuedAt="cont_002049"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>INL Project</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Throughout the duration of these umbrella agreements, all R&amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three and nine months ended September 30, 2025, the Company recorded $<ix:nonFraction id="fid_1102" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-07-01to2025-09-30_ltbr_INLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.8</ix:nonFraction> million and $<ix:nonFraction id="fid_1103" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-01-01to2025-09-30_ltbr_INLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.4</ix:nonFraction> million in R&amp;D expenses associated with INL, respectively. For the three and nine months ended September 30, 2024, the Company recorded $<ix:nonFraction id="fid_1094" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-01to2024-09-30_ltbr_INLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million and $<ix:nonFraction id="fid_1095" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30_ltbr_INLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.1</ix:nonFraction> million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>INL Modifications to the CRADA and SPPA Project Task Statements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;D activities were increased by approximately $<ix:nonFraction id="fid_1104" name="ltbr:ResearchAndDevelopmentArrangementExpense" contextRef="From2025-01-01to2025-01-16_ltbr_BattelleEnergyAllianceLLCMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.6</ix:nonFraction> million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $<ix:nonFraction id="fid_1105" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-01-01to2025-01-16_ltbr_CRADAMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">4.2</ix:nonFraction> million. This modification also required that a $<ix:nonFraction id="fid_1096" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2025-01-16" format="ixt:numdotdecimal" unitRef="USD" decimals="0">600,000</ix:nonFraction> advance payment be made, which was due and paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $<ix:nonFraction id="fid_1106" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-03-01to2025-03-18_ltbr_BattelleEnergyAllianceLLCMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.6</ix:nonFraction> million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $<ix:nonFraction id="fid_1107" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-03-01to2025-03-18_ltbr_StrategicPartnershipProjectAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.6</ix:nonFraction> million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 6, 2025, the Company and BEA entered into Modification No. 3 to the SPPA extending the duration of this umbrella agreement from 7 years to 12 years. On November 5, 2025, the Company and BEA entered into Modification No. 1 to the CRADA with INL, extending the period of performance from September 27, 2029 to September 27, 2032.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_002049"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $<ix:nonFraction id="fid_1113" name="ltbr:InvestmentCompanyExcessCostReimbursable" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">6.8</ix:nonFraction> million on a cost reimbursable basis over the performance periods. The balance of the PTS obligations as of September 30, 2025 was $<ix:nonFraction id="fid_1114" name="ltbr:InvestmentCompanyExcessProjectTaskObligations" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.0</ix:nonFraction> million. These PTS obligations are generally cancellable with 30 days&#8217; notice and therefore, are not considered firm commitments. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Romania Feasibility Study</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $<ix:nonFraction id="fid_1097" name="ltbr:ResearchAndDevelopmentExpensePayable" contextRef="AsOf2023-10-16_ltbr_CANDUMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction> million was payable in three installments, including an advance payment of $<ix:nonFraction id="fid_1098" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-10-16_ltbr_CANDUMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million and an interim milestone payment and final payment totaling approximately $<ix:nonFraction id="fid_1099" name="ltbr:PaymentsToResearchAndDevelopmentCost" contextRef="From2024-12-01to2024-12-31_ltbr_CANDUMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $<ix:nonFraction id="fid_1111" name="ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" contextRef="From2025-01-01to2025-09-30_ltbr_CANDUMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-6" scale="6">0</ix:nonFraction> million in R&amp;D expenses associated with RATEN ICN feasibility study. For the three and nine months ended September 30, 2024, the Company recorded zero and $<ix:nonFraction id="fid_1112" name="ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30_ltbr_CANDUMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million, respectively in R&amp;D expenses associated with RATEN ICN feasibility study.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study that was completed in 2024 and has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $<ix:nonFraction id="fid_1108" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2025-01-01to2025-09-30_ltbr_FEEdMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-6" scale="6">0</ix:nonFraction> million in R&amp;D expenses associated with this FEED study. For the three and nine months ended September 30, 2024, the Company recorded $<ix:nonFraction id="fid_1100" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-01to2024-09-30_ltbr_FEEdMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million and $<ix:nonFraction id="fid_1101" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30_ltbr_FEEdMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction> million, respectively in R&amp;D expenses associated with this FEED study.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_197" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true" continuedAt="cont_e4a524"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Increase in Authorized Common Shares </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 8, 2025, the Company held the 2025 annual meeting of stockholders (the Annual Meeting) at which the Company&#8217;s stockholders approved increasing the authorized common shares from <ix:nonFraction id="fid_1289" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_BottomMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">25,000,000</ix:nonFraction> shares to <ix:nonFraction id="fid_1290" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_TopMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">100,000,000</ix:nonFraction> shares. The Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada on May 8, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock and Common Stock Equivalents Outstanding</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At September 30, 2025, <ix:nonNumeric id="fid_1291" name="ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" contextRef="From2025-01-01to2025-09-30">the Company had a total of 30,648,611 shares of common stock and common stock equivalents outstanding, comprised of 30,384,981 common shares outstanding (including outstanding RSAs totaling 2,113,036 shares) and stock options to purchase 263,630 shares of common stock (of which 250,547 stock options were vested).</ix:nonNumeric>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, <ix:nonNumeric id="fid_1292" name="ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" contextRef="From2024-01-01to2024-12-31">the Company had a total of 19,248,852 shares of common stock and common stock equivalents outstanding, comprised of 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares) and stock options to purchase 464,940 shares of common stock (of which 445,275 stock options were vested).</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Issuance and Redemption of Series X Preferred Stock&#160;</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee, an independent member of the Board (the Purchaser), pursuant to which the Company agreed to issue and sell one <ix:nonNumeric id="fid_1287" name="ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember">(1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the Series X Preferred Stock), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was received by the Company. The Company redeemed the Series X Preferred Stock for $100 cash after the Annual Meeting and filed the Certificate of Withdrawal with the Secretary of State of Nevada on May 8, 2025</ix:nonNumeric>. The Series X Preferred Stock did not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock was entitled to <ix:nonFraction id="fid_1288" name="ltbr:PreferredStockVotingRightsShares" contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">25,000,000</ix:nonFraction> votes on such proposal, voting together with the holders of the Company&#8217;s common stock. The votes by the holder of Series X Preferred Stock were cast at the Annual Meeting automatically in the same &#8220;mirrored&#8221; proportion as the aggregate votes cast &#8220;for&#8221; and &#8220;against&#8221; the proposal by the holders of the common stock who voted on such proposal (excluding abstentions, broker non-votes and shares of common stock that were not voted &#8220;for&#8221; or &#8220;against&#8221; such proposal). The voting power attributable to the Series X Preferred Stock was disregarded for purposes of determining whether a quorum is present at the Annual Meeting.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_e4a524" continuedAt="cont_867cb4"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Common Stock Equity Offerings</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>At-the-Market (ATM) Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024, pursuant to which the Company issued and sold shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. <ix:nonNumeric id="fid_1278" name="us-gaap:IntercompanyAgreementsDescription" contextRef="From2019-05-01to2019-05-28">Under this amended agreement, the Company paid Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement</ix:nonNumeric>. This agreement was terminated on May 30, 2025. Sales of the Company&#8217;s common stock through Stifel, were made by any method that is deemed to be an at-the-market (ATM) equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric id="fid_1273" name="ltbr:MarketOfferingsDisclosureDescription" contextRef="From2024-03-01to2024-03-29">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the First Prospectus Supplement), pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $12.6 million from time to time through an ATM offering. The Company exhausted all capacity under the First Prospectus Supplement</ix:nonNumeric>. On November 22, 2024, the Company filed a prospectus supplement (the Second Prospectus Supplement) pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $<ix:nonFraction id="fid_1284" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" contextRef="From2024-11-01to2024-11-22" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">45.0</ix:nonFraction> million from time to time through an ATM offering. The Company exhausted all capacity under the Second Prospectus Supplement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company filed a shelf registration statement on Form S-3 (File No. 333-287563) on May 23, 2025 registering the sale of up to $<ix:nonFraction id="fid_1293" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2025-05-01to2025-05-23" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">150.0</ix:nonFraction> million of the Company&#8217;s securities that was declared effective on June 4, 2025. On June 5, 2025, the Company filed a prospectus supplement (the June Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $<ix:nonFraction id="fid_1294" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2025-06-01to2025-06-05" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">75.0</ix:nonFraction> million of&#160;its shares of common stock through the Company&#8217;s new sales agent, Jefferies LLC (Jefferies).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 5, 2025, the Company entered into an Open Market Sale Agreement<sup style="vertical-align:super">SM</sup> (the Sales Agreement) with Jefferies pursuant to which the Company may issue and sell from time to time shares of its common stock through Jefferies as the Company&#8217;s sales agent. Sales of the Company&#8217;s common stock through Jefferies, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-287563) , and the base prospectus filed as part of such registration statement and a prospectus supplement. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 26, 2025, the Company filed a prospectus supplement (the September Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $<ix:nonFraction id="fid_1348" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2025-09-01to2025-09-26" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">75.0</ix:nonFraction> million of&#160;its shares of common stock through Jefferies. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold <ix:nonFraction id="fid_1295" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">9,854,669</ix:nonFraction> shares under the ATM for the nine months ended September 30, 2025 resulting in net proceeds of $<ix:nonFraction id="fid_1296" name="ltbr:ProceedsFromStockIssuances" contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">120.4</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1297" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">4.2</ix:nonFraction> million). The Company sold <ix:nonFraction id="fid_1298" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,436,821</ix:nonFraction> shares under the ATM for the nine months ended September 30, 2024 resulting in net proceeds of $<ix:nonFraction id="fid_1299" name="ltbr:ProceedsFromStockIssuances" contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.7</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1300" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended September 30, 2025, the Company sold <ix:nonFraction id="fid_1301" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,612,403</ix:nonFraction> shares under the ATM, resulting in net proceeds of $<ix:nonFraction id="fid_1302" name="ltbr:ProceedsFromStockIssuances" contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">57.3</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1303" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.0</ix:nonFraction> million). For the three months ended September 30, 2024, the Company sold <ix:nonFraction id="fid_1304" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">608,690</ix:nonFraction> shares under the ATM, resulting in net proceeds of $<ix:nonFraction id="fid_1305" name="ltbr:ProceedsFromStockIssuances" contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.5</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1306" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Stock-Based Compensation</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2020 Omnibus Incentive Plan </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (as subsequently amended, the 2020 Plan). On September 3, 2020, the stockholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. </p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_867cb4" continuedAt="cont_340b95"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, <ix:nonNumeric id="fid_1277" name="ltbr:DescriptionOfEquityIncentivePlan" contextRef="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares</ix:nonNumeric>. This increase was approved by the stockholders at the annual meeting of stockholders on April 19, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, <ix:nonNumeric id="fid_1285" name="ltbr:DescriptionOfEquityIncentivePlan" contextRef="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember">the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000</ix:nonNumeric>. This increase was approved by the stockholders at the annual meeting of stockholders on May 8, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of shares of common stock available for future issuance under the 2020 Plan was <ix:nonFraction id="fid_1307" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2025-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,008,361</ix:nonFraction> shares and <ix:nonFraction id="fid_1349" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,471,026</ix:nonFraction> shares at September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock options issued to the Company&#8217;s employees, directors and consultants are summarized as follows for the nine months ended September 30, 2025:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_216" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1198" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">464,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1203" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">16.24</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1208" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:durmonth">3.07</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1216" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2024-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">184,818</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1199" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,418</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1204" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">10.33</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1200" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">195,855</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1205" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">6.35</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1222" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,834,474</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1201" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="Shares" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1206" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1202" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">17,873</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1207" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">75.60</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1221" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">263,630</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1220" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">19.28</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1209" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:durmonth">2.35</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1219" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,045,064</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1212" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">263,630</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1214" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">19.28</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1210" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:durmonth">2.35</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1217" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,045,064</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1213" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">250,547</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1215" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">20.04</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1211" name="ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:durmonth">2.01</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1218" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,829,575</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company issued 12,418 and 71,330 stock options, respectively, to two consultants. The <ix:nonFraction id="fid_1308" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,418</ix:nonFraction> stock options and the <ix:nonFraction id="fid_1311" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">71,330</ix:nonFraction> stock options were assigned a fair value of $<ix:nonFraction id="fid_1309" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">6.85</ix:nonFraction> per share and $<ix:nonFraction id="fid_1312" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.19</ix:nonFraction> per share, respectively (total fair value of $<ix:nonFraction id="fid_1310" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">85,000</ix:nonFraction> for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the nine months ended September 30, 2025 and 2024, was $<ix:nonFraction id="fid_1313" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">10.33</ix:nonFraction> and $<ix:nonFraction id="fid_1314" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.91</ix:nonFraction>, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The intrinsic value is calculated as the difference between the fair value of the Company&#8217;s common stock and the exercise price of the stock options. The fair value of the Company&#8217;s common stock was $<ix:nonFraction id="fid_1315" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">21.21</ix:nonFraction> per share and $<ix:nonFraction id="fid_1350" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-09-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.80</ix:nonFraction> per share at September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#8217;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#8217;s expected holding term or option life determined by using the simplified method. The Company recognizes forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the nine months ended September 30, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_217" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1225" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2025-01-01to2025-09-30_ltbr_TopMember" unitRef="Pure" decimals="4" scale="-2">109.24</ix:nonFraction>% - <ix:nonFraction id="fid_1243" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember" unitRef="Pure" decimals="4" scale="-2">117.44</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1226" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-01-01to2024-09-30_ltbr_TopMember" unitRef="Pure" decimals="4" scale="-2">75.36</ix:nonFraction>% - <ix:nonFraction id="fid_1244" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember" unitRef="Pure" decimals="4" scale="-2">92.89</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1233" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2025-01-01to2025-09-30_ltbr_TopMember" unitRef="Pure" decimals="3" scale="-2">3.80</ix:nonFraction>% - <ix:nonFraction id="fid_1241" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember" unitRef="Pure" decimals="4" scale="-2">3.95</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1234" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-01to2024-09-30_ltbr_TopMember" unitRef="Pure" decimals="4" scale="-2">3.76</ix:nonFraction>% - <ix:nonFraction id="fid_1242" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember" unitRef="Pure" decimals="4" scale="-2">4.54</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1384" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2025-01-01to2025-09-30" format="ixt:zerodash" unitRef="Pure" decimals="0" scale="-2">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1385" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-01to2024-09-30" format="ixt:zerodash" unitRef="Pure" decimals="0" scale="-2">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1235" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember" format="ixt-sec:duryear">2</ix:nonNumeric>-<ix:nonNumeric id="fid_1227" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2025-01-01to2025-09-30_ltbr_TopMember" format="ixt-sec:duryear">6</ix:nonNumeric> years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1236" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember" format="ixt-sec:duryear">2</ix:nonNumeric>-<ix:nonNumeric id="fid_1228" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2024-01-01to2024-09-30_ltbr_TopMember" format="ixt-sec:duryear">6</ix:nonNumeric> years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$<ix:nonFraction id="fid_1229" name="us-gaap:SharePrice" contextRef="AsOf2025-09-30_ltbr_TopMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">9.42</ix:nonFraction> - $<ix:nonFraction id="fid_1237" name="us-gaap:SharePrice" contextRef="AsOf2025-09-30_ltbr_BottomMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">15.13</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$<ix:nonFraction id="fid_1230" name="us-gaap:SharePrice" contextRef="AsOf2024-09-30_ltbr_TopMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.49</ix:nonFraction> - $<ix:nonFraction id="fid_1238" name="us-gaap:SharePrice" contextRef="AsOf2024-09-30_ltbr_BottomMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.62</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_340b95" continuedAt="cont_b9ea44"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, total unrecognized compensation cost related to option awards was $<ix:nonFraction id="fid_1316" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">47,813</ix:nonFraction>, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_1317" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="From2025-01-01to2025-09-30" format="ixt-sec:duryear">2.26</ix:nonNumeric> years. As of September 30, 2024, total unrecognized compensation cost related to option awards was $<ix:nonFraction id="fid_1351" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">47,853</ix:nonFraction>, which was expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_1318" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="From2024-01-01to2024-09-30" format="ixt-sec:duryear">2.26</ix:nonNumeric> years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Exercise of Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three and nine months ended September 30, 2025, the Company received approximately $<ix:nonFraction id="fid_1352" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2025-07-01to2025-09-30_ltbr_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.6</ix:nonFraction> million and $<ix:nonFraction id="fid_1319" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2025-01-01to2025-09-30_ltbr_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.2</ix:nonFraction> million in net proceeds from the exercise of <ix:nonFraction id="fid_1353" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_ltbr_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">96,141</ix:nonFraction> and <ix:nonFraction id="fid_1320" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">195,855</ix:nonFraction> stock options by employees and consultants, respectively. There were no options exercised for the nine months ended September 30, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company issued <ix:nonFraction id="fid_1321" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">6,302</ix:nonFraction> shares (with an average stock price of $<ix:nonFraction id="fid_1323" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">7.14</ix:nonFraction> per share) and <ix:nonFraction id="fid_1324" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,201</ix:nonFraction> shares (with an average stock price of $<ix:nonFraction id="fid_1354" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">3.41</ix:nonFraction>&#160;per share) of common stock, respectively, to its investor relations firm for services provided during the period, which were recorded as stock-based compensation expense. These shares vested immediately upon issuance. The expense recorded for these share issuances was $<ix:nonFraction id="fid_1322" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,000</ix:nonFraction> for each quarter. The shares were valued based on the closing market price of the Company&#8217;s common stock on the date of grant. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 19, 2024, the Company issued an equity grant valued at $<ix:nonFraction id="fid_1283" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">180,000</ix:nonFraction> to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant <ix:nonFraction id="fid_1355" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" contextRef="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">71,713</ix:nonFraction> shares of common stock on the grant date, valued at $<ix:nonFraction id="fid_1279" name="ltbr:CommonStockValuedGrantDatePricePerShare" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.51</ix:nonFraction> per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $<ix:nonFraction id="fid_1280" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">180,000</ix:nonFraction> began to be recognized on a straight-line basis over the requisite service period and fully amortized to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 29, 2025, the Company issued an equity grant valued at $<ix:nonFraction id="fid_1356" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">300,000</ix:nonFraction> to the same consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, which resulted in issuing the consultant 19,828 shares of common stock on the grant date, valued at $<ix:nonFraction id="fid_1358" name="ltbr:CommonStockValuedGrantDatePricePerShare" contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">15.13</ix:nonFraction> per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $<ix:nonFraction id="fid_1357" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">300,000</ix:nonFraction> began to be recognized on a straight-line basis over the requisite service period. Approximately $<ix:nonFraction id="fid_1325" name="us-gaap:OperatingExpenses" contextRef="From2025-01-01to2025-09-30_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">25,000</ix:nonFraction> was recorded to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, the unrecognized compensation cost of approximately $<ix:nonFraction id="fid_1326" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">275,000</ix:nonFraction> was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of <ix:nonNumeric id="fid_1327" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="From2025-01-01to2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember" format="ixt-sec:duryear">0.92</ix:nonNumeric> years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Restricted Stock Awards (RSAs) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">RSAs are awards of common stock that are legally issued and outstanding. RSAs are subject to time-based restrictions on transfer and unvested portions are generally subject to a risk of forfeiture if the award recipient ceases providing services to the Company prior to the lapse of the restrictions or does not meet certain performance conditions. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">RSAs were included in common stock issued and outstanding and were considered contingently issuable in the calculation of weighted-average shares outstanding for purposes of calculating diluted loss per share. The grantees receiving RSAs have all rights as a shareholder with respect to these shares, whether vested or unvested, including, without limitation, rights to vote the shares, receive dividends, etc.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_b9ea44" continuedAt="cont_d7dc1d"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following summarizes the Company&#8217;s restricted stock award activity and the RSAs outstanding: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_218" name="ltbr:ScheduleOfOutstandingRSATableTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1256" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">781,864</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1257" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">5.19</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1258" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,698,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted (including performance-based RSAs of 1,125,000 shares)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,467,940</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1248" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">13.50</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1252" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,821,822</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1246" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">136,768</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1249" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">6.10</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1253" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,346,731</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1247" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:zerodash" unitRef="Shares" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1250" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1254" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1259" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,113,036</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1251" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">10.91</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1255" name="ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">44,817,494</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The aggregate fair value was calculated as the fair value of the Company&#8217;s common stock. The fair value of the Company&#8217;s common stock was $<ix:nonFraction id="fid_1328" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">21.21</ix:nonFraction> per share and $2.80 per share at September 30, 2025 and 2024, respectively. The fair value of the RSAs vested for the&#160;nine months ended September 30, 2025 and 2024 was $<ix:nonFraction id="fid_1329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">1.3</ix:nonFraction> million and $<ix:nonFraction id="fid_1330" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="-6" scale="6">0</ix:nonFraction> million, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, total unrecognized compensation cost related to RSAs was $<ix:nonFraction id="fid_1331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">20.5</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_1332" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt-sec:duryear">2.57</ix:nonNumeric> years. As of September 30, 2024, total unrecognized compensation cost related to RSAs was $<ix:nonFraction id="fid_1359" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-4" scale="6">1.45</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_1360" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt-sec:duryear">1.64</ix:nonNumeric> years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">August 28, 2025 &#8211; Equity Grant of 1,800,000 shares of Restricted Stock Awards Program</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 28, 2025, the Board of Directors approved an aggregate restricted stock award program of <ix:nonFraction id="fid_1362" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">1.8</ix:nonFraction> million shares of common stock. Pursuant to this approval, on August 28, 2025, the Company granted <ix:nonFraction id="fid_1363" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">1.1</ix:nonFraction> million restricted stock awards with an aggregate grant-date fair value of approximately $<ix:nonFraction id="fid_1364" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">17.1</ix:nonFraction> million to its executives, directors, and employees. These awards consisted of <ix:nonFraction id="fid_1365" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">275,000</ix:nonFraction> RSAs and <ix:nonFraction id="fid_1366" name="ltbr:StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">825,000</ix:nonFraction> performance-based restricted stock awards (PSAs). The total value of approximately $17.1 million was based on the Company&#8217;s closing stock price of $<ix:nonFraction id="fid_1367" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">15.54</ix:nonFraction> per share on the grant date. The remaining portion of the Board-approved program has been authorized for future issuance by management, subject to applicable conditions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The first tranche of <ix:nonFraction id="fid_1368" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">275,000</ix:nonFraction> RSAs are subject to service-based vesting, with the shares vesting in three equal installments on the first, second and third anniversaries of the date of grant. These shares were included in the total outstanding common shares as of September 30, 2025 due to their voting rights. These awards were valued at approximately $<ix:nonFraction id="fid_1369" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited" contextRef="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">4.3</ix:nonFraction> million. The Company recognized $0.1 million in stock-based compensation expense for the three and nine months ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The second tranche of <ix:nonFraction id="fid_1371" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2025-08-01to2025-08-28_ltbr_SecondTrancheMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">825,000</ix:nonFraction> PSAs are subject to both service-based and performance-based vesting conditions. The PSAs have three specific R&amp;D fuel milestones relating to key technical development and commercialization objectives of the Company&#8217;s R&amp;D fuel program and one specific financial milestone vesting in unequal tranches based on which milestone is certified. Each milestone applies only to a separate portion of the 825,00 PSAs. The respective portions of each tranche will vest upon the later of achievement and Board or Compensation Committee certification of operational milestones and is subject to (i) the grantee&#8217;s continued service through the certification date and (ii) the grantee having completed at least twelve months of continuous service with Lightbridge as of the operational milestone achievement date. The performance period for achieving these operational milestones extend from the grant date to December 31, 2028. Any unvested shares will be forfeited if the corresponding operational and financial milestones are not achieved by December 31, 2028 or if the grantee&#8217;s service with the Company ends prior to vesting. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of the grant date and September 30, 2025, management concluded that the performance conditions associated with these performance milestones were probable of achievement. In accordance with ASC 718, the Company applied the graded vesting attribution amortization to the related RSAs from the grant date through each milestone&#8217;s estimated achievement date. These awards were valued at approximately $<ix:nonFraction id="fid_1372" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">12.8</ix:nonFraction> million. The Company recognized $<ix:nonFraction id="fid_1386" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million in stock-based compensation expense for the three and nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">April 3, 2025 &#8211; Equity Grant of 300,000 Performance-Based Restricted Stock Awards</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 3, 2025, the Company granted <ix:nonFraction id="fid_1333" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">300,000</ix:nonFraction> PSAs to certain executives, key employees, and consultants under the 2020 Equity Incentive Plan. These awards were valued at approximately $<ix:nonFraction id="fid_1335" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.1</ix:nonFraction> million in total, based on the Company&#8217;s closing stock price of $<ix:nonFraction id="fid_1334" name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">6.99</ix:nonFraction> per share on April 7, 2025, which was the final date of communication with the certain executives, key employees and consultants regarding the awards.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_d7dc1d"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These PSAs are subject to both service-based and performance-based vesting conditions. The performance condition requires the successful insertion of the Company&#8217;s coupon fuel samples into the Advanced Test Reactor at INL by December 31, 2026 and is subject to the grantees continuous service over a three-year period from the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of the grant date and September 30, 2025, management concluded that the performance condition was probable of achievement. The Company recognized $<ix:nonFraction id="fid_1374" name="us-gaap:ShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million in stock-based compensation expense for the three months ended September 30, 2025, and $<ix:nonFraction id="fid_1375" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.6</ix:nonFraction> million for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Director Compensation - Equity-Settled Awards</span></em><span style="text-decoration:underline">&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 12, 2025, the Board of Directors granted <ix:nonFraction id="fid_1286" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">57,940</ix:nonFraction> RSAs to its five independent directors for their service during the year ending December 31, 2025. The awards were valued at $<ix:nonFraction id="fid_1346" name="ltbr:RSAFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million, based on the Company&#8217;s closing stock price of $<ix:nonFraction id="fid_1337" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">8.63</ix:nonFraction> per share on the grant date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These RSAs vest in four equal quarterly installments, beginning March 31, 2025. As of September 30, 2025, a total of <ix:nonFraction id="fid_1376" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">43,455</ix:nonFraction> shares had vested. The Company recognized $<ix:nonFraction id="fid_1377" name="us-gaap:ShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-4" scale="5">0.1</ix:nonFraction> million in stock-based compensation expense for the three months ended September 30, 2025, and $<ix:nonFraction id="fid_1378" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 4, 2024, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_1274" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">500,000</ix:nonFraction> in total to its five independent directors for the service period and year ended December 31, 2024, which resulted in granting a total of <ix:nonFraction id="fid_1276" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" contextRef="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">85,915</ix:nonFraction> shares of common stock, valued on the grant date at $<ix:nonFraction id="fid_1275" name="ltbr:CommonSharesEquityGrantPricePerShares" contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">5.82</ix:nonFraction> per share on December 4, 2024, which shares vested on January 2, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_1272" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">240,000</ix:nonFraction> in total to its six independent directors for the service period and year ended December 31, 2023, which resulted in granting a total of <ix:nonFraction id="fid_1281" name="ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">60,456</ix:nonFraction> shares of common stock, valued on the grant date at $<ix:nonFraction id="fid_1282" name="ltbr:CommonSharesEquityGrantPricePerShares" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">3.97</ix:nonFraction> per share on November 20, 2023, which shares vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the shares granted was determined based on the closing market price of the Company&#8217;s common stock on the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In March 2025, the Company accelerated the vesting of <ix:nonFraction id="fid_1339" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">70,710</ix:nonFraction> RSAs in connection with a separation agreement with a former employee, resulting in approximately $<ix:nonFraction id="fid_1338" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million of stock-based compensation expense, including $<ix:nonFraction id="fid_1340" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction> million of incremental fair value. This expense was recognized in the first quarter of 2025 and is included in the results for the nine-month period ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">RSAs Summary - 2025 and 2024</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025 and December 31, 2024, the Company had <ix:nonFraction id="fid_1343" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,113,036</ix:nonFraction> shares (including performance-based RSAs of 1,125,000 shares) and <ix:nonFraction id="fid_1341" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">781,864</ix:nonFraction> shares (including performance-based RSAs of 0 share) of RSAs, respectively, included in its total issued and outstanding common stock </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company recorded $<ix:nonFraction id="fid_1345" name="us-gaap:ShareBasedCompensation" contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.2</ix:nonFraction> million and $<ix:nonFraction id="fid_1347" name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.1</ix:nonFraction> million, respectively, in stock-based compensation expense related to RSAs granted. For the three months ended September 30, 2025 and 2024, the Company recorded $<ix:nonFraction id="fid_1379" name="us-gaap:ShareBasedCompensation" contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.6</ix:nonFraction> million and $<ix:nonFraction id="fid_1380" name="us-gaap:ShareBasedCompensation" contextRef="From2024-07-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million, respectively, in stock-based compensation expense related to RSAs granted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options and RSAs included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2025 and 2024 are as follows (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_219" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1266" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-07-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1267" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1260" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-01-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.9</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1261" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1268" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-07-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1269" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1262" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-01-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.7</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1263" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.0</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1270" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-07-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1271" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1264" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-01-01to2025-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1265" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_198" name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Segment Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (CODM), or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#8217;s CODM is the chief executive officer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. R&amp;D expenses, general and administrative (G&amp;A) expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while R&amp;D milestones scorecard results and scorecard G&amp;A budgeted results are used in establishing management&#8217;s incentive compensation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the significant expense categories regularly provided to the CODM for the three and nine months ended September 30, 2025 and 2024 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_220" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1136" name="us-gaap:Revenues" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1137" name="us-gaap:Revenues" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1116" name="us-gaap:Revenues" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1117" name="us-gaap:Revenues" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1138" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1139" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.7</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1118" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">9.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1119" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">5.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">INL project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1140" name="ltbr:InlProject" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.8</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1141" name="ltbr:InlProject" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1120" name="ltbr:InlProject" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1121" name="ltbr:InlProject" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1142" name="ltbr:RomaniaFeasibilityStudy" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1143" name="ltbr:RomaniaFeasibilityStudy" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1122" name="ltbr:RomaniaFeasibilityStudy" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1123" name="ltbr:RomaniaFeasibilityStudy" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1144" name="ltbr:CentrusEnergyFeedStudy" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1145" name="ltbr:CentrusEnergyFeedStudy" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1124" name="ltbr:CentrusEnergyFeedStudy" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1125" name="ltbr:CentrusEnergyFeedStudy" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Allocated employee compensation and stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1146" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.9</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1147" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1126" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1127" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1148" name="us-gaap:OtherExpenses" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1149" name="us-gaap:OtherExpenses" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1128" name="us-gaap:OtherExpenses" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1129" name="us-gaap:OtherExpenses" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1150" name="ltbr:ResearchAndDevelopmentExpenseNet" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.0</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1151" name="ltbr:ResearchAndDevelopmentExpenseNet" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1130" name="ltbr:ResearchAndDevelopmentExpenseNet" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">5.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1131" name="ltbr:ResearchAndDevelopmentExpenseNet" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1152" name="ltbr:OtherSegmentsItem" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">1.1</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1153" name="ltbr:OtherSegmentsItem" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">0.3</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1132" name="ltbr:OtherSegmentsItem" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">2.1</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1133" name="ltbr:OtherSegmentsItem" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">1.0</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1154" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">4.1</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1155" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">2.7</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1134" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">12.4</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1135" name="ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated" contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" sign="-" scale="6">7.8</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 13.5pt; text-align:justify;">(1) Other segment items include interest income.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_199" name="us-gaap:SubsequentEventsTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>ATM Sales</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the Company&#8217;s ATM from October 1, 2025 to November 6, 2025 amounted to <ix:nonFraction id="fid_1156" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,891,613</ix:nonFraction> shares, which resulted in total net proceeds of approximately $<ix:nonFraction id="fid_1157" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">42.0</ix:nonFraction> million, stock issuance costs were approximately $<ix:nonFraction id="fid_1158" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.3</ix:nonFraction> million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Safety Analysis Code Development Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 27, 2025, Lightbridge Corporation entered into an Agreement for Safety Analysis Codes and Services for Lightbridge Fuel Designs with Numerical Advisory Solutions, LLC (&#8220;NAS&#8221;). Under the agreement, NAS will develop customized safety-analysis computer codes, models, and documentation to evaluate Lightbridge&#8217;s proprietary metallic uranium-zirconium fuel designs for water-cooled reactors. The firm-fixed-price contract totals approximately $<ix:nonFraction id="fid_1159" name="ltbr:ResearchAndDevelopmentArrangementObligationAmount" contextRef="From2025-10-01to2025-10-27_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.8</ix:nonFraction> million and will commence in the fourth quarter of 2025. All deliverables, including related intellectual-property rights, will be owned by Lightbridge.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="fo">FORWARD-LOOKING STATEMENTS </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. We use words such as &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;continue,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;future,&#8221; &#8220;anticipate,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;optimistic,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; or similar expressions, which are intended to identify forward-looking statements. Such statements include, among others:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">those concerning market and business segment growth, demand, and acceptance of our nuclear fuel technology and other steps toward the commercialization of Lightbridge Fuel&#8482;;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any projections of sales, earnings, revenue, margins, or other financial items;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements of the plans, strategies, and objectives of management for future operations and the timing and outcome of the development of our nuclear fuel technology;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements regarding future economic conditions or performance;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements about future financings and liquidity;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company&#8217;s anticipated financial resources and position; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all assumptions, expectations, predictions, intentions, or beliefs about future events and other statements that are not historical facts.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The forward-looking statements are not historical facts, and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates, and projections are expressed in good faith and we believe there is a reasonable basis for them. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions that if they were to ever materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties, among others, include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to commercialize our nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating our technology and the degree of market adoption of the Company&#8217;s product and service offerings;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our dependence on strategic partners;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any adverse changes to our agreements or relationship with the U.S. government and its national laboratories;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to fund our future operations, including general corporate overhead and outside research and development (R&amp;D) expenses, and continue as a going concern;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the future market and demand for our fuel for nuclear reactors and our ability to attract customers;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to manage the business effectively in a rapidly evolving market;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to employ and retain qualified employees and consultants that have experience in the nuclear industry;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">competition and competitive factors in the markets in which we compete, including from accident tolerant fuels;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">access to and availability of nuclear test reactors and the risks associated with unexpected changes in our nuclear fuel development timeline;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">access to and availability of adequate resources and manufacturing capabilities at national laboratories that affect our nuclear fuel development timeline and project costs;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the increased costs associated with metallization of our nuclear fuel;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">uncertainties related to conducting business in foreign countries;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">public perception of nuclear energy generally;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">changes in laws, rules, and regulations governing our business;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">changes in the political environment;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">development and utilization of, and challenges to, our intellectual property domestically and abroad;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the trading price of our securities is likely to be volatile, and purchasers of our securities could incur substantial losses; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the other risks and uncertainties identified in Item 1A. Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report for the period ended June 30, 2025.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Most of these factors are beyond our ability to predict or control and you should not put undue reliance on any forward-looking statement. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements. Forward-looking statements speak only as of the date on which they are made. The Company assumes no obligation and does not intend to update these forward-looking statements for any reason after the date of the filing of this report, to conform these statements to actual results or to changes in our expectations, except as required by law.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i2">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, or MD&amp;A, is intended to help the reader understand Lightbridge Corporation, our operations, and our present business environment. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our unaudited condensed consolidated financial statements and the accompanying notes thereto contained in Part I, Item 1 of this report, as well as those included in our Annual Report on Form 10-K for the year ended December 31, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This MD&amp;A consists of the following sections:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Overview of Our Business and Recent Developments of Lightbridge Fuel&#8482; - a general overview of our business and updates;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Critical Accounting Estimates;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operations Review - an analysis of our condensed consolidated results of operations for the periods presented in our condensed consolidated financial statements; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Liquidity, Capital Resources, and Financial Position - an analysis of our cash flows and an overview of our financial position.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed in more detail under &#8220;Forward-Looking Statements&#8221; preceding this MD&amp;A, the following discussion contains forward-looking statements that are based on our management&#8217;s current expectations, estimates, and projections, which are subject to a number of risks and uncertainties. Our actual results may differ materially from those discussed in these forward-looking statements because of the risks and uncertainties inherent in future event<em>s, </em>including those set forth under &#8220;Forward-Looking Statements&#8221; and Part II. Item 1A. Risk Factors included herein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>OVERVIEW OF OUR BUSINESS AND DEVELOPMENT OF LIGHTBRIDGE FUEL<sup style="vertical-align:super">TM</sup></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in this Quarterly Report on Form 10-Q, the terms &#8220;Lightbridge,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refer to Lightbridge Corporation together with its wholly-owned subsidiaries Lightbridge International Holding LLC and Thorium Power Inc. on a consolidated basis. Lightbridge&#8217;s principal executive offices are located at 11710 Plaza America Drive, Suite 2000, Reston, Virginia, 20190, USA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Our Business and Current Industry Trends</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At Lightbridge, we are developing next generation nuclear fuel for water-cooled reactors that could significantly improve the economics and safety of existing and new nuclear power plants, large and small, and enhance proliferation resistance of spent nuclear fuel while supplying clean energy to the electric grid or to &#8220;behind the meter&#8221; customers for electric power, including data centers. We believe that the world&#8217;s energy needs and climate goals can only be met if nuclear power&#8217;s share of the energy-generating mix grows substantially in the coming decades. We believe Lightbridge can benefit from a growing nuclear power industry, and that our nuclear fuel can help enable that growth to happen. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We believe our metallic fuel will offer significant economic and safety benefits over traditional nuclear fuel, primarily because of the superior heat transfer properties and the resulting lower operating temperature of our all-metal fuel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The increased projected power need for data centers is driving large tech companies to invest in nuclear power, which in turn is driving utilities to seek ways to increase power output of existing nuclear plants and to explore deploying new plants. Data centers will need massive, constant power that nuclear power can provide. Advances in reactor technology, combined with growing corporate and governmental support for clean energy, can position nuclear power as a cornerstone of future energy strategies for data-intensive industries, which may be willing to pay a premium for reliable, clean, and sustainable baseload electricity. We believe that by integrating nuclear power, the data center sector can achieve operational efficiency, energy security, and sustainability. We believe uses of our fuel could include providing additional power via power uprates of existing reactors. Oil and gas producing companies are investing in low-emission energy technologies to reduce fossil fuel emissions from oil and gas production. Advances in nuclear reactor and fuel technology can position nuclear power as a key energy source for this purpose. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging nuclear technologies include small modular reactors (SMRs), which are now in the development and licensing phases. We expect that Lightbridge Fuel&#8482; can provide water-cooled SMRs with the same benefits our technology brings to large reactors, with such benefits being even more meaningful to the economic case for deployment of SMRs, including potential load following capability when included on a virtually zero-carbon electric grid with renewable energy sources. We expect Lightbridge Fuel&#8482; to enable power uprates in SMRs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have built a significant portfolio of patents, and we anticipate testing our nuclear fuel through third-party vendors and others, including the United States Department of Energy&#8217;s (DOE) national laboratories. Currently, we are performing the majority of our R&amp;D activities within and in collaboration with the DOE&#8217;s national laboratories. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of Artificial Intelligence Tools</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We continue to explore and adopt innovative technologies to enhance our business operations and research capabilities. In this regard, the Company has begun utilizing certain nuclear industry-focused artificial intelligence tools that leverage machine learning and advanced analytics to support information gathering, data analysis, and research workflows related to nuclear fuel development and industry trends.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company uses tools to supplement internal analysis and decision-making. While the tool is designed to improve efficiency and support our R&amp;D and market research efforts, it does not replace the professional judgment of our management, engineers, or other technical personnel. The Company does not rely exclusively on AI-generated content or recommendations for any material regulatory submissions, safety decisions, or financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Developments of Lightbridge Fuel&#8482;</em></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Loading of Capsules Containing Lightbridge Fuel Material Samples for Irradiation Testing</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 9, 2025 we announced the successful completion of the loading of capsules containing Lightbridge Fuel material samples comprised of enriched uranium&#8209;zirconium alloy, recently manufactured at INL, into an experiment assembly. The experiment assembly was inserted into the ATR for irradiation testing in October 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Memorandum of Understanding with Oklo, Inc.</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In January 2025, we signed a memorandum of understanding (MOU) with Oklo, Inc. Oklo is developing advanced micro-reactors to provide clean, reliable, and affordable energy at scale. The scope of the MOU includes the following areas: (1) to conduct a preliminary evaluation of feasibility of co-locating a Lightbridge Commercial-scale Fuel Fabrication Facility at Oklo&#8217;s proposed commercial fuel fabrication facility; (2) to explore opportunities for collaboration on reprocessing and recycling of spent uranium zirconium fuel; and (3) to explore any other areas of collaboration that may be of mutual interest. We believe there may be some potential synergies in co-locating our commercial scale fuel fabrication facility at Oklo&#8217;s proposed site. We also believe recycling and reprocessing spent uranium-zirconium fuel may represent another area of potential synergies. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Idaho National Laboratory Agreements </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2022, Lightbridge entered into agreements with Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for Idaho National Laboratory (INL), to support the development of Lightbridge Fuel&#8482;. The framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), each with BEA, with an initial duration of seven years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that the initial phase of work under the two agreements that has been released will culminate in the insertion of extruded unclad fuel material samples using enriched uranium supplied by the DOE for irradiation testing in the ATR at INL. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data will support fuel performance modeling and regulatory licensing efforts for commercial deployment of Lightbridge Fuel&#8482;. We use a rolling wave planning approach for project management purposes on the released scopes of work. It is an iterative planning technique in which the work to be accomplished in the near term is planned in detail, while work further in the future is planned at a higher level. As such, periodic revisions to the scope and/or cost estimates are anticipated. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 26, 2024 and October 24, 2024, the Company and BEA entered into Modifications No. 2 and No. 3 respectively, to Project Task Statement (PTS) No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modifications No. 2 and No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million and $0.3 million, respectively, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to approximately $2.0 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $2.6 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025, the Company and BEA entered into Modification No. 3 to PTS No. 1 under the CRADA, dated September 27, 2022, as amended in May 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased from $2.6 million by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $4.2 million. This modification also required that a $0.6 million advance payment be made, which was paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 6, 2025, the Company and BEA entered into Modification No. 3 to the SPPA extending the duration of this umbrella agreement from 7 years to 12 years. On November 5, 2025, the Company and BEA entered into Modification No. 1 to the CRADA with INL, extending the period of performance from September 27, 2029 to September 27, 2032.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for all modifications, cash payments from Lightbridge to Battelle under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods. The balance of the obligations as of September 30, 2025 was $2.0 million. These obligations are generally cancellable with 30 days&#8217; notice and, therefore, are not considered firm commitments. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company anticipates entering into additional Project Task Statements and/or modifications to the existing PTS under the SPPA and/or CRADA with INL to expand the scope of work, including performing additional extrusions, creating a detailed plan for post-irradiation examination, reviewing and contributing to Lightbridge&#8217;s Fuel Qualification Plan, and other potential activities. The successful execution of this project is subject to increase in project scope and risks, including potential delays, cost overruns, regulatory challenges, and changes in funding availability. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that subsequent phases of work under the two umbrella agreements that have not yet been released may include post-irradiation examination of the irradiated fuel material coupons, loop irradiation testing in the ATR, and post-irradiation examination of one or more uranium-zirconium fuel rodlets, transient experiments in the Transient Reactor Test Facility at INL, Fuel Qualification Plan support, safety analysis modeling development and support, as well as fuel thermo-mechanical modeling development and support.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Safety Analysis Code Development Agreement</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 27, 2025, we entered into an Agreement for Safety Analysis Codes and Services for Lightbridge Fuel Designs with Numerical Advisory Solutions, LLC (&#8220;NAS&#8221;), a provider of nuclear engineering analysis software. Under the agreement, NAS will perform code-development, benchmarking, and modeling services to support the creation of Lightbridge&#8217;s proprietary fuel-safety analysis methods and the adaptation of industry-standard computer codes for the Lightbridge Fuel&#8482; helical-cruciform metallic U-Zr design.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The work scope includes hold-point reviews and deliverable acceptance by Lightbridge with an estimated completion window between October 2026 through January 2027. The total contract value is approximately $0.8 million, with milestone-based payments. The resulting software and analysis models will be owned by Lightbridge and are expected to strengthen Lightbridge&#8217;s internal capability to perform reactor safety analyses in support of future regulatory submissions and commercial fuel demonstrations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Romania Feasibility Study of Lightbridge Fuel&#8482; for use in CANDU reactors</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, we engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in Canada Deuterium Uranium (CANDU) reactors. This assessment covers key areas including mechanical design, neutronics analysis, and thermal and thermal-hydraulic evaluations. The findings from this engineering study will play an important role in guiding future economic evaluations and navigating potential regulatory licensing-related issues for potential use of Lightbridge Fuel&#8482; in CANDU reactors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The results of this Feasibility Study indicated that Lightbridge Fuel&#8482; can double the discharged burnup in a CANDU reactor at U-235 enrichment levels of less than 3% compared to conventional uranium dioxide fuel. Based on these favorable initial results, we plan to continue further evaluation of Lightbridge Fuel&#8482; in CANDU reactors and are currently in the process of finalizing the scope of work for the next phase of activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2025, we entered into an agreement with RATEN ICN (the 2025 RATEN ICN Agreement) to design and conduct irradiation test(s) for several Lightbridge fuel rodlets, with the objective of irradiating the rodlets to one or more target discharge burnups and subjecting the irradiated rodlets to Post Irradiation Examination. In accordance with the terms of the 2025 RATEN ICN Agreement, the work will occur in two phases: (1) In Phase 1, ICN RATEN will conduct scoping studies to develop preliminary experiment designs, evaluate infrastructure and equipment needs, and obtain cost and schedule estimates for potential new driver fuel; (2) In Phase 2, ICN RATEN will implement refurbishments, procure equipment and driver fuel as needed, finalize experiment design, fabricate and operate the test assembly, and complete post-irradiation examination. Lightbridge will be responsible for supplying experimental fuel rodlets for use in the irradiation tests. The Phase 1 work began in August 2025 at a cost of $35,000. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Nuclear Energy University Program Awards </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Texas A&amp;M University (TAMU), NuScale Power, and Structural Integrity Associates are working on a 3-year study of our nuclear fuel, led by TAMU. The TAMU study is expected to be completed in 2026. In mid-2023, TAMU was awarded $1.0 million by the DOE&#8217;s Nuclear Energy University Program (NEUP) R&amp;D Awards to conduct this study. The project entails a characterization of the performance of the Lightbridge Fuel&#8482; Helical Cruciform advanced fuel design, which will generate sets of experimental data on friction factor, flow, and heat transfer behavior under NuScale&#8217;s SMR simulated normal and off-normal conditions. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We previously announced the ongoing NEUP project with the Massachusetts Institute of Technology (MIT). The study led by MIT and funded by DOE relates to evaluation of accident tolerant fuels in various SMRs. The project aims to simulate the fuel and safety performance of Lightbridge Fuel&#8482; for the NuScale SMR and provide scoping analysis to improve the safety and economics of water-cooled SMRs. In October 2024, MIT presented a technical paper with preliminary safety evaluation results at the TopFuel 2024 Conference in Grenoble, France. According to MIT, the results have shown promising safety and performance benefits for Lightbridge Fuel&#8482;. Compared to conventional fuel, Lightbridge Fuel&#8482; demonstrated improved thermal-hydraulic margins, lower operating temperatures, and greater potential for power uprates, which contributes to enhancing reactor economics.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not have any performance obligations with the collaboration teams working on the above-mentioned projects and will not receive any revenue or record any economic benefits from these awards.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Future Steps Toward Our Fuel Development and Timeline For The Commercialization of Our Nuclear Fuel Assemblies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate fuel development milestones for Lightbridge Fuel&#8482; over the next 2-3 years will consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>INL:</strong> Produce samples, coupons, and rodlets necessary for testing to be performed under our INL agreements. We will continue to execute the SPPA/CRADA work at INL leading to casting and extrusion of fuel material samples using enriched uranium and their subsequent insertion for irradiation testing in the ATR.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Modeling:</strong> Continue development and/or validation (benchmarking) of Lightbridge-specific methods and modifications to existing modeling codes to accurately predict Lightbridge Fuel&#8482; performance over the full domain of operating conditions for which Lightbridge Fuel&#8482; will be licensed.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fuel Qualification Plan:</strong> Develop a Fuel Qualification Plan that describes our approach to characterizing and validating the performance our fuel rods, assemblies, and assembly components in relevant operation scenarios, and validation of the modeling tools that accurately describe the performance of Lightbridge Fuel&#8482; in the relevant conditions.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NRC Engagement Plan</strong>: Prepare and submit the Nuclear Regulatory Commission (NRC) Engagement Plan that outlines how and when Lightbridge will engage the NRC regarding submission of relevant information and supporting documentation for license applications.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fabrication:</strong> Continue manufacturing efforts relating to establishing a manufacturing process for the co-extrusion of cladded rodlets for loop irradiation testing and other fuel testing. In addition, we plan to complete site selection and begin deployment of a Lightbridge Expandable Fuel Fabrication Facility with capacity to produce fuel samples, fuel coupons, fuel rodlets, and full-length fuel rods for lead test rods and lead test assemblies for demonstration of our fuel in commercial reactors.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Thermal-Hydraulic Analysis and Experiments:</strong> Perform thermal-hydraulic modeling of Lightbridge Fuel&#8482; to prepare for a series of thermal-hydraulic experiments to confirm pressure drop, critical heat flux performance, and other thermal-hydraulic parameters of Lightbridge Fuel&#8482; under various operating conditions in different types of reactors.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The long-term milestones towards development and commercialization of nuclear fuel assemblies include, among other things, irradiating nuclear material samples and prototype fuel rods with enriched uranium in test reactors, conducting post-irradiation examination of irradiated material samples and/or prototype fuel rods, performing thermal-hydraulic experiments, performing seismic and other out-of-reactor experiments, performing advanced computer modeling and simulations to support fuel qualification, designing a lead test assembly (LTA), entering into a lead test rod/assembly agreement(s) with a host reactor(s), demonstrating the production process of lead test rods and/or lead test assemblies at a pilot-scale fuel fabrication facility and demonstrating the operation of lead test rods and/or lead test assemblies in commercial reactors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The above future steps describe our current proposed approach to deploying Lightbridge Fuel&#8482; in CANDU and/or U.S. pressurized water reactors (PWRs).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There are inherent uncertainties in the cost and outcomes of the many steps needed for successful deployment of our fuel in commercial nuclear reactors, which makes it difficult to accurately predict the timing of the commercialization of our nuclear fuel technology. However, based on our best estimate and assuming adequate R&amp;D funding levels, we expect to begin demonstration of lead test rods and/or possibly LTAs with our metallic fuel in commercial reactors in the 2030s and begin receiving purchase orders for initial fuel reload batches from utilities 15-20 years from now, with deployment of our nuclear fuel in the first reload batch in a commercial reactor taking place approximately two years thereafter. We are exploring ways of shortening this timeframe that may include securing access to expanded irradiation test loop capacity in existing or new research reactor facilities. Lightbridge aims to engage early with relevant nuclear regulators to inform our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">While we continue to target LTAs with our metallic fuel in commercial reactors in the 2030s, there are several potential developments that, if successful, could accelerate our anticipated timelines. These developments include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expedited nuclear fuel testing through advanced modeling and simulation, as well as potential use of accelerated irradiation techniques, such as the use of high-enriched uranium in so called Fission Accelerated Steady-state Test type experiments;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Early engagement with a strategic partner to establish fabrication infrastructure or a pilot-scale fuel fabrication facility to complete development of the manufacturing process for our fuel rods;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Streamlined regulatory pathways enabled by pre-submission consultations with the NRC, in part supported by recent legislation such as the ADVANCE Act and longstanding federal initiatives;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Supportive federal policies originating from recent Executive Orders, which laid groundwork for continued federal prioritization of next-generation nuclear technology and a mandate given to the NRC to shorten regulatory review and approval timelines to 12 months for existing reactors and 18 months for new reactor applications. These initiatives, along with current regulatory and legislative efforts, reinforce a policy environment that may be favorable to an accelerated commercialization pathway for Lightbridge Fuel; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Some companies developing advanced reactors have deployed pilot-scale facilities that include buildings with security and infrastructure features similar to what Lightbridge would require. Their success may assist Lightbridge in having more certainty regarding the cost and timing of deploying such a facility. </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">CRITICAL ACCOUNTING ESTIMATES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make a variety of estimates and assumptions that affect (i) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and (ii) the reported amounts of revenues and expenses during the reporting periods covered by the financial statements. For a discussion of the accounting judgments and estimates that we have identified as critical in the preparation of our financial statements, please see &#8220;Critical Accounting Estimates&#8221; under Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 3, 2025. There have been no significant changes in our critical accounting policies and estimates during the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management expects to make judgments and estimates about the effect of matters that are inherently uncertain. As the number of variables and assumptions affecting the future resolution of the uncertainties increase, these judgments become even more subjective and complex. Although we believe that our estimates and assumptions are reasonable, actual results may differ significantly from these estimates. Changes in estimates and assumptions based upon actual results may have a material impact on our results of operations and/or financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">OPERATIONS REVIEW</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial information is included in Part I, Item 1 of this Quarterly Report on Form 10-Q. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Condensed Consolidated Results of Operations - Three Months Ended September 30, 2025 and 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our historical operating results and the change in amounts for the periods indicated (rounded to millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change %</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">88</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Research and development </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">54</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5.2 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3.0 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">267</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4.1 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2.7 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">52</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.1 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.7 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">52</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Operating Expenses</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">General and Administrative</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">G&amp;A expenses consist mostly of compensation and related costs for personnel and facilities, stock-based compensation, finance, human resources, information technology, fees for consulting, IT services and other professional services. Professional services are principally comprised of legal, audit, strategic advisory services, and outsourcing services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">G&amp;A expenses increased by $1.5 million for the three months ended September 30, 2025, as compared to the three months ended September 30, 2024. The increase primarily consisted of an increase in professional fees of $0.6 million, an increase in consulting fees of $0.1 million, and an increase in stock-based compensation of $0.8 million. The increase was primarily attributable to an increase in grants of performance-based restricted stock awards ( PSAs).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in G&amp;A expenses was $1.1 million and $0.3 million for three months ended September 30, 2025 and September 30, 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses consist primarily of costs associated with our CRADA and SPPA agreements with INL, employee compensation and related fringe benefits including stock-based compensation and related allocable overhead costs for the R&amp;D of our fuel. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our total R&amp;D expenses, including internal costs and other outside R&amp;D costs, for the three months ended September 30, 2025 and 2024 (rounded to millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Centrus Energy front-end engineering and design (FEED)<em> study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses increased by $0.7 million for the three months ended September 30, 2025, as compared to the three months ended September 30, 2024, due to the increase in R&amp;D activities related to the development of Lightbridge Fuel&#8482;. This increase primarily consisted of an increase in INL project labor costs of $0.4 million, an increase in allocated employee compensation and stock-based compensation expenses of $0.4 million and an increase in consulting fees of $0.1 million, partially offset by a decrease in R&amp;D expenses related to the Centrus Energy FEED study of $0.1 million, which was completed in 2024, and a decrease in IT expenses of $0.1 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in research and development expenses was $0.5 million and $0.1 million for the three months ended September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of our R&amp;D expenditures, future costs and schedule estimates are inherently uncertain and can vary significantly as new information and the outcome of these R&amp;D activities become available. Our future long-term business operations are dependent on budgetary constraints due primarily to market conditions and the uncertainty of future liquidity and capital resources available to us to conduct our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Interest Income</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest income increased by $0.8 million for the three months ended September 30, 2025, driven by higher cash balances from our ATM sales. The additional cash generated was deployed in purchasing treasury bills and deposited into bank savings, which collectively yielded greater interest income compared to the same period in 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Condensed Consolidated Results of Operations </strong>&#8211;<strong> Nine Months Ended September 30, 2025 and 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our historical operating results and the change in amounts for the periods indicated (rounded to millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change %</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">61</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Research and development </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">66</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(14.5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8.9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Interest Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">110</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(12.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7.9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">57</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(12.4</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7.9</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">57</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Operating Expenses</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">General and Administrative</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">G&amp;A expenses increased by $3.5 million for the nine months ended September 30, 2025, as compared to the nine months ended September 30, 2024. The increase primarily consisted of an increase in professional fees of $1.3 million, an increase in consulting fees of $0.3 million, an increase in IT services fees of $0.1 million, an increase in employee compensation and employee benefits of $0.1 million, and an increase in stock-based compensation of $1.7 million primarily due to the accelerated vesting of RSAs issued to a former employee of $0.5 million and an increase in grants of PSAs of $1.2 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in G&amp;A expenses was $2.7 million and $1.0 million for nine months ended September 30, 2025 and September 30, 2024, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our total R&amp;D expenses, including internal costs and other outside R&amp;D costs, for the nine months ended September 30, 2025 and 2024 (rounded to millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses increased by $2.1 million for the nine months ended September 30, 2025, as compared to the nine months ended September 30, 2024, due to the increase in R&amp;D activities related to the development of Lightbridge Fuel&#8482;. This increase primarily consisted of an increase in INL project labor costs of $1.3 million, an increase in allocated employee compensation and stock-based compensation expenses of $1.1 million, and an increase in consulting services fees of $0.1 million included in Other R&amp;D expenses, partially offset by a decrease in R&amp;D expenses related to the Romania feasibility study and Centrus Energy FEED study of $0.4 million, both of which studies were completed in 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in research and development expenses was $0.9 million and $0.2 million for the nine months ended September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently anticipate investing approximately $12.0 million in the R&amp;D of our nuclear fuel for the full year 2025. However, this projected spending for 2025 is subject to change and actual expenditures may vary.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of our R&amp;D expenditures, future costs and schedule estimates are inherently uncertain and can vary significantly as new information and the outcome of these R&amp;D activities become available. Our future business operations are dependent on budgetary constraints due primarily to market conditions and the uncertainty of future liquidity and capital resources available to us to conduct our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Interest Income</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interest income increased by $1.1 million for the nine months ended September 30, 2025, driven by higher cash balances from our ATM sales. The additional cash generated was deployed in purchasing treasury bills and deposited into bank savings, which collectively yielded greater interest income compared to the same period in 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Overview</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We assess our liquidity based on our ability to fund the cash requirements of our R&amp;D activities, G&amp;A expenses, contractual obligations, and other operating needs. Based on our current level of operating expenses and our available cash resources, we believe we have sufficient liquidity to fund our operations and meet our anticipated cash requirements for at least the next 12 months.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Short-Term Liquidity and Capital Resources</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, we had cash and cash equivalents of $153.3 million, compared to $40.0 million as of December 31, 2024, an increase of $113.3 million. During the nine months ended September 30, 2025, we raised net proceeds of $120.4 million from the sale of approximately 9.9 million shares of common stock. Our net cash used in operating activities for the nine months ended September 30, 2025, was $8.1 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We believe that our existing cash and cash equivalents of $153.3 million as of September 30, 2025, together with any additional sources such as cash flows from potential financing and ATM proceeds will be sufficient to meet our working capital and capital expenditure requirements for at least the next 12 months from the date of this filing. Given the uncertainties inherent in our R&amp;D programs and the industry, we cannot precisely estimate our total cash requirements over the next 12 months. We expect these expenditures to increase over time as we advance the development and potential commercialization of our Lightbridge Fuel&#8482;. While we do not anticipate any material incoming cash flows from operations in the near term, we expect to continue funding our business primarily through our ATM equity offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Long-Term Liquidity and Capital Requirements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Beyond 12 months, we expect to require additional capital to continue R&amp;D activities over a protracted time period as we advance the development and potential commercialization of our Lightbridge Fuel&#8482;.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The actual amount and timing of future capital requirements will depend on several factors, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The scope, timing, and cost of R&amp;D activities conducted at DOE national laboratories.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The design and execution of future fuel development programs.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The timing and structure of potential strategic partnerships and collaborations.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There is inherent uncertainty in forecasting future expenditures, and actual costs may vary materially from current estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We plan to raise the required long-term capital through a combination of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additional equity issuances.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Potential strategic investments from industry partners.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Government grants and other forms of in-kind or financial support.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Sources of Liquidity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our current primary source of liquidity is cash on hand and potential proceeds from our ATM equity offering. On June 5, 2025, we entered into an Open Market Sale Agreement with Jefferies LLC (Jefferies) to offer and sell up to $75.0 million of our common stock, from time to time, pursuant to our effective shelf registration statement on Form S-3 (File No. 333-287563), filed on May 23, 2025, and declared effective on June 4, 2025. Sales under the ATM will be made pursuant to the base prospectus filed as part of the shelf registration and the prospectus supplement filed on September 26, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although we expect the ATM offering to remain our primary source of working capital in 2025, there are inherent uncertainties associated with our ability to continue raising capital through the ATM program. These uncertainties include potential declines in our stock price, fluctuations in trading volume, adverse market conditions, or regulatory changes that could limit our access to capital under the current ATM arrangement. In addition, the issuance of additional shares through the ATM may result in significant dilution to existing stockholders, and the potential for such dilution could negatively impact the market price of our common stock. There can be no assurance that the ATM financing will remain available to us on acceptable terms, or at all, when needed. See Note 7. Stockholders&#8217; Equity and Stock-Based Compensation of the Notes to our Unaudited Condensed Consolidated Financial Statements included in Part I. Item 1. Financial Statements of this Quarterly Report on Form 10-Q for additional information regarding our prior equity financings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently have no debt or lines of credit and have historically funded our operations through the sale of preferred and common stock. Although management believes additional public or private equity investments may be available in the future, adverse market conditions, unfavorable stock price movements, or reduced trading volumes could substantially impair our ability to raise capital when needed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate continued negative cash flows from operations for the foreseeable future. If we are unable to secure adequate funding through equity sales, strategic partnerships, or government support, we may be required to seek additional financing, which could include the issuance of common stock, preferred stock, or convertible securities. Any such future financings may result in dilution to existing stockholders or could impose additional financial or operational restrictions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to continue the development of our nuclear fuel and achieve key R&amp;D milestones is dependent on securing sufficient funding and forming strategic partnerships in the future. Failure to obtain adequate funding on acceptable terms in the future could significantly delay or prevent the advancement of our nuclear fuel development program.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Cash Flow</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table provides detailed information about our net cash flows for the nine months ended September 30, 2025 and 2024 (rounded in millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8.1 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5.7 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">121.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Increase (Decrease) in Cash and Cash Equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">113.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.0 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Operating Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash used in operating activities increased by $2.4 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. This increase was primarily due to increased spending on R&amp;D and G&amp;A expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Financing Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash provided by financing activities increased by $117.7 million for the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024. This increase was primarily due to an increase in the net proceeds received from the issuance of common stock under our ATM offering of $116.7 million and net proceeds from the exercise of stock options of $1.2 million, partially offset by an increase in net share settlement of equity awards for the payment of withholding taxes of $0.2 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash provided by our ATM offering was $120.4 million (sale of approximately 9.9 million common shares) and $3.7 million (sale of approximately 1.4 million common shares) for the nine months ended September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Inflation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business, revenues, and operating results have not been affected in any material way by inflation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i3">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is not required to provide the information required by this Item as it is a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i4">ITEM 4. CONTROLS AND PROCEDURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Evaluation of Disclosure Controls and Procedures</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act)) that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (a) recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms, and (b) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating such controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Changes in Internal Control Over Financial Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There were no changes in the Company&#8217;s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p2">PART II-OTHER INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii1">ITEM 1. LEGAL PROCEEDINGS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii1a">ITEM 1A. RISK FACTORS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There have been no material changes to our risk factors from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024 and the Form 10-Q for the quarter ended June 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii2">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES OR USE OF PROCEEDS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">None.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii3">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii4">ITEM 4. MINE SAFETY DISCLOSURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">31</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii5">ITEM 5. OTHER INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Trading Arrangements</em> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_802" name="ecd:MtrlTermsOfTrdArrTextBlock" contextRef="From2025-01-01to2025-09-30" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September 30, 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (&#8220;Rule 10b5-1 Plan&#8221;) and was adopted during an open insider trading window and no sales will commence under the plan until completion of the required cooling off period under Rule 10b5-1, were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Title</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Action</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Date Adopted</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Expiration Date</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate # of Securities to be Purchased/Sold</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_463" name="ecd:TrdArrIndName" contextRef="From2025-01-01to2025-09-30">Seth Grae</ix:nonNumeric><sup style="vertical-align:super">(1)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_467" name="ecd:TrdArrIndTitle" contextRef="From2025-01-01to2025-09-30">Chief Executive Officer and Chairman of the Board</ix:nonNumeric></p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1164" name="ecd:TrdArrAdoptionDate" contextRef="From2025-01-01to2025-09-30">9/30/2025</ix:nonNumeric></p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_479" name="ecd:TrdArrExpirationDate" contextRef="From2025-01-01to2025-09-30">12/30/2026</ix:nonNumeric></p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_483" name="ecd:TrdArrSecuritiesAggAvailAmt" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">98,711</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_803" name="ltbr:TrdArrIndNameSecond" contextRef="From2025-01-01to2025-09-30">Andrey Mushakov</ix:nonNumeric><sup style="vertical-align:super">(2)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_1161" name="ltbr:TrdArrIndTitleSecond" contextRef="From2025-01-01to2025-09-30">Executive Vice President of Fuel Operations</ix:nonNumeric></p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_476" name="ltbr:TrdArrAdoptionDateSecond" contextRef="From2025-01-01to2025-09-30">9/30/2025</ix:nonNumeric></p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_480" name="ltbr:TrdArrExpirationDateSecond" contextRef="From2025-01-01to2025-09-30">12/31/2026</ix:nonNumeric></p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_484" name="ltbr:TrdArrSecuritiesAggAvailAmtTwo" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">180,593</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_1160" name="ltbr:TrdArrIndNameThird" contextRef="From2025-01-01to2025-09-30">Mark Tobin</ix:nonNumeric><sup style="vertical-align:super">(3)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_1162" name="ltbr:TrdArrIndTitleThird" contextRef="From2025-01-01to2025-09-30">Director</ix:nonNumeric></p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_475" name="ltbr:TrdArrAdoptionDateThird" contextRef="From2025-01-01to2025-09-30">9/30/2025</ix:nonNumeric></p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1165" name="ltbr:TrdArrExpirationDateThird" contextRef="From2025-01-01to2025-09-30">12/31/2026</ix:nonNumeric></p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1166" name="ltbr:TrdArrSecuritiesAggAvailAmtThird" contextRef="AsOf2025-09-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">15,000</ix:nonFraction></p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1) Seth Grae, the Chief Executive Officer and Chairman of the Board, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Grae&#8217;s plan provides for the sale, subject to certain price limits, of up to 98,711 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 30, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2) Andrey Mushakov, the Executive Vice President of Fuel Operations, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Mushakov&#8217;s plan provides for the sale, subject to certain price limits, of up to 180,593 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3) Mark Tobin, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Tobin&#8217;s plan provides for the sale at market price, of up to 15,000 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended September 30, 2025, no other director or officer of the Company adopted, modified or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as each term is defined in Item&#160;408(a)&#160;of&#160;Regulation S-K.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="ii6">ITEM 6. EXHIBITS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>EXHIBIT INDEX -</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;<strong>Exhibit</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Number</strong></p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Description </strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225006428/ltbr_ex101.htm">10.1&#8224;</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1084554/000147793225006428/ltbr_ex101.htm">Form of Performance-Based Restricted Stock Award Agreement (incorporated by reference to the Exhibit 10.1 to the Form 8-K filed by the Company on August 29, 2025).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex102.htm">10.2*&#9650;</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex102.htm">Modification No. 3 to the Strategic Partnership Project, dated October 6, 2025, by and between the Company and Batelle Energy Alliance, LLC.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">31.1*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Executive Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">31.2*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Financial Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">32*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">Section 1350 Certifications.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interactive data files pursuant to Rule 405 of Regulation S-T.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.INS</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.SCH</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Schema Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.CAL</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.DEF</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.LAB</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Labels Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.PRE</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">104</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">* Filed or furnished herewith</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8224; Indicates a management contract or compensatory plan. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9650; Portions of this exhibit have been omitted in compliance with Item 601 of Regulation S-K.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">32</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="sig">SIGNATURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>LIGHTBRIDGE CORPORATION </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: November 6, 2025</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Seth Grae </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">President, Chief Executive Officer, and Director </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Executive Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name:</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Larry Goldman </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Financial Officer and Principal Accounting Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">33</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ltbr_ex102.htm
<DESCRIPTION>MODIFICATION NO. 3 TO THE STRATEGIC PARTNERSHIP PROJECT
<TEXT>
<html><head><title>ltbr_ex102.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.2</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;Portions of this exhibit have been omitted in compliance with Item 601 of Regulation S-K.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex102img1.jpg">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex102img2.jpg">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex102img3.jpg">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex102img5.jpg">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex102img4.jpg">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ltbr_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex311.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Certification of Principal Executive Officer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I, Seth Grae, certify that: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: November 6, 2025</p></td> <td style="width:3%;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">President, Chief Executive Officer and Director</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">(Principal Executive Officer) </p></td> <td></td></tr></table><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ltbr_ex312.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex312.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;<strong>EXHIBIT 31.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Certification of Principal Financial Officer</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I, Larry Goldman, certify that: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:justify;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: November 6, 2025</p></td> <td style="width:3%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Financial and Principal Accounting Officer)</p></td> <td></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>ltbr_ex32.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex32.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;<strong>EXHIBIT 32</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Section 1350 Certifications</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>STATEMENT FURNISHED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The undersigned, the Chief Executive Officer and Chief Financial Officer of Lightbridge Corporation, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The Quarterly Report on Form 10-Q of Lightbridge Corporation for the quarter ended September 30, 2025, filed on the date hereof with the Securities and Exchange Commission (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lightbridge Corporation.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: November 6, 2025</p></td> <td style="width:5%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td> <td style="width:10%;"></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="margin:0px">President, Chief Executive Officer and Director</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">(Principal Executive Officer)</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman</em></p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Chief Financial Officer</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">(Principal Financial Officer and Principal Accounting Officer)</p></td> <td></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ltbr-20250930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/06/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2025" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:ltbr="http://ltbr.com/20250930" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://ltbr.com/20250930">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://ltbr.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" id="UnauditedCondensedConsolidatedBalanceSheets">
        <link:definition>110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" id="UnauditedCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" id="UnauditedCondensedConsolidatedStatementsOfOperations">
        <link:definition>124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" id="UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity">
        <link:definition>148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/InsiderTradingArragements" id="InsiderTradingArragements">
        <link:definition>995445 - Disclosure - Insider Trading Arragements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements">
        <link:definition>995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShare" id="NetLossPerShare">
        <link:definition>995447 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" id="PrepaidProjectCostsAndOtherLongtermAssets">
        <link:definition>995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
        <link:definition>995449 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995450 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" id="ResearchAndDevelopmentCosts">
        <link:definition>995451 - Disclosure - Research and Development Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" id="StockholdersEquityAndStockbasedCompensation">
        <link:definition>995452 - Disclosure - Stockholders Equity and StockBased Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReporting" id="SegmentReporting">
        <link:definition>995453 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995454 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies">
        <link:definition>995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables">
        <link:definition>995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
        <link:definition>995457 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
        <link:definition>995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" id="StockholdersEquityAndStockbasedCompensationTables">
        <link:definition>995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReportingTables" id="SegmentReportingTables">
        <link:definition>995460 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails">
        <link:definition>995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative">
        <link:definition>995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareDetails" id="NetLossPerShareDetails">
        <link:definition>995463 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" id="PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative">
        <link:definition>995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
        <link:definition>995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
        <link:definition>995466 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" id="ResearchAndDevelopmentCostsDetailsNarrative">
        <link:definition>995467 - Disclosure - Research and Development Costs (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" id="StockholdersEquityAndStockbasedCompensationDetails">
        <link:definition>995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" id="StockholdersEquityAndStockbasedCompensationDetails1">
        <link:definition>995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" id="StockholdersEquityAndStockbasedCompensationDetails2">
        <link:definition>995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" id="StockholdersEquityAndStockbasedCompensationDetails3">
        <link:definition>995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" id="StockholdersEquityAndStockbasedCompensationDetailsNarrative">
        <link:definition>995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SegmentReportingDetails" id="SegmentReportingDetails">
        <link:definition>995473 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
        <link:definition>995474 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20250930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" name="SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" name="SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IssuanceOfRestrictedShareAwardsShares" name="IssuanceOfRestrictedShareAwardsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IssuanceOfRestrictedShareAwardsAmount" name="IssuanceOfRestrictedShareAwardsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProfitAndLoss" name="ProfitAndLoss" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" name="IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CashPaidDuringThePeriodAbstract" name="CashPaidDuringThePeriodAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" name="PaymentOfAccruedLiabilitiesWithCommonStock" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockIssuedForConsultingServices" name="CommonStockIssuedForConsultingServices" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameSecond" name="TrdArrIndNameSecond" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedFlagSecond" name="Rule10b51ArrAdoptedFlagSecond" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleSecond" name="TrdArrIndTitleSecond" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateSecond" name="TrdArrAdoptionDateSecond" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateSecond" name="TrdArrExpirationDateSecond" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrSecuritiesAggAvailAmtTwo" name="TrdArrSecuritiesAggAvailAmtTwo" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndNameThird" name="TrdArrIndNameThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_Rule10b51ArrAdoptedFlagThird" name="Rule10b51ArrAdoptedFlagThird" nillable="true" xbrli:periodType="duration" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrIndTitleThird" name="TrdArrIndTitleThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrAdoptionDateThird" name="TrdArrAdoptionDateThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrExpirationDateThird" name="TrdArrExpirationDateThird" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TrdArrSecuritiesAggAvailAmtThird" name="TrdArrSecuritiesAggAvailAmtThird" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidProjectCostsDisclosureTextBlock" name="PrepaidProjectCostsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ScheduleOfOutstandingRSATableTextBlock" name="ScheduleOfOutstandingRSATableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentPercentage" name="ResearchAndDevelopmentPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InvestmentsInDebtSecuritiesPurchased" name="InvestmentsInDebtSecuritiesPurchased" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProjectAbandonmentCosts" name="ProjectAbandonmentCosts" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" name="AccruedResearchAndDevelopmentExpensesCurrent" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" name="LeasePaymentUnderNonCancellableOperatingLeases" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LesseeOperatingLeaseTerm" name="LesseeOperatingLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InvestmentCompanyExcessCostReimbursable" name="InvestmentCompanyExcessCostReimbursable" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InvestmentCompanyExcessProjectTaskObligations" name="InvestmentCompanyExcessProjectTaskObligations" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentArrangementExpense" name="ResearchAndDevelopmentArrangementExpense" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" name="RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentExpensePayable" name="ResearchAndDevelopmentExpensePayable" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PaymentsToResearchAndDevelopmentCost" name="PaymentsToResearchAndDevelopmentCost" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" name="SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" name="SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" name="StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" name="DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PreferredStockVotingRightsShares" name="PreferredStockVotingRightsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesIssuancesEquityGrant" name="CommonSharesIssuancesEquityGrant" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockShareOutstanding" name="CommonStockShareOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" name="DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RSAFairValue" name="RSAFairValue" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesEquityGrantPricePerShares" name="CommonSharesEquityGrantPricePerShares" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockValuedGrantDatePricePerShare" name="CommonStockValuedGrantDatePricePerShare" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_MarketOfferingsDisclosureDescription" name="MarketOfferingsDisclosureDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_DescriptionOfEquityIncentivePlan" name="DescriptionOfEquityIncentivePlan" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProceedsFromStockIssuances" name="ProceedsFromStockIssuances" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InlProject" name="InlProject" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RomaniaFeasibilityStudy" name="RomaniaFeasibilityStudy" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CentrusEnergyFeedStudy" name="CentrusEnergyFeedStudy" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentExpenseNet" name="ResearchAndDevelopmentExpenseNet" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OtherSegmentsItem" name="OtherSegmentsItem" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" name="OperatingNetIncomeLossFromSegmentsToConsolidated" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentArrangementObligationAmount" name="ResearchAndDevelopmentArrangementObligationAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" name="BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" name="PrepaidExpensesCurrentAndLongTermAssetsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommitmentsAndContingenciesAbstract" name="CommitmentsAndContingenciesAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element name="BottomMember" id="ltbr_BottomMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelOneMember" id="ltbr_TreasuryBillsLevelOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="INLMember" id="ltbr_INLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BattelleEnergyAllianceLLCMember" id="ltbr_BattelleEnergyAllianceLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TopMember" id="ltbr_TopMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CRADAMember" id="ltbr_CRADAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="StrategicPartnershipProjectAgreementMember" id="ltbr_StrategicPartnershipProjectAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CANDUMember" id="ltbr_CANDUMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FEEdMember" id="ltbr_FEEdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="AvailableForSaleSecuritiesMember" id="ltbr_AvailableForSaleSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardsProgramMember" id="ltbr_RestrictedStockAwardsProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OptionsMember" id="ltbr_OptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CommonShareIssuancesMember" id="ltbr_CommonShareIssuancesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="PrepaidExpenseAndOtherCurrentAssetMember" id="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwentyTwentyFiveTransactionsMember" id="ltbr_TwentyTwentyFiveTransactionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardsSummaryMember" id="ltbr_RestrictedStockAwardsSummaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FirstTrancheMember" id="ltbr_FirstTrancheMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="SecondTrancheMember" id="ltbr_SecondTrancheMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardMember" id="ltbr_RestrictedStockAwardMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BoardOfDirectorsMember" id="ltbr_BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CODMMember" id="ltbr_CODMMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelTwoMember" id="ltbr_TreasuryBillsLevelTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelThreeMember" id="ltbr_TreasuryBillsLevelThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwoThousandTwentyEquityIncentivePlanMember" id="ltbr_TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockUnitsRSAMember" id="ltbr_RestrictedStockUnitsRSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="SeriesXPreferredStockMember" id="ltbr_SeriesXPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ltbr-20250930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/06/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl_98b6e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl_98b6e8" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl_2ae621" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl_2ae621" xml:lang="en-US">Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_d71a6b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_d71a6b" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_90dca2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_90dca2" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_1a7b19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl_1a7b19" xml:lang="en-US">Total Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl_5" xml:lang="en-US">[Assets, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl_967f58" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl_967f58" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl_b3acf6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl_b3acf6" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_4f1250" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_4f1250" xml:lang="en-US">Trademarks</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_ad90d2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl_ad90d2" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl_9" xml:lang="en-US">[Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl_1bbc55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl_1bbc55" xml:lang="en-US">Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_99ce5c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_99ce5c" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_cf351e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_cf351e" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl_12" xml:lang="en-US">[Liabilities, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_1c4e53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_1c4e53" xml:lang="en-US">Commitments and contingencies - Note 5</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl_8fed03" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl_8fed03" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl_3d022f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl_3d022f" xml:lang="en-US">Preferred stock, $0.001 par value, 10,000,000 authorized shares, no shares issued and outstanding at September 30, 2025 and December 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_1bf294" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl_1bf294" xml:lang="en-US">Common stock, $0.001 par value, 100,000,000 authorized, 30,384,981 shares and 18,783,912 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl_aa15a8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl_aa15a8" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_a94c56" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_a94c56" xml:lang="en-US">Accumulated deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_9079ff" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl_9079ff" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl_19" xml:lang="en-US">[Equity, Attributable to Parent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_3ec377" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_3ec377" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_20" xml:lang="en-US">[Liabilities and Equity]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_0dee18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_0dee18" xml:lang="en-US">Preferred Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_18217f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_18217f" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_b5f352" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_b5f352" xml:lang="en-US">Preferred Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_0ae1dc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_0ae1dc" xml:lang="en-US">Preferred Stock, Shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_96e6aa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_96e6aa" xml:lang="en-US">Common Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_e2a5aa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_e2a5aa" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_f491d4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl_f491d4" xml:lang="en-US">Common Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_e5d4c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_e5d4c4" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl_677c5d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl_677c5d" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl_b9cfb7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl_b9cfb7" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_c73ead" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_c73ead" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_4486b1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_4486b1" xml:lang="en-US">Research and development</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_dcee71" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl_dcee71" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl_5" xml:lang="en-US">[Operating Expenses]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_8dd4fe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl_8dd4fe" xml:lang="en-US">Operating Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl_6" xml:lang="en-US">[Operating Income (Loss)]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl_450de8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl_450de8" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl_6a2354" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl_6a2354" xml:lang="en-US">Interest income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl_1115d3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl_1115d3" xml:lang="en-US">Total Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl_9" xml:lang="en-US">[Other Nonoperating Income (Expense)]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_5376c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_5376c4" xml:lang="en-US">Net Loss Before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_10" xml:lang="en-US">[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl_141b6e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl_141b6e" xml:lang="en-US">Income taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_1f96df" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_1f96df" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl_12" xml:lang="en-US">[Net Income (Loss) Attributable to Parent]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl_d4c020" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl_d4c020" xml:lang="en-US">Net Loss Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl_c31315" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl_c31315" xml:lang="en-US">Basic and diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl_df680d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl_df680d" xml:lang="en-US">Weighted Average Number of Common Shares Outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_742d43" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_742d43" xml:lang="en-US">Basic and diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_16" xml:lang="en-US">[Weighted Average Number of Shares Outstanding, Diluted]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6fa35d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6fa35d" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl_2b9b4a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl_2b9b4a" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl_054e2a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl_054e2a" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_0e86e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_0e86e1" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl_0daa4a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl_0daa4a" xml:lang="en-US">Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl_767a3e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl_767a3e" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl_4f775e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl_4f775e" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_4abb32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl_4abb32" xml:lang="en-US">Balance, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl_2" xml:lang="en-US">[Shares, Issued]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_32ffe6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl_32ffe6" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_lbl_d975a7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_lbl_d975a7" xml:lang="en-US">Shares issued - registered offerings, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_lbl_24cbc4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_lbl_24cbc4" xml:lang="en-US">Shares issued - registered offerings, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_34e1e5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_34e1e5" xml:lang="en-US">Shares issued to consultants and directors for services, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_6aa13e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_6aa13e" xml:lang="en-US">Shares issued to consultants and directors for services, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:to="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_lbl_fa77bf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_lbl_fa77bf" xml:lang="en-US">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:to="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_lbl_f28d06" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_lbl_f28d06" xml:lang="en-US">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_50a1fa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_50a1fa" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_c4716d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_c4716d" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsShares" xlink:label="ltbr_IssuanceOfRestrictedShareAwardsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IssuanceOfRestrictedShareAwardsShares" xlink:to="ltbr_IssuanceOfRestrictedShareAwardsShares_lbl_4c1cb3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IssuanceOfRestrictedShareAwardsShares_lbl_4c1cb3" xml:lang="en-US">Issuance of restricted share awards, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsAmount" xlink:label="ltbr_IssuanceOfRestrictedShareAwardsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IssuanceOfRestrictedShareAwardsAmount" xlink:to="ltbr_IssuanceOfRestrictedShareAwardsAmount_lbl_ba428f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IssuanceOfRestrictedShareAwardsAmount_lbl_ba428f" xml:lang="en-US">Issuance of restricted share awards, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3df647" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3df647" xml:lang="en-US">Shares issued through the exercise of options, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl_09d1ba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl_09d1ba" xml:lang="en-US">Shares issued through the exercise of options, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_f99ae5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl_f99ae5" xml:lang="en-US">Balance, shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_281317" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl_281317" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl_205f68" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl_205f68" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_bb3da8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_bb3da8" xml:lang="en-US">Operating Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProfitAndLoss" xlink:to="ltbr_ProfitAndLoss_lbl_aadb6e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ltbr_ProfitAndLoss_lbl_aadb6e" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProfitAndLoss" xlink:label="ltbr_ProfitAndLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProfitAndLoss" xlink:to="ltbr_ProfitAndLoss_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProfitAndLoss_lbl_3" xml:lang="en-US">[Net Loss]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_f43d9e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_f43d9e" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_0e39fd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_0e39fd" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl_5" xml:lang="en-US">[Share-Based Payment Arrangement, Noncash Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_0dcb93" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_0dcb93" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_b08ec4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_b08ec4" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_7" xml:lang="en-US">[Increase (Decrease) in Prepaid Expenses, Other]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_c345d9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_c345d9" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_8" xml:lang="en-US">[Prepaid project costs and other long-term assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_e11e68" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_e11e68" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_9" xml:lang="en-US">[Increase (Decrease) in Accounts Payable and Accrued Liabilities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_1a6497" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_1a6497" xml:lang="en-US">Net Cash Used in Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_10" xml:lang="en-US">[Cash Provided by (Used in) Operating Activity, Including Discontinued Operation]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_c785d9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_c785d9" xml:lang="en-US">Investing Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_2a539f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_2a539f" xml:lang="en-US">Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_12" xml:lang="en-US">[Payments to Acquire Intangible Assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_670f5e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_670f5e" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_13" xml:lang="en-US">[Cash Provided by (Used in) Investing Activity, Including Discontinued Operation]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_dc92a2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_dc92a2" xml:lang="en-US">Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_073829" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_073829" xml:lang="en-US">Gross proceeds from the issuances of common stock under the ATM program</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl_dec1c6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl_dec1c6" xml:lang="en-US">Payment of offering costs and commissions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl_16" xml:lang="en-US">[Payment of Financing and Stock Issuance Costs]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_3b85aa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_3b85aa" xml:lang="en-US">Net proceeds from the exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_f8b811" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_f8b811" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl_18" xml:lang="en-US">[Payment, Tax Withholding, Share-Based Payment Arrangement]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_0bf4ea" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_0bf4ea" xml:lang="en-US">Net Cash Provided by Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_19" xml:lang="en-US">[Cash Provided by (Used in) Financing Activity, Including Discontinued Operation]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_b0a6a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_b0a6a9" xml:lang="en-US">Net Increase (Decrease) in Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_20" xml:lang="en-US">[Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_51e845" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_51e845" xml:lang="en-US">Cash and Cash Equivalents, Beginning of Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_310fe9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_310fe9" xml:lang="en-US">Cash and Cash Equivalents, End of Period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="ltbr_CashPaidDuringThePeriodAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CashPaidDuringThePeriodAbstract" xlink:to="ltbr_CashPaidDuringThePeriodAbstract_lbl_2efa57" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CashPaidDuringThePeriodAbstract_lbl_2efa57" xml:lang="en-US">Cash paid during the period:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl_807128" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl_807128" xml:lang="en-US">Interest paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl_a07a86" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl_a07a86" xml:lang="en-US">Income taxes paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_dd8fda" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_dd8fda" xml:lang="en-US">Non-Cash Financing Activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:to="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_ead1d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_ead1d0" xml:lang="en-US">Payment of accrued liabilities with common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockIssuedForConsultingServices" xlink:label="ltbr_CommonStockIssuedForConsultingServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockIssuedForConsultingServices" xlink:to="ltbr_CommonStockIssuedForConsultingServices_lbl_ea7c4e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockIssuedForConsultingServices_lbl_ea7c4e" xml:lang="en-US">Common stock issued for prepaid consulting services</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl_af4900" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl_af4900" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl_6cc9e9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl_6cc9e9" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl_2dbd3f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl_2dbd3f" xml:lang="en-US">Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl_57c2e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl_57c2e8" xml:lang="en-US">Non Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl_79b880" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl_79b880" xml:lang="en-US">Non Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl_29b78b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_lbl_29b78b" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl_2e80f0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl_2e80f0" xml:lang="en-US">Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl_b67e0c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl_b67e0c" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl_2aecd2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrAdoptionDate_lbl_2aecd2" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl_10" xml:lang="en-US">[Trading Arrangement Adoption Date]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl_6aa603" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl_6aa603" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl_beaf50" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl_beaf50" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameSecond" xlink:to="ltbr_TrdArrIndNameSecond_lbl_adf208" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrIndNameSecond_lbl_adf208" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndNameSecond" xlink:label="ltbr_TrdArrIndNameSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameSecond" xlink:to="ltbr_TrdArrIndNameSecond_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameSecond_lbl_13" xml:lang="en-US">[Trading Arrangement, Individual Name]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_Rule10b51ArrAdoptedFlagSecond" xlink:label="ltbr_Rule10b51ArrAdoptedFlagSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedFlagSecond" xlink:to="ltbr_Rule10b51ArrAdoptedFlagSecond_lbl_9c6fb4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedFlagSecond_lbl_9c6fb4" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleSecond" xlink:to="ltbr_TrdArrIndTitleSecond_lbl_c8296d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrIndTitleSecond_lbl_c8296d" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndTitleSecond" xlink:label="ltbr_TrdArrIndTitleSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleSecond" xlink:to="ltbr_TrdArrIndTitleSecond_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleSecond_lbl_15" xml:lang="en-US">[Trading Arrangement, Individual Title]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateSecond" xlink:to="ltbr_TrdArrAdoptionDateSecond_lbl_510517" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrAdoptionDateSecond_lbl_510517" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrAdoptionDateSecond" xlink:label="ltbr_TrdArrAdoptionDateSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateSecond" xlink:to="ltbr_TrdArrAdoptionDateSecond_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateSecond_lbl_16" xml:lang="en-US">[Trading Arrangement Adoption Date 1]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateSecond" xlink:to="ltbr_TrdArrExpirationDateSecond_lbl_3b1c20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrExpirationDateSecond_lbl_3b1c20" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrExpirationDateSecond" xlink:label="ltbr_TrdArrExpirationDateSecond" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateSecond" xlink:to="ltbr_TrdArrExpirationDateSecond_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateSecond_lbl_17" xml:lang="en-US">[Trading Arrangement Expiration Date]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_534891" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_534891" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtTwo_lbl_18" xml:lang="en-US">[Trading Arrangement, Securities Aggregate Available Amount]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameThird" xlink:to="ltbr_TrdArrIndNameThird_lbl_a7bdd3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrIndNameThird_lbl_a7bdd3" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndNameThird" xlink:label="ltbr_TrdArrIndNameThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndNameThird" xlink:to="ltbr_TrdArrIndNameThird_lbl_19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndNameThird_lbl_19" xml:lang="en-US">[Trading Arrangement, Individual Name 1]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedFlagThird" xlink:to="ltbr_Rule10b51ArrAdoptedFlagThird_lbl_2913c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_Rule10b51ArrAdoptedFlagThird_lbl_2913c1" xml:lang="en-US">Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_Rule10b51ArrAdoptedFlagThird" xlink:label="ltbr_Rule10b51ArrAdoptedFlagThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_Rule10b51ArrAdoptedFlagThird" xlink:to="ltbr_Rule10b51ArrAdoptedFlagThird_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_Rule10b51ArrAdoptedFlagThird_lbl_20" xml:lang="en-US">[Rule 10b5-1 Arragement Adopted [Flag]]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleThird" xlink:to="ltbr_TrdArrIndTitleThird_lbl_08608d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrIndTitleThird_lbl_08608d" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndTitleThird" xlink:label="ltbr_TrdArrIndTitleThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrIndTitleThird" xlink:to="ltbr_TrdArrIndTitleThird_lbl_21" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrIndTitleThird_lbl_21" xml:lang="en-US">[Trading Arrangement, Individual Title 1]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrAdoptionDateThird" xlink:label="ltbr_TrdArrAdoptionDateThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrAdoptionDateThird" xlink:to="ltbr_TrdArrAdoptionDateThird_lbl_5c386f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrAdoptionDateThird_lbl_5c386f" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateThird" xlink:to="ltbr_TrdArrExpirationDateThird_lbl_66af7c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrExpirationDateThird_lbl_66af7c" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrExpirationDateThird" xlink:label="ltbr_TrdArrExpirationDateThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrExpirationDateThird" xlink:to="ltbr_TrdArrExpirationDateThird_lbl_23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrExpirationDateThird_lbl_23" xml:lang="en-US">[Trading Arrangement Expiration Date 1]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtThird" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtThird_lbl_33e074" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtThird_lbl_33e074" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrSecuritiesAggAvailAmtThird" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtThird" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TrdArrSecuritiesAggAvailAmtThird" xlink:to="ltbr_TrdArrSecuritiesAggAvailAmtThird_lbl_24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TrdArrSecuritiesAggAvailAmtThird_lbl_24" xml:lang="en-US">[Trading Arrangement, Securities Aggregate Available Amount 1]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:to="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_lbl_8afc64" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_lbl_8afc64" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_800d52" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_800d52" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_f90191" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_f90191" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_2" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:to="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_308826" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_308826" xml:lang="en-US">Prepaid Project Costs and Other Longterm Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:to="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_2c912a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_2c912a" xml:lang="en-US">Prepaid Project Costs and Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_dda93e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_dda93e" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_67da8d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_67da8d" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="ltbr_CommitmentsAndContingenciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommitmentsAndContingenciesAbstract" xlink:to="ltbr_CommitmentsAndContingenciesAbstract_lbl_d88baf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommitmentsAndContingenciesAbstract_lbl_d88baf" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_73258e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_73258e" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl_1d4519" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl_1d4519" xml:lang="en-US">Research and Development Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_96caa9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_96caa9" xml:lang="en-US">Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl_d3dbd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl_d3dbd9" xml:lang="en-US">Stockholders Equity and StockBased Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_1d7bac" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_1d7bac" xml:lang="en-US">Stockholders' Equity and Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl_f18ba4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl_f18ba4" xml:lang="en-US">Segment Reporting</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_12904d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_12904d" xml:lang="en-US">Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl_5863c8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl_5863c8" xml:lang="en-US">Subsequent Events</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_57e042" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_57e042" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_2" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_f625bf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_f625bf" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl_e7216e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl_e7216e" xml:lang="en-US">Certain Risks and Uncertainties</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_494c8f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_494c8f" xml:lang="en-US">Recent Adopted Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl_f9f2f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl_f9f2f5" xml:lang="en-US">Schedule of fair value of financial instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_5304f8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_5304f8" xml:lang="en-US">Summary of outstanding securities excluded from diluted weighted shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_ee9aa6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_ee9aa6" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl_ff4cf9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl_ff4cf9" xml:lang="en-US">Schedule Of stock option</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_329d4d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_329d4d" xml:lang="en-US">Schedule Of Share-based Compensation, Stock Options, Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:label="ltbr_ScheduleOfOutstandingRSATableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:to="ltbr_ScheduleOfOutstandingRSATableTextBlock_lbl_afc00c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ScheduleOfOutstandingRSATableTextBlock_lbl_afc00c" xml:lang="en-US">Schedule Of outstanding RSA</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_4210c5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_4210c5" xml:lang="en-US">Schedule of stock based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl_2502ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl_2502ef" xml:lang="en-US">Schedule of summarizes the expense categories Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_214efd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_214efd" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="ltbr_TreasuryBillsLevelOneMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelOneMember" xlink:to="ltbr_TreasuryBillsLevelOneMember_lbl_eaa63a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelOneMember_lbl_eaa63a" xml:lang="en-US">Level I</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="ltbr_TreasuryBillsLevelTwoMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelTwoMember" xlink:to="ltbr_TreasuryBillsLevelTwoMember_lbl_b77757" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelTwoMember_lbl_b77757" xml:lang="en-US">Level II</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="ltbr_TreasuryBillsLevelThreeMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelThreeMember" xlink:to="ltbr_TreasuryBillsLevelThreeMember_lbl_367935" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelThreeMember_lbl_367935" xml:lang="en-US">Level III</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_0866c5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_0866c5" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_083fe3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_083fe3" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_3" xml:lang="en-US">[Accounts Payable and Accrued Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl_795ea6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl_795ea6" xml:lang="en-US">Product Or Service Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_INLMember" xlink:label="ltbr_INLMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_INLMember" xlink:to="ltbr_INLMember_lbl_f55eaa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_INLMember_lbl_f55eaa" xml:lang="en-US">Idaho National Laboratory (INL)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="ltbr_ResearchAndDevelopmentPercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentPercentage" xlink:to="ltbr_ResearchAndDevelopmentPercentage_lbl_8f8234" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentPercentage_lbl_8f8234" xml:lang="en-US">Percentage of research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="ltbr_InvestmentsInDebtSecuritiesPurchased" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:to="ltbr_InvestmentsInDebtSecuritiesPurchased_lbl_819e3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InvestmentsInDebtSecuritiesPurchased_lbl_819e3a" xml:lang="en-US">US Treasury instruments purchased</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_ff5dfb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_ff5dfb" xml:lang="en-US">Stock options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_791a77" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_791a77" xml:lang="en-US">Restricted stock awards outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_ae1b2e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_ae1b2e" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xml:lang="en-US">[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl_3dde38" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl_3dde38" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl_e09c6c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl_e09c6c" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_300d4c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_300d4c" xml:lang="en-US">Related Party Transactions By Related Party Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_60be70" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_60be70" xml:lang="en-US">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="ltbr_BottomMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BottomMember" xlink:to="ltbr_BottomMember_lbl_ddc8e9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BottomMember_lbl_ddc8e9" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="ltbr_BattelleEnergyAllianceLLCMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BattelleEnergyAllianceLLCMember" xlink:to="ltbr_BattelleEnergyAllianceLLCMember_lbl_4eb97b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BattelleEnergyAllianceLLCMember_lbl_4eb97b" xml:lang="en-US">Battelle Energy Alliance, LLC (BEA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="ltbr_TopMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TopMember" xlink:to="ltbr_TopMember_lbl_a858ee" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TopMember_lbl_a858ee" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProjectAbandonmentCosts" xlink:label="ltbr_ProjectAbandonmentCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProjectAbandonmentCosts" xlink:to="ltbr_ProjectAbandonmentCosts_lbl_a2709e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProjectAbandonmentCosts_lbl_a2709e" xml:lang="en-US">Prepaid project costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_c0de63" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_c0de63" xml:lang="en-US">Trade payables</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:to="ltbr_AccruedResearchAndDevelopmentExpensesCurrent_lbl_0110ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AccruedResearchAndDevelopmentExpensesCurrent_lbl_0110ca" xml:lang="en-US">Accrued research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_416d76" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_416d76" xml:lang="en-US">Accrued bonus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_ce9ec0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_ce9ec0" xml:lang="en-US">Accrued professional and consulting fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_1676be" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_1676be" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl_334ebf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl_334ebf" xml:lang="en-US">Total rent expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl_fee181" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl_fee181" xml:lang="en-US">Operating lease monthly payment</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:to="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_287fb1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_287fb1" xml:lang="en-US">Future minimum lease payments required under the non-cancellable operating leases</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="ltbr_LesseeOperatingLeaseTerm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LesseeOperatingLeaseTerm" xlink:to="ltbr_LesseeOperatingLeaseTerm_lbl_a63525" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LesseeOperatingLeaseTerm_lbl_a63525" xml:lang="en-US">Operating lease term</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl_53d5dc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl_53d5dc" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CRADAMember" xlink:label="ltbr_CRADAMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CRADAMember" xlink:to="ltbr_CRADAMember_lbl_684383" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CRADAMember_lbl_684383" xml:lang="en-US">CRADA</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StrategicPartnershipProjectAgreementMember" xlink:to="ltbr_StrategicPartnershipProjectAgreementMember_lbl_7857bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember_lbl_7857bc" xml:lang="en-US">Strategic Partnership Project Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CANDUMember" xlink:label="ltbr_CANDUMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CANDUMember" xlink:to="ltbr_CANDUMember_lbl_f5f900" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CANDUMember_lbl_f5f900" xml:lang="en-US">Canada Deuterium Uranium (CANDU)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FEEdMember" xlink:label="ltbr_FEEdMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_FEEdMember" xlink:to="ltbr_FEEdMember_lbl_3bb5c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_FEEdMember_lbl_3bb5c1" xml:lang="en-US">Front-end engineering and design (FEED)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessCostReimbursable" xlink:label="ltbr_InvestmentCompanyExcessCostReimbursable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InvestmentCompanyExcessCostReimbursable" xlink:to="ltbr_InvestmentCompanyExcessCostReimbursable_lbl_42ef66" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InvestmentCompanyExcessCostReimbursable_lbl_42ef66" xml:lang="en-US">Cost reimbursable</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessProjectTaskObligations" xlink:label="ltbr_InvestmentCompanyExcessProjectTaskObligations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InvestmentCompanyExcessProjectTaskObligations" xlink:to="ltbr_InvestmentCompanyExcessProjectTaskObligations_lbl_0a3ce5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InvestmentCompanyExcessProjectTaskObligations_lbl_0a3ce5" xml:lang="en-US">Project task obligations</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_05bcc6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_05bcc6" xml:lang="en-US">Advance payment made</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="ltbr_ResearchAndDevelopmentArrangementExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentArrangementExpense" xlink:to="ltbr_ResearchAndDevelopmentArrangementExpense_lbl_a304e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentArrangementExpense_lbl_a304e8" xml:lang="en-US">Increase in estimated cost under R&amp;D agreement</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" xlink:to="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense_lbl_edd58b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense_lbl_edd58b" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" xlink:label="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" xlink:to="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense_lbl_6" xml:lang="en-US">[Research and development expenses]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_062f17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_062f17" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="ltbr_ResearchAndDevelopmentExpensePayable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpensePayable" xlink:to="ltbr_ResearchAndDevelopmentExpensePayable_lbl_8a724a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpensePayable_lbl_8a724a" xml:lang="en-US">Payable amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="ltbr_PaymentsToResearchAndDevelopmentCost" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PaymentsToResearchAndDevelopmentCost" xlink:to="ltbr_PaymentsToResearchAndDevelopmentCost_lbl_2369b1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PaymentsToResearchAndDevelopmentCost_lbl_2369b1" xml:lang="en-US">Final payment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_cb1c14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_cb1c14" xml:lang="en-US">Options outstanding, Beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_7c6ace" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_7c6ace" xml:lang="en-US">Options outstanding, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_661bde" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_661bde" xml:lang="en-US">Options outstanding, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_4" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_d17556" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_d17556" xml:lang="en-US">Options outstanding, Forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_7297c0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_7297c0" xml:lang="en-US">Options outstanding, Expired</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_6" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_e90a81" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_e90a81" xml:lang="en-US">Options outstanding, End of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_94e25f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_94e25f" xml:lang="en-US">Options vested and expected to vest, End of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl_8" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_6f0f93" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_6f0f93" xml:lang="en-US">Options outstanding options, exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_9" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_90f207" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_90f207" xml:lang="en-US">Weighted Average Exercise Price, Beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_10" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_402074" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_402074" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_1f5e7e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_1f5e7e" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl_4c0e67" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl_4c0e67" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl_a3c313" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl_a3c313" xml:lang="en-US">Weighted Average Exercise Price Stock Options, Expired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_ea5715" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_ea5715" xml:lang="en-US">Weighted Average Exercise Price, End of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_c3f8c6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_c3f8c6" xml:lang="en-US">Weighted Average Exercise Price, vested and expected to vest, End of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_lbl_16" xml:lang="en-US">[Weighted Average Exercise Price, vested and expected to vest, End of the period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_3196c5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_3196c5" xml:lang="en-US">Weighted Average Exercise Price Options, exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_17" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl_da692e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_lbl_da692e" xml:lang="en-US">Weighted Average Remaining Contractual Life - Years Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_lbl_f9d983" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_lbl_f9d983" xml:lang="en-US">Weighted Average Remaining Contractual Life - Years Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_lbl_494d8b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_lbl_494d8b" xml:lang="en-US">Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:to="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_lbl_3a257f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_lbl_3a257f" xml:lang="en-US">Weighted Average Remaining Contractual Life - (Years) exercisable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_aa1a6f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_aa1a6f" xml:lang="en-US">Options aggregate intrinsic value, Outstanding beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_lbl_22" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding beginning]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_lbl_88bd44" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_lbl_88bd44" xml:lang="en-US">Options aggregate intrinsic value, Outstanding exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_4245c8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_4245c8" xml:lang="en-US">Options aggregate intrinsic value, Outstanding ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_lbl_24" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding ending]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_lbl_932df4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_lbl_932df4" xml:lang="en-US">Options aggregate intrinsic value, Vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_lbl_db7371" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_lbl_db7371" xml:lang="en-US">Options aggregate intrinsic value, Options exercisable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TopMember" xlink:to="ltbr_TopMember_lbl_2831c7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_TopMember_lbl_2831c7" xml:lang="en-US">Minimum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BottomMember" xlink:to="ltbr_BottomMember_lbl_248a71" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_BottomMember_lbl_248a71" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_2bfee3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_2bfee3" xml:lang="en-US">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_67e166" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_67e166" xml:lang="en-US">Risk free interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_8e2996" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_8e2996" xml:lang="en-US">Dividend yield rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl_9056e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl_9056e1" xml:lang="en-US">Closing price per share - common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_fe2e84" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_fe2e84" xml:lang="en-US">Expected Life</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardMember" xlink:label="ltbr_RestrictedStockAwardMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardMember" xlink:to="ltbr_RestrictedStockAwardMember_lbl_977e44" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardMember_lbl_977e44" xml:lang="en-US">Restricted Stock Award [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d1177d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d1177d" xml:lang="en-US">Shares, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_83de64" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_83de64" xml:lang="en-US">Shares, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_3" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl_827366" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl_827366" xml:lang="en-US">Shares, forfieted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_973de8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_973de8" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_lbl_5" xml:lang="en-US">[Outstanding at end of period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_29a80f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_29a80f" xml:lang="en-US">Outstanding at beginning of period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_lbl_6" xml:lang="en-US">[Outstanding at beginning of period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_666b9c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_666b9c" xml:lang="en-US">Weighted average fair value grant date, beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_7" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_f7709c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_f7709c" xml:lang="en-US">Weighted average fair value grant date, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_640637" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_640637" xml:lang="en-US">Weighted average fair value grant date, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl_e6a173" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl_e6a173" xml:lang="en-US">Weighted average fair value grant date, forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_45846e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_45846e" xml:lang="en-US">Weighted average fair value grant date, ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_lbl_a62144" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_lbl_a62144" xml:lang="en-US">Options aggregate intrinsic value, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_lbl_a8d2e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_lbl_a8d2e7" xml:lang="en-US">Options aggregate intrinsic value, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_lbl_55acd6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_lbl_55acd6" xml:lang="en-US">Options aggregate intrinsic value, forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_1426f4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_1426f4" xml:lang="en-US">Options aggregate intrinsic value, Outstanding ending</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:to="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_lbl_16" xml:lang="en-US">[Options aggregate intrinsic value, Outstanding ending 1]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl_e72d32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl_e72d32" xml:lang="en-US">Income Statement Location Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_f23a85" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_f23a85" xml:lang="en-US">Research And Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl_4402e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl_4402e2" xml:lang="en-US">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_2d1967" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_2d1967" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl_ae85d7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl_ae85d7" xml:lang="en-US">Financial Instrument Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl_50834c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl_50834c" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl_308a72" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl_308a72" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="ltbr_AvailableForSaleSecuritiesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AvailableForSaleSecuritiesMember" xlink:to="ltbr_AvailableForSaleSecuritiesMember_lbl_1dce2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AvailableForSaleSecuritiesMember_lbl_1dce2f" xml:lang="en-US">Available for sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsProgramMember" xlink:label="ltbr_RestrictedStockAwardsProgramMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardsProgramMember" xlink:to="ltbr_RestrictedStockAwardsProgramMember_lbl_d0657d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardsProgramMember_lbl_d0657d" xml:lang="en-US">Restricted Stock Awards Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OptionsMember" xlink:label="ltbr_OptionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OptionsMember" xlink:to="ltbr_OptionsMember_lbl_04f7b1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OptionsMember_lbl_04f7b1" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonShareIssuancesMember" xlink:label="ltbr_CommonShareIssuancesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonShareIssuancesMember" xlink:to="ltbr_CommonShareIssuancesMember_lbl_1438a0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonShareIssuancesMember_lbl_1438a0" xml:lang="en-US">Common Share Issuances [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:to="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_c22f56" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_c22f56" xml:lang="en-US">Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:to="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_1106" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidExpenseAndOtherCurrentAssetMember_lbl_1106" xml:lang="en-US">[Prepaid Expenses And Other Current Assets [Member]]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="ltbr_TwentyTwentyFiveTransactionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwentyTwentyFiveTransactionsMember" xlink:to="ltbr_TwentyTwentyFiveTransactionsMember_lbl_5c5f79" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwentyTwentyFiveTransactionsMember_lbl_5c5f79" xml:lang="en-US">2025 Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="ltbr_RestrictedStockAwardsSummaryMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardsSummaryMember" xlink:to="ltbr_RestrictedStockAwardsSummaryMember_lbl_ea4092" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardsSummaryMember_lbl_ea4092" xml:lang="en-US">RSA Summary 2025 and 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FirstTrancheMember" xlink:label="ltbr_FirstTrancheMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_FirstTrancheMember" xlink:to="ltbr_FirstTrancheMember_lbl_9c4cd6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_FirstTrancheMember_lbl_9c4cd6" xml:lang="en-US">First Tranche [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SecondTrancheMember" xlink:label="ltbr_SecondTrancheMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SecondTrancheMember" xlink:to="ltbr_SecondTrancheMember_lbl_17ebcc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SecondTrancheMember_lbl_17ebcc" xml:lang="en-US">Second Tranche [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardMember" xlink:to="ltbr_RestrictedStockAwardMember_lbl_e3b9b5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_RestrictedStockAwardMember_lbl_e3b9b5" xml:lang="en-US">Restricted Stock Award [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BoardOfDirectorsMember" xlink:label="ltbr_BoardOfDirectorsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BoardOfDirectorsMember" xlink:to="ltbr_BoardOfDirectorsMember_lbl_9febe7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BoardOfDirectorsMember_lbl_9febe7" xml:lang="en-US">Board of Directors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl_b51cd3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl_b51cd3" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_f9fb73" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_f9fb73" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="ltbr_RestrictedStockUnitsRSAMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockUnitsRSAMember" xlink:to="ltbr_RestrictedStockUnitsRSAMember_lbl_790850" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockUnitsRSAMember_lbl_790850" xml:lang="en-US">Restricted Stock Units R S A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="ltbr_SeriesXPreferredStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SeriesXPreferredStockMember" xlink:to="ltbr_SeriesXPreferredStockMember_lbl_552c94" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SeriesXPreferredStockMember_lbl_552c94" xml:lang="en-US">Series X Preferred Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_c7b670" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_c7b670" xml:lang="en-US">Shares, granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_7dca55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_7dca55" xml:lang="en-US">Options outstanding, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl_3717fd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl_3717fd" xml:lang="en-US">Exercise price lower range limit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_d586ad" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_d586ad" xml:lang="en-US">Weighted average fair value per share at grant date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_ea8357" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_ea8357" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl_db5865" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl_db5865" xml:lang="en-US">Total fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber_lbl_de60b9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber_lbl_de60b9" xml:lang="en-US">Share-Based compensation arrangement, restricted stock authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod_lbl_0b9aa3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod_lbl_0b9aa3" xml:lang="en-US">Share-Based compensation arrangement, restricted stock grant-date fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl_affefc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl_affefc" xml:lang="en-US">Restricted stock awards granted</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" xlink:label="ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" xlink:to="ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced_lbl_ba8c5a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced_lbl_ba8c5a" xml:lang="en-US">Performance-based restricted stock awards granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl_942382" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl_942382" xml:lang="en-US">Number of shares granted under share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl_d1bd97" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl_d1bd97" xml:lang="en-US">Fair value of share-based awards granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl_a6a4ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl_a6a4ca" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, grant-date fair value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_lbl_6e1973" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_lbl_6e1973" xml:lang="en-US">Shares, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_lbl_15" xml:lang="en-US">[Shares, vested]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_35a5e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_35a5e7" xml:lang="en-US">Shares, vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl_bec9b6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl_bec9b6" xml:lang="en-US">Stock price per share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl_289ae7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl_289ae7" xml:lang="en-US">Restricted stock awards shares value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_c9124d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_c9124d" xml:lang="en-US">Weighted average fair value grant date, granted</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:to="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement_lbl_aa7429" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement_lbl_aa7429" xml:lang="en-US">Description of subscription and investment representation agreement</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="ltbr_PreferredStockVotingRightsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PreferredStockVotingRightsShares" xlink:to="ltbr_PreferredStockVotingRightsShares_lbl_cdfffd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PreferredStockVotingRightsShares_lbl_cdfffd" xml:lang="en-US">Preferred stock voting rights shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="ltbr_CommonSharesIssuancesEquityGrant" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesIssuancesEquityGrant" xlink:to="ltbr_CommonSharesIssuancesEquityGrant_lbl_053081" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesIssuancesEquityGrant_lbl_053081" xml:lang="en-US">Common shares issuances equity grant value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_e91aad" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl_e91aad" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_9549db" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_9549db" xml:lang="en-US">Unrecognized compensation cost related to option awards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl_7a40b1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl_7a40b1" xml:lang="en-US">Unrecognized compensation cost related to option awards vesting period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_c26dda" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_c26dda" xml:lang="en-US">Proceeds from stock option exercise</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3345c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl_3345c4" xml:lang="en-US">Proceeds from stock options, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_abe9ed" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_abe9ed" xml:lang="en-US">RSAs vested</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockShareOutstanding" xlink:label="ltbr_CommonStockShareOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockShareOutstanding" xlink:to="ltbr_CommonStockShareOutstanding_lbl_1f7a53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockShareOutstanding_lbl_1f7a53" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" xlink:label="ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" xlink:to="ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding_lbl_9a775d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding_lbl_9a775d" xml:lang="en-US">Description of common Stock and common stock equivalents outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_79b454" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_79b454" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RSAFairValue" xlink:label="ltbr_RSAFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RSAFairValue" xlink:to="ltbr_RSAFairValue_lbl_d708ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RSAFairValue_lbl_d708ef" xml:lang="en-US">Fair value of the RSAs vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="us-gaap_IntercompanyAgreementsDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyAgreementsDescription" xlink:to="us-gaap_IntercompanyAgreementsDescription_lbl_6aab33" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyAgreementsDescription_lbl_6aab33" xml:lang="en-US">ATM agreement amendment, description</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_dc236e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_dc236e" xml:lang="en-US">Shares of common stock issued</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_lbl_35423a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_lbl_35423a" xml:lang="en-US">Number of shares granted</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesEquityGrantPricePerShares" xlink:to="ltbr_CommonSharesEquityGrantPricePerShares_lbl_025932" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares_lbl_025932" xml:lang="en-US">Common shares equity grant price per shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl_d7526c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_lbl_d7526c" xml:lang="en-US">Compensation cost recognized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_407e41" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingExpenses_lbl_407e41" xml:lang="en-US">Consulting expense</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="ltbr_CommonStockValuedGrantDatePricePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockValuedGrantDatePricePerShare" xlink:to="ltbr_CommonStockValuedGrantDatePricePerShare_lbl_f5df70" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockValuedGrantDatePricePerShare_lbl_f5df70" xml:lang="en-US">Common stock, valued grant date price per share</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_657152" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_657152" xml:lang="en-US">Fair value of the company's common stock per share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_52cd8c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_52cd8c" xml:lang="en-US">Fair value of the Company's common stock per share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl_837ce8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl_837ce8" xml:lang="en-US">Offering price, ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="ltbr_MarketOfferingsDisclosureDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_MarketOfferingsDisclosureDescription" xlink:to="ltbr_MarketOfferingsDisclosureDescription_lbl_3e94bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_MarketOfferingsDisclosureDescription_lbl_3e94bd" xml:lang="en-US">Description related to ATM offerings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_c7b72b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_c7b72b" xml:lang="en-US">Total number of common stock available for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="ltbr_DescriptionOfEquityIncentivePlan" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_DescriptionOfEquityIncentivePlan" xlink:to="ltbr_DescriptionOfEquityIncentivePlan_lbl_6ce0f1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_DescriptionOfEquityIncentivePlan_lbl_6ce0f1" xml:lang="en-US">Description of equity incentive plan</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_f2ace7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_f2ace7" xml:lang="en-US">Proceeds from sale of common stock, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="ltbr_ProceedsFromStockIssuances" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedsFromStockIssuances" xlink:to="ltbr_ProceedsFromStockIssuances_lbl_992cf9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProceedsFromStockIssuances_lbl_992cf9" xml:lang="en-US">Net proceeds from stock issuance under ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_6be2a7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_6be2a7" xml:lang="en-US">Stock issuence cost</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitAxis" xlink:label="us-gaap_ReportingUnitAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReportingUnitAxis" xlink:to="us-gaap_ReportingUnitAxis_lbl_487242" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReportingUnitAxis_lbl_487242" xml:lang="en-US">Reporting Unit Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CODMMember" xlink:label="ltbr_CODMMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CODMMember" xlink:to="ltbr_CODMMember_lbl_d49b41" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CODMMember_lbl_d49b41" xml:lang="en-US">CODM</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_323e0e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl_323e0e" xml:lang="en-US">Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_7e1424" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_7e1424" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_3" xml:lang="en-US">[Other General and Administrative Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InlProject" xlink:label="ltbr_InlProject" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InlProject" xlink:to="ltbr_InlProject_lbl_27b776" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InlProject_lbl_27b776" xml:lang="en-US">INL Project</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="ltbr_RomaniaFeasibilityStudy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RomaniaFeasibilityStudy" xlink:to="ltbr_RomaniaFeasibilityStudy_lbl_2a2fb0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RomaniaFeasibilityStudy_lbl_2a2fb0" xml:lang="en-US">Romania feasibility study</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="ltbr_CentrusEnergyFeedStudy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CentrusEnergyFeedStudy" xlink:to="ltbr_CentrusEnergyFeedStudy_lbl_f0cd75" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CentrusEnergyFeedStudy_lbl_f0cd75" xml:lang="en-US">Centrus Energy FEED study</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_781ff6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_781ff6" xml:lang="en-US">Allocated employee compensation and stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl_57b2e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl_57b2e2" xml:lang="en-US">Other outside R&amp;D expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="ltbr_ResearchAndDevelopmentExpenseNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseNet" xlink:to="ltbr_ResearchAndDevelopmentExpenseNet_lbl_7a158b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseNet_lbl_7a158b" xml:lang="en-US">Total research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OtherSegmentsItem" xlink:label="ltbr_OtherSegmentsItem" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OtherSegmentsItem" xlink:to="ltbr_OtherSegmentsItem_lbl_63f73b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OtherSegmentsItem_lbl_63f73b" xml:lang="en-US">Other segments item (1)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:to="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_ee3e43" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_ee3e43" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:to="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated_lbl_11" xml:lang="en-US">[Net loss]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl_6a8bbc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl_6a8bbc" xml:lang="en-US">Subsequent Event Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl_846d48" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl_846d48" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_3b6286" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_3b6286" xml:lang="en-US">Sales of common stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_63b503" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_63b503" xml:lang="en-US">Net proceeds from sale of stocks</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl_543a28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl_543a28" xml:lang="en-US">Stock issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementObligationAmount" xlink:label="ltbr_ResearchAndDevelopmentArrangementObligationAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentArrangementObligationAmount" xlink:to="ltbr_ResearchAndDevelopmentArrangementObligationAmount_lbl_1841e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentArrangementObligationAmount_lbl_1841e1" xml:lang="en-US">Research and development arrangement total contract amount</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>ltbr-20250930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/06/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250930.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250930.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250930.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250930.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250930.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250930.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250930.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250930.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProfitAndLoss" xlink:label="loc_ltbrProfitAndLoss" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ltbrProfitAndLoss" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="loc_us-gaapPaymentOfFinancingAndStockIssuanceCosts" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentOfFinancingAndStockIssuanceCosts" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Costs (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ltbr-20250930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/06/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250930.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250930.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250930.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250930.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250930.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250930.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250930.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250930.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_dd6953" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapAssetsCurrentAbstract_dd6953" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f3a9a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f3a9a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_ebaf12" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_ebaf12" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_cd1d82" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapAssetsCurrent_cd1d82" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract_f3ab74" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapOtherAssetsAbstract_f3ab74" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets_8c961e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets_8c961e" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_a5e34b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_a5e34b" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_adc782" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapAssets_adc782" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_1b52e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_1b52e5" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_c80750" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_1b52e5" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_c80750" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_d7e2f6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_1b52e5" xlink:to="loc_us-gaapLiabilitiesCurrent_d7e2f6" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_a07d1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_a07d1b" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_59fb27" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapStockholdersEquityAbstract_59fb27" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_5546e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_59fb27" xlink:to="loc_us-gaapPreferredStockValue_5546e1" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_7c312e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_59fb27" xlink:to="loc_us-gaapCommonStockValue_7c312e" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_9d23b7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_59fb27" xlink:to="loc_us-gaapAdditionalPaidInCapital_9d23b7" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_a4ed71" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_59fb27" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_a4ed71" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_3223b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_59fb27" xlink:to="loc_us-gaapStockholdersEquity_3223b9" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_786c20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_e4927d" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_786c20" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_733654" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_a103e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_a103e1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_332612" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_332612" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_907e75" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapPreferredStockSharesIssued_907e75" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_991d43" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_991d43" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_7e8f7b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_7e8f7b" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_ee2b64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapCommonStockSharesAuthorized_ee2b64" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_13a3b1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapCommonStockSharesIssued_13a3b1" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_31e421" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_733654" xlink:to="loc_us-gaapCommonStockSharesOutstanding_31e421" order="8" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_b7b8de" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_b3e98b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_b7b8de" xlink:to="loc_us-gaapOperatingExpensesAbstract_b3e98b" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_8ce653" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_b3e98b" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_8ce653" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_6938a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_b3e98b" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_6938a2" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_26db97" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_b3e98b" xlink:to="loc_us-gaapOperatingExpenses_26db97" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_554ee0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_b3e98b" xlink:to="loc_us-gaapOperatingIncomeLoss_554ee0" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_b3e98b" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther_a2d9b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" xlink:to="loc_us-gaapInterestIncomeOther_a2d9b9" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_4011d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_4011d1" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f6d3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f6d3" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_4e4bdb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_5ee14a" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_4e4bdb" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_c1c6a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_b7b8de" xlink:to="loc_us-gaapNetIncomeLoss_c1c6a3" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_e2ba89" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_b7b8de" xlink:to="loc_us-gaapEarningsPerShareAbstract_e2ba89" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_910881" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_e2ba89" xlink:to="loc_us-gaapEarningsPerShareDiluted_910881" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract_3e569f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_b7b8de" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasicAbstract_3e569f" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_cfc753" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_b7b8de" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_cfc753" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_8b7313" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_4c5484" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_8b7313" xlink:to="loc_us-gaapStatementTable_4c5484" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_82a4f3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_4c5484" xlink:to="loc_us-gaapStatementLineItems_82a4f3" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_ad5ab0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_4c5484" xlink:to="loc_us-gaapStatementEquityComponentsAxis_ad5ab0" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_781636" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_ad5ab0" xlink:to="loc_us-gaapEquityComponentDomain_781636" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_f4d110" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_781636" xlink:to="loc_us-gaapCommonStockMember_f4d110" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_3d53c2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_781636" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_3d53c2" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_2f9651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_781636" xlink:to="loc_us-gaapRetainedEarningsMember_2f9651" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_37c38b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapSharesIssued_37c38b" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_a3b0ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockholdersEquity_a3b0ca" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_13cf0f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares_13cf0f" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_05c2b1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount_05c2b1" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_87a58b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_87a58b" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_13913b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_13913b" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_dfe372" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares_dfe372" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_47e777" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount_47e777" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_88d1c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_88d1c7" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_46c088" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapNetIncomeLoss_46c088" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsShares" xlink:label="loc_ltbrIssuanceOfRestrictedShareAwardsShares_45f600" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrIssuanceOfRestrictedShareAwardsShares_45f600" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsAmount" xlink:label="loc_ltbrIssuanceOfRestrictedShareAwardsAmount_4e8fab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_ltbrIssuanceOfRestrictedShareAwardsAmount_4e8fab" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_dc2ba8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_dc2ba8" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_4fc67b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_4fc67b" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_b68c57" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapSharesIssued_b68c57" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_757fc3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_82a4f3" xlink:to="loc_us-gaapStockholdersEquity_757fc3" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_e31d26" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_e31d26" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProfitAndLoss" xlink:label="loc_ltbrProfitAndLoss_cd1c53" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_e31d26" xlink:to="loc_ltbrProfitAndLoss_cd1c53" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f3a44" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_e31d26" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f3a44" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_48c5aa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f3a44" xlink:to="loc_us-gaapShareBasedCompensation_48c5aa" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f3a44" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_69d6b7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_69d6b7" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_0d382c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_0d382c" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_22be2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_22be2c" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_e7961a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_153bd3" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_e7961a" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_71ce39" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_71ce39" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_f049c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_71ce39" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_f049c1" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_688860" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_71ce39" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_688860" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_1e70d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_1e70d7" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="loc_us-gaapPaymentOfFinancingAndStockIssuanceCosts_786c00" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" xlink:to="loc_us-gaapPaymentOfFinancingAndStockIssuanceCosts_786c00" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_568059" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_568059" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_d82a3b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" xlink:to="loc_us-gaapPaymentsRelatedToTaxWithholdingForShareBasedCompensation_d82a3b" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_ec25ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_cda8e9" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_ec25ee" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_049ae6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_049ae6" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7bf0bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7bf0bc" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_823883" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_823883" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="loc_ltbrCashPaidDuringThePeriodAbstract_3197ea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_ltbrCashPaidDuringThePeriodAbstract_3197ea" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet_e49e37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCashPaidDuringThePeriodAbstract_3197ea" xlink:to="loc_us-gaapInterestPaidNet_e49e37" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet_07c955" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapIncomeTaxesPaidNet_07c955" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_e02464" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_42fc92" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_e02464" order="25" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_64d995" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_e02464" xlink:to="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_64d995" order="26" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockIssuedForConsultingServices" xlink:label="loc_ltbrCommonStockIssuedForConsultingServices_ca3ec8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_e02464" xlink:to="loc_ltbrCommonStockIssuedForConsultingServices_ca3ec8" order="27" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arragements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems_ad348d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock_74a3f6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock_74a3f6" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag_91bc12" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdRule10b51ArrTrmntdFlag_91bc12" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag_3e1b20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag_3e1b20" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag_9293fd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag_9293fd" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName_669a53" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdTrdArrIndName_669a53" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag_b29fe3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdRule10b51ArrAdoptedFlag_b29fe3" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle_45d411" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdTrdArrIndTitle_45d411" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate_da74d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdTrdArrAdoptionDate_da74d8" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate_dd9d48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdTrdArrExpirationDate_dd9d48" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt_1f449d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt_1f449d" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndNameSecond" xlink:label="loc_ltbrTrdArrIndNameSecond_ef4e82" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrIndNameSecond_ef4e82" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_Rule10b51ArrAdoptedFlagSecond" xlink:label="loc_ltbrRule10b51ArrAdoptedFlagSecond_b617f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrRule10b51ArrAdoptedFlagSecond_b617f8" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndTitleSecond" xlink:label="loc_ltbrTrdArrIndTitleSecond_bfe9f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrIndTitleSecond_bfe9f9" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrAdoptionDateSecond" xlink:label="loc_ltbrTrdArrAdoptionDateSecond_2bc60a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrAdoptionDateSecond_2bc60a" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrExpirationDateSecond" xlink:label="loc_ltbrTrdArrExpirationDateSecond_fb48d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrExpirationDateSecond_fb48d4" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrSecuritiesAggAvailAmtTwo" xlink:label="loc_ltbrTrdArrSecuritiesAggAvailAmtTwo_fbdb71" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrSecuritiesAggAvailAmtTwo_fbdb71" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndNameThird" xlink:label="loc_ltbrTrdArrIndNameThird_d98472" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrIndNameThird_d98472" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_Rule10b51ArrAdoptedFlagThird" xlink:label="loc_ltbrRule10b51ArrAdoptedFlagThird_2524cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrRule10b51ArrAdoptedFlagThird_2524cb" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrIndTitleThird" xlink:label="loc_ltbrTrdArrIndTitleThird_908b74" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrIndTitleThird_908b74" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrAdoptionDateThird" xlink:label="loc_ltbrTrdArrAdoptionDateThird_6c377a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrAdoptionDateThird_6c377a" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrExpirationDateThird" xlink:label="loc_ltbrTrdArrExpirationDateThird_14b8e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrExpirationDateThird_14b8e5" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TrdArrSecuritiesAggAvailAmtThird" xlink:label="loc_ltbrTrdArrSecuritiesAggAvailAmtThird_190b91" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_ad348d" xlink:to="loc_ltbrTrdArrSecuritiesAggAvailAmtThird_190b91" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_7020c8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_899c33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_7020c8" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_899c33" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_9699dd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock_03a7ea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_9699dd" xlink:to="loc_us-gaapEarningsPerShareTextBlock_03a7ea" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_70aecf" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_f05f1a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_70aecf" xlink:to="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_f05f1a" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_5a217d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_84f884" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_5a217d" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_84f884" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="loc_ltbrCommitmentsAndContingenciesAbstract_99650b" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_7d4cc3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_99650b" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_7d4cc3" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_002453" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_98c1f2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_002453" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_98c1f2" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_6a231c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_9c0b1d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_6a231c" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_9c0b1d" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_c4fef8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock_686068" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_c4fef8" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock_686068" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_ac329d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_3eb749" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_ac329d" xlink:to="loc_us-gaapSubsequentEventsTextBlock_3eb749" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_4fb701" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_968ca2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_4fb701" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_968ca2" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_b1e0de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_4fb701" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_b1e0de" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_9c0459" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_4fb701" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_9c0459" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_a635b4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_916e13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_a635b4" xlink:to="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_916e13" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_45d449" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_007be2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_45d449" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_007be2" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e3cdac" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1611a5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e3cdac" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1611a5" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_0f8aee" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_1e658b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0f8aee" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_1e658b" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7eaaf8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0f8aee" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7eaaf8" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ScheduleOfOutstandingRSATableTextBlock" xlink:label="loc_ltbrScheduleOfOutstandingRSATableTextBlock_0388f6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0f8aee" xlink:to="loc_ltbrScheduleOfOutstandingRSATableTextBlock_0388f6" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_536f25" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0f8aee" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_536f25" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_b106d6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_ce8191" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_b106d6" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock_ce8191" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_8ee017" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_a35478" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_8ee017" xlink:to="loc_us-gaapStatementTable_a35478" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_1bcd35" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a35478" xlink:to="loc_us-gaapStatementLineItems_1bcd35" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_ff552d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a35478" xlink:to="loc_us-gaapStatementClassOfStockAxis_ff552d" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_835a88" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_ff552d" xlink:to="loc_us-gaapClassOfStockDomain_835a88" order="1020" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember_6ada51" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_835a88" xlink:to="loc_ltbrTreasuryBillsLevelOneMember_6ada51" order="1021" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember_8652f4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_835a88" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember_8652f4" order="1022" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember_07c34a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_835a88" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember_07c34a" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cbdfe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1bcd35" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cbdfe" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_519cf6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_1bcd35" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_519cf6" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations" xlink:label="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_dab78c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_6b4851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations_dab78c" xlink:to="loc_us-gaapStatementTable_6b4851" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_dcb7b3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_6b4851" xlink:to="loc_us-gaapStatementLineItems_dcb7b3" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_b7280b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_6b4851" xlink:to="loc_srtProductOrServiceAxis_b7280b" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_1e2987" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_b7280b" xlink:to="loc_srtProductsAndServicesDomain_1e2987" order="1020" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember_17d940" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_1e2987" xlink:to="loc_ltbrINLMember_17d940" order="1021" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="loc_ltbrResearchAndDevelopmentPercentage_c0c77b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dcb7b3" xlink:to="loc_ltbrResearchAndDevelopmentPercentage_c0c77b" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="loc_ltbrInvestmentsInDebtSecuritiesPurchased_82409a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dcb7b3" xlink:to="loc_ltbrInvestmentsInDebtSecuritiesPurchased_82409a" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_0b3bf4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_9d613c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_0b3bf4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_9d613c" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_1b970d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_0b3bf4" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_1b970d" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_823adf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_0b3bf4" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_823adf" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_a4d048" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_a4f7f2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_a4d048" xlink:to="loc_us-gaapStatementTable_a4f7f2" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_0486c2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a4f7f2" xlink:to="loc_us-gaapStatementLineItems_0486c2" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis_655500" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a4f7f2" xlink:to="loc_us-gaapBalanceSheetLocationAxis_655500" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_db9620" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis_655500" xlink:to="loc_us-gaapBalanceSheetLocationDomain_db9620" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_6e4883" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a4f7f2" xlink:to="loc_us-gaapAwardTypeAxis_6e4883" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a9271" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_6e4883" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a9271" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21497b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a4f7f2" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21497b" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_fc85b3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_21497b" xlink:to="loc_us-gaapRelatedPartyDomain_fc85b3" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_5fbd2e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain_db9620" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_5fbd2e" order="1061" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember_7f8010" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a9271" xlink:to="loc_ltbrBottomMember_7f8010" order="1062" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember_89c3b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_fc85b3" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember_89c3b9" order="1063" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember_1582fe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a9271" xlink:to="loc_ltbrTopMember_1582fe" order="1064" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProjectAbandonmentCosts" xlink:label="loc_ltbrProjectAbandonmentCosts_42cef6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0486c2" xlink:to="loc_ltbrProjectAbandonmentCosts_42cef6" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_f9a49c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" xlink:to="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_f9a49c" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="loc_ltbrAccruedResearchAndDevelopmentExpensesCurrent_260345" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" xlink:to="loc_ltbrAccruedResearchAndDevelopmentExpensesCurrent_260345" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_5de9fb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" xlink:to="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_5de9fb" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_19565f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_19565f" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_28c6d6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9b0dba" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_28c6d6" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommitmentsAndContingenciesAbstract" xlink:label="loc_ltbrCommitmentsAndContingenciesAbstract_09618e" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_07c7c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_09618e" xlink:to="loc_us-gaapOperatingLeaseExpense_07c7c4" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_84eb28" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_09618e" xlink:to="loc_us-gaapOperatingLeasePayments_84eb28" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_3cb23a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_09618e" xlink:to="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_3cb23a" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="loc_ltbrLesseeOperatingLeaseTerm_2ea8c5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCommitmentsAndContingenciesAbstract_09618e" xlink:to="loc_ltbrLesseeOperatingLeaseTerm_2ea8c5" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Costs (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_cecaa7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_101c76" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_cecaa7" xlink:to="loc_us-gaapStatementTable_101c76" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_0d66d0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_101c76" xlink:to="loc_us-gaapStatementLineItems_0d66d0" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_e804ed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_101c76" xlink:to="loc_srtProductOrServiceAxis_e804ed" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_f32ec2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_e804ed" xlink:to="loc_srtProductsAndServicesDomain_f32ec2" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ea8b8a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_101c76" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ea8b8a" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_ecdfd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ea8b8a" xlink:to="loc_us-gaapRelatedPartyDomain_ecdfd4" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_1626eb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_101c76" xlink:to="loc_us-gaapPlanNameAxis_1626eb" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_e46762" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_1626eb" xlink:to="loc_us-gaapPlanNameDomain_e46762" order="1040" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember_f6ed64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f32ec2" xlink:to="loc_ltbrINLMember_f6ed64" order="1041" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember_e60f82" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_ecdfd4" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember_e60f82" order="1042" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CRADAMember" xlink:label="loc_ltbrCRADAMember_cf0e65" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f32ec2" xlink:to="loc_ltbrCRADAMember_cf0e65" order="1043" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember_0bf959" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_e46762" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember_0bf959" order="1044" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CANDUMember" xlink:label="loc_ltbrCANDUMember_cfcfb2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f32ec2" xlink:to="loc_ltbrCANDUMember_cfcfb2" order="1045" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FEEdMember" xlink:label="loc_ltbrFEEdMember_79fa44" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_f32ec2" xlink:to="loc_ltbrFEEdMember_79fa44" order="1046" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessCostReimbursable" xlink:label="loc_ltbrInvestmentCompanyExcessCostReimbursable_44c0d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrInvestmentCompanyExcessCostReimbursable_44c0d1" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessProjectTaskObligations" xlink:label="loc_ltbrInvestmentCompanyExcessProjectTaskObligations_77c498" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrInvestmentCompanyExcessProjectTaskObligations_77c498" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_9ec758" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_9ec758" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="loc_ltbrResearchAndDevelopmentArrangementExpense_b23dee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrResearchAndDevelopmentArrangementExpense_b23dee" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" xlink:label="loc_ltbrRelatedPartyTransactionAmountsResearchAndDevelopmentExpense_6aef03" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrRelatedPartyTransactionAmountsResearchAndDevelopmentExpense_6aef03" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_f79b60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_f79b60" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="loc_ltbrResearchAndDevelopmentExpensePayable_a05833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrResearchAndDevelopmentExpensePayable_a05833" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="loc_ltbrPaymentsToResearchAndDevelopmentCost_6c93da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0d66d0" xlink:to="loc_ltbrPaymentsToResearchAndDevelopmentCost_6c93da" order="8" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_b74e24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_345bda" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_345bda" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8609f0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8609f0" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_71ff49" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_71ff49" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_addb11" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_addb11" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_907bf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_907bf1" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_437908" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_437908" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_5929e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_5929e5" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f3495b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f3495b" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a7ecdc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a7ecdc" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a3b6d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a3b6d4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a56d01" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a56d01" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_75273e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_75273e" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ccf4b4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ccf4b4" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_efeca3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_efeca3" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_c02019" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice_c02019" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_23a125" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_23a125" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_c1601f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm_c1601f" order="17" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_f2127e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF_f2127e" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_b41f0c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested_b41f0c" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable" xlink:label="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_224d36" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable_224d36" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_566f1d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_566f1d" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_5f605c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised_5f605c" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_de61c8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding_de61c8" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_ae744c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest_ae744c" order="24" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_afd8c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_b74e24" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable_afd8c7" order="25" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_67882d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_478b81" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_67882d" xlink:to="loc_us-gaapStatementTable_478b81" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_6c651b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_478b81" xlink:to="loc_us-gaapStatementLineItems_6c651b" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_477d11" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_478b81" xlink:to="loc_us-gaapPlanNameAxis_477d11" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_f756d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_477d11" xlink:to="loc_us-gaapPlanNameDomain_f756d1" order="1010" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember_46fbb1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f756d1" xlink:to="loc_ltbrTopMember_46fbb1" order="1011" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember_75efeb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_f756d1" xlink:to="loc_ltbrBottomMember_75efeb" order="1012" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_686395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6c651b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_686395" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_120819" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6c651b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_120819" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b2f452" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6c651b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b2f452" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_468b6f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6c651b" xlink:to="loc_us-gaapSharePrice_468b6f" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4113f0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6c651b" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4113f0" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_0ef1a1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_e721aa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0ef1a1" xlink:to="loc_us-gaapStatementTable_e721aa" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_6b8cff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e721aa" xlink:to="loc_us-gaapStatementLineItems_6b8cff" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_cbb8ad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e721aa" xlink:to="loc_us-gaapAwardTypeAxis_cbb8ad" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1288a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_cbb8ad" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1288a" order="1010" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember_4d5aa2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1288a" xlink:to="loc_ltbrRestrictedStockAwardMember_4d5aa2" order="1011" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_515b6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_515b6e" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_87ac6a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_87ac6a" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_0cbf6d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_0cbf6d" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_64936d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94_64936d" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_223a2f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding_223a2f" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c78f53" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c78f53" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1ff0b7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1ff0b7" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_8c3d45" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_8c3d45" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_8ecd20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_8ecd20" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_1e4ebb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_1e4ebb" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_998a1e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding_998a1e" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_2a011c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted_2a011c" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_8170bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested_8170bc" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_6d261c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited_6d261c" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_84952b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6b8cff" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings_84952b" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_0573e6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_15ce3a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_0573e6" xlink:to="loc_us-gaapStatementTable_15ce3a" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_397748" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_15ce3a" xlink:to="loc_us-gaapStatementLineItems_397748" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis_a68af7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_15ce3a" xlink:to="loc_us-gaapIncomeStatementLocationAxis_a68af7" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_6f8b5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis_a68af7" xlink:to="loc_us-gaapIncomeStatementLocationDomain_6f8b5a" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_876976" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_6f8b5a" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_876976" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_868eae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_6f8b5a" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_868eae" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_04ed06" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_397748" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_04ed06" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_269fe1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_510f10" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_269fe1" xlink:to="loc_us-gaapStatementTable_510f10" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_16df72" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapStatementLineItems_16df72" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_f5a949" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapFinancialInstrumentAxis_f5a949" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621355" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_f5a949" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621355" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_ae3e35" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapPlanNameAxis_ae3e35" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_b71a09" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_ae3e35" xlink:to="loc_us-gaapPlanNameDomain_b71a09" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_551b5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapAwardTypeAxis_551b5d" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c32b6f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_551b5d" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c32b6f" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis_e3873f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapVestingAxis_e3873f" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_e22439" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis_e3873f" xlink:to="loc_us-gaapVestingDomain_e22439" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_bc341c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_bc341c" order="1080" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_a3a556" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis_bc341c" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_a3a556" order="1080" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_8cc936" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_8cc936" order="1090" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_42dd39" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_8cc936" xlink:to="loc_us-gaapRelatedPartyDomain_42dd39" order="1090" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_c6b481" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_510f10" xlink:to="loc_us-gaapStatementClassOfStockAxis_c6b481" order="1100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_20e86b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_c6b481" xlink:to="loc_us-gaapClassOfStockDomain_20e86b" order="1100" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember_98ca28" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_621355" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember_98ca28" order="1101" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsProgramMember" xlink:label="loc_ltbrRestrictedStockAwardsProgramMember_8e3f4d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrRestrictedStockAwardsProgramMember_8e3f4d" order="1102" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OptionsMember" xlink:label="loc_ltbrOptionsMember_b2ebed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c32b6f" xlink:to="loc_ltbrOptionsMember_b2ebed" order="1103" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember_19b1da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain_e22439" xlink:to="loc_ltbrCommonShareIssuancesMember_19b1da" order="1104" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember_604316" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_a3a556" xlink:to="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember_604316" order="1105" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="loc_ltbrTwentyTwentyFiveTransactionsMember_db50ba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrTwentyTwentyFiveTransactionsMember_db50ba" order="1106" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="loc_ltbrRestrictedStockAwardsSummaryMember_14f78c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrRestrictedStockAwardsSummaryMember_14f78c" order="1107" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FirstTrancheMember" xlink:label="loc_ltbrFirstTrancheMember_f01515" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrFirstTrancheMember_f01515" order="1108" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SecondTrancheMember" xlink:label="loc_ltbrSecondTrancheMember_1bcaaf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrSecondTrancheMember_1bcaaf" order="1109" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember_7489ad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c32b6f" xlink:to="loc_ltbrRestrictedStockAwardMember_7489ad" order="1110" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BoardOfDirectorsMember" xlink:label="loc_ltbrBoardOfDirectorsMember_aace6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_42dd39" xlink:to="loc_ltbrBoardOfDirectorsMember_aace6e" order="1111" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_586907" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_42dd39" xlink:to="loc_srtBoardOfDirectorsChairmanMember_586907" order="1112" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_ac9d56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_ac9d56" order="1113" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="loc_ltbrRestrictedStockUnitsRSAMember_7310a8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c32b6f" xlink:to="loc_ltbrRestrictedStockUnitsRSAMember_7310a8" order="1114" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="loc_ltbrSeriesXPreferredStockMember_3b5f1e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_20e86b" xlink:to="loc_ltbrSeriesXPreferredStockMember_3b5f1e" order="1115" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember_6e4adc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrBottomMember_6e4adc" order="1116" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember_43f6e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b71a09" xlink:to="loc_ltbrTopMember_43f6e5" order="1117" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb1e19" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eb1e19" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_e35e0b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_e35e0b" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_63c75c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_63c75c" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_4f19b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_4f19b6" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_1c8cbe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensation_1c8cbe" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_b217d6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_b217d6" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber_5e8c4b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber_5e8c4b" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod_36534c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod_36534c" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_4aedf2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_4aedf2" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" xlink:label="loc_ltbrStockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced_731dda" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrStockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced_731dda" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_35f159" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_35f159" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_934fe8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_934fe8" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_0387e4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_0387e4" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_aae144" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross_aae144" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_6ef8d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_6ef8d8" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_7398df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSaleOfStockPricePerShare_7398df" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_1caddf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_1caddf" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4b665a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4b665a" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement_324efc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement_324efc" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="loc_ltbrPreferredStockVotingRightsShares_9a44af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrPreferredStockVotingRightsShares_9a44af" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant_0c20da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant_0c20da" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_40c692" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapCommonStockSharesIssued_40c692" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9f9bae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9f9bae" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5512c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a5512c" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_29e67a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_29e67a" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_c33677" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_c33677" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6e2e0e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6e2e0e" order="27" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockShareOutstanding" xlink:label="loc_ltbrCommonStockShareOutstanding_d6b77a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrCommonStockShareOutstanding_d6b77a" order="28" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" xlink:label="loc_ltbrDescriptionOfCommonStockAndCommonStockEquivalentsOutstanding_dc134f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrDescriptionOfCommonStockAndCommonStockEquivalentsOutstanding_dc134f" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_f93262" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapCommonStockSharesAuthorized_f93262" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RSAFairValue" xlink:label="loc_ltbrRSAFairValue_97716f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrRSAFairValue_97716f" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription_9d4b1c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapIntercompanyAgreementsDescription_9d4b1c" order="32" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_98bb48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_98bb48" order="33" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_1f79f0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted_1f79f0" order="34" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares_572f60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares_572f60" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_58eeb7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense_58eeb7" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_430ca2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapOperatingExpenses_430ca2" order="37" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="loc_ltbrCommonStockValuedGrantDatePricePerShare_99bfc6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrCommonStockValuedGrantDatePricePerShare_99bfc6" order="38" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_818bb7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice_818bb7" order="39" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_084aa6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_084aa6" order="40" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering_63f4c0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering_63f4c0" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="loc_ltbrMarketOfferingsDisclosureDescription_3dd361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrMarketOfferingsDisclosureDescription_3dd361" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_8e98fb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_8e98fb" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="loc_ltbrDescriptionOfEquityIncentivePlan_e34ead" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrDescriptionOfEquityIncentivePlan_e34ead" order="44" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_490512" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_490512" order="45" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances_8d50a0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_ltbrProceedsFromStockIssuances_8d50a0" order="46" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_6b32cf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_16df72" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_6b32cf" order="47" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract_74a48a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_97401b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract_74a48a" xlink:to="loc_us-gaapStatementTable_97401b" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_48c190" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_97401b" xlink:to="loc_us-gaapStatementLineItems_48c190" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaapReportingUnitAxis_5a00ea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_97401b" xlink:to="loc_us-gaapReportingUnitAxis_5a00ea" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain_af16df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReportingUnitAxis_5a00ea" xlink:to="loc_us-gaapReportingUnitDomain_af16df" order="1020" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CODMMember" xlink:label="loc_ltbrCODMMember_bee4bd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReportingUnitDomain_af16df" xlink:to="loc_ltbrCODMMember_bee4bd" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_556167" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_us-gaapRevenues_556167" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_1d4d1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_1d4d1b" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InlProject" xlink:label="loc_ltbrInlProject_11e911" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrInlProject_11e911" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="loc_ltbrRomaniaFeasibilityStudy_4a8e33" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrRomaniaFeasibilityStudy_4a8e33" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="loc_ltbrCentrusEnergyFeedStudy_6611c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrCentrusEnergyFeedStudy_6611c4" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_48b7d2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_48b7d2" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses_2d8e97" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_us-gaapOtherExpenses_2d8e97" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="loc_ltbrResearchAndDevelopmentExpenseNet_f4d033" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrResearchAndDevelopmentExpenseNet_f4d033" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OtherSegmentsItem" xlink:label="loc_ltbrOtherSegmentsItem_fe41e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrOtherSegmentsItem_fe41e8" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated_d7e183" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_48c190" xlink:to="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated_d7e183" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_54a6ac" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_45fc9e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_54a6ac" xlink:to="loc_us-gaapStatementTable_45fc9e" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_e94dab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_45fc9e" xlink:to="loc_us-gaapStatementLineItems_e94dab" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis_c4c7fe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_45fc9e" xlink:to="loc_us-gaapSubsequentEventTypeAxis_c4c7fe" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_1b568e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis_c4c7fe" xlink:to="loc_us-gaapSubsequentEventTypeDomain_1b568e" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_a957d5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain_1b568e" xlink:to="loc_us-gaapSubsequentEventMember_a957d5" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_209470" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e94dab" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_209470" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_77b1bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e94dab" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_77b1bc" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_0727a2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e94dab" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_0727a2" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementObligationAmount" xlink:label="loc_ltbrResearchAndDevelopmentArrangementObligationAmount_fbd481" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_e94dab" xlink:to="loc_ltbrResearchAndDevelopmentArrangementObligationAmount_fbd481" order="4" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>ltbr-20250930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/06/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20250930.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20250930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20250930.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongtermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReporting" xlink:href="ltbr-20250930.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20250930.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20250930.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingTables" xlink:href="ltbr-20250930.xsd#SegmentReportingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ltbr-20250930.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20250930.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20250930.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20250930.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20250930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20250930.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20250930.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SegmentReportingDetails" xlink:href="ltbr-20250930.xsd#SegmentReportingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20250930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" xlink:label="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="10" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsShares" xlink:label="loc_ltbrIssuanceOfRestrictedShareAwardsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrIssuanceOfRestrictedShareAwardsShares" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_IssuanceOfRestrictedShareAwardsAmount" xlink:label="loc_ltbrIssuanceOfRestrictedShareAwardsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrIssuanceOfRestrictedShareAwardsAmount" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" order="14" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="995447 - Disclosure - Net Loss Per Share" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets" xlink:title="995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="995449 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="995450 - Disclosure - Commitments and Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="995451 - Disclosure - Research and Development Costs" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation" xlink:title="995452 - Disclosure - Stockholders Equity and StockBased Compensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReporting" xlink:title="995453 - Disclosure - Segment Reporting" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="995454 - Disclosure - Subsequent Events" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="995457 - Disclosure - Net Loss Per Share (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingTables" xlink:title="995460 - Disclosure - Segment Reporting (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelOneMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember" order="1022" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember" order="1023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrINLMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentPercentage" xlink:label="loc_ltbrResearchAndDevelopmentPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentPercentage" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentsInDebtSecuritiesPurchased" xlink:label="loc_ltbrInvestmentsInDebtSecuritiesPurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInvestmentsInDebtSecuritiesPurchased" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="995463 - Disclosure - Net Loss Per Share (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1050" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="1060" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="1070" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="1080" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" order="1061" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrBottomMember" order="1062" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember" order="1063" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrTopMember" order="1064" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProjectAbandonmentCosts" xlink:label="loc_ltbrProjectAbandonmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProjectAbandonmentCosts" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995466 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="995467 - Disclosure - Research and Development Costs (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" order="1030" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="1050" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="1060" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_INLMember" xlink:label="loc_ltbrINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrINLMember" order="1041" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember" order="1042" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CRADAMember" xlink:label="loc_ltbrCRADAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrCRADAMember" order="1043" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember" order="1044" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CANDUMember" xlink:label="loc_ltbrCANDUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrCANDUMember" order="1045" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FEEdMember" xlink:label="loc_ltbrFEEdMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ltbrFEEdMember" order="1046" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessCostReimbursable" xlink:label="loc_ltbrInvestmentCompanyExcessCostReimbursable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInvestmentCompanyExcessCostReimbursable" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InvestmentCompanyExcessProjectTaskObligations" xlink:label="loc_ltbrInvestmentCompanyExcessProjectTaskObligations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInvestmentCompanyExcessProjectTaskObligations" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementExpense" xlink:label="loc_ltbrResearchAndDevelopmentArrangementExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentArrangementExpense" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense" xlink:label="loc_ltbrRelatedPartyTransactionAmountsResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRelatedPartyTransactionAmountsResearchAndDevelopmentExpense" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpensePayable" xlink:label="loc_ltbrResearchAndDevelopmentExpensePayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentExpensePayable" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PaymentsToResearchAndDevelopmentCost" xlink:label="loc_ltbrPaymentsToResearchAndDevelopmentCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPaymentsToResearchAndDevelopmentCost" order="8" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="1030" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTopMember" order="1011" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrBottomMember" order="1012" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="5" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2" xlink:title="995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="1030" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardMember" order="1011" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueVested" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited" order="14" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" xlink:label="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings" order="15" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3" xlink:title="995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" order="1022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="1050" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="1040" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1050" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="1060" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="1060" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="1070" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" order="1080" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" order="1080" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" order="1090" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableByTypeAxis" xlink:to="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain_10" order="1100" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="1090" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="1100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="1110" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="1100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="1110" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="1120" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember" order="1101" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsProgramMember" xlink:label="loc_ltbrRestrictedStockAwardsProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardsProgramMember" order="1102" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OptionsMember" xlink:label="loc_ltbrOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrOptionsMember" order="1103" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ltbrCommonShareIssuancesMember" order="1104" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PrepaidExpenseAndOtherCurrentAssetMember" xlink:label="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityInterestIssuedOrIssuableTypeDomain" xlink:to="loc_ltbrPrepaidExpenseAndOtherCurrentAssetMember" order="1105" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwentyTwentyFiveTransactionsMember" xlink:label="loc_ltbrTwentyTwentyFiveTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTwentyTwentyFiveTransactionsMember" order="1106" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardsSummaryMember" xlink:label="loc_ltbrRestrictedStockAwardsSummaryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardsSummaryMember" order="1107" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_FirstTrancheMember" xlink:label="loc_ltbrFirstTrancheMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrFirstTrancheMember" order="1108" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SecondTrancheMember" xlink:label="loc_ltbrSecondTrancheMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrSecondTrancheMember" order="1109" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockAwardMember" xlink:label="loc_ltbrRestrictedStockAwardMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardMember" order="1110" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BoardOfDirectorsMember" xlink:label="loc_ltbrBoardOfDirectorsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBoardOfDirectorsMember" order="1111" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" order="1112" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" order="1113" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RestrictedStockUnitsRSAMember" xlink:label="loc_ltbrRestrictedStockUnitsRSAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ltbrRestrictedStockUnitsRSAMember" order="1114" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_SeriesXPreferredStockMember" xlink:label="loc_ltbrSeriesXPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrSeriesXPreferredStockMember" order="1115" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_BottomMember" xlink:label="loc_ltbrBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrBottomMember" order="1116" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_TopMember" xlink:label="loc_ltbrTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTopMember" order="1117" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" xlink:label="loc_ltbrStockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrStockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement" xlink:label="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfSubscriptionAndInvestmentRepresentationAgreement" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_PreferredStockVotingRightsShares" xlink:label="loc_ltbrPreferredStockVotingRightsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPreferredStockVotingRightsShares" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="27" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockShareOutstanding" xlink:label="loc_ltbrCommonStockShareOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockShareOutstanding" order="28" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" xlink:label="loc_ltbrDescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfCommonStockAndCommonStockEquivalentsOutstanding" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" order="30" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RSAFairValue" xlink:label="loc_ltbrRSAFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRSAFairValue" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntercompanyAgreementsDescription" order="32" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" order="33" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted" order="34" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCompensationExpense" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses" order="37" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CommonStockValuedGrantDatePricePerShare" xlink:label="loc_ltbrCommonStockValuedGrantDatePricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockValuedGrantDatePricePerShare" order="38" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice" order="39" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_MarketOfferingsDisclosureDescription" xlink:label="loc_ltbrMarketOfferingsDisclosureDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrMarketOfferingsDisclosureDescription" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_DescriptionOfEquityIncentivePlan" xlink:label="loc_ltbrDescriptionOfEquityIncentivePlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrDescriptionOfEquityIncentivePlan" order="44" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" order="45" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ProceedsFromStockIssuances" xlink:label="loc_ltbrProceedsFromStockIssuances" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedsFromStockIssuances" order="46" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" order="47" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SegmentReportingDetails" xlink:title="995473 - Disclosure - Segment Reporting (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitAxis" xlink:label="loc_us-gaapReportingUnitAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapReportingUnitAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapReportingUnitAxis" xlink:to="loc_us-gaapReportingUnitDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReportingUnitDomain" xlink:label="loc_us-gaapReportingUnitDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapReportingUnitAxis" xlink:to="loc_us-gaapReportingUnitDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CODMMember" xlink:label="loc_ltbrCODMMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReportingUnitDomain" xlink:to="loc_ltbrCODMMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_InlProject" xlink:label="loc_ltbrInlProject" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInlProject" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_RomaniaFeasibilityStudy" xlink:label="loc_ltbrRomaniaFeasibilityStudy" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRomaniaFeasibilityStudy" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_CentrusEnergyFeedStudy" xlink:label="loc_ltbrCentrusEnergyFeedStudy" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCentrusEnergyFeedStudy" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpenses" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentExpenseNet" xlink:label="loc_ltbrResearchAndDevelopmentExpenseNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentExpenseNet" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OtherSegmentsItem" xlink:label="loc_ltbrOtherSegmentsItem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOtherSegmentsItem" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated" xlink:label="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOperatingNetIncomeLossFromSegmentsToConsolidated" order="10" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="995474 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="1020" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="1030" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" order="1040" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" order="1021" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20250930.xsd#ltbr_ResearchAndDevelopmentArrangementObligationAmount" xlink:label="loc_ltbrResearchAndDevelopmentArrangementObligationAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentArrangementObligationAmount" order="4" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ltbr_ex102img3.jpg
<TEXT>
begin 644 ltbr_ex102img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MI:+J=KJ=C(3Y=U:3+-$^"0<,I(."".O45K4 %%?,W_#:OPM_Z 'BK_P%MO\
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MW_\ (U 'T)17SW_PUI\,?^@I;_\ ?-W_ /(U'_#6GPQ_Z"EO_P!\W?\ \C4
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M5I9^)K)+JYMK/4E9K2]APB3*=IW*X#J5902 6X()KLO[2\4?]"S!_P"# ?\
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MNHX&>%Q]' S[9KY4^%?P!^,GA/XL^'?$FI>"Q'9Z?=B:5FU*UP!@C^&1CW[
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ML?\ Z+6ORN^*W_);_'G_ &,%_P#^E+T <51110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ':_"G_DM_@/_L8+#_TI2OUCK\G/A3_R6_P'_P!C
M!8?^E*5^L= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %9>J?\A+0_^OUO_2>:M2LO5/\ D):'_P!?
MK?\ I/-0!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %5-2_Y!5Y_P!<7_\ 035NJFI?\@J\_P"N+_\ H)H
M\:_:2_Y-,\1?]<;#_P!*H*_->OTH_:2_Y-,\1?\ 7&P_]*H*_->@ HHHH **
M** "BBB@ HHHH **** .T^'/Q UCX9^+X_%&@VME<WL<+PA+U'>/:XP>$93G
M\:]F_P"&U/BE_P! #PK_ . MS_\ 'Z^9:* /IK_AM3XI?] #PK_X"W/_ ,?H
M_P"&U/BE_P! #PK_ . MS_\ 'Z^9:* /IK_AM3XI?] #PK_X"W/_ ,?K[)^&
M?BC4/&GPP\/>*M4CMX;W4;43RI;*RQJQ)'RAB2!QW)K\G*_4OX!_\F]^"O\
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M1110 5] ?LA_\G#6G_8/N?\ T$5[]^Q5_P D1UG_ +&";_TFMZ^FJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *R]4_Y"6A_]?K?^D\U:E9>J?\A+0_\ K];_ -)YJ -2BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M JIJ7_(*O/\ KB__ *":MU4U+_D%7G_7%_\ T$T &F_\@JS_ .N*?^@BK=5-
M-_Y!5G_UQ3_T$5;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH SI/^1BL_P#KUG_]#BKX2_;4_P"2VZ-_V+\/_I3<5]VR?\C%9_\ 7K/_
M .AQ5\)?MJ?\EMT;_L7X?_2FXH ^9:*** "O9_V6_P#DYOPC_P!OG_I'-7C%
M=[\)_&UK\.?BGHWC*^L9;VWT_P _=!"P5G\R"2,8)XX+@_A0!^K=%?)O_#;W
MA7_H2-5_\"(Z/^&WO"O_ $)&J_\ @1'0!]945\F_\-O>%?\ H2-5_P# B.NK
M^'?[4&@?$?XAZ7X,L_"^H6-QJ'F[9YID94\N)Y#D#GD(1^- 'T/1110 4444
M %%%% &;9?\ (6U7_KK'_P"BUK\KOBM_R6_QY_V,%_\ ^E+U^J-E_P A;5?^
MNL?_ *+6ODCQE^R+XD\3>//$'B2W\8:9;Q:IJ5S>I$\$A:-996<*2.XW8H ^
M,**^L_\ AB'Q5_T.^E?^ \E'_#$/BK_H=]*_\!Y* /DRBOK/_AB'Q5_T.^E?
M^ \E'_#$/BK_ *'?2O\ P'DH ^3**^L_^&(?%7_0[Z5_X#R4?\,0^*O^AWTK
M_P !Y* /DRBOK/\ X8A\5?\ 0[Z5_P" \E'_  Q#XJ_Z'?2O_ >2@#Y,HKZS
M_P"&(?%7_0[Z5_X#R4?\,0^*O^AWTK_P'DH ^3**^L_^&(?%7_0[Z5_X#R4?
M\,0^*O\ H=]*_P# >2@#Y,HKZS_X8A\5?]#OI7_@/)1_PQ#XJ_Z'?2O_  'D
MH ^3**^L_P#AB'Q5_P!#OI7_ (#R4?\ #$/BK_H=]*_\!Y* /DRBOK/_ (8A
M\5?]#OI7_@/)1_PQ#XJ_Z'?2O_ >2@#TO]BK_DB.L_\ 8P3?^DUO7TU7DWP+
M^%^H?"7P)?>&]2U2WU.:XU*2^$MNC(JJT42;<'O^[)_&O6: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *R]4_Y"6A_P#7ZW_I/-6I67JG_(2T/_K];_TGFH U**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFI?\
M(*O/^N+_ /H)JW534O\ D%7G_7%__030 :;_ ,@JS_ZXI_Z"*MU4TW_D%6?_
M %Q3_P!!%6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH **** "BBB@ HHHH **** ,Z3_D8K/\ Z]9__0XJ^$OVU/\
MDMNC?]B_#_Z4W%?=LG_(Q6?_ %ZS_P#H<5?"7[:G_);=&_[%^'_TIN* /F6B
MBB@ HHHH **** "MGP_KVL>&-=MM<T&^FT_4K;=Y-S"<.FY2C8^JL1^-8U%
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M<?\ @9-_\70!OT5@?\(AH/\ S[W'_@9-_P#%T?\ "(:#_P ^]Q_X&3?_ !=
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MZ$"R_P#!K=__ !='_#5UY_T(%E_X-;O_ .+H _02BOS[_P"&KKS_ *$"R_\
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M 4444 %%%% !1110 4444 %5-2_Y!5Y_UQ?_ -!-6ZJ:E_R"KS_KB_\ Z":
M/&OVDO\ DTSQ%_UQL/\ TJ@K\UZ_2C]I+_DTSQ%_UQL/_2J"OS7H **** "B
MBB@ HHHH **** /TQ_9<_P"39/"/_;Y_Z635[/7C'[+G_)LGA'_M\_\ 2R:O
M9Z "BBB@ HHHH **** "BBB@#.D_Y&*S_P"O6?\ ]#BKX2_;4_Y+;HW_ &+\
M/_I3<5]VR?\ (Q6?_7K/_P"AQ5\)?MJ?\EMT;_L7X?\ TIN* /F6BBB@ KM?
MA3_R6_P'_P!C!8?^E*5Q5=K\*?\ DM_@/_L8+#_TI2@#]8Z*** "BBB@ HHH
MH **** "BBB@#-LO^0MJO_76/_T6M?E=\5O^2W^//^Q@O_\ TI>OU1LO^0MJ
MO_76/_T6M?E=\5O^2W^//^Q@O_\ TI>@#BJ*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH [7X4_\EO\  ?\ V,%A_P"E*5^L=?DY\*?^2W^
M_P#L8+#_ -*4K]8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *R]4_P"0EH?_ %^M_P"D\U:E9>J?
M\A+0_P#K];_TGFH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "JFI?\@J\_ZXO_ .@FK=5-2_Y!5Y_UQ?\
M]!- 'C7[27_)IGB+_KC8?^E4%?FO7Z4?M)?\FF>(O^N-A_Z505^:] !1110
M4444 %%%% !7L7[-MG:WW[1WA6UO+6*ZMW^U[HID#HV+28C(/!Y ->.U[/\
MLM_\G-^$?^WS_P!(YJ /TCM;2UT^T2ULK:*VMTSMBA0(BY.3@#@<DFKU%% !
M1110 4444 %%%% !1110!G2?\C%9_P#7K/\ ^AQ5\)?MJ?\ );=&_P"Q?A_]
M*;BONV3_ )&*S_Z]9_\ T.*OA+]M3_DMNC?]B_#_ .E-Q0!\RT444 %7(9I+
M6=)X)&BEC8.CHQ5E8'(((Z$53HH V_\ A+/%/_0S:K_X&2?_ !5'_"6>*?\
MH9M5_P# R3_XJL2B@#;_ .$L\4_]#-JO_@9)_P#%4?\ "6>*?^AFU7_P,D_^
M*K$HH V_^$L\4_\ 0S:K_P"!DG_Q5'_"6>*?^AFU7_P,D_\ BJQ** -O_A+/
M%/\ T,VJ_P#@9)_\51_PEGBG_H9M5_\  R3_ .*K$HH _7SPJS/X+T-Y&+.U
MA S,W))\M>:W*Q?"?_(CZ#_V#[?_ -%K6U0!FV7_ "%M5_ZZQ_\ HM:_*[XK
M?\EO\>?]C!?_ /I2]?JC9?\ (6U7_KK'_P"BUK\KOBM_R6_QY_V,%_\ ^E+T
M <51110 4444 %%%% !1110 4444 %%%% !1110 4444 ?7_ .Q=I.EZI_PG
MG]I:9:7OE?8-GVB%9-F?M&<;@<9P/RKZ^_X1/PK_ -"SI7_@%'_\37R=^PS_
M ,U!_P"X=_[<U]F4 8,/ACPW#-'-!H.G12QL'21+2-65@<@@@<$5O444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5EZI_P A+0_^OUO_ $GFK4K+U3_D):'_ -?K?^D\U &I1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 54U+_D%7G_7%_\ T$U;JIJ7_(*O/^N+_P#H)H \:_:2_P"33/$7_7&P
M_P#2J"OS7K]*/VDO^33/$7_7&P_]*H*_->@ HHHH **** "BBB@ KT3X.>,M
M*^'OQ?T3Q=K4-S<6%AY_FQV:*TK;X)(QM#,HZN,Y(XS7G=% 'W__ ,-J_"W_
M * 'BK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C]? %% 'W__ ,-J_"W_ * '
MBK_P%MO_ (_1_P -J_"W_H >*O\ P%MO_C]? %% 'W__ ,-J_"W_ * 'BK_P
M%MO_ (_1_P -J_"W_H >*O\ P%MO_C]? %% 'W__ ,-J_"W_ * 'BK_P%MO_
M (_1_P -J_"W_H >*O\ P%MO_C]? %% 'ZC?"OXS>%OB_P#VO_PC6GZI:#2?
M)\_^T8HTW>;OV[=DCY_U;9SCJ.M>I5\9_L,_\U!_[AW_ +<U]F4 9TG_ ",5
MG_UZS_\ H<5?"7[:G_);=&_[%^'_ -*;BONV3_D8K/\ Z]9__0XJ^$OVU/\
MDMNC?]B_#_Z4W% 'S+1110 5UO@/P;JGCWQSI_@_1+BT@O\ 4/,$<EV[+$NR
M)I#N*JQZ(<8!YQ7)5[/^RW_R<WX1_P"WS_TCFH [/_ABOXI?]!_PK_X%7/\
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M^$0\4?\ "2V&JW?]K?9?)_L^*-]OE>=NW;Y$Q_K%QC/0]*]^_P"&U?A;_P!
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M* "BBB@ HHHH **** "BBB@ K+U3_D):'_U^M_Z3S5J5EZI_R$M#_P"OUO\
MTGFH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "JFI?\@J\_P"N+_\ H)JW534O^05>?]<7_P#030!X_P#M
M"6EU??LNZ_:V=M+=3O#8[8H4+LV+J G ')X!-?G;_P (GXI_Z%G5?_ .3_XF
MOURTW_D%6?\ UQ3_ -!%6Z /R"_X1/Q3_P!"SJO_ (!R?_$T?\(GXI_Z%G5?
M_ .3_P")K]?:* /R"_X1/Q3_ -"SJO\ X!R?_$T?\(GXI_Z%G5?_  #D_P#B
M:_7VB@#\@O\ A$_%/_0LZK_X!R?_ !-'_")^*?\ H6=5_P# .3_XFOU]HH _
M(+_A$_%/_0LZK_X!R?\ Q-'_  B?BG_H6=5_\ Y/_B:_7VB@#\@O^$3\4_\
M0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B:_7VB@#\@O^$3\4_P#0LZK_ . <
MG_Q-'_")^*?^A9U7_P  Y/\ XFOU]HH _(+_ (1/Q3_T+.J_^ <G_P 31_PB
M?BG_ *%G5?\ P#D_^)K]?:* /R"_X1/Q3_T+.J_^ <G_ ,31_P (GXI_Z%G5
M?_ .3_XFOU]HH ^0/V+=)U32SX\_M+3;NR\W[!Y?VB%H]^/M&<;@,XR/SKZ_
MHHH SI/^1BL_^O6?_P!#BKX2_;4_Y+;HW_8OP_\ I3<5]VR?\C%9_P#7K/\
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M_P J=Y_\>H _,ZBOTQ_X9<^!?_0C?^5.\_\ CU'_  RY\"_^A&_\J=Y_\>H
M_,ZBOTQ_X9<^!?\ T(W_ )4[S_X]1_PRY\"_^A&_\J=Y_P#'J /S.HK],?\
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MJU*R]4_Y"6A_]?K?^D\U &I1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 54U+_D%7G_7%_P#T$U;JIJ7_ ""K
MS_KB_P#Z": #3?\ D%6?_7%/_015NJFF_P#(*L_^N*?^@BK= !1110 4444
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MONV3_D8K/_KUG_\ 0XJ^$OVU/^2VZ-_V+\/_ *4W% 'S+1110 4444 %??\
M_P ,5?"W_H/^*O\ P*MO_C%? %?LQ0!\S?\ #%7PM_Z#_BK_ ,"K;_XQ1_PQ
M5\+?^@_XJ_\  JV_^,5],T4 ?,W_  Q5\+?^@_XJ_P# JV_^,4?\,5?"W_H/
M^*O_  *MO_C%?3-% 'S-_P ,5?"W_H/^*O\ P*MO_C%'_#%7PM_Z#_BK_P "
MK;_XQ7TS10!\S?\ #%7PM_Z#_BK_ ,"K;_XQ7TS110!FV7_(6U7_ *ZQ_P#H
MM:TJS;+_ )"VJ_\ 76/_ -%K6E0 4444 %%%% !1110 4444 %%%% !1110
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M/^%L?%+_ **7XJ_\'-S_ /%T ?J?_;UG_P \-0_\%MQ_\11_;UG_ ,\-0_\
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M+_HI?BK_ ,'-S_\ %T ?J?\ V]9_\\-0_P#!;<?_ !%']O6?_/#4/_!;<?\
MQ%?EA_PMCXI?]%+\5?\ @YN?_BZ/^%L?%+_HI?BK_P '-S_\70!^I_\ ;UG_
M ,\-0_\ !;<?_$4?V]9_\\-0_P#!;<?_ !%8/PWNKJ^^%'@R^OKF:ZNKG1;*
M::>9R\DKM;H69F/)))))/)-=G0!E?V]9_P#/#4/_  6W'_Q%']O6?_/#4/\
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M *3S4 :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !534O^05>?\ 7%__ $$U;JIJ7_(*O/\ KB__ *": /$/
MV@/^3-M6_P"O+3?_ $IMZ_.&OT>_: _Y,VU;_KRTW_TIMZ_.&@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ^YOV(?\ D2/%O_80B_\ 1=?65?)O[$/_
M ")'BW_L(1?^BZ^LJ "BBB@#*G_Y&O3_ /KRN?\ T."OA;]M3_DMNC?]B_#_
M .E-Q7W3/_R->G_]>5S_ .AP5\+?MJ?\EMT;_L7X?_2FXH ^9:*** "BBB@
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M** "BBB@ HHHH **** "BBB@ JIJ7_(*O/\ KB__ *":MU4U+_D%7G_7%_\
MT$T >(?M ?\ )FVK?]>6F_\ I3;U^<-?H]^T!_R9MJW_ %Y:;_Z4V]?G#0 4
M444 %%%% !1110 4444 %==\/=-L-8^)WA/1=4@^TV&H:M:6MQ%N9?,B>9%=
M<J01D$C((-<C7:_"G_DM_@/_ +&"P_\ 2E* /OS_ (9<^!?_ $(W_E3O/_CU
M'_#+GP+_ .A&_P#*G>?_ !ZO9Z* /&/^&7/@7_T(W_E3O/\ X]1_PRY\"_\
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M^5;P_P!GVK[%]-S1%CU[DUY510![/_PU'\=?^AZ_\IEG_P#&:/\ AJ/XZ_\
M0]?^4RS_ /C->,44 >S_ /#4?QU_Z'K_ ,IEG_\ &:/^&H_CK_T/7_E,L_\
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MU:E9>J?\A+0_^OUO_2>:@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *J:E_P @J\_ZXO\ ^@FK=5-2_P"0
M5>?]<7_]!- 'D_Q7\,ZYXO\ V9;KPUX;L?MVJWEG8""W\Q(]^R:%V^9R%&%5
MCR>U?&/_  RY\=?^A%_\J=G_ /'J_1SPW_R*FD?]>4/_ * *U: /S._X9<^.
MO_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZOTQHH _,[_AESXZ_P#0B_\
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M_0?\*_\ @5<__&*/^&*_BE_T'_"O_@5<_P#QBOOZB@#X!_X8K^*7_0?\*_\
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M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,J?_D:]/\
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M"W[:G_);=&_[%^'_ -*;BONF?_D:]/\ ^O*Y_P#0X*^%OVU/^2VZ-_V+\/\
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M?_7ZW_I/-0!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD$\[%<[.N&4_B* /DVBNT_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\
M@FN?_B* .+HKM/\ A4_Q2_Z)IXJ_\$US_P#$4?\ "I_BE_T33Q5_X)KG_P"(
MH XNOV8K\F_^%3_%+_HFGBK_ ,$US_\ $5^I_P#;UG_SPU#_ ,%MQ_\ $4 :
MM%97]O6?_/#4/_!;<?\ Q%']O6?_ #PU#_P6W'_Q% &K165_;UG_ ,\-0_\
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M/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">&H?^"VX_^(H
MU:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X
M+;C_ .(H_MZS_P">&H?^"VX_^(H U:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GA
MJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">&H?^"VX_^(H U:*R
MO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_
M .(H_MZS_P">&H?^"VX_^(H U:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@
MMN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">&H?^"VX_^(H U:*RO[>L
M_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H
M_MZS_P">&H?^"VX_^(H U:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_
M (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">&H?^"VX_^(H U:*RO[>L_P#G
MAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS
M_P">&H?^"VX_^(H U:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@
M#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">&H?^"VX_^(H U:*RO[>L_P#GAJ'_
M (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5HK*_MZS_YX:A_X+;C_ .(H_MZS_P">
M&H?^"VX_^(H U:*RO[>L_P#GAJ'_ (+;C_XBC^WK/_GAJ'_@MN/_ (B@#5K+
MU3_D):'_ -?K?^D\U)_;UG_SPU#_ ,%MQ_\ $5G7%]'J&K:0MO;WA\FZ:1VE
MLYHE5?(E7)9E ZL!^- '34444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 445C:DVLM!''HJVJW$C%6GN@S1P
M+C[VQ2"YS@;=R]_F&.0#7HKQOX4_$#QIXL\6>*_#_BK1]/,6@7)MH]7TE9%M
M;B0'#1@.S?,!@G#<="!W]ESS2Z)]PZM"T444P"BBB@!**\F\4?%:'1/C1I7P
MY-YIND?:]/-\^I:F28V8N42!%WH-QVDY+=L $FNEAU[6M%;Q'=^-GT^#1=,M
MX[N#4;6.1%DBPYDWJS-AEVC@$Y!![X"OI<H[2C%>0?#7Q]XP^*%K?^)M-L=/
MT+PM]H>#3&N[>2XN;Q58AI&VR(J#(QCYN<C/&3L:MXZOO!.B^*==^($=M%I6
MD&)K.YLH73[:KKPH5F;#[SLQG'<D \&R)W/1J*\D\!^*/B5X[^'7_"7K:Z%H
MTE\KRZ783V\TY:,?<,L@E7&XCLO P><X&?X'^,DWCSX?^(;BWM;?1?&'AU95
MU#3[B-IXHW0-@C#*2K%".N001SP2=6NP+6UCVK%+Z5\OV/QT^(%Q^SK/\6Y;
M;P^7M+[[/+IZ6DR!T,BQY5S.<'+@]#TK2^(7QP\7>'E^&5_H=EI0L_&T<<C0
MWUM*\MIN$/1EE4-_KC_".@II-NR[V%H?2%%<2M[XN7Q380QW6DZCI0GDM]16
M"SDBFM6\DR1MN,S#!)0$;<_.*T_%GBC1O!?A2_\ $VOW/V;3[&/S)& R22<*
MJCNQ)  ]30]!K4Z&C;Q7D'PW\8?$/XD> 9/%R6NBZ!#>22?V9:3V\MRSQJ<!
MY'$J=6!'"]!GG.*K^ OBY>>./#GB>SEL[;1?&GAAI8]0LI4:> ,A8;DPRDJ2
MA'WL@CN,$IZ-I[H%W1[12UX3\(/B;XR^)7PWD\5:M>Z#H\HU%M/1(]/F="Q\
ML)UN 22T@&*]9T.37)M MVUU;:/5=K+-]GC98MX8@,JEB0IP#@L3SUIM-"3N
M;=)CI7@WA'XK>+K[]H'Q#\+?$QT:S-C"\MA-!9S(]WPK(?FG8?<8,0.NUN12
M>"?BOXRU']H+7_A?XPCT:'^SH7FMIM/M94:Y VLN=TSA24<-C!Z$9I+6R[JX
M]K^1[YV%%>5ZE\1+KPOX,\9^-O$DEI-HVE7+PZ:MM T,EUMVH06:1P29BT8(
M 'R%L$&F>#?$WQ&\9?#.#QI"NAZ=<:A ]U9:8]G-,0@)V*\OG+DL .0@QNZ&
METN.QZM2"O"_"OQLN/'7P1\0^--%M[+3-?T&">2\L+E6N(U:.-G7HT;;7"\'
M/!##G&:Y_P /_&+X@:[^SSJ?Q0=/#T5UI\DNZQ%C-LE1&4$!_M&5)!/8].E/
MJUV)[>;L?2O:EKQ>;XJ:]??LU#XKZ/9V5E>K8O=O9WD,DT;,CE"H*NA )4D'
MG@BIOAY\3]7\4?!K2?%FM+9?V]K!N!:Z?IMH[F0QR,FU8VERW"9+%U4;AD@<
MT;7\A]#V.BN:\+KXN_L6.3QE=:7)J4BAFCTRVDACA..5R\KE\>OR_2NEI@%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<AXM\6>#_  S'9Z=X
MPUJ+2X]<=[. S.\:R';\P\Q>(^#]XE>HYS77UCZSH&A^(K$6/B#1;'6+0,'$
M%];)/&&'0[7!&?>I ^?/A7X;'@W]H3Q1I_@W5)Y/AX--%Y,GVDS6MO=.4^3>
M207"JQSG.TC)/%>X^$?&GAOQUHQUGPGJ\>JV"3/;M*B,FV1<94A@"."#TY!!
M'!K8T[3--T?3XM.TFPMK"RB&V.WMHEBC0>@50 *BTO1]+T.R^PZ)I=IIEH&+
M^19P+#'N)R3M4 9)ZFJZ6["ZW[FO1110,**** /"?B;X1^'?Q8\9W7@'Q$HT
M_P 4V=A#=V%_$ZK.T3L^54'AU5E.Y3GA\C!YKSWPSX7^(C>"?BW\);[Q(_BF
M'3;&"+3+LRE@'*,WV<$DE3M504)(7CL>?IW5-!T/6[2:SUK1;'4[:8J98;NV
M29)"OW=P8$'&3C/2K6FZ9INCV$>GZ1I]MI]G$,1V]K"L4:#T"J !2Z-+J.^S
M['B?[+NN6<_P7M?"LF;/7/#\\]O?6,XV31;I6D#%#\P!#XR1U!':M7X[:+<?
M$?X'^(=(\)R+J5]:RQR^5 =WFM&RNT:D<,VT]!GG ZUZ-K'@[PAXBN8[GQ!X
M5TC5KB/_ %<M]8Q3LGT+J2.E:\4$=O"D,,:QQHH540850.@ '04WKZB6AY5\
M$_%FAW?P"T.\FO8+)-$L5L]069@AM'A&QO,!^[G;NY]:\G^!^AZG-8?%CXF7
M5J]GH_B);IM/$BE#-'F60R '^'Y@ >YW>E?2.H>"O!NK:JFJZIX2T:_U%,;;
MNYL(I9EQTP[*3Q]:O:KH>CZ[IITS6M(LM3L20QM;RW2:(D=#M8$<=N*3W<NK
M5@7NI+H?-_[.'@?POXR_9\AM_$EG+J-JNISLUJ]Y,L!92I!:)7"'UY%4OVH[
M>TM?&WPAL8D2VMH;R6-8XCY8CC$EL !C&T #C'3%?2&C>#?"/AJXDN/#OA72
M-&FE79))86,5NSKG."44$C/:H-2\ >!=:U"34M<\%Z'JE]( 'N;S389I6 &!
MEF4DX'%._O)]M16T?F8-FVE_#>6ZM=0U9[N7Q%KZG3X)K@R7#F811[<N<L$V
MN<\X11SFHOCMX1U7QO\ !+7] T5/-U%ECGAA[S&.19"@]R%('OBNAT_X=_#[
M2-1AU#2? OA^PO(&W17-KID$4D9Z95E4$'Z5UN*):^HUH>+?L_\ B;2;KX!:
M4LT\5A+H4;V>HQS,(S:O&QR7!^[D8;GU->;?!71[[4/$?Q;^)PMY8-!UQKM=
M.DE4I]I0R22&10>J@;1GU)'8U]':EX+\'ZQJD>JZQX4T?4=00#;=75A%+*N.
MF'921CZU;U+0]&UK2AI.L:/9:EIQQ_HEW;I+"=O*_(P(XP,<<4MY.75H%HK=
M#Y=_9J\(_P#"2?!6RNK?4;B"XTWQ6EZT8N9!#*D?DLRM&#M)QD@XSN"\XKZ\
MQ7,:-X(\&^&KY[[P[X1T;1[MXS&TUA816[LA()4LB@D9 ./85TU7>XDK:GRW
M^TCI-[X<\=^ ?BMX=M7.J6VHI87 BRK7 )S&A('0CS4)[AP*S?BEX2\1?#SX
MA?#[XE:"/[3UA[E-,U1(P5-]<3,[,>^%??(H_N@(!TX^I;NSL]01(;RSAN8X
MY$F59HPX5T8,C 'HRL 0>H(!%27%K;7!B:>W28PN)(_,4-L<9 89Z'D\^]0M
M+>3O_P  >]_-6/'OCEX)U+6/V;[_ ,/Z/&]W>Z?%!<".*,LUQY3 O@#DL1N;
MW/UK0^#OB;1XOV=?#^I37D$$6D:8(;T.X4P-""K!Q_"<J>#ZUZ]7,7G@?P5J
M6K#6M2\'Z+>:F&#"\N-/ADF!'(.\J6R/K1;?S#MY'RI\%?"FI:7^SS\5O&&H
M1O:V^O:;<K:P2*5)2.&4^9SP03)@?[IKBO#^C^*?^&6;7Q9H&H27>CZ3JDLF
MMZ#)(Q@OH1)&P+*#T'\0XRIS_#7W?K&A:+K]D-/\0:39:M9AA)]GO;=)X]PZ
M-M<$9&3S[U2TGP7X/T)+N+1?">CZ9'>IY=PMG8Q0B9.?E<*HW#D\'/4T^K?D
MDOD#UMZMGDOBCQ%X;\3?L=ZSK/ABW@T_3)-&*)91%<6;#"F'"\#!&.@SP>]?
M/_A.P\5?#OX6>"OCUX=U*6^LK2.;3]3TJ9F*K UY*#M/(5&.SC'#X;G)Q]D_
M\*K^&.TQ_P#"N_#.UB"5_LBWP2,X.-GN?S-6D\ >!(]&ET./P7H2Z5+*)Y+%
M=-A$#R 8#E-NTL!WQFC9M]P^RDR7P;XPT'QUX7L_$&@WB7-K<1J[*KAG@8C)
MC<#[K#H174USNB^#_"/AF2:;PWX9TG1I)U"ROI]E%;F0#D!BBC(^M=%0[=!*
M_4****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!YO\3O'6M> /"]UX@T_P>VN6=DHENI&U".U6./."5R&9
MF''&T>Q/2NNT/5H]<\.Z=K<,,MO%?VT5TL4RX>,.@8*P[$9YKR/XL:_\+_$U
MUJ/PG\=-J%G?^0EW9S+:R$RN02K6Y0,79>A4C!Z<X.-WP#XB7PKX.\!>"?'6
MJRIXPU:RVPP2PR/)(47<59PI4,B%02Q&2*%K<'NOQ-+2/BAI.M?%S4?AO;:5
MJ45_IMF]Y/<74/DQE0\:KY8/S,#OSNP!QQG/'HOI7S!H?BKPRO[</B&X;Q%I
MJQ3Z''I\4ANXPLESYD(\A3G!DR"-HYR",5]/4ELF#T;'T444P"O+H/BA/XF\
M8ZQX9^'NBPZ[-H<GDZG>7U\;&VMY26 C5A%*\C91@<)M&.M>HGI7S'\)HX?@
M_P".?B!I/C^\@T&VU;41>Z9J5]((K:]CS*3B5OD#@%<H2&Y/%2,]7\%_$C3_
M !9K^M>%[BPDTKQ/H3!;^P=Q*BYZ/%( /,0\<D*>1D"O0>]?,7@GP*WC3XX_
M$_QE?Z:[>$M>L3IMG<31_N[T,(P98PWWE'E9#8QR"#6A\#_#/B;3_"MUX<US
M1;:.Z\$7=Y:Z;<31*3<3R#>LBD\JH5^O<2#^[3;MTUM<5KO?J?1]'>OD'X*6
MNFZM'I-]X@UBYTSQ-X3GOUUVS>S>,W*2EBSWTSMM9 O0MC&TC!XK1_9Q\)^
M_%'AK5KK4(;/5M1TS7KF>W@,^X6L3KL4B,'&QQOZ@AMO?:,/_*XK]?.Q]6X!
MKGO#^JZ_J%UJ\6M>&3HL%K=&*RF-['<?;H>TV$YCS_=;FO#OA7X-?P[XU\3_
M  GOO#\=_P"&=&U)-=L[^YB5U82QXCB8'JRGD-_TS;IQ7CD=[J(\"_&C_A$V
M2X1/%275W!:$,S:>)I2S!5()CR%!Q@;<\XS2[>8^_D?>F,FCT-?,_P#PKGPS
M\0OA;XVU'0-4FU2RUZWCO]/B33S;6EC=1(V/LR.25+$;7VGU&>U<7H6C^,M=
MU?X?_$Z+18Q<^+["7P[>Q",;+>,0E$NL$<Y2-Y,'C"A<\BG;<%;>Y]GT50T^
MRM=+TRVTVQA6"UMHEABC0 !548  'L*OT %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 G>BO"_'WQ$\?>'?C?X5\"Z//H"Z?XD#>7/>:?--+:E1\V=MP@DR1D<+
MC..<9.IHWQ3U#3_BQ/\ "_Q];6%KJK6IOK'4[%FCM;N$*2V4D8M&P".<;F'R
MGGC)2U5T#T=F>PT5RB^/O!+VEM>IXUT%K:ZG-K!,-2A*33#&8U;=AF&1\HYY
M'K2WWCKP7I-]=6.I^,M$L[NS4/<P7&H0QO I( +JS J,LHR?4>M,#JJ*Y^\\
M5>&=-2/^T?$FF6?F!&3[1>1Q[@_W",D9SV]:YS6OB;X=T;XEZ'X#N+J)M1U2
M.6>1VE"):QJA92Q/!+D !<^I] 3<#T.BN$\->+!J#^)+K4O$'A:ZT_3[PI#+
MI-_YOV:''2Z+'"29#9QQCZ5MP>*O#5QI=WJ%OXBTR6SL5#W5PEW&T=NI&078
M'"C'/..* .@HKE]+\=^"=:U"+3]'\9:)J5Y*I>.WM-0AED=1U(56)(]ZUM2U
M33=&L7OM6U"VT^SBQON+J58HTSP,LQ % &E1WKA_$WQ"T/0O >N^+M/O;/6;
M;1X))'2UNT(>11Q$7&0K$X'<\]*R?A1XI\9^-/#B^*->305TC4H8[C3TTPS>
M?%G.^.8.2I*G #*1G!RJ]!('IE%>'^%/BIKGCJ36KKPQ<:#'<:;<3VZ>&-0#
MQZA,8Q]]I1)A Q[>2P&,%LY(B\:?$#X@:#\8_"'@W2IM!BM/$\;,LEWIL\LM
MFR+E@=MP@DR<XX7 XYQDOL.UKWZ'NN.*,5\]1_&+QEJ'AOXB1VUKH]KK_P /
MVD:[G>WFFL]111+Q&HE1H6_=]VDQ[YX;HOQF\76LOPWN?%5OH]_8^.@(XH]+
MMIH)[&0E1E@\L@E3YADC:1SQ3[$['T31110,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW_ /\C"T?XG:MXJM/!FGZ+;66GZWXDTN75))[Q&F@M5B*JP6)71I"S-P-ZX
MR2<8-S6O''BC1[70])U.RBL?$E_!<S326FEW>KP(L$B)O6&V_>;9/,1AN8;
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M&1UZ28X5L[2V5#::Z M3W;%+7(^*M<\1>'O UWKFG>&XM:U.S@$\FFQ7AC#
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MN%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVZ\\>LTA/(HM<+GDVA_#SQ/X?U+POJECJ6G?:=-T*/P_?V\JNT=U%%S%*C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;J='=(Y#+(I\O" ?)SEC\PVX+=D[>@TF]3U&XN;>SM);J[N$MX(E+22R,%5
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M&F?+C19+5L*N2!W/<D\UUGAW0SX?TZ2UDUB_UB:>=[B6\U!T::1FQ_SS1%
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MW+*S 2N$R ,D\GH!R:S[6]O'\07BR:CIDFF);Q20PQ9^T1D[MSR'<5V$8VX
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M4E3;;R*ON>=_"?3-!T_P=<77A6^U>]TC4[Z;4+>34HA#_K2&;R8_+C*1%LD
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M94# 21Q2C:T8!P64XRH%?87>EJN9A9'#^)M<TB^^$^N:WI^_Q)I<EA.P&CW
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M#X&M?[0U";4+FX562:5<,MNJA+=,>HB5,]RQ8GK41O;4IVOH8?Q2N-3F\;>
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MS\KX' Y]+>L^"_B)I?Q!NO$WP_\ $&BBWUF&WAU2UUVWED&^%2JSQF(J2Q7
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M'(>S:["6MO,]SHKY]\'ZUXD\46WA#6AXNLM-UB.^9=8L)-3EFDN,LRR6QM"
ML3+U!'*A<]"37NEO=6UY$9+6>.= Q0M&X8!@<$9'<4^EP>CL7J*** "BBB@
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M(RNU3R>@[FH6\!^!6O+*\;P7H;7&GJD=I,=-A+VRH<HL9VY0*>0!C':NKHH
MP=%\+^'/#?G_ /".^'M,T87+!IQ86L=OYI&<%M@&XC)Z^IJ&?P?X1NKNYO+K
MPEH\]S=2I/<326$3/-(GW'=BN69>Q/([5TE% &))X=\/S>((O$,VAZ?)K,2>
M7'J#VJ&X1.?E$F-P')XSW-+<>'M!NM?M]>N=#T^?5[9=D-_):HT\2\\+(1N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMBGL 4444 %%<WX@\7>'?"YTQ=>U);%M5NTL;,.K,9IG^ZHV@X^IP!W(KI*
M"BJDLT,"H;B5(][!%+L!N8\ #/<^E8VF>+O#>K>(]8\.Z?JD5UJVB^6+^W16
MS 7!*Y)&#T/0G'?% '24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR[+ZZCU:\#W ]&_>^W:CJ+H?*_@?X@>(/AK\+_BAK7AVUAN=%M]?6VT=Y<M
MCN[AV4 C(""(XX&2/I7L_P#PD7QDA\ >++JSTF_OKB%+.ZT6:X^P&^N87(^T
M );&2+*@$QDH<@C(<C!]+_X5OX%7P,_@=?"]FOAV4[GLE4A&;(.[(.[=D [L
MYXZU-I'@?PWHNBQZ/IMK=1V<1C\L2:A<2O$(_N*DCR%U5<G"@@#)XY-'EZ"Z
M^KN>(7WQPU&3PQX/@T7Q#/\ :?$&O+I-_=ZC911W>C "-9(V0*(S*"Q;>4V\
MGY,# UOC%KWQ(^&_PLTG4+#QT][K/]LI:-<G3;:(7,,@9E21"K ,NT#<FP')
M^7I7HNH?"/X>ZMHLVD:MX=BO+:>];49&>>7SFN&&#*9=_F;L<9W= /2IM;^&
M/@OQ)H%OH6N:;=ZA86]P+I%FU*Z,AE VJ[R>9O<@< LQP.E-VNO4-;6/,/B=
M?_$#P1=>#9KOQPNK?VMXKA@,!TBVCCAMWP1&-RNV5*MB0,K8<YR0",5O&_Q(
MNO&/QELX/'MU:V_@R!K[3HOL%FP;"N_E2$PY*87;G(;H=W7/NOB3P+X9\8+I
M*^(K&:\&E3K<VA%Y/$8I5Z/E'4LPQU;/?UKR+PC\,-8N?C'\2[KQAX5U"'PS
MXB*K;S#4E59T0E2LBPS^80X.0&!XSNQG!2Z_,;Z,YKQ!XG\0>./&OP-U8:[J
M.A)XA6::6SM&C,4$R+CS462-@Q.XX\P. ,8 Y)OCXE>+?"/B7XU276H#6U\,
MV]K)8BZM((W+2#CS&ACC+@;AU[#ZFO;]4^'?@W6DT-=0T-%;0/\ D&-:S26S
M6@P%VHT3*=N !CIQTJ&'X7^!8-4U[4O[#WW'B"+R=3$MS-)'=)C 5HV<H !P
M, 8[8H7X"Z>>AY3X>^(GC*/Q!X9T/5=>FU$^+_"CZRDPM8$?2[GRFD_=[4 :
M/' $@<Y R3R*X[P/\7/BA-I_PQ\0:UXL35;;Q+K4VDW5@^GP1+L#A1)O10VX
M;LC&!P,@\Y^B]+^&O@[1Y?-T_27CD&G_ -E1R/=3R-#:_P#/&,NY,:_[N.WI
M61;?!#X9V=EI%C:Z#<0V^C7+7E@BZI=@6\S$$NO[WKD#K3OL-ZW.2TGXB>+;
M#XY7O@WQ_<7.B1ZCJ#+H"BSCDLKZU7.%60#>LQ^4DLS#G&U#C/O0KDF\!^&9
MM5T_4I["6:XTZZDO;02W<SQP3.26=8RY0'+-VXSQBNNH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8Y8$J!D9R+%K\;+:\\*^"+N/1?\ B?>,BPT[3'NB(D*MAS+.(R54 CD1DG.
MO>C?5 >S45\\_%SXE?$+PYX=\'+::'!X?U'7-76PO();T3,H#C"QRHI 1Q_'
M@.H/W,]*B^.M!\,_M%>+=2\6>'3I&K:=X:2YO=1M-7DNX&A!AQ$D30Q_-N8
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MNH?LXQW7P<?X=VOBPPM<ZL=8N]1DL/,,LIXPL8D7:,8ZLW2OH"BF&QY-X?\
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M='_"V/A9_P!%+\*_^#FV_P#BZ_)JB@#]9?\ A;'PL_Z*7X5_\'-M_P#%T?\
M"V/A9_T4OPK_ .#FV_\ BZ_)JB@#]9?^%L?"S_HI?A7_ ,'-M_\ %T?\+8^%
MG_12_"O_ (.;;_XNOR:HH _67_A;'PL_Z*7X5_\ !S;?_%T?\+8^%G_12_"O
M_@YMO_BZ_)JB@#]9?^%L?"S_ **7X5_\'-M_\71_PMCX6?\ 12_"O_@YMO\
MXNOR:HH _67_ (6Q\+/^BE^%?_!S;?\ Q='_  MCX6?]%+\*_P#@YMO_ (NO
MR:HH _67_A;'PL_Z*7X5_P#!S;?_ !='_"V/A9_T4OPK_P"#FV_^+K\FJ* /
MUE_X6Q\+/^BE^%?_  <VW_Q='_"V/A9_T4OPK_X.;;_XNOR:HH _67_A;'PL
M_P"BE^%?_!S;?_%T?\+8^%G_ $4OPK_X.;;_ .+K\FJ* /UE_P"%L?"S_HI?
MA7_P<VW_ ,71_P +8^%G_12_"O\ X.;;_P"+K\FJ* /UE_X6Q\+/^BE^%?\
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M_)JB@#]9?^%L?"S_ **7X5_\'-M_\71_PMCX6?\ 12_"O_@YMO\ XNOR:HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!]_?L5?\ )$=9_P"Q@F_])K>OIJOF7]BK_DB.L_\ 8P3?
M^DUO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5Q?Q6_Y(AX\_P"Q?O\ _P!)GKM*XOXK?\D0\>?]B_?_ /I,
M] 'Y-T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MW]^Q5_R1'6?^Q@F_])K>OIJOF7]BK_DB.L_]C!-_Z36]?35 !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7%_%;_D
MB'CS_L7[_P#])GKM*XOXK?\ )$/'G_8OW_\ Z3/0!^3=%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!]_?L5?\D1UG_L8)O\ TFMZ
M^FJ^9?V*O^2(ZS_V,$W_ *36]?35 !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7%_%;_ )(AX\_[%^__ /29Z[2N
M+^*W_)$/'G_8OW__ *3/0!^3=%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!]_?L5?\D1UG_L8)O_ $FMZ^FJ^9?V*O\ DB.L_P#8
MP3?^DUO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5Q?Q6_Y(AX\_[%^__P#29Z[2N+^*W_)$/'G_ &+]_P#^
MDST ?DW1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ??W[%7_ "1'6?\ L8)O_2:WKZ:KYE_8J_Y(CK/_ &,$W_I-;U]-4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
M7\5O^2(>//\ L7[_ /\ 29Z[2N+^*W_)$/'G_8OW_P#Z3/0!^3=%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]_?L5?\D1UG_L8)
MO_2:WKZ:KYE_8J_Y(CK/_8P3?^DUO7TU0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5Q?Q6_Y(AX\_[%^_\ _29Z
M[2N+^*W_ "1#QY_V+]__ .DST ?DW1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ??W[%7_)$=9_[&";_ -)K>OIJOF7]BK_DB.L_
M]C!-_P"DUO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5Q?Q6_P"2(>//^Q?O_P#TF>NTKB_BM_R1#QY_V+]_
M_P"DST ?DW1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W]^Q5_P D1UG_
M +&";_TFMZ^FJ^9?V*O^2(ZS_P!C!-_Z36]?35 !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7%_%;_DB'CS_ +%^
M_P#_ $F>NTKB_BM_R1#QY_V+]_\ ^DST ?DW1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ??W[%7_)$=9_[&";_TFMZ^FJ^9?V*O
M^2(ZS_V,$W_I-;U]-4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<7\5O^2(>//^Q?O_ /TF>NTKB_BM_P D0\>?
M]B_?_P#I,] 'Y-T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'W]^Q5_R1'6?^Q@F_P#2:WKZ:KYE_8J_Y(CK/_8P3?\ I-;U]-4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<7\5O\ DB'CS_L7[_\ ])GKM*XOXK?\D0\>?]B_?_\ I,] 'Y-T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W]^Q5_R1'6
M?^Q@F_\ 2:WKZ:KYE_8J_P"2(ZS_ -C!-_Z36]?35 !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7%_%;_DB'CS_L
M7[__ -)GKM*XOXK?\D0\>?\ 8OW_ /Z3/0!^3=%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"%3_"S_HFGA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^":V_^(H_X5/\+/\
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M *)IX5_\$UM_\179T4 <9_PJ?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\
M!-;?_$5V=% '&?\ "I_A9_T33PK_ .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\
M$5V=% '&?\*G^%G_ $33PK_X)K;_ .(H_P"%3_"S_HFGA7_P36W_ ,179T4
M<9_PJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q%=G10!QG_"I_A9_T
M33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\179T4 <9_P *G^%G_1-/"O\
MX)K;_P"(H_X5/\+/^B:>%?\ P36W_P 179T4 <9_PJ?X6?\ 1-/"O_@FMO\
MXBC_ (5/\+/^B:>%?_!-;?\ Q%=G10!QG_"I_A9_T33PK_X)K;_XBC_A4_PL
M_P"B:>%?_!-;?_$5V=% '&?\*G^%G_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_
M  36W_Q%=G10!QG_  J?X6?]$T\*_P#@FMO_ (BC_A4_PL_Z)IX5_P#!-;?_
M !%=G10!QG_"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$5V=%
M '&?\*G^%G_1-/"O_@FMO_B*/^%3_"S_ *)IX5_\$UM_\179T4 <9_PJ?X6?
M]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\ "I_A9_T33PK_
M .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $5V=% '&?\*G^%G_ $33PK_X)K;_
M .(H_P"%3_"S_HFGA7_P36W_ ,179T4 <9_PJ?X6?]$T\*_^":V_^(H_X5/\
M+/\ HFGA7_P36W_Q%=G10!QG_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7
M_P $UM_\179T4 <9_P *G^%G_1-/"O\ X)K;_P"(H_X5/\+/^B:>%?\ P36W
M_P 179T4 <9_PJ?X6?\ 1-/"O_@FMO\ XBC_ (5/\+/^B:>%?_!-;?\ Q%=G
M10!QG_"I_A9_T33PK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$5V=% '&?\*G^%
MG_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_  36W_Q%=G10!QG_  J?X6?]$T\*
M_P#@FMO_ (BC_A4_PL_Z)IX5_P#!-;?_ !%=G10!QG_"I_A9_P!$T\*_^":V
M_P#B*/\ A4_PL_Z)IX5_\$UM_P#$5V=% '&?\*G^%G_1-/"O_@FMO_B*/^%3
M_"S_ *)IX5_\$UM_\179T4 <9_PJ?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX
M5_\ !-;?_$5V=% '&?\ "I_A9_T33PK_ .":V_\ B*/^%3_"S_HFGA7_ ,$U
MM_\ $5V=% '&?\*G^%G_ $33PK_X)K;_ .(H_P"%3_"S_HFGA7_P36W_ ,17
M9T4 <9_PJ?X6?]$T\*_^":V_^(H_X5/\+/\ HFGA7_P36W_Q%=G10!AZ+X>T
M/PU9/8>'=#L-'M9)#,T-A;);QLY !8J@ )PJC/7 'I6Y110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTVYUFU7R6N=.E=XYT4 *[;T0A^Q !'&<\X'9TQ(****!A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNV\$:*UW%'#+]BA^6)S(,;!@Y*KSCMCCWKI^U4R(W:NQ:***"@HHHH ****
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MC:))$&5W<'/0$BCIO@*XTC5O#^H6.MH4T;2KG3%BN+5I/,\YXW# ^8-JJ8E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ltbr_ex102img5.jpg
<TEXT>
begin 644 ltbr_ex102img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MGVXW;&+8;&1G'3(H ZVBL.Q\1Z!J6B2:WINN:?>Z5&&9[VWNDD@4*,L2X)4
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MH)(IH7#I(A&0RL."".010!H45S>O>+?#OAB338M>U6*REU2Z2RLXV#,T\S$
M*JJ">I&3T&>2*Z2@ HK"L/$WAO5M2N]+TKQ!IU_J%GQ<VMM=QRRP<X^=%)*\
M\<BMV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1N@'S?*S=.A/%;'Q5^']YX\T/21I=[#:ZMHFI0ZI9_:-WDRO'G]VY4$A2#U
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MUY?,W=2U2S^%>EZQXB\2>)M1O]!*V\5A9SM]HN(I,N#%&Q^:4L67!=F;@Y;
M&*\WQBT&VTWQ/<7FC:Q:ZEX8A6YU+1Y%@^U1PL PD7$IB==ISQ(3VQG JO\
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M ?&?[<W_ #3[_N(_^VU?&=?9G[<W_-/O^XC_ .VU?&= !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %??W[%7_)$=9_[&";_P!)K>O@&OO[]BK_ )(C
MK/\ V,$W_I-;T ?35%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?&?[<W_-/O\ N(_^VU?&=?9G
M[<W_ #3[_N(_^VU?&= !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?
M?W[%7_)$=9_[&";_ -)K>O@&OO[]BK_DB.L_]C!-_P"DUO0!]-4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!\9_MS?\T^_[B/_ +;5\9U]F?MS?\T^_P"XC_[;5\9T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5]_?L5?\D1UG_L8)O_2:WKX!K[^_
M8J_Y(CK/_8P3?^DUO0!]-4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!\9_MS?\T^_[B/\ [;5\
M9U]F?MS?\T^_[B/_ +;5\9T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5]_?L5?\ )$=9_P"Q@F_])K>O@&OO[]BK_DB.L_\ 8P3?^DUO0!]-4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!\9_MS?\ -/O^XC_[;5\9U]F?MS?\T^_[B/\ [;5\9T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5]_?L5?\D1UG_L8)O_ $FM
MZ^ :^_OV*O\ DB.L_P#8P3?^DUO0!]-4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\9_MS?\T^
M_P"XC_[;5\9U]F?MS?\ -/O^XC_[;5\9T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5]_?L5?\D1UG_L8)O\ TFMZ^ :^_OV*O^2(ZS_V,$W_ *36
M] 'TU1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'QG^W-_S3[_N(_\ MM7QG7V9^W-_S3[_ +B/
M_MM7QG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W]^Q5_R1'6?^
MQ@F_])K>O@&OO[]BK_DB.L_]C!-_Z36] 'TU1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'QG^W
M-_S3[_N(_P#MM7QG7V9^W-_S3[_N(_\ MM7QG0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7W]^Q5_P D1UG_ +&";_TFMZ^ :^_OV*O^2(ZS_P!C
M!-_Z36] 'TU1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'QG^W-_P T^_[B/_MM7QG7V9^W-_S3
M[_N(_P#MM7QG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W]^Q5_
MR1'6?^Q@F_\ 2:WKX!K[^_8J_P"2(ZS_ -C!-_Z36] 'TU1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU 'C%%>S_\
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MQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\ \,N?'7_H1?\
MRIV?_P >H_X9<^.O_0B_^5.S_P#CU 'C%%>S_P##+GQU_P"A%_\ *G9__'J/
M^&7/CK_T(O\ Y4[/_P"/4 >,45[/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0
MB_\ E3L__CU 'C%%>S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X
M]0!XQ17L_P#PRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./4 >,45[/_
M ,,N?'7_ *$7_P J=G_\>H_X9<^.O_0B_P#E3L__ (]0!XQ17L__  RY\=?^
MA%_\J=G_ /'J/^&7/CK_ -"+_P"5.S_^/4 >,45[/_PRY\=?^A%_\J=G_P#'
MJ/\ AESXZ_\ 0B_^5.S_ /CU 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/C
MK_T(O_E3L_\ X]0!XQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.
MS_\ CU 'C%%>S_\ #+GQU_Z$7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]0!XQ
M17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\ \,N?
M'7_H1?\ RIV?_P >H_X9<^.O_0B_^5.S_P#CU 'C%%>S_P##+GQU_P"A%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !17C'_#47P*_Z'K_ ,IEY_\ &:/^&HO@3_T/7_E,O/\
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MN PPRL.1VH WZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _&>BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OTQ_9<_Y-D\(_]OG_ *635^9U?IC^RY_R;)X1_P"W
MS_TLFH ]GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *_3']ES_DV3PC_P!OG_I9-7YG5^F/[+G_ ";)X1_[?/\
MTLFH ]GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *_3']ES_DV3PC_V^?\ I9-7YG5^F/[+G_)LGA'_ +?/_2R:
M@#V>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /QGHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K],?V7/^39/"/_ &^?^EDU?F=7Z8_LN?\ )LGA'_M\_P#2R:@#
MV>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /QGHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K],?V7/^39/"/_;Y_P"EDU?F=7Z8_LN?\FR>$?\ M\_]+)J /9Z*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH _&>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OTQ_9<_Y-D\(_\ ;Y_Z635^9U?IC^RY_P FR>$?^WS_ -+)J /9Z***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _&>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OTQ_9<_Y-D\(_]OG_ *635^9U?IC^RY_R;)X1_P"WS_TLFH ]GHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M_3']ES_DV3PC_P!OG_I9-7YG5^F/[+G_ ";)X1_[?/\ TLFH ]GHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M O\ Z$;_ ,J=Y_\ 'J /S.HK],?^&7/@7_T(W_E3O/\ X]2_\,N? K_H1O\
MRIWG_P >H _,VBOTQ_X9<^!?_0C?^5.\_P#CU'_#+GP+_P"A&_\ *G>?_'J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8?*$62YB?8)QAOF5^ W#9&*^0O\ A;'Q2_Z*5XJ_\'-S_P#%TO\ PM?XI?\
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M:N+B !@KL0#AF&>N"?6@#[>HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\G/BM_P EO\>?]C!?
M_P#I2]<57:_%;_DM_CS_ +&"_P#_ $I>N*H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY_V,%_\ ^E+UQ5=K\5O^2W^//^Q@O_\ TI>N*H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KZ:_8K_P"2VZS_ -B_-_Z4V]?,M?37[%?_ "6W6?\
ML7YO_2FWH ^_J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _)SXK?\ );_'G_8P7_\ Z4O7%5VO
MQ6_Y+?X\_P"Q@O\ _P!*7KBJ "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *^FOV*_^2VZS_P!B_-_Z4V]?,M?37[%?_);=9_[%^;_TIMZ /OZBBB@
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M** "BBB@ HHHH **** "BBB@ KZ:_8K_ .2VZS_V+\W_ *4V]?,M?37[%?\
MR6W6?^Q?F_\ 2FWH ^_J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _)SXK?\EO\>?]C!?_ /I2
M]<57:_%;_DM_CS_L8+__ -*7KBJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *^FOV*_\ DMNL_P#8OS?^E-O7S+7TU^Q7_P EMUG_ +%^;_TIMZ /
MOZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /R<^*W_ "6_QY_V,%__ .E+UQ5=K\5O^2W^//\
ML8+_ /\ 2EZXJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OIK]BO
M_DMNL_\ 8OS?^E-O7S+7TU^Q7_R6W6?^Q?F_]*;>@#[^HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#\G/BM_R6_P >?]C!?_\ I2]<57:_%;_DM_CS_L8+_P#]*7KBJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *^FOV*_^2VZS_V+\W_I3;U\RU]-
M?L5_\EMUG_L7YO\ TIMZ /OZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R<^*W_);_'G_ &,%
M_P#^E+UQ5=K\5O\ DM_CS_L8+_\ ]*7KBJ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *^FOV*_P#DMNL_]B_-_P"E-O7S+7TU^Q7_ ,EMUG_L7YO_
M $IMZ /OZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /R<^*W_);_'G_8P7_P#Z4O7%5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'X
MST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XST5^S%% 'XSU]-?L5_\
M);=9_P"Q?F_]*;>OOZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 04&N7UWQGX>\-W
M=K9ZI>3M?72L\-G9V<UY<.B_><10H[[1D9;&/>LS4OBAX'TGPNWBB\UIWT:.
M8P37=K:3W,<+C&5D\I&\L@L =V,-\O7BI [NBN!T?XJ>"?$&L1Z/I^L3KJ4U
MM]L@M;O3[FUEN(=I8/$LL:F48!/R9R*RO^%[?#%OMS2:Q?PKITRV][)-HM]&
MEG(3@+,S0@1'.1\Q'0TP/5.U':LB35['^P_[9@F:ZL3#]I22SC:X,L>W<"BQ
MAF?(Z!02>U<+;_';X6W%D;I/$%S%9K=?8WNY]*O(;>*?KY;RO"$1O9B*.MNH
M=+GJ-%<@WC[PK'X\M_ K:HX\07<!NK>V-K-MEB"EMZR[/+(P#T;MCK77TP"B
MBB@!.U+25YMXH^-7PU\$^*/^$:\2>)OL6J[4?[,EG<3G#_=YCC89/IG/3UI=
M; >E45#&X=%;G!&1D8/Y5R?C+X@>%_ -I#J'BV^GL+.9MBW"6-Q<1JW& S11
ML$)SP&(SSC.#3V!:G8XI:XS0?B+X/\3:]<:#I>J2+J]O&)I+"]LY[.X"''S"
M.=$8KR.0".:[.@ HHJG#<6TYD$,R2^6QC?8P.QAU4XZ'GI0!<I,5P'B;XJ>"
M?!NMVFB^(KR]L]0O6"VT:Z7=S"Y8X^6-HXF5V^8 A22"0#796\RW4$<Z!PDB
MAE$B,C 'GE6 (/L0"*%JKH/(O4444 %)6?>7D=A837DZS-%"AD800O,Y &3M
M1 68^R@D]A7%P_%[X=W'@I_&B>) NAI>"P:[DM9X\3$@;-C('[CG&!SSP:6[
ML!Z+13%964,IR#R".]5IKB"'9Y\R1>8XC3>P7<QZ*,]2?2F!<HKFM.\8>&]4
M\2ZOX8T_5([C6-&$?VZU56!AWC*\D8/'H3COBNEI>8"49HKF?$WBK2?"&BRZ
MYKTUQ;Z?"?WL\%G-<B(8)W.(D8JO'+$ #CGD4.R&M3IZ*\ZLOC!X'U*VT^\M
M;S57LM2FCM[2[?0K^.VF>1MB 3- $Y;C.[%>BTQ!1110 445S<WC#P[;^-+7
MP9<:DL>O7=LUW!9E6W21*2"V<;>QXSG@\<4 =)1110 451DGABN((Y9A&TS%
M(U9@"[ %B .YP">.P-9&A>+O#_B;4=8L-#U2.]NM$NC9W\2*RF"7^Z<@9Z'D
M9&01G@T =+1110 E+15"\O+33;&:^OKB.VM;>-I99I&"I&BC)8D] !2;MJP+
M]%<9X3^(7@_QQ<7D/AC6/MTMJB23(UO+"P1QE' D5=R,!PRY!]:P[SXY?#C3
MWL_MFI:E +^4P6;MH=_MNY VTK$WD8D.<#Y2>HI^0'I]':O-=1^-'P_TK1I]
M8U+4M1L[&VN39W$L^BWR?9Y@J-LD!AS&2)$QN SGC.#BWI?Q:\"ZMK]EH,.L
M3VNI:A&)K2#4;"YL6ND/0Q^?&@?/;;G-"UV!Z'?T5YK)\7O \7BRY\*M=ZM+
MKEL"TEA#H6H2S*@_CVK 24Y&&&0<@@\UU'AOQ1HOBRSN+W1)IY8K>=K69;BU
MFMI(Y5 +*R2JK C<.W>CS!Z'145SVG>)-%U+7]7T'3]22XU+1FB6^@56!A,B
M[DR2,'(]"<=^:P/$'Q8\#^%;G48]<OKZU73&C2\F32[R:"W9U5D5IHXFC!(=
M>-W<4KH=CT"CM7&^'_B%X8\6:@MAH=U>-<26@OXUNM,NK02VY( D0S1H'4EA
MRI/6J/B;XJ>"?!NMVFC^(KR]L]0O6"VT:Z5=S"Y8X^6-HXF5V^8 A22"0#1M
M9=Q'H%%4K>9;J".= X210RB1&1@#SRK $'V(!%7:8!2&EK,U'4;?2M,GU&\\
MXV]NA>3R())WP.N$C#,WT )I7MN!IT5YY#\7/A[<>#[+QA'XFC70KZ\%A;W4
MEO,@><DC9M9 PZ'D@ 8SG%>ATP"BJ<UQ#"\222(C3/Y:!V +M@G:/4X!./0&
MKE !3:Y/Q=XX\-^!=)&L^*KV:RL X1ITM)IU0G@;S$C; 3P"V 3QUK7EU6UA
MT9M8S/-:>2)Q]GMY)I&0C(VQHI=CCL 3[4O,.WF:]%<)X0^)7@_Q]/=1>$]0
MNK\VA*SR-I]U!'&PQE"\D:KOY'RYW8YQQ6GJ7C#P[I/B32?#>I:I';:MK1D%
MC;,K$S[!EN0,#KW(SVS1V\P[^1U':DI*Y+P[XX\-^*-;UG1-#U-Y]1T258M0
M@DM9H&A8E@!^\10V=IY7([]Q3\@\SKZ3O52:XAA>))I41IG\M [ %VP3M'J<
M G'H#7/>&?'GA?QAJ6L:;X?U"6YN]&E$%_#+:36[6[DL I$J+G[K=,]* .M[
M445S-[XN\/Z;XNTSPC?:I'#KFJQR36=H58M,J#+'(&T=#P2,X.,X-'D!TU%<
MCXN\?>%_ L=G<>)M0GL(+R3R(919SS1F0]%+QHRJ3V#$9P<=#774O, HHK/N
MKR.SLIKJ997BA1I&$,3RN0!D[40%F/H%!)["F!H45YAIOQL^'NL&]_LF^UC4
M3I[%+O[+X?U&7[,PSQ)M@.P\'@XZ'TKN-&UC3_$&B66MZ3<&XL+Z)9X)2C)O
M1AD':P!'T(!H\P->BBN2\1>//"_A&\TFS\1:A)8RZM<"TLS]EFE264D (71"
MJDY'WB._H:74#K:***8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45R&J?$+P+HNI2Z
M7K?C;0-,U" CS+6\U.&&6/*AAN1F!&001D="#4?_  MCX6?]%+\*_P#@YMO_
M (N@#S_XF>"_%VH?$.W\9_"_Q5!IWC#3-.2WN=.O!NBN[1I'9 <@XRRN.G)
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M!=_1'@?CCQ7XI^('[/VG>.->UHF"\\51Q1:5'!$L-I&F\+M<*)"W7)=F!R,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ??W[%7_ "1'6?\ L8)O_2:WKZ:KYE_8J_Y(CK/_ &,$W_I-;U]-4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 ?F=^U)_P G-^+O^W/_ -(X:\8KV?\ :D_Y.;\7?]N?
M_I'#7C% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ??W[%7_)$=9_[
M&";_ -)K>OIJOF7]BK_DB.L_]C!-_P"DUO7TU0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^
M9W[4G_)S?B[_ +<__2.&O&*]G_:D_P"3F_%W_;G_ .D<->,4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!]_?L5?\ )$=9_P"Q@F_])K>OIJOF7]BK
M_DB.L_\ 8P3?^DUO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!^9W[4G_ "<WXN_[<_\
MTCAKQBO9_P!J3_DYOQ=_VY_^D<->,4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!]_?L5?\D1UG_L8)O\ TFMZ^FJ^9?V*O^2(ZS_V,$W_ *36]?35
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'YG?M2?\G-^+O\ MS_](X:\8KV?]J3_ ).;\7?]
MN?\ Z1PUXQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W]^Q5_P D
M1UG_ +&";_TFMZ^FJ^9?V*O^2(ZS_P!C!-_Z36]?35 !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'YG?M2?\ )S?B[_MS_P#2.&O&*]G_ &I/^3F_%W_;G_Z1PUXQ0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'W]^Q5_R1'6?^Q@F_P#2:WKZ:KYE
M_8J_Y(CK/_8P3?\ I-;U]-4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?F=^U)_R<WXN_P"W
M/_TCAKQBO9_VI/\ DYOQ=_VY_P#I'#7C% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ??W[%7_ "1'6?\ L8)O_2:WKZ:KYE_8J_Y(CK/_ &,$W_I-
M;U]-4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ?F=^U)_P G-^+O^W/_ -(X:\8KV?\ :D_Y
M.;\7?]N?_I'#7C% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ??W[%
M7_)$=9_[&";_ -)K>OIJOF7]BK_DB.L_]C!-_P"DUO7TU0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!^9W[4G_)S?B[_ +<__2.&O&*]G_:D_P"3F_%W_;G_ .D<->,4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!]_?L5?\ )$=9_P"Q@F_])K>O
MIJOF7]BK_DB.L_\ 8P3?^DUO7TU0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^9W[4G_ "<W
MXN_[<_\ TCAKQBO9_P!J3_DYOQ=_VY_^D<->,4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!]_?L5?\D1UG_L8)O\ TFMZ^FJ^9?V*O^2(ZS_V,$W_
M *36]?35 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'YG?M2?\G-^+O\ MS_](X:\8KV?]J3_
M ).;\7?]N?\ Z1PUXQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^[^<;2.%R>HQD$5'I/QF^'.N7.DPZ;XA,@U>4V]C++97$44\H.#&)'C"!_\
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M_H>?_*99_P#QFC_AJ/XZ_P#0\_\ E,L__C->,44 >S_\-1_'7_H>?_*99_\
MQFC_ (:B^.O_ $//_E,L_P#XS7C%% 'L_P#PU'\=?^AY_P#*99__ !FC_AJ/
MXZ_]#S_Y3+/_ .,UXQ10![/_ ,-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4R
MS_\ C->,44 >S_\ #4?QU_Z'G_RF6?\ \9H_X:C^.O\ T//_ )3+/_XS7C%%
M 'L__#4?QU_Z'G_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\ ^,UXQ10![/\ \-1_
M'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C->,44 >S_P##47QU_P"AY_\
M*99__&:/^&HOCK_T//\ Y3+/_P",UXQ10![/_P -1?'3_H>?_*99_P#QFL/_
M (79\0_^$A'B+[9HW]LA_,&H_P#"/:=]H#=-WF>1NS[YKS2BCS#R/9_^&HOC
MK_T//_E,L_\ XS1_PU'\=?\ H>O_ "F6?_QFO&** /9_^&H_CK_T//\ Y3+/
M_P",T?\ #4?QU_Z'G_RF6?\ \9KQBB@#V?\ X:B^.O\ T//_ )3+/_XS1_PU
M'\=?^AY_\IEG_P#&:\8HH ]G_P"&HOCK_P!#S_Y3+/\ ^,T?\-1?'7_H>?\
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QFO&** /9_P#AJ/XZ_P#0]?\
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M]N: /LRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#X!_;4_Y+;HW_ &+\/_I3<5\RU]-?
MMJ?\EMT;_L7X?_2FXKYEH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OLS]
MAG_FH/\ W#O_ &YKXSK[,_89_P":@_\ <._]N: /LRBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#X!_;4_P"2VZ-_V+\/_I3<5\RU]-?MJ?\ );=&_P"Q?A_]*;BOF6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *^S/V&?^:@_]P[_ -N:^,Z^S/V&
M?^:@_P#<._\ ;F@#[,HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^ ?VU/^2VZ-_V+\/_
M *4W%?,M?37[:G_);=&_[%^'_P!*;BOF6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *^S/V&?^:@_]P[_VYKXSK[,_89_YJ#_W#O\ VYH ^S**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /@']M3_DMNC?]B_#_ .E-Q7S+7TU^VI_R6W1O^Q?A_P#2
MFXKYEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OLS]AG_ )J#_P!P[_VY
MKXSK[,_89_YJ#_W#O_;F@#[,HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^ ?VU/^2VZ-
M_P!B_#_Z4W%?,M?37[:G_);=&_[%^'_TIN*^9: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K[,_89_YJ#_ -P[_P!N:^,Z^S/V&?\ FH/_ '#O_;F@#[,H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ^ ?VU/\ DMNC?]B_#_Z4W%?,M?37[:G_ "6W
M1O\ L7X?_2FXKYEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OLS]AG_FH
M/_<._P#;FOC.OLS]AG_FH/\ W#O_ &YH ^S**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/@']M3_DMNC?]B_#_P"E-Q7S+7TU^VI_R6W1O^Q?A_\ 2FXKYEH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OLS]AG_FH/_<._]N:^,Z^S/V&?^:@_]P[_
M -N: /LRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#X!_;4_Y+;HW_8OP_P#I3<5\RU]-
M?MJ?\EMT;_L7X?\ TIN*^9: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K[
M,_89_P":@_\ <._]N:^,Z^S/V&?^:@_]P[_VYH ^S**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /@']M3_DMNC?\ 8OP_^E-Q7S+7TU^VI_R6W1O^Q?A_]*;BOF6@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *^S/V&?^:@_P#<._\ ;FOC.OLS]AG_
M )J#_P!P[_VYH ^S**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@']M3_ )+;HW_8OP_^
ME-Q7S+7[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,4
M4 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/17[,44 ?C/7V9^P
MS_S4'_N'?^W-?9E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNN"U^^Q[;XF\;:MIOBX>%/"_AM?$&LIIQU6:"6_6T7R?,\L!&*,#(6S@-M7
M.6'%;7B+Q7IOA/P;=>*O$6ZQM+2$2S1Y#N&.,1K@X9BQ"C!P37B>AQ^#F_:>
MLH=>7P[+XD7PQ;&Y)6W,IU42Y<C_ *;[1GCYMN.U=9\7-)\67UAK.IKIND:C
MH.GZ/<M;QW&I2V\D$[0N))S&MNZR,J'" NN,MW((6O+?J&G-8]+\.ZY:^)_#
M&E^(K&*6.UU*UCNX4G #JCJ& 8 D X/.":WJ\V^#+:@_P1\(G4+>"!O[+MEB
M$$S2AX_*7:S91=K$=5&0/[QZUZ1VJFK-HF+;2N+11104%%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ltbr_ex102img4.jpg
<TEXT>
begin 644 ltbr_ex102img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5]-?L5_\EMUG_L7YO_2FWKYEKZ:_
M8K_Y+;K/_8OS?^E-O0!]_4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XQ^U'_ ,FR>+O^W/\
M]+(:]GKQC]J/_DV3Q=_VY_\ I9#0!^9U%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5]-?L5_P#);=9_[%^;_P!*;>OF6OIK]BO_ )+;K/\ V+\W_I3;
MT ??U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %>,?M1_\FR>+O^W/_P!+(:]GKQC]J/\ Y-D\
M7?\ ;G_Z60T ?F=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\
MP*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?
M_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C%
M'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+1
M7TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_
MPQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\
M4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\
MH/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\
MA7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P
M*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_
M (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1
M_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,
M5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+
M_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^
M%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\
MP*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?
M_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C%
M'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+1
M7TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_
MPQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\
M4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\
MH/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\
MA7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P
M*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_
M (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1
M_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,
M5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+
M_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^
M%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\
MP*N?_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?
M_C% 'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C%
M'S+17TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+1
M7TU_PQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_
MPQ7\4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\
M4O\ H/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\
MH/\ A7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+17TU_PQ7\4O\ H/\
MA7_P*N?_ (Q1_P ,5_%+_H/^%?\ P*N?_C% 'S+7TU^Q7_R6W6?^Q?F_]*;>
MC_ABOXI?]!_PK_X%7/\ \8KUG]G_ /9_\9?"GXBW_B+Q%J>CW-I<:7)9*EA-
M*\@=I8G!(>)1C$;=\YQQ0!]2T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]HG5M4\+W5I=>#/'>F_VC>7T<RF*-(G3SB&&0=V\@'TG)_AI>7J'GVM\SO\
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M$<;B#I_#R^\)Z=\5/@K<Z9?:=:WUYX?D@U&59E#2SM&R1I*<\N6&U0>>%4=
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ME/X7T#2]#N;*.UAG#WL$SR;G!)Y251C\*^L*_.?]KS_DX:[_ .P?;?\ H)H
MVO\ AM3XI?\ 0 \*_P#@+<__ !^C_AM3XI?] #PK_P" MS_\?KYEHH ^FO\
MAM3XI?\ 0 \*_P#@+<__ !^C_AM3XI?] #PK_P" MS_\?KYEHH ^FO\ AM3X
MI?\ 0 \*_P#@+<__ !^C_AM3XI?] #PK_P" MS_\?KYEHH ^FO\ AM3XI?\
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M33],>VBD\P ,T@CE!=@ 0,G W'C/->-\T<TUIL#U/IG_ (;4^*7_ $ /"O\
MX"W/_P ?H_X;4^*7_0 \*_\ @+<__'Z^9:*0'TU_PVI\4O\ H >%?_ 6Y_\
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M_0 \*_\ @+<__'Z/^&U/BE_T /"O_@+<_P#Q^OF6B@#Z:_X;4^*7_0 \*_\
M@+<__'Z/^&U/BE_T /"O_@+<_P#Q^OF6B@#Z:_X;4^*7_0 \*_\ @+<__'Z/
M^&U/BE_T /"O_@+<_P#Q^OF6B@#Z:_X;4^*7_0 \*_\ @+<__'Z/^&U/BE_T
M /"O_@+<_P#Q^OF6B@#Z:_X;4^*7_0 \*_\ @+<__'Z/^&U/BE_T /"O_@+<
M_P#Q^OF6B@#Z:_X;4^*7_0 \*_\ @+<__'Z/^&U/BE_T /"O_@+<_P#Q^OF6
MB@#Z:_X;4^*7_0 \*_\ @+<__'Z/^&U/BE_T /"O_@+<_P#Q^OF6B@#Z:_X;
M4^*7_0 \*_\ @+<__'Z/^&U/BE_T /"O_@+<_P#Q^OF6B@#Z:_X;4^*7_0 \
M*_\ @+<__'Z^UO!&M77B7P%X;\17L<<=WJFEVM[,D((C5Y(E=@H)) RQQDDX
M[FOR/K]9/A3_ ,D0\!_]B_8?^DR4 =I1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G/^UY_P G#7?_
M &#[;_T$U^C%?G/^UY_R<-=_]@^V_P#030!\_P!%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?K)\*?^2(> _^Q?L/_29*_)NOUD^%/_)$/ ?_
M &+]A_Z3)0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5^<_[7G_)PUW_ -@^V_\ 037Z,5^<_P"U
MY_R<-=_]@^V_]!- 'S_1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7ZR?"G_DB'@/_ +%^P_\ 29*_)NOUD^%/_)$/ ?\ V+]A_P"DR4 =I111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?G/^UY_R<-=_]@^V_P#037Z,5^<_[7G_ "<-=_\ 8/MO_030
M!\_T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^LGPI_Y(AX#_
M .Q?L/\ TF2OR;K]9/A3_P D0\!_]B_8?^DR4 =I1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G/\
MM>?\G#7?_8/MO_037Z,5^<_[7G_)PUW_ -@^V_\ 030!\_T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5^LGPI_P"2(> _^Q?L/_29*_)NOUD^
M%/\ R1#P'_V+]A_Z3)0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^<_[7G_ "<-=_\ 8/MO_037
MZ,5^<_[7G_)PUW_V#[;_ -!- 'S_ $444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5^LGPI_Y(AX#_[%^P_])DK\FZ_63X4_\D0\!_\ 8OV'_I,E
M ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7YS_M>?\G#7?\ V#[;_P!!-?HQ7YS_ +7G_)PUW_V#
M[;_T$T ?/]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?K)\*?
M^2(> _\ L7[#_P!)DK\FZ_63X4_\D0\!_P#8OV'_ *3)0!VE%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5^<_[7G_)PUW_V#[;_ -!-?HQ7YS_M>?\ )PUW_P!@^V_]!- 'S_1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7ZR?"G_DB'@/\ [%^P_P#2
M9*_)NOUD^%/_ "1#P'_V+]A_Z3)0!VE%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^<_P"UY_R<-=_]
M@^V_]!-?HQ7YS_M>?\G#7?\ V#[;_P!!- 'S_1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7ZR?"G_ )(AX#_[%^P_])DK\FZ_63X4_P#)$/ ?
M_8OV'_I,E ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7YS_M>?\ )PUW_P!@^V_]!-?HQ7YS_M>?
M\G#7?_8/MO\ T$T ?/\ 1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7ZR?"G_DB'@/_L7[#_TF2OR;K]9/A3_R1#P'_P!B_8?^DR4 =I1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %?G/^UY_R<-=_P#8/MO_ $$U^C%?%G[1/P3^)WCSXQ3^(/"OA?\
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M0!XQ17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\
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M )4[/_X]0!XQ17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!X[X^\?>+/#/Q9\"^$]+;2OL'B:2:.1[JTEDE@,:J<@K,H.=W3
M''O7'M\</%W_  BOQ5F.GZ0VI^!;M8(;A(93;7BF5D.4\S<K?)GASC/MR?&5
M;RZ^.WPZO(/#?B6_TW0Y9GU&\TS3+N1(EE"A=LD2Y8C!)V$D=.O%=+\5/".E
M:9^SYXJT?P5X7D6?5(U9;;3;&26>YE9T.YU52Y.!RS=,<FHC?EUWN_ST&]T=
M-\.OB;H'CG1=,CCUC3YO$;:9;WFH6%H_-NSHI88)) #-C&21D \UK6'Q \&Z
MCKEKHUAXDLKF^O%D>UCCDR+D(2',;?=?:58':3C:?0U\[?#K3]6TSXN>';V3
MP5X@M[*+P-!I,[/H]U;QF\5%9XF<Q@#)!&\G;GOFL?P;X?\ &:^./AAXBC^&
M.N:%HNF:C?VZZ4L3,-/CD'#DS-YFTEF9GD*@D$(HXW:/==F+9/ND?5%IXT\+
MW^J)I=EKUK/=O<2VL<:M_K)8@3*B'HQ0 [L9V\9QD5-8^*_#NIZJ=-L=7AN+
MK=*JHN<2&)@LH1L8<HQ ;:3M)P<5\_V?@WQMI?Q6?3? ZZWIWAK6DO[N^MM6
MM 8=&N9(I%2>WGY&69\A4;>!D.!GB]\#?#-W9IHGA?Q;\/=?L]=\%R7)AUJX
MNIDL&$KMDP?/MD+!@"H4K@$D@X!2#H=_\7/B9=?#EO#"K##;V6L:@+2ZU:\A
M>6WL$QG+*C*2QYQ\PX5CSBKGPO\ &VK>.+/Q#/?VMLUKI^J2V=CJ5DC+!J,*
M])4#,W';(8CT-8WQBTK4-6O?"<.I:-<:YX'%Z_\ ;VGV=J]Q</E"()-D8+E$
M?EMG/3@BN!^'=]XD^"OPO\0ZSK/AOQ#J'AK^V'.E:<%S<6-A\Q\Z1'.8UQC*
MG!!R2!G-$=G<;Z'O?C*^U31_!>KZQH\ELEW86<UTHNH6EC?9&S;2%=#R0.<U
MY+X'^*GCKQO\,--UZSN_#,?BC4$N+B'1_L4Q\Z*"4HY'^D;AD  -@C<0*]$^
M(&IC_A5.M20Z?J-Y+J&G306]M9V,US,[R0ML4I&K%>3@DX [D5YA^S7X'T_2
M? 6E:EJ'A&ZT3Q?8-<V]W->:;+:33122,R@LZKY@P$Y&[;C'%)=?(5[I/N>I
M2_$SP+%#K%S+XAMU@T298-28J^+-V8J!)\ORY*D<]^.]7[OQGX9L+'3[RXUJ
M!+?4;=KNV8;F,L*H':4  G8JD$L1@ C)%?+GC#PCXVTP?'+1;?P3K6J?\)1<
M6M_8WEE;^; T8G+E>#N9_GQM521@DX')UY-#\3Z#XD\#^)=4\'^(_$GAZ^\(
MP>'[K3M,CGBNK"0*GF"2/*%5)!SN*@\Y/ R+5)]P>FW0]3U#XG:S9_M'>&_A
M[9_V9=>']:TE]2^U*CM-D+*1M</L*GRP?N]#U[UZ'JD?B.2_M?['O-/MK14D
M^T?:K:2>1V^78$VR(%'W\DY[8QS7@*^%[CP_^U)\/Y-+\(ZQ9^'M+T)M/:6.
MWN+NWM'?S]D;7!5@<>8H)+$+G&<"OHK5-0CTS2KB^FAN9HX$+&.UMWN)6]EC
MC!9C[ &AZ1T'N[>AY%\)?'WCSXG>#[S7)9]!L9+/5VLG@6PG*R0IL+$-Y_RN
M58X." 0.*9X/^-UC)JGBNP^(6MZ'HS:5KLNDV,B[K?[2J?Q%7=^>F2, 9%9/
M[+]MJND^"M=T/7_#>MZ+?-JDM\BZAIL]NDD3J@&UW4*3E3E<Y]L5XYXH\.Z]
MJG@?XHPV/@/Q))J6M>*TOK(G0+M9)[7>[!@3%P!DG!P1NZ<T_M+M;\=!='Z_
M@?8VM^,?#/AN>.#6M>MK&:6)YT25N?*7[TA Z(O=C@#N:JZC\1/!>D:DMCJ7
MB2TM9I+0WT9E8JDEN%W&57QM9<=P37AOC+1=:B^+NC^(=4\$^(O%?A?Q!X83
M19[33%EBFM2Q!9)1N0HISSO9 -QSRM3:QX;M[/\ :$^'-M#X)U4^'=#TEK%]
MNG7-[:V<CJWE(TVQE<+N7+9(7N1@D+MZL5]'Z'KDWQ@^&=KY/G>-M,A6:V%Y
M$TLNQ9(3D!U)&",@CCN".O%6(/B9\/[J\T>UM?&&F37&M#=I\:3AC<#<5&W_
M ($"N#CD$=17D.M:"=*_:^T/5K3P;J*>&=)\.O:+/8Z+-);02!)F"1^7&5SM
M< !>[;>O%>2>%/#?B#2?!_PVM[OP/XC@O](\8'4KXC0;LM#; Q'>2(LD8'09
M/RGCBFK-V#9'V/J?CKPCI.J3:7J7B*SMKR#R_/C9\_9_,.(_-(XCW$C&XC/:
MNJZ5\D>*O!?BZUUOXR:/_P (WJ>K3>.I+)M&NK>U>6#:)"6$L@&V'RPP^^5^
M[QFO8K7P/\4+?5M%FC^+AATJRAM([K3/[$@F^T^6B+-_I#'>/,*L<XRN[CI0
MAO1FG)\8OA?#<RVUSXXTJVGBN3:213S>6Z2@X*D-@C!ZGH.^*V])\;>$]>\0
M:CX?T?Q!97VJ:;G[5:PRAGAP=IS]#P?0\&OD6^\-^(I/AO\ &VU7P1X@;4?$
M&OPSZ:HT.ZWW,7VII-RGR_NA0QYQC([L,]QX)T?5&^-MQ+:>'=<T>TO?!,6D
MQ7TVC7-M"EV(XR0S&,!2-IY.!E< YP*2U5P>C/H'3O&WA/6-5&EZ9KUI=WC>
M9Y:129$OED"38W1]I(#;2<=\54C^('A'4-3_ +#TGQ5ITFK3&:*VC+;UEEC'
MSJO($A7^)5;(]J\,^"?A/4=.TNR\+^(OA_XATOQ/X9^W"UUN:61;"(3AAF'$
MFV1CN PJD<;BP-:/P3AU;P[X<A\+>,/A?J(U/PE)>/#K[V"RQ^7(6=FMWP99
M'?.W;$K;AC)[4GU] _SL=-\*_C=I?BKPKI,GC+6M$TOQ)JEU+;V]A YB\T+(
M43"N[$%B,#)Y/ KT;6?'7A'P_-)'KFN6VGB*1(I9)F(CA=QE%D?&U"PY 8C(
MYKXUTWPWXBM?AQ\/+/\ X07Q)#J>F^*GU'4 N@70=(=Z$2,1'\WRXQ@D\8[5
MU7QNT/QMXDO_ (AZ;X?^'>M0VCW%C<-/:V[SKJSIA?-RS'[JD )"G9B[< 5;
MMH+J^UV?2?B+XF>!?"NIC3?$WB:ST>[:(3I'=,4\R,]&4D88<$<9Y!%97BSX
MB06VA^%M:\*>)O#266LZA'#]IU/SFCN822'6 Q?\ML] W'!STKQSX@:?JM]\
M:?#^K-X-\07%G:^#KBSF:/1I[A8;F2WFVQ;D1E+?O%4[20"<9ZUR%UH7BEOV
M=_A5HG_"'^)'U+1/$#SWUM_8MT9+>-97?<1Y?*[9%P1D'D#E2 D@N?6.L>//
M!OA_49=/UGQ)96-Q#Y?G"9\+!YF?+\QNB;L'&XC..*=JGC;PCH-PT&L>(+2R
M,<D<4K2OA(7D&461_NQEAR Q&1R.*\5L--\1:'\<?'&B^)/AS?>--#\77,%]
M9WWV5)K6#8#L29I?D0(#CKN&P;5.17'?%;0/&'B"/XGZ?X=^&^N6$,EU:3.]
MNAGCUATE ,PW$L2%QM2!0  Q=L@+2[>>Y26Y[;'X^U[_ (:4E^&\L>GMHQT7
M^TXYDA<7 ?>%VEMY4CJ?NCM^,OQD\5^./!/@E_$/@JUTS4)X&S+9WMM)(6C5
M'>1U9)4^ZJ9Q@\ UP>AQZQ)^U7INO77A?7;/3W\+PZ>]Q-ILWE17)PYC:55,
M? X+!BH/&<UZOXHURQL]?T+2KK2M7O%FN&:62UTFYNH(XVAEC_>/&C*N68#!
M.0#D@+S1)-15OZU%%IR>FG_ ,&_^*0F^ L/Q#T$V<]]>:<;FVMY S1F=(V>6
M,@$$[!'+D9'W#S3?AK\1[K7/@YIOQ$\<7^D:7%>[R1!&T$<1$SQA<O(Y8L5&
M ,')Q@UY1X9^'GB3P3\/?BMHVIZ=?WNGVIO;3PY:VMK+</)]IAQOC5 2P(,2
MY PI\W)'S5DV/A+Q5K'[-G@+2;7P_K,&H>#]734-4TN[T^>WEEB\^5LPB1 )
MF"MG:A)YQUP"NK:V=AVT2ZZ_\ ^H[?Q5X?GTO4-5&K6\5GIK-'>23OY/V5E
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MNX-2\*C3M.G&@W9$MQA,HI\KCH>> <=:KW%]8>"?#/P,\1>*+JZ\.7^B6E[
M\6KZ=="+.T1M&RJA='YRIV$$#.< 92Z-]1=78^I/#OBC0?%VD+JWAW4EU#3V
M<HMQ$K!&(X."0,X/''>O,I?B)XY;]HB?X8VTVAQV/]F'4(KN33YGD4]E8"X
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M(OV@M5\"VDVG76@6^C+J4-Q#!)'<*Y>,!'W.1C:^?N*2"IZ=?"=+\#^-M5^
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M ( -_C1_PUY\&_\ G]U7_P  &_QK\YJ* /T9_P"&O/@W_P _NJ_^ #?XT?\
M#7GP;_Y_=5_\ &_QK\YJ* /T9_X:\^#?_/[JO_@ W^-'_#7GP;_Y_=5_\ &_
MQK\YJ* /T9_X:\^#?_/[JO\ X -_C1_PUY\&_P#G]U7_ , &_P :_.:B@#]&
M?^&O/@W_ ,_NJ_\ @ W^-'_#7GP;_P"?W5?_   ;_&OSFHH _1G_ (:\^#?_
M #^ZK_X -_C1_P ->?!O_G]U7_P ;_&OSFHH _1G_AKSX-_\_NJ_^ #?XT?\
M->?!O_G]U7_P ;_&OSFHH _1G_AKSX-_\_NJ_P#@ W^-'_#7GP;_ .?W5?\
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M_P"?W5?_   ;_&C_ (:\^#?_ #^ZK_X -_C7YS44 ?HS_P ->?!O_G]U7_P
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MGR]N.F><]?>NQ_X:[^#?_/[JO_@ W^-?G/11TL!^C/\ PUY\&_\ G]U7_P
M&_QH_P"&O/@W_P _NJ_^ #?XU^<U% 'Z,_\ #7GP;_Y_=5_\ &_QH_X:\^#?
M_/[JO_@ W^-?G-10!^C/_#7GP;_Y_=5_\ &_QH_X:\^#?_/[JO\ X -_C7YS
M44 ?HS_PUY\&_P#G]U7_ , &_P :/^&O/@W_ ,_NJ_\ @ W^-?G-10!^C/\
MPUY\&_\ G]U7_P  &_QH_P"&O/@W_P _NJ_^ #?XU^<U% 'Z,_\ #7GP;_Y_
M=5_\ &_QH_X:\^#?_/[JO_@ W^-?G-10!^C/_#7GP;_Y_=5_\ &_QH_X:\^#
M?_/[JO\ X -_C7YS44 ?HS_PUY\&_P#G]U7_ , &_P :/^&O/@W_ ,_NJ_\
M@ W^-?G-10!^C/\ PUY\&_\ G]U7_P  &_QH_P"&O/@W_P _NJ_^ #?XU^<U
M% '[,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80
MN/\ T8U8E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[,444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8
ME !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8E !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8E !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^07BS_D
M=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8E !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '[,4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^07BS_D=]>_["%Q
M_P"C&K$K;\6?\COKW_80N/\ T8U8E !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '[,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K
M;\6?\COKW_80N/\ T8U8E !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% '[,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COK
MW_80N/\ T8U8E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[
M,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\
MT8U8E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8E !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!^07BS_D=]>_["%Q_P"C&K$K;\6?\COKW_80N/\ T8U8E !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '[,4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X-?
M?LI_"/4-0N;^YL]3,]S*TTA6^8#<Q)/&/4U#_P ,A_!O_GRU7_P/;_"O?Z*
M/ /^&0_@W_SY:K_X'M_A1_PR'\&_^?+5?_ ]O\*]_HH \ _X9#^#?_/EJO\
MX'M_A1_PR'\&_P#GRU7_ ,#V_P *]_HH \ _X9#^#?\ SY:K_P"![?X4?\,A
M_!O_ )\M5_\  ]O\*]_HH \ _P"&0_@W_P ^6J_^![?X4?\ #(?P;_Y\M5_\
M#V_PKW^B@#P#_AD/X-_\^6J_^![?X4?\,A_!O_GRU7_P/;_"O?Z* / /^&0_
M@W_SY:K_ .![?X4?\,A_!O\ Y\M5_P# ]O\ "O?Z* / /^&0_@W_ ,^6J_\
M@>W^%'_#(?P;_P"?+5?_  /;_"O?Z* / /\ AD/X-_\ /EJO_@>W^%'_  R'
M\&_^?+5?_ ]O\*]_HH \ _X9#^#?_/EJO_@>W^%'_#(?P;_Y\M5_\#V_PKW^
MB@#P#_AD/X-_\^6J_P#@>W^%'_#(?P;_ .?+5?\ P/;_  KW^B@#P#_AD/X-
M_P#/EJO_ ('M_A1_PR'\&_\ GRU7_P #V_PKW^B@#P#_ (9#^#?_ #Y:K_X'
MM_A1_P ,A_!O_GRU7_P/;_"O?Z* / /^&0_@W_SY:K_X'M_A1_PR'\&_^?+5
M?_ ]O\*]_HH \ _X9#^#?_/EJO\ X'M_A1_PR'\&_P#GRU7_ ,#V_P *]_HH
M \ _X9#^#?\ SY:K_P"![?X4?\,A_!O_ )\M5_\  ]O\*]_HH \ _P"&0_@W
M_P ^6J_^![?X4?\ #(?P;_Y\M5_\#V_PKW^B@#P#_AD/X-_\^6J_^![?X4?\
M,A_!O_GRU7_P/;_"O?Z* / /^&0_@W_SY:K_ .![?X4?\,A_!O\ Y\M5_P#
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MO_GRU7_P/;_"O?Z* / /^&0_@W_SY:K_ .![?X4?\,A_!O\ Y\M5_P# ]O\
M"O?Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBN9\3:Y)I5K!:V41N=8U%VM]/@"Y#2["VYS_  QJ 68GL,#)
M(! -"'5-/N-8N-+@U"VEU"V57GM4F5I85;[I9 <J#@X)'.*TO6OF+X!QW4?Q
M\^+L5YJ%QJ$\5Y%&US<L#))MDE )P !P!P  !P!BOI_-+>S[HG9M=F.HHHIE
M!1110!0OM0L=+LVN]2OH+.UC^_-<2+&B_5B0!6?:>*O#.H7D5E8^(]+NKJ9=
M\<,-Y&[NOJ%!R17SA\6-1N/%G[6?@KX;ZTYE\,6_EWS6.WY)YMDC[G_O#Y N
M#P 6]376?M16,)^#9\30$V^K>'[VWNK"[B.V2!VE5#M(Y'4'ZJ/2I>B3?5V#
M[7+Y7/7-8\9^#_#UTMMKWBK1])G?[L=[?10,W?@.P/<?G4]YXH\-Z=I\&I:A
MXATZTL[AMD-Q/=QI'*V<85B<$YXXKY,^,VO7GBCX0_!;Q!JC![^]NXY9Y-H4
M.^U S8' R1G KZB\?8_L#3>,_P#$ZTW_ -+(JKK;SL)O2_D=+'-'-$LL4BNC
MJ&5E.0P/0@^E165Y::C:)>6%U%=6TF=DT$@=&P<'!'!Y!'X5B^+Y&D\/G1[>
M^>RO-9?[!!+%_K$W@EW3_:6-9''NM>'_ ++^N:IH\OBOX.Z](K7GA:Z<VS+_
M !1-(P?!]-Y##_KI4K5OR'T3/<+GQUX)L]7_ +'N_&6AV^I9V_9)=1A6;/IL
M+9['MVK=DN+>&U:ZFN(T@5=[2NP"!>N2>F/>OF/Q=_RD*\$G_J$G_P!%75?4
MS=*?2XKZM'+6/CSP3J-W-9V'C#0[RY@!,L,&HPR/&!UW -D8P<Y]*27XC?#^
M*"WN)?'?AY(KC_4NVJ0!9?\ =.[YOPKY]^!MK%>_M$_&^SN%W0W%W+%( <95
MKB4']#2_M70QP:A\+[>&,)%'J3JB*,!0#" !0M;>=AO2_D?0,WCSP1;PS37'
MC/1(H[8JL[OJ,*K"6SM#$M\N<'&>N*T=+\2>']<L)-2T37+#4[),[KBSNDFC
M7&<Y920.A_*J?B'PGHGB;2-7TW5;;S(M7LQ8W+*<,8U+E<'L5,C$'UKYM^"/
MB;7_ (?^+?$_P'U*22[O;&9O[!819 W$NS,>@3:RR\_[8&20*%JVNHNB?WGU
M#I&N:'X@M'NM!UBQU6V1S&TME<).BN.JDJ2 1Z5JLRJI+' '))[5DZ#HNG^'
M=$M]'TN(Q6T&XC<VYG9F+,['NS,2Q/<DUC^/%FU#PU)X9M;Y[.]U_=IT$L?W
MHPR,97'IMC5R#ZX'4BB3LF-*[.AL;ZSU*PBOM/O(+RVF7='-!()(Y!ZAAP1]
M*I7GB3P_IM\UGJ&O:?9W2J':&>ZCC<*>A*DYQ[UX1^R_XDU"VT?7OA3X@VKJ
MOA*[>) O(,32,&&>^)-W/HRUC^*/&GC[X%_%3Q%XBUCP^VO> _$5\MTU[%CS
MH&,:HJ;L_+M"A0K@!@."#FEI=+NM&)7U\CZ3CU[19-&;6$UBS?35SNO!<(85
MP=IR^=O!X//6J]MXJ\-7EVMK:>(-,N)W!*Q17D;.P"EB0 <] 3] 37ANLV:^
M-OV?]*U+X#W!F73=<_MJ+3[D!"\BS/,]NRG ^61PP4G!"C!/!H^'/QFT+XA>
M.M!T'QYH=QX;^(6BR3K#&T92&:1HF22,;LLA*_-L;NJX8]#26_D)Z:]#VRT\
M=>";[5_['LO&&B76I9V_9(=0A>;/IL#9[CMWJS)XH\-PZG-ILOB+34O85WR6
MS748DC49R2N<@<'KZ&OG?P3Q_P % /'V!C_B4#_T"TKZ)M_^1XU/U_L^T_\
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MS3V[OY_G>5)F.-E&?ER-WK[5T&H?#_7/%$6MZOKMY8Z9XBO+6WM;%K$M<0V
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MHB;EF9 7=O+.5;&TGAF'R@2?-KL#VNCT+6?$T.EZQI>A6L/VO5]4,AM[8R;
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M^(1)&&_V@3S7-?$KX<^(/&>H:_\ 94TB[@U#13I]C-J<D@?2ISOWM$BQL")
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M6I+\2GE\82^&M/\ "][/+_8XUF"YEGACAGA.!QAF8<G;RN=W;;\U<-KOPO\
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M"DM%&6W2*@==QXZ_+NP<=GXG\2Z3X1\+7WB36;@PV-E'O<H-S.2<*JCNS$@
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MK;1Q1L[HJ@*SR-(Q'NS$D_4FK= PHHHH **** "BBB@ HHHH **** "BBB@
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M6[+]THA&%([$ 8J+3?"'AG1]9N=9TGPSI&GZI=;A/>6ME%%-+N;<VYU4,V2
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M;0W&JW'V=)YDMX@$9WEE<X5%5069CZ &C;7N+R(%\'^$XUU-(_#.E*NK9_M
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M;-?1VJ+/*/1I -Q'U-1:9X9\/Z/>W%]I.@:=IUU<JJ336MK'%)*JC"AF4 L
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MDTZXBBU#5 TA$,>''F"1G656 *G.W(&&QR/3-<\8>&_#>JZ-IFN:M%9WVM7
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MD_$#Q5KT.DZMI.DK<6%WJ[V<]HNGW >&U$SQ&?[06$9(VARNT\$@'(S73_\
M"N['_A;G_"RO[<U4:E]A_LW['F#[+]GSNV8\K?\ ?^?._.>,[?EJOI'PST70
M_$LVL:/JVM65E/.UT^BQWI^P&=FW-((R-P);DJ&"Y_AHTL@?D>7:;KUQX=^(
MWQQUS4/(U"&SGTU?L[6S-O=H0L('S' #,,\'/48Z5TOB3X@>/-"M_$]S#HL%
MQIFEZ*VJ6NJSZ;<6T3SHWSVKQ/(&)*_,'! 'H<5O6GPET>'7/%FI7VM:MJT7
MBM NIV=X;?R)-J[8RNR%70HO"D-[G) -)-\*;2[\&:CX9OO&?BJ^BU",V\MW
M=WL<\ZPM]Z)=\90 ]"VTO_M4FV_N0]+Z_P!(I7GQ UO3&\%P7OV2>[\78:%K
M;3IW6S1;;SI,HLC-*2V ,;, Y.=ISCZM\3?'&DW?ANSN-&L[1M4\4#1#-=64
MT8N;9QN2XCC,@:,X!4JV[D9XZ5V-]\-=+U3PEI7A_4-4U62?1BK6&KI)'#>V
MK*-JLCQHJ9V_+]S!'W@3S536/A/I^N1^'5O/%GB W&A7BZA%=&:"26>X7A9)
M3)"P.!D!5"KR>*:T>HGK:V]BC)\1M7M9-2TJYAT]]2B\46_A^WG$3QPD30QS
M>8R%R20KN,!AN('3-7=4\7>+O#*W$/B*SL7%WJUMI^E7ME#(ZS)*,NSP!V<,
MFUQ@-\QQC%0R?!S1[ZWUVUUO7M;UB+6KI+Z7[1);Q-!=(%5)XF@AC9'544#D
MKQR#DUJR_#?3+CPG)X?U;Q!KFJR.Z2IJ=W>9O(9(SNCDC=%4(R'D$+W.<YI.
M]E;<.OD<EJ7Q4\3:!=7>GZQX=$;7FLV.DZ%J#V\MM#>FX^\S1.2Z^5M;(R-W
M&-N<TOAE=0C_ &I_%BZC<03S?\(]98>")HE*^:_\)9N>O>NKF^&6BWWA5=#U
MK4M8UJ5)DN(M3O[O?=PS1DF.6-@ J,I/&% /\0;)S+H?P_L='\:7'C";7-8U
M;6+FS2QEFO9(E5T1B5RD4:+D9],=\9R:I/J2U=67D9GB;QQJ7AOXFZ9HFH7N
MF6.@ZMIMU-;WD]I(S17, #LCL)0I7RRS8P#\I&:@\&^-/%'BK3M#AD&G66K>
M=>IK4+6<@\@0.%"JAERC-YD3?,6X8UU_B7PEHOBR/3EUBW\XZ;>1WUN1P5=<
M\'U5@2K#N"1533/ FBZ/XO\ $7BO37N(-2\0+$+EMZLD;(FT-&I& 3\I.<@E
M1Q4HH\?\0^,O%?B;X;Z==7%W9V-S#XX@TF;[)"XCGCBO JY!D) )4,1GG&,C
MOKZEK6M>&?&GQA\2:?)9/=Z7H>G7C)<6[M',T<-PV,"0%0<$=3C/?'/2VWP;
MT>'PE<>&V\3:]/%)JJZU'=RO;>?;W0D\PNF( A!;DAE8<\8I]]\([?4KGQ1-
M<>-_$87Q/:K97T:_8MIA4,%5<VV1A7=<Y)(8DDG!!;1+JAW7,^S#1?'6N:UJ
MG@8QPV-O9>*M FU0HT3O);3(D# ;MX#)^^Z8!^7KSQS/A/XM>*=6\!^#O%&I
M6^F;-<\0'19[:V@D0QJ9)4617:5N1L4D$'//2NIT_P"$L6GR^'I++QWXEB_X
M1^P;3;$8L6"0L%#!LVQW'$<8R?[@]3G+L_@7I.F^%]'\-V/C3Q-!8Z1J7]JV
MH'V)F2XW;@Q)MCD!BQ /'S'.0  ^OD39\K[FW\6)M6M?"%HVDWRV3-J^FQ2$
MQ;_,5[R%-OWA@<\^HXR,UPBWFL:7\>?B5J=G<6;7UCX9M+AC+;.T<C(LC8"B
M0$ X_O&O8/$WAVU\4: ^CWEW<VZF2&=+FV*"6.2*194==RLN0R*<%2#Z5RMQ
M\);6X\1Z_KW_  F?B&.\UZQ73[LK]C*^2HP H:W.#@MS_M'VQ/\ F4NM^IC:
M5\5KWQ!JF@:786:V%SJGAJ+7YIC93WZQ&1@BQ+'$5.,[B6)'0#J>.VT7Q-=G
MX;+XH\5Z9+HMU;VDEQ?VI4DP^7NWD#K@A=P'7!%<TGP<T.#2-#M;7Q!KUCJ&
MB6WV&SUJUN(8KP6O_/NY6(1O&./O(3D YSDGOX=+M8=*&E%6N+<QF.07#&1I
M0?O%R?O$Y.<]<U4K6?*2M&KGS_XPUK6/%6G?!;Q5>?9(;+5O%%E=0VL43"2!
M71RBLY<ASMZD*O-=GHOQ0\1>)--TOQ!H>@M>:==ZL]E-9K8SB2&U69XC<?:"
M1&2-H<IMZ$KG(S6A+\&] >/1;-]>U[^R]!ODU#3-.6XC6*R90P5$81^:4&[@
M,[$8 ! R#JZ5\-=&T7Q%-JFE:EJ]I832M<-HD=UC3_.8Y:01[=P)/)7=LS_#
M1IHA[W[GFW@/Q1XHL=!^*>N7&JV-Y<67BVXM4DU$^5%$BM#'N+;P BQ]$')*
MX!):M:'XI>)KBS^*-O#!8?;/!-O'=VT\MC/"ERC6[3;7A>0.I^0C.[N#BNG3
MX4Z'':^)+6WU'5;2/7M4367\F:/-I=JZ2>;%E#R7C0X?>..  2*K2_"'39Y?
M%D[>*M?BN?%MO#;:K,C6NZ58XS%\H,!52RDYP.,_+MHT^=E]XNK[7,W5;HW'
MQ^^&VH3J%:70M1E?:.!E82<=^]26/Q$\470\,:XFEK=>'=5@:ZU%TTZX@;3(
MC%YB/YKMME'\)VJ,]16U#\,XH_%/A_Q)/XPUZ[NM!MVM+=)?L@CDB?&]9 MN
M"=P"@D$'Y1C!R39\._#?2_#-_*VGZSKLVEG)M]'N+XO96F?X8TP#MYX5F91V
M P*5K7M\AI[7^9Y+\0/$&I^,/"?PF\62/:Q:;JGC+3I[>V2%Q+$A:39N<N0Q
MVCG"KR?;GTGX^#_C'[QCP#_H)Z_[RU#<?!GP[=6VF:<VL:Y%HNDZC'J>G:9%
M/$D-G(A8A8V$?F[,L3@N<8&T@<5T_CKPC:^._"EUX6U#5+^PL;O"W#6!B$DJ
M?W"9$< $X/ !XZXR"/6-BD[23['E&H:/XPUOQ/X9^(EKH9\+V_A'1+AF?49(
M9I-3=X?ECV6\K?NEV[LLZG+<+WK5TWXG>)6\ ^!/$5\-*-WXRN+2QM[>*UE1
M+223>SR,QE.]0J\( IS_ !8/'H[>%FD\"/X3DU[4G5[8VK:@1 +G81CM%Y>=
MORYV=/?FL"Q^%OA^W^'>G>";J\U&^L])E2;3[J=XUN;&1/\ 5O&\<:#<AS@E
M3G)!W#BB^OEH1T\S'UKXA>(-(U;QCX?FCT^34]$T/_A(+.Z6WD$,\(WAHWC\
MS*MN3 8/R&SC@@VO^$ZUR^33[.PC@AOYM!MM6D;^S;F\1I9MP5 L3 HH,;<L
MQZCT)JIXTTA=%T'6-+CTW7_%7B+Q-I=S8#6?L<<I4K&WDPS-"B)"A:0[3L"Y
MR6.>:U?^%8V=]IOAF:76-6T37-)T^+3WO=&N_)::-57=$X*LKIN&1D9'4$4M
MWY%/1(JZ#XZ\5>(+VV\/#2;70_$J:&NJWUO?1O*L<SR-&D0 =2!E&).3@%16
M(NL>.;WXU_#^UUF2'1WN=#N[J\TA?W\44ZLBM\ZL-S8; .2%YX.23V6N_#G2
M]8O=-U.UUC6]%U/3X3;#4=-O-MQ<0$[C%*SJ_F*6^;D9!Y!&35V;P+H[^)]#
MUZ&:]MK[1XYHHWCFW>?'*0TBREPQ;+ -D$-GO@D4=K]P[G1S6EJ]_#?/;QM<
MQ1M'',5RR*V"P![ [1GZ"O+_ (2P0M\"-$O6M(;FYL3>7%MYQ"A9!/. =Q^[
MD$@GT)KTW4;6XOM/GM;?4+G39)%VK=6PC,D7NOF*RY^JD5R7A7X=6?AGP9=^
M#_[>U;5](GCDA6*_:#="DF\R!6BB0_,7)^8MCC&*+/5H+JUNYR'A?XI>)M5\
M::/H5U;Z7J"ZIX>EU9?[/BDC"W",H,*3.[1S)\V-Z\9'7%4/&'C2;Q/\%_B!
MI]Y<0)?6OAYY+JQ:REL[FTE9&RKQRL2R\<.HVG!P3Q78VGPAT6WN],O+CQ!K
ME_<:=I<VCQ27$T(+6T@ VL$B497 P0 3_%NI=5^$VEZU8:M;:GXCUNYGU.R_
MLLW;-;^=;V9;<T"'R<%2>K.'?_:SS3W%L9WPBU[4/$/@K1FT_4--&D:;86MC
M);F%WNC,D*^86.\",=-H*$D?-G!%:/Q(T7Q->WV@>(O!LUE<Z_H+S7$&D:@^
MV"_1T$;\Y!5U##:_0%L'AJ9X<^$MAX2UR#5]$\5:];R"VM[.YAQ:>5?QP\1^
M<!;Y+!<)O4JVT=>I/5:WX<CUB[M+Z/5-0TN^LXY8X+FQD4,@DV;B5=61_N#A
ME8=\9P0Y6D[HF*MHSQ#Q/XP_MCX(_$F]L=!NO!'BZUM8TUJPFA4/E@0)$=<;
MPZEE$G7"]. :[;Q)XR\4>&+*>WC;2W^Q>'VU-)#;2SO<2IGY##')OBC "YE8
ME<MVQBN@NOAGHVI>&O$&CZMJ&IZG+X@A$%_J,\J"Y=5!";=B+&FW)("H!DG(
M.356Y^%NE75W=7DFN:S]HOM)_L?4)!)"#?0@,%9_W>%<;FP8]@YY!'%&NQ1R
M$7B+7-6_:$\(RKJ7D:7<^$GU/["T9=5+R1[SPPR^, ,<X Z<G.[I/CKQGK-S
MX4OM.TA+O2==C\R[;^SKB$Z:KQ;XG,CL%F7)"G:!GJ,5LV'PWT:PU[P]K<=]
MJ3W^A:>=,CE>2/\ TF D$)* @'!4'Y-GH<@D4F@_#?3_  S<7']DZ]KZ6+;O
MLFG/?>9:Z>3GF%&4\ G(5RZ@@87BC36PM=+G':C\2O&FF^"+#Q!)'HDLK^)W
MT&XA6UF4-&+M[<2(?-.UOE#8.1UJQKWQ:U7POJ/C;3;[3[2_FT+^S?LCPQR1
M"0WC^6 Z[G/RGGY>HXP#5RX^"-E>: -%NO'7BF6R34CK"J39!A=&1I2^1;9Q
MYC%MO3/;'%7;CX.^']4UO7]4\0:QJ^MQ^(((K>_LKQK=8)%B.8BOE0HZLAY!
M# YZYHCI\6HWKL8_C/XA>-O#/ACQ/K%M8VMS%I5C#>VE[<Z7<6L4KF0I) T;
MR!B0"C!P<88C&1FKFK>,O$R^(M?\*FXLU9?"K:U:WD%LZ/!)N9"I!D8-V(/&
M.^:N:A\([/5O U]X2U+QKXIOK>^VI+=75S#+<>2,'R59H2JJ2%)(7>2HRQ Q
M5FU^&-O'XI/B._\ %FOZG<2:8=(EAN?LBQ2VQS\I$=NC [CNR"#GVXI-7V ?
M\(6O'^#'A&6]N%N)9-+MW#A"IP8U^\2QW-ZGC/H*Q?AC?3Z]X1\8>)+^5IKK
M4]6ODP_(AAA8PQ1+_LA4SCU=CWKM_"?AF'PCX4T_PS:ZE>7]M81B&&2\*&01
MCA5)1%& , <9XY)/-<MI7A.Z\/OK_A."ZU*UTO7[R?4+._L88V-@9,-+ =ZN
MJY;>RLRD$.5X8+E]7Y[$KW4M>NIY'X1\.^)_'WPC^$NE6'AV;1[70[J'4I->
MN9X-ICC+?) D<C2DOGG>J ;><U[!XDLK73?B!\++&PMX[:V@O[Q(XHUVJBBP
MGX K>\"^#[?P'X5M_#-CJVHZG86GRVQO_*+PI_<!CC3(SDY;)YZXP!3\2>!6
M\2^)-*UX>,->TF726:2S@L1:>5$[(T;/B6!RQ*L1AB0.P!I25]%WN4O/L<Q\
M1/!&N+XDT3QMX!AL;C6] :YN3H=P D6H^<JH[!LCRY<+P^,$]2.<S?#W6/#W
MC+3_ !=8RZ#-H'B">5?^$@T2Y4;K:9X0@8$* ZNJ!@_?KQ7;:QX9AU6_@U"/
M5M3TK4+>%X8;NRF52BL5+9C=6C?[H^^C =L5B+X?7PC8:E>:+:W^L^)M=D2.
MXU&?89)I A6.29E58XXXU[*JC P%+-@OI8.MRG\$?$VH^+O@OH.L:P_F:@$D
MMII2<F5H9&BWGW8("?<FO//!^M:EH)^+&NWDUI?-;^*A!&D\+!?/;R(HFW;S
MM12R\8) '!%>R^"/"MAX)\"Z5X6T]B\5C"$,K#!FD)+/(?=F+-^-<QI/PBT3
M38?$MI>:[K6LV7B65[C4+6^:W"/,Q7]ZK10HZ,-HQA@!UQG!H^U?<7V=--2Y
MJGB;Q1H.N_V7?2Z9=+>Z5=WME<16<L?E36X0LDBF5MRL),@AEQM(YR#3_AAX
M@\1>,? FC>+M<ETY%U.S286MG:R1F)]S;CO:5MP(Q@;01SR<\64\!J;.ZM[[
MQ5K>H74MI)8P7]TUNT]I#)MWK'B$(2=JY9U=C@<UH>"_"=KX'\)67A>QU"]O
M[.Q&RW>]\LR(G9,QH@('/)!//)-&EGW%K='CGB&\\075M\?K74=66[M+'3?)
MAB: J8T:Q:150[L  N<Y!))SD5M_#WQ)K&D>&OA?H#K:75GJWA8W$0$;1212
M000$!G+E2K"0@_*,8!KL]:^%^CZP_BP_VIJ=@OBNW2WU%+5XL':GE[UWQMAC
M'\ASD8Y #?-6-;_!_3[=O#L;>,/$4UMH%B^FVMO)]CV-;.JK)&Y6W#'<BJN0
M0P"Y!!R3,=%9^1I)WM8R/"OQ,\4:[XI\-:)=MH__ !/M)NKLRV,$DD=I<1,H
MVK-YACN%&[!*'&Y3S72?!>XU2Z^#N@7FJ7B7DUQ"TOF",JQ)=B2QW'<2<G(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8^)_#>I:5-JVE^(=-OM/@R)KJWNXY(HL==SJ2!CODU-I^M:/K!F_LO5K._\
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MEQRWUTD"NWH"Y )]JCU/Q%H.D^2NK:YIU@9T:2(75TD7F*JEF9=Q&0%!)(Z
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M>>.<5'X=L=6L?VBYO$%Q8ZD^BR>#TMUG@T2XMH(Y$G&(%0J6W!!D!BS<G'&
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M!7\L( [ G:6)/4!<-UWAO1=*^&_P\M]+$WDZ5HUM)+(Y9W6) 6D?&XLVT9.
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MYMTW7-/L=*UCQ5\2M!TE!I_B^X.GW46I2%DO_,\E%9FBC41*@ \QF(VIDH,
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MY<7X3V]K9?"[X.^*(88EUF[\1SV,U^PW3202&\W1%SR4) .WIN^;J<U[[;^
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M/> ]/T3XC6%MXJU7P[#H\FDZ6WAXQ01FTFM9URMTJ21D,L:X"IM88#2=,FN
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M#0?M)T70]/TLW4GFSFSM4A\Y_P"\^T#<?<ULT4 %%%% !1110 4444 %%%%
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M<GFI/!_P[T'P.C#2;C5+IO*$$;ZCJ$MT8(@<B.,.2$7('"@9P,YP*[>BA:;
M]3F+SPKIMYXPT_Q8WGQ:I96[VBR1R85XG97*,.XW*#Q@]NA(JA:_#WP_9&W1
M?/DL+2^;4K73Y)<VUM<$EMZ+C. S,P4DJI.0 0".V[T4@.<\1>&]/\56MI:Z
M@UQ$UG=17UO-;R;)(9HSE6!Y'<C!!!!-<W<?"/PS<6NM6_VK5(HM;O8]0OE6
MZSYTZ,C*WS X^:-#@8Z8Z$BO1J*>P;G!-\,_#]QKNMZMJ4]YJ-QKM@--U!;A
MTV3P $ ;45=I&3RN.M%K\-]!C\1Z-X@GU#6;[4]%@:UM)KC4)#B-L95PI DZ
M<[LYXW9P,=[BC%): ]3E=6\%Z/JWB*VUZ>2[@U""UEL"]M<-$);>0@M&V.V0
M"",$'H17GEW\.;O2/&OP\L?#.GZNF@>'$O8WO8[Z'=!YL<:Q@!WRRC:<KL([
MX)->W44UH[@]3QCQMX!NH=+\*:/X6T;4[R&T\21ZS?W45]&LY_UADD,DLBLS
MEG!P.,<=!BNIU'X9^']7T+6-)O;K49%URX2YU*<S RW+)MV*25(15V+A4"@8
M]SGO:2DM >K.7U7PE8ZU-I-Y=7E]%J>CNTEKJ$$@CF4L-KA@%V,K #*E2IP.
M.*MZ?X?TK3='FT>&!Y;6Z:5[C[1(TKSM(27+LQ).<GV P!@ "M^BC<%H<A)X
M#\,3?#@?#^330_A\6BV7V?<03& ,'<.=V0#NZYYK+L?A;X5L_"^H>')O[3U.
MSOX4MY7U+49KETC0YC6-G8^6%)RNS&" >H%>A44;WOU!:'%67P[T6T\;VWC2
M:[U.]URWLO[/2XN+QL-#DG:R+M5^3GY@>0&^]S5[6/!VDZQK^G>(99+NTUG3
M%DCM;RUF*LJ28WH5.4<' ^\IQVQ7444P.!UK16T_P@_@W1/#EWJ5KJ<%S;R3
M&>+RX6ESODG:602-N:1F)17).>!Q75Z/I-CH.AV.BZ;"(;&Q@2W@C!SM1%"J
M/?@5IT=J .-D\%VZ^,+GQ9%KNJ0ZK<VRVC.K0E5@5RZQA6C( #,>>O/)-9^J
M?"[0=8TYK'4+[4Y3)JJ:S+-YZB26Y0*$9OEQM4(H"@!>!Q7H-'>C8#R#5O =
MUK'C76M4O6\9:>)YD\N71->^RVTL:Q(H9HQ,I#Y4Y^4#IUY-=#:^ 8?[3M]>
MNM>U636%TL:3)<&2(EH?O$',>"2WS;NN>^.*[^BETL'6YY_I7PQ\.Z/I_ANR
ML9K]$\-M+_9SF8;XTE4JZ$[>003R?F'8BIC\-O"^^[C:&>33[S4/[4GTV23?
M;276X-YA4@G[P#;,[,C.VNZHIWZATL<CI/@^STGQ'KFOVNI7WV[7-ANR[1LI
M*+MC*C9QM4X'8]P:S/\ A5?AM]"M-'GFU">*RU!M5L[AKC;/:W3.SM(CJ >6
M=R0V1SC&.*]!HH6FP'D7BSX6V-WIVJW.GQZWJ%[K=S;'4_*U>2)WCC=&+QH9
M$B$@\M0"0,#(&!\M3Z+\.-KW%O>:EXGN]%O[66UU#3?$6K?;UN%884+\[[,9
M;)5E/3KV]6HHZ6#K<X#PS\-=!\*:=-I^CWFMBWEMS:PK<:I/-]BB/\-ON8B+
ML<KS\HYX%==9V*V=C;V8FFG6"-8_-N)#)(^!C+,>6)[D]:T:*=Q6"BBBD,**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBL^^O[/2["74-2O(;*SMU+RSW$@CCC4=V9B ![F@#0H
MJ".1)8UDC8.C %6!R"/454N-2T^WU""QFOK>.\N,F&W>51)+@$G:I.3@ GCT
M- &E1169;:IIUY?7=C9ZC;7%U9E1<0Q3*[P%L[=Z@Y7.#C/7!H TZ**S+/4]
M/OKF\AL=0MKJ:SE\FYCAE5V@DP#L< _*V"#@\X(H TZ*S?[2T]]4;2TU"W:_
MC3S'M1*IE5./F*YR!R.<=ZTJ "BBB@ HHHH **** "BBB@ HHK+N-3T^PN;.
MUOM0M[:XO7,5M%-*J/.X!8J@)RQ !.!G@4 :E%%% !1165>:IINGW%I#J%];
MVDMY,(+9)YE0SR$$A$!/S-@$X'/!H U:*** "BBB@ HHHH **RFU32_[6CTA
MM1MEU%XS,EH9E$S1@@%PF<E02.<8Y%36=Y::A8PWUA=17=M.H>.:"0.DBGH5
M8<$>XH OT444 %%9RWMH^J/8+=Q&[CC69[<2#S%1B0KE>H4E6 /0D'TK1H *
M*** "BBLLZIIBZTNC-J-N-3:$W"V9F7SC$#M,@3.[;GC.,9H U**S;K4M/L9
M[>&^O[:UENG\N!)I51IF_NJ"?F/(X'K6E0 455N)X+6WDFN9DABC&YY)&"JH
M]23P*BM;JWO;.&ZM;B.XMIT$D4T3!TD4C(92."".010!?HHHH **** "BJEQ
M/#:V\EQ<W"00QJ6>21@JJ/4D\ 5G_P!N:*;K3K==8LFFU2,RV,8N$W7:!0Q:
M(9RX"D$E<\$&@#;HHHH **** "BBB@ HHHH **** "BBB@ HJE>7EII]E+>W
MUU#:6T*[Y)IG"(@]2QX J6.:.:)98G5XW 964Y# ]"#0!8HHHH **** "BJ5
MQ<6]I;2W5U.D$$2EY)9&"JBCDDD\ #UIEK=6]]:075K<1W%M.@DBFB8.DBD9
M#*1P01R"* -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \2\7:/IMU^TS\/Y+K2[2=YM-U(R&2%6+E5CVDY'.,G&>F:
M['XI>(+KPG\+M=\16FE6FJ&R@\V2UNY"D<B9 ;.%;/';C/J*R?$7@?Q9K'Q0
MTKQMI?BS3=/_ +(MYK:ULKK1WN%(E $C.ZW,98Y48P% ]^IA\1?#WQAXL\+>
M)=$UKQM8F;6X8K5);?162*TA4DN$C-RS%G)Y8OQ@<5,=%8;:9?U+QSJ$>I_V
M3H]G;+=V^@'7)/M ;RW7.U(4(QC)#9;G;\ORMGC@UUS4/%WQ%^#GBY='L--O
M=7M=2E1!</-MA-NA7<YBC9B S';C&>C8.:K^,/#/B+Q!XML]!;XB-X/ET;2(
M[0WTVBQFTU82?ZP0^8_ PJ!XS(V>/EP,GI-'\ >.KS5?!_B#4?&FFRR>&UN(
M;?S?#S0-=12C869%G01'8%"J%XQDYSM!OKY_@*.EK]OQ,N;XF>(/$GAK1;C3
M?LNE7*^,H_#U^#$\RR&.;.]#O4JK;1E3DX8C/<TO#-UKVB_%+XWZAH=OI\\]
MD]C=20RJT:W#+:EF5=I.PM\QW'=SC(.2:Z#1/@WJFD:!<Z?/XNM;J\;Q(OB:
MWN%TMHTBGW[GC9//)=#T'S*1GJ:UI?AC?1^*/$>K:5XMDMK;Q/%##K$,]DLL
MDGEQ^5N@D5D$+,N<Y5QDY '%4M+^8/7Y&)8_%KQ%XF\?VWAWPCHVE-!J'AR+
MQ!975_<RKO1I%0QR!4^0@EQQNZ ]R*GT?XE72Q^,3=>'=.L]5T_7XM$M88;D
M[+ZXEV+$SR; ?XP2=I(4'KBM32_A;-H_Q@M?'&FZU9VVE6NC+H,&CII[9CME
M(<8F\[[V\9SLQMXQGYJHV?P?OUMO%L>I>*XIKC7=4CUFTNK73?)?3+N,@QNN
MZ5PX78G! SALD[N!V^SL'3[C#_M2]\,_'3QGX@UC3K5I=/\ !J7K_8 5%V$E
MD<G!R0V05YSPH/? Z!?B9K&F_$"/POK^FZ8+3^P&\17&I6]U(HMX%RKHL91O
M,(;'S%D!!)QD;3G>(/ GB33)-<\<:IXPO-5U"703I$EMI>D1(KY9@)=C&1B%
MW[RH.25;DJ0@RO 'PZU;2M?ADD^)%AXRT:\LGL+RU7088"EMY9VQ^>C,T8#$
M8B.!AFP,C(F-[-==2G:]^AV>@_$#7M3\3>';.X\,WDFE:]9/=?;8;&Y2/3I
MH=8YG=-K!E. X*C<,8.0:S?B5-=:O\3_ (<^!9+BXMM'U.>[OKX12%!=BVC#
M+ V/O(2V67H0!6QX'\#>)?"EZRZI\1-1U_1;=?+TW39K6*+[*G0"25<O,0N
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M!.< -UR"%'^\.77E-3QEXJN/$FB_$CP_HVG6=Q9^'-/>.[EO"6^T3M"TACC
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M#SB2;YV$TW(^?"J,$!0":SKCX;:MI-II6N:EX^ED?P]HMQIA2"PA@CNHF5
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MFO7:X/P+X';P3/XC6'5C>V>KZK/JD<)MQ&UNTQ!=2VX[^0,'"X'8]:[RA]+
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M5]J-@_*0A3 /8CMBM+$K4]?HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** $)HS7G_B;XF:/X7O]7M;C2M5OVT6P34[YK.&,K!
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M]-ETN[U*2T36+N*(26[0#:]NLOE@KEP5V[6)R0V<TNB976Q[.**\<^&]O?\
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M-C=S1Q;?.9F5$<+(67<4.#C'J15K3?B=I%WI>LZO<Z5J6G:;H=Q<VNI7=UY
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M@58$$@J0003[$:JK(L2B1@[@#+!< GN<<XKC=-^(FDZI/X>,6GZA#9^(B_\
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MCGLYYX@C)M5&61"1D-N4KGHU>PU@V6N-=^)-5T3^R-2MO[.2%_MT]OMM;KS
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M7_:8J.@SD@$ ZVBD!R :6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)-8\1>
M*=2\?>*/">AW5Y:SZ7IMM+:?8UM"6EE$AWR_:"24!5%^4?WN<D5A^.?$WQ \
M*Q^'-9F\1QVUM?::T6KVB6\<R:;-Y: WR$1%FAC=LL&;!RN.N*]'\1_#OP;X
MJU*UU/7=$6XO[3B*ZBED@EVYSL9XV4LF?X&)7VJ6Z\#^';R?4Y+BVN_^)I9#
M3KF--0N$B-N!@(D:R!8^,\H%/+<\G(!R_B#5-;T]M%TG3_%5Y?S/I=U=226M
MO;/=73)Y>R<ED$"1#<V>%))0+GFN3\(>./%WB:'X37]UKDELOB6TO?[2@AMX
M=LCPQL5=2R$J21D@''3 '.?0;/X9^#[&STNTL]-NK>+2HY(;4#4KHE(GP6A8
MF3+Q':/W;$H,<"JEC\(? >GG17L;#4;5M$#+IXAUF^5;8,26V@38^;)!SG(P
MIR !1T8EHUZ'GNG_ ! \:?\ " >+->N=>DN+OP[XO.BQ9MX%6YMA=PQXE C^
M]ME893;V/UOZMXP\80^)OC1IT/B&:*#PSI-OJ&E;;: F!VMY)6!)C.]2R@?-
MDX'!!YKK(_@O\/%TF^TK^R]3%E?W8O;J$:Y?[9YP<^8_[_YFR <GJ54]0,2_
M\*;\"M+JTLEGJTDNL0K;ZC(^O7[/=QJ,*LC&?+#''/8D="12>JLMQK2[9@Z?
MXP\16WQ8\*Z)?:XUSI>K^&Y-2N$N885$4R;#O#(BD#!.021]*R]!\;>+KKQ_
MX*T.\UBZNK'Q+HMS<2W+6L,*-*B*PFMAM$BI\QP)1DC:<5WMC\*_!6GZWI^M
M0V.H2WNGV[6MO)=:O>7 2%LYBVR2LK(<_=((X'H*DT_X9^"]+U/1]0L]-N!=
MZ(LD>GO)J%S+]G1P T:AY"-F ,(<JO8"FK7UVU%T5MSQK2_$'B;PW\%?AU>:
M7XDNM^J^)X]/NQ<1PS>9#+=S"0;F3=D[>6))Y/X>C7_B#Q)K'A_QYJVCZU-H
MUUX?N[BVM8)+>%XCY$*/F3<A8AR2<AAA67'(.=?4/A-X#U*PMK"ZTFZ^RV=Z
M=0MX8=3NH5@G+%MZ!)1MPS,5 X4LVT#)SJWW@/POJ6N2:Q>Z>[W$ZA+A%NID
MANP!@">%7$<V!Q^\5N /2HMI:_<TNKWL<);>*/$^L?$.WTY=<NM.L;WP<FN"
MVB@MR8+AI ORL\;' '9B>:ZSX3^(]3\6?"+PWXBUB02ZA>VH>>0($#L&*EL#
M@9QGCBI=1^&/A'5/$4_B*ZAU-=4FMS:--;ZS>P 0D?ZM5CF553OM  SSUYJM
M8_#70]#;P[9^'/MFFV.AS230H-1N93AP T.UY""C8S\V0N#M +%A:,]BUXRU
MC4+/4_#VFZ=J+V\E_=2+);VT2/=7*+"[8B\P&-0&V%F? QP#D@'RG2_B%XTU
M#P_X NIM:EM[G4?%,^A7Y6WM\SPH\H#$;"%?$:@E,#KQTQ[9K7AG1?$$UC<:
MI;3-<Z?*9K6>WN);>6%B-K8>)E;:0<%<X8=0:Y=O@S\/Y/L@72[V%;.\DO[=
M8-6O(E@N'8LTB!)@%.2>G3)QC)I>HWY'GU[\5/$VFZCKWA^2[-U,/&-EX>L[
M]XH]UM#<*&9F"J$+* X4D=2,YQST/AJWN+?]J?Q7%<7\U\W_  C]D1+.J*P'
MFOQ\BJ/7M76V_P *O ]N=;7^R9K@:XXEOQ=7UQ<":0?=D DD;8X[.N&&!@C
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MW# 8#$L20PZY!!SSUYJ"X^%/@F[\$OX-N-)FDT.:4330&_N=\S Y&^7S/,<
MXP&8@8'' Q3UT] 3LTR7Q[XDO/!_P?U?Q-I\:O=V%@)(O,4LJM@ ,P'4#.3[
M"N>\30Z^/!?B:_D\6IK7A^]\+W+Q1RQ1++Y_E$^9&T:*&C9&Y!S@XQUKT1='
ML5T1=#EMQ=6 @%JT-VQN/,CV[=KF0L7R.I8DGOFN:LOA/X#T_0=2T.PT6:UL
M-34QW$<.H7*'RR<F-&$FZ-#T*(54C@C'%#U#8X+PIXAUC1=9^%FA_P!L,^C:
MMX6>XG@GCB"0O#!"RNK!0P&&(.6(Q^=-T/QEXNN?'G@K0[K6KJ>S\2:+=7$E
MT;6")#-&JLLUL-F\)\QP)5Y&TXKNK/X3^";'4M)O(;#46GTB$V]EY^L7LR0Q
M'@QA'F*E"."I!!  (P *;'\)_ L;:=(FGWT<NF0RV]E*FKWBO;12*%:-&$N5
M7 &U0<+_  XHZM]R4K)+L<)H_C+Q7<? O1?&5]XT6WU;4YTM/])M8BDA:\9,
M0I'%N,QC7:H.5SR0.6%FX^('B+2Y]6TG4-1GM-GBFPTB.\OX[?SK6"X@CE;=
MY0\K.2P5B#C>,YQ7;6WPK\$VOA+_ (1%=)N&T59UN8;>;4+F4V\JG<KPNTA>
M$@Y/R%>23W-6[CX<>"[R+5[>]T&.\BU@1_;H[F6259BBJJOAF(#X5?G&&)4$
MDD9I1T=WJ4]=M#@OB9I_BJW\ >)H]4\5/>67]I:=+IYBCCCN$B:YB5XY=J!6
M&[)4@<@8.>15^\\3>+=2^(/BOP3H\]^L^B:9;2VMQ"MIOGGF60^9+YH V JB
MX11_%GJ*ZVW^''@ZU\'S^$X=+?\ LBZP9HWNIGD<J0RGSBYD!! ((;C'&*36
MOASX/\17&FW&L:2;JXTU=EO/]JF28KUVO(KAI5)&2'+ G).<FGV$NMSS[3_$
M7CS5OCA9^"M2\1R:1#-X1CU6YATV.VD$-X)UC?RWDB?*<-P<_>/MB31_%GCJ
M^G\<V<.I2:I/I'B5+*UA1;:&Y-IL61XX=ZK&\NW<1OZ@'D5Z$GP_\+P^.D\;
M0V,\>NI;BS6=+ZX6-8 ,"(0A_+V=]NW&[YOO<U1M?A?X+L&U)K73[U)-3NA>
MW,C:K=L[3@,!*K&4E' 8_,N#P/[HPGK8K1?@>4>-]>;Q3;?#>Y@UG4DDC\=1
MV4T=Q"D$]NZ[R$ECV;?,3C'!4YSSFM7QM\2O%'@F[^*EU%>?VC%H-KI<FG0W
M$";;=KEF5V8HJLR@X/)/3%>G77P\\)W>C6>DW&E/+;V5ZNI0R-=3&<7(SB8S
M[_,9^>69B2.#D4VW^'?A.W\0ZOKG]GSW-YK4?DWZW5Y<7$-RG96AD=H]H&0H
MVX4$@8!Q3NMK$I=RQI$.N6_B%GNO$B:KH]U8QO;QS)&MP)@QWNIC108RK1]<
MD'O@UB7'B+4M9^*^I^"+.^N=)@TO28[YYHHHV:X>5V4#]XK?(H7L 22>>*V_
M"W@3PKX+AFA\.Z8;59CEM]Q+.0.RJ9&8JO'W5POM4^M>#]"U_4;74M2M9OMM
MH"L5S;74UK)L)R8V:)E+H3U1LJ?2I>MAQTO<\#^"FL:K;_"/X<Z'I>K-";T:
MK+-964<;WDX2X?:Z&4&)(U).XN1DE0,DXJ0ZWKGBW5/@1K&I:K<0WE[=7PN/
M)"*K21PNOF;-I7<0#V(&XXQFO7]-^%'@'1H-+CTG0/L TII&M7M[F:-U\S_6
M*SA]TBM@95RRG XJ>#X:^#;;3M+T^WT4I!I%RUW8C[5,6MY&SNVL7W;2"04S
MM(.,8JF[_>'5^C_$\^U'Q]XHL/%'A:2WU:2_T[5_$]QI$S"VA2S>$-*$6)B!
M,70(H+\H6#X)&*Z#XY>)M>\)_"^YU[PUJ3Z=J$-U;1B00QR@J\JHP(=6'1NV
M#D"MNX^%_@>2>WG;2YLVNH_VK;H+^Y$=O<DL2\:"3:@)9B44!6)Y!K3\7>#_
M  _XXT=-&\26<UYIRR+-Y45W-;AG7[I)B=2V#R <C(!Z@4)I6\GKZ"MJ_0Y3
M4M4\06OCY?!]MKFKW/F:9)J2S0I8BXW--L"CS$5"D8']TM\PW,:SM)U#X@+X
MN\%:#XFUYK6\U'2K^34HK.*W9/.@DB5'1C&<$B0EADC/0#%=MKWP]\(^)K33
MK?7M):^.F@+:W#W,JW,0P ?WZN)#G W98[N^:XGQ)X6O-0^*7A6&W\%ZLGAK
M2+.YLGOK#48;01&8PE70I<). OEL&( 8YX#9HZI>O_ #H_D5/#/C;Q-?>);+
MP7J6H3FX;6-4LSK"P0J\\-JJM&N-FP.?-&2$ _=M@#-5M?\ %WC;2]!\<6P\
M1.;SPYK=A;VM^EK!F:WN6@S'*I0J642MRH7^$^U>G3>!?#-QX?MM!_LD6UC:
MS>?;_99I+>6&7))D66-ED5SELL&R=QR3DU4U/X;^$M8T"/0[S3[DV F%RZ0Z
MA<P//*,$23.DBO,X*J=TA8Y /45"35KN]BFT]E8Y;Q/97UG\8O KMX@U*X'V
M759=K" <*L3!0!&!T.W)!; ZYR31\!^+O'/B_P .^$/&$<DCVFHSL=3A<VJV
MB0L70"':3-YB/Y8PQY^;(SC'I%QX/T.\FT2:ZANII]$S]BG>^G,J@J%8.^_=
M*& &X2%@V.<U2TOX=>#=$\4S^)-(T-+/4IRS,8Y)!$&(PS+#N\M6/=@H)R>>
M36G8BV_F>8WFJ:QXJ^'/@GQA>:Q,RZAXFT^8V'D1+%"GVX*J A=^Y<#)+')#
M<<C'6_'P$_!N_ 8J3>V'(ZC_ $R&MJ3X7^!99;A9-#S!<72WK6PN)A;K.K;_
M #%AW^6C%N254;N^:Z'5-&TW6M'FT;5K&&[TZ9 CV\BY7 Z8]"" 01R" 1@B
MH:WMWN6M&O0\XU/5_%T?QJD^'MEXHN$M-1\/R:E#=?9K=I]/F28("/W>UHVS
MC#*3GH14G@+Q9KGC;^P8XM;ECGT:.:'Q-$8X0SWB'RQ"1Y? ++(^4V_*%]:Z
M:?15\%^'-1OO!_AN37];V*$@NM3<W%T PQ&;JX9V"J"2 3@=@,T[P3H-UI<>
MJ:UJ6GVNGZQK]T+^]MK4ATMV\M$$6\ >80$R6P,LS$<&J6@GJ<A\??\ D6_!
M_P#V-FF?^C:S_'_@-?'7Q7U"WM=0DTG7=/T.SO-)U.+A[2X6XN<'W4]&'<?0
M5Z)XL\ ^'/''V)/$UK=7:6,HGMTAU"YME20='Q%(H+#LQR1SC&318>!/#NG^
M*T\36JZFVKK MIY\^KWDX:)1@(R/*48#)/(/S$M]XDU*T^]L;U1PWPG\=:AX
MS\7:U8Z]I<FF>)M LX-/U: C]VTPDE_>1GNC#YA]>XP3N_!(A?@]I[,< 7FH
M$D]O]-GKK;KP_I=Y=7MY);R175];K:SW%K-);S/&I8J/,C964@LV""",]:Y6
MU^$/@FSTLZ39QZY;Z<=X:SC\0ZDL)#$E@4%QM.223QSDYZU6[3\A;7]4=W9W
M5OJ%C!?6THEMKB-98G .&1AD'GU!KSOQ'XD\0:9\>?"'A^UU0)H^I:=?37-K
M)''L:2%04;?MWK][G!QQTKI[7PO#;^/)O$T<DEOOM/L36Z7$K1R@%"K&,MY:
M%=I VKDAB2><!NI>!?#>L>+[+Q9J%G/)K%C&T%O,E]<1K&C9W+Y:N$(;/.5Y
MXSG I>@'+> _%6N7GB"S\/\ BJ2]@UEM-DNY8Y(839WF'C'FVDT0^>,!ONL=
MP#KD=ZT-9\3:@_Q@T;P#9W4VG1W.F3ZK<7D<:,S['6-(D+JR]2S-QG[N,9-;
MNB>"_#OAR\6ZTJQFB=(?L\2RW<TT=M'QE(4D=EA4[5R$"@[1G.!4NN>$]#\3
M"V;5K64SVCE[>ZM;F6UN(21@[)HF5U!'4!L'OFA]+#74^=_ASXJUCP]._AJR
M\Z5]>\>:S;W%W$L(EQ%&'P@DQ&&=@.O& P SBO0)O%7CS2=8T7PWK;.CZIK5
MQ#;W$36ANWM%@,L2,"1"LI;@X'*KP,G-=:/A7X!70M0T$>&H?L&H71OKA3+)
MYC3EMWF"3=O1LDX*L,=!BKUS\.?!=YX1B\)W>@0W&D1,)$CE=VD5QTD$I;S!
M)_M[MWO5DVN</>ZE\1-);P_#JFMSV[WOBH:>H:*U>2>P>%Y%\W8A5905(RF!
MC'!S6-K'C3QII?A[XMW,?B:XEG\(W"-I[O:V_*-"DGER 1@, 6(R,''?O7H5
MS\*_!=Y9Z7I\FGW\=OI4GGV@@U:\@9)>GFEDE!>0#@.Q+ ' .*CE^#?P_F@U
MJ&;3]3ECUTAM15]<OB+LC&-_[[GH!]..G%1L/S.37QMXN\4>*==\/Z*+JSN-
M/T6QO+9K06Q\RXN(W?=)Y^?W8(1<(,_>R>16EX=\3>+/$_CR]\,ZCJ(T2;2=
M&LKBZ33TBE$]U-O\PJ\BN#&NP   ').370:A\+_ ^HV^D0WVBO.=(C$-I*UY
M<><L8Y$;RA]\B<?=<LOM6MJ/@;POJFJV>K7.F>5?VD8ACN+2:2U<Q#_EDYB9
M=\?^PV5]JK3MN39Z:]#E/A#=-I_[._AZ^:%[AK?37E*1CYI"I8X ]3BJGA/Q
M'XMU_P &>$_B$NM6KZ=?027&J:=)&@7YE;RX[=@H;>LH5,.QSD]3BO0/#WAO
M1/">C1:/X?TV.PL8\E8DR>?4DDDGW)K*T?X=^#= \177B#2=#2VO[EFD<K)(
MT2L?O,D18QQL><E%!.3ZFDW>3?<:5HI'GECX]\4-\)_!WQ&&K-?2:M>VD=YI
MD<$0@*3S>4R1_+Y@9"PP2YR5.<YXQ%^(7C:W\'_$[7F\12SS^%O$OV&RB>VM
MPCVXEB78^(P3D.W((//!KV33O ?A?2=6.HZ=IK6S^89EMTN9?LL<AZR);[O)
M1SS\ZH&Y//)K!?X+_#UM/U73VTW46L]7NA>7\7]M7VVZF!SO?]]R<\GU(4G[
MHP[J^P6=MSG-9\1:UXLB^+FF)J<FFV/ARU:S@MX88R9BUJ9'>0NK$@DX 7;P
M.N3D9W@7Q#XB'Q!\&^#(]:FBT2Y\ V^H?9UAA)BN 4C#JQ0MT[,2,GI7HUU\
M,?!][,;JZT^X,SVHL[B5-0N4>\B"[0MPPD!N,#H9=Q'K4T?PY\&0RZ3/:Z*E
MI)I$36]H]M-)"RQ,<F)BC#S(R>=C[ESVIW2"QY;X%^(OB?7V^'F@ZIKQ@N-=
ML]2NKB_6WA6:Y>"8I'&@V>6/ERS83)VCISFWXEL_$"^.OA+::WXD:[U&+5K^
M*6XLUC19,6\IC=D*;1)Y94,,8!+;1SFN[F^$OP[N/#MMX=?PK;+I]I(9K<1/
M)'+"YZLDRL)%)P,D-SWK2N? OA>[LM%M9-+81Z'-]HL#%<2Q/"^""=ZL&;<&
M(8,2&R=V:7,KIV%9V:ON>>:7XP\?>*--GU[0H9(S9Z[/:SVMPUJEH+2&=HW5
MF),PDV#=G@;O]FN7\7>(-8\<? CQWKUUJDEK#::M)8PZ=%%&(UBANHT D)4N
M7/WB0P&2.,#GV8_#OP?_ ,)B_BX:+&-6<AI)5DD$;N. [1;O+9Q_?*[N!SQ5
M?4?AGX'U6[U&:\T,[=38/>V\5U-%;W+@@^9)"CB-GR!\Y7<?6A.UO(;UO;0[
ME?NCZ4X54M+6"RLX;.UB6*"%!'&B]%4# %6Q2!!1110,**** "BBB@ HHHH
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MQ?B_1?$FO6NE^*-!\'MINKZ5K%MJLFEW4MLDVI;$:*0-)'(\>X1L C,W!7G
MQ4?B_P ,^(O$PT;Q'HOA--&O=+UVTUB?3[E[=+G4/+5XY-[Q.T9;RR@0L_\
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M2K:XC/V9+N82H8RY1&*[%#\]_ESCEFH>"/%4=U>:I:^'YIWU3QG9:ZUK#<0
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MT.;U;P(UAXJO_B3I][J^K^)HM#?2H+026T23IDNH!\H;7W\[LX]L<5SWP_\
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M-O;['!)(W)PRN_/4G.:].?Q1X:CUZ#0)/$&GKJ]P@EAL&NHQ/*A!(98\[B,
M\@=JBD\7^%+>Z6RG\3:3%=M<"T6%[V(.9CTB"EL[_P#9ZT67WCOIZ&)X?^'-
MKX9LDTO3?$VN2:3;JZV-A/+"\5CN! V'RM[!0QVB1G4<<<"LC1_@SH^A^&_#
M?AS3_$6NK8>'+]M1LMS6S/YIW_>/D<C]Z_''7V%=YJWB#0]">U36]<T_2VO)
M/*MQ>7*0F9_[J;B-QY' YYI=4\0Z#H36JZUKEAIK7;^5;B\N4A,S_P!U-Q&X
M^PIIL3U6IROA_P"&MKX8N;A='\2Z[;Z7-=/>#2#-$]M%(S;B4W1&15W?-L#[
M<]0<G);_  STV/PCXA\+W&KZI>6.O3SW-PTKQ+(DDSEW9"D:X^8YP01QC&,Y
MZW5-6TS0]-EU36M2M=.L8<>9<W<RPQ1Y( RS$ 9) Y/4BLNW\<>"[S4X-/L_
M%VBW-]<Q":&VAU"%Y98RNX.JALE=H+9'&.:D/,S'^&NEW'BK4O$5]JVIWMYJ
MFD_V+=+*T*I)!ECG"1J0WS'D''M5?_A5NE-J7@S47US5VD\'1M'IZ%H-KJT8
MB(DQ%ELHH'!%;EKXHT76&TR;0?%6BW=K<3O$##<)<?:BJ$M'$R2 !U.&/#?*
M",#.1YI>_%+Q;:^#OBIJRV^DM>>#K][>TS!+Y<\81&_>#S,[OF[$#VI]0.Z_
MX5YIOE:G8C5=3&CZC=O>3Z7NB,!=Y/,D )C\P*[Y)4/CDXQFL_4_A7INJW/B
M^2?Q%K2#Q; EOJ"1FW 5$0HHCS"2ORDC))_.NHEU&^/@UM4A\I+O[%]H7>A9
M ^S=RH()&>V1]:YGX9_$2S\:>$]"GU#5-)C\2W]B+V?2[:X421J3]X1%BX7I
MR<]:=M_+02ELUU-?3=%UC2-4T>QM=7NI]$L=/^RS1W(@/F,N!&PV1J^_'4Y"
MX487))%K6O"=EK7B'0=>DO+JUO=#DFDMFMRFUO-38ZN&5L@CTP?>KR^(M ;7
MSX?77+ ZRJ>8=/%RGV@)_>\O.['OBI]0U+3M)L9=1U6_MM/LH1NEN+F58HXQ
MZLS$ ?C1<#C8OA7X;AT:?P^LUZWA^6^^WMI#,AMQ)YHFP#L\S9Y@W;=^.HZ<
M5M^,O"MGXW\(7_A?4KV[M+._3RYGM"@D*YS@%U8#IZ9J_#XBT&YT$^(+?7+"
M72-I?[>ERC6^T'!/F [<9[YKCO%GCQ].M_!^I^&=0TK4])US6H-,FG4^<I23
M=EXY$<*"-A'(8<^V"KV212NW<T(_ :KXHA\1'Q1K#7L>F-I:@K:[/*+*Q.!!
M][<H.<X]L<5@:/\ !'P_H/AWP_I6BZ_KUE<^'I9WT_4XY8/M,2S-NEC.83&Z
M,><,A^M=I+XAT>\\,W>M:/XFT@6L8=1J+S)/:PN.#O*NH.#U&]3VR*MZIXBT
M'08K>37=<L-+2X<10O>7*0B5S_"NXC)]A3$<QJ_PQTK5KC1M4.M:U9Z]H[RR
M6^LV\\?VEC)@2!PZ-$RL% VE-H    XJ[?> ["^N?#EY=:QJ3ZAH-U)>0W>Z
M+S)Y)$9'\P>7M((8\*JXP,8 Q6LWBOPNOB1?#;>)=*77&/RZ:;V/[2?EW<1;
MMWW>>G3FJX\:^#?[&GUH>+M&.F6TWV>:]&H1>3%)_<9]VT-R."<\T)VV!J^C
M#Q!X;A\2#36FOKNRETR]2_MIK4IN6159,$.K*05=@01WXP1FN5_X4[I*P:K;
MP^(-:ACU76DU^X"M;G-TKHXQF$X7=&IQ]:[34/$&AZ;HO]M:CK5C9Z7A6%]<
M7*1P8;A3YA(7G(QSSFN/^%OCK5/'-OXJDU#[ 5T?7KC2K::Q1E2>*-4*R'+M
MDG<3P<8Q]:5OPU#IY/0D_P"$;TWP+XD\2?$;S/$&M7^K16\-W:6]NEPS"/"(
M8XHHU;(!YY(QD]JM_#[PI;>%]'U-K?2VTK^U=2N-1-H[AVA#GA3@D#@!MH)
M+$5G>%?B-#<ZYXDTGQ9JVC:=/9:Z^DZ<#(+9KL".-P LDA+OF3'R^W%=7#XN
M\+W&LW&B6_B72IM5M%9[BQ2]B,\*K]XO&&W*!D9R.,T[6_KN*]_Z['E_Q"LM
M3OOVC?AE<V-EK26EA%?+=:C9:;)+%;&:,)&&D,;1C)!!S]T<G'!KL[CX8^'[
MNSM4>XOXM0M=5;6H]2BD5;C[6V0TA^7805.W:4V[0!CBNJTC6M'UZP34M#U2
MTU2R<E5N;.=9HF(." RDC@U6M=8L5T.;6+S7M/FLH6E:2]A98[>-%=AAF+L
M5 VL=V,J3A>@+M)+L#L]3GM>^&&A^*/"^OZ%K5Y>SC7C#]LO5:-)V\HJ8P"J
M!0%*\#;W.<YI]W\/8YO$R^(K'Q1KFD:@]JEG=O920!+Y$)V&5'B9=PW, RA6
M /!J'PCXTD\0:]XL@DU#2KS2M(EMS:7]D<1RPR0"7<S;V4XW8W @<9Q70V_B
M[PI>:(^N6OB?2I])C;8]]%>QM C=,&0-M!Y'&:>H)W6FQB-\.M/7Q7)XDCUS
M5HKEM*_L81!H7C6#.[J\18MNYW,QR>N:J:#\)]#\,Z3X7T_3=6U9O^$7:X-A
M-*\+/MF!#H_[L*P^8XX!'K6WJ7CSP?I.F:SJEUXFTPP:+E;X)=QLUN_.(W .
M5<D8"GDG@"FZ)XMTGQ'9:#J&C^(M(>'4%8FW699WF81EFCC97 #(>6^5N%(P
MO43TT'U,*W^$^CPS:Q-_;FL//JFKPZT\I>#,-S$RE"@$0&WY0"K!AQZ\TMU\
M(])NHO&*-KVLQ_\ "8;/[2*-;YPL?EX3,)VY7KUYZ8K)N/C%H-WXHUC2=-\;
M>$]/CT:6WCE?5;M0MUN.9O+<2*!L4[<[6&_@XKO/^$S\(K;:9<'Q1I0AU9BF
MGR&^BVWC @$1'=B0Y('RYY-"M;39@]]=R>]T-K[PO/H,VJ7@$\)@DNU$0F*D
M8)^YLSCC[M<_<_#71[KX?:9X-N-4U,P:3Y#:??I+''=VCP@+&Z.J!=P QRIS
MDYSFM;2?$-B=&M+S4/%.BW[75RUM%=V;+#!-)O*B) 99,N,;2 Q)8'@=!>T_
MQ!H>K:?-J6DZU87UE"S+)<VMRDL2%?O!F4D COGI1W8+2R.9U3X:Z9K=A9QZ
MUK6L:CJ-G?0ZA;:I)+$EQ#-%D1E52-8@ &;*^7@Y)()YK@K/PW#XF^+_ ,2O
M#OB#3]>ET?7--LK-=0FT^:".<PJXDVS"-8\@LN".&[9%>S:3KFC>(+/[=H6K
M6>JV98H+BRG2:,L.HW*2,BL+6/B+X3T/QIIW@V^UZQM=:U!2T<,\JIL&,+G)
M'+-@*N<MSCI1Z]0*:?#JTC\4Z?XD/B36/[2L=-;2H9/]'P8203E?)QNR <^W
MID5FVOP;T6SL?"EC%XBUHQ>%;E[JPW-;Y+MG._\ <_,/F;ICK2?#7XF1^*M'
M\OQ-J6CV.N2ZE>65K9P2>2]PD$A7<D;NS,<#)QD5W,_B'0+76X=#N-<T^#5I
MUW0V,ERBSR#U6,G<1]!5:IHG37\3GKSX>V]QXTN?%NG^)-;T.^OH4@O8K"6+
MR;M4&%+I+&^& X#+M8#O5>Z^&ME>77B21O$&L1KX@L4TVYC0VY6.%%=5"$PD
MY E<98L3GFNYGN(;:![BXF2&*-2SR2,%50.I)/05D0>+?"MUH+:_:^)M*FT@
M-L:_CO(V@!SC!D#;<YXZU-KZ%WL<M9_"G2K+_A#_ "]>UAT\)6[VMC'*;8K)
M&\8C99?W/S90!>,=/7FK?A3X9V/@NT73=%\1:XNC0,[VNF3RPRPVC-GE&,7F
M$ L2%=V4'G%:UUXDTMKFS-GXHT6*%[N2VECE=9'N'13OAC82*%D4C+9#X ((
M'485G\4O"/B31=;N/#/CC0+=],D\M[R\E66&-1MS*Z"2,["2RAMP!(R"157;
M)LMBE9_!?2+'1-&T6W\3:]]DT?53K%MN:V+?:-[/\Q\CE<NW'O6M%\-M-@N=
M9N+76M5MFU;5(M8D$<D6(KA-F"F8R=I\M<JQ8'GUKH]0\0:#H[6<.L:UI^GR
MWK".V6YN$A-PY_AC#'YCST&>M)JWB3P_H,EI#K6O:=IDEV_EVR7MU'"9VX^5
M Q&X\C@>HI;!N0Z+X=M]%FU*XANKBYNM3N!=74\^P,[B-(QPBJHPL:C@?7-8
MEQ\-=#FD\1K!=W]G9>)26U2RA=/*N69-CM\R%T++@'8R],C!YJ&Z\7:U:_'/
M2_!/DV3:5?:1/J&_RW$Z21R*NW=NVE3NS]W->@U.]F/;0XZ3P-:-XJTG7K76
M-0L?[)M'L;6RMU@%ND+^7N3#1%N?*3^+C'&*N^)/#*>*=.AL9]4O;".*ZANP
MUGY6YGBD61,^8CC 9%/ &:Z6BJN*R.4\1>"]#\4'1IM:A-U=Z+>PW]G<\+)'
M+&P;.0,8;;AAC!]L#$"^!K5?B1/XX_MK4FOY;)=/:V/D?9_(#EPN/*W?>)YW
M9KLJ*5AW//\ 3?AAX=TW0-4\*JUU<>%]1\W.ASF-K: 2'<PB(02*-V6 WD*3
MQCC&GI?A1M+TB+2?^$DU:[T^*(6\<$[0Y6( *$WK$KG@8R6W>^>:ZZBGL!&J
MK&@1%"J!@ #  J2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /GZ\T'1]2_;
M%NUU'1;.[L;OPD(;C[1;*\4]P+@$*VX89_+53@Y.U1V%<]X-TNSN/%<&@^++
MSQ;:>)],\1RZA%:II,/V6Z<S$BX6Z%J7\HQD!M\P) VCC:*^H:*+[+L!\E^*
MIO"FI:AK'A3Q#<6\4:^,#JLU[>:3>S2"-) &C.VW:)EV@QAC+M\LC(&,5O?$
M*&*/PI\:='AL9&GU'['<6-O!;LPN(_LL"AXPHPP#1L"1T(&<9%>VV7AD6,$]
MFFNZE+8S/(YMI?)95$C%F7=Y>\@EFZL3SUZ5TX P!C I='YAM)-=#Y]N-46#
MXL>"M2CL+RY\KP;=+]F\F2&5Y2(V6$A@"DC;& #8-0>!=R^./ 6JP0RV&GW&
MAWMK'I<5I(5TU6> I;R3."\LN[<6+$8VEMJ@DGZ*]:2G>^XCY#\-V$%E\!?A
MA:ZMIQM]8TGQ9&[K<0%9K5/MLC2'D95=NTMV *D]17;75E?MX<^+_AWQ1;R7
MFNZO=S7.BN%RU["\0%DL![F)UZ#[A^8XSFOHCBEIMW']KF/G'3=)M=(^,+'Q
M!]AGUB/P)'#J6H&-?](OP=LA9\?-(8QW^;9[5VG[/9NO^&?_  O!?>:MS;PR
M0R1S AX]LK[5(/(PNW ],5ZQ123T:$UJF>6Z??6<O[0FK*EU&^[0;6W!!&&E
M2XN6>,'NRJP)7J >:X34H=2L?A[\1/AS'IMXVM:MK-S%8*EN["YAO9-XG#8(
M*('<.V<+LP<$C/T9@9I>-U*R#T[W/.?BEX'N_'7P=UCP;IMPD%U<0Q+!),QV
MEHW1P&/7!V8SSUS4G@_QII5UX/LHKFUO+#5[:!+>?2+BW:.Z$RJ%*HA WC(X
M=<KCG( ./0Z*?5ON'1+L>-ZS-IE]^T%H4-]=26X70;J%_(NWB\N=YX"L321L
M/F(5L*3SCITK(^+VCZ7X=^%?ASPWIK3FWMM<LW2+S&>985GWNV1\V%!^]U'&
M3GFO>J7O4Q]VUNCN'?S/&- ^Q>!_BC=P^()KC5&\2@RZ1X@G#S^7!NS]ADE)
M(15+;D/ 8-S\PY[CQMXRTWP/H:ZIJ,=Q,9I5MX8H+>29BY_B81JS!%&2Q /
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M>0"1]*44^K?<A*RL?+_@72]/O?$VDZ-XGO/&-MXMT/6YKQ;0Z3 EM+(78R7
MNEM=QA=2<[YLMP.?EKU'XL7$,2>$X9M%6[>36HC;ZA-YK6^E3!&*7$J1D>8
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M?@JYW2.!X8GBEE9& $K.A"DD8R=K$>HY'!%>ZTZBD*PM%%%4,**** "BBB@
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M*G):>.7RA%E 7 5Y&(!& >*K7O@W7=#\0>'O'%Y-9M:^%/#\]C/!;B2:2?\
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MMZ;KOA'5KC4M-N=0T2ZNIK[4&A;[1JS2QM&LLK==RJP&TDCC 8# !IHNFO\
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MXA][<0");?Q#X@TOXD_#MH-4U'4F\3^'KF[O[2>X9XYIHX%EC,<9^2(Y)7Y
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M*:5XT+RJ&P6VY(VD\DUZ%0 4444 %%%% !1110 4444 %%%% !1110 4444
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MT+AT);#C8I.!SVQGBD'D:TWA/PY=:I+JEQI,,EU</'+,6!V321X\MW3.UF7
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M<^4)<AR<8V'/KP1U! 6FP_/L=AINGV>D:3::3I]NMM96<2000H,+&B@*JCZ
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M=JSN"'E5,[5D8$Y< $Y//)I^D^%M$T4WKZ7:/ ;Z1IKD--)()9&P&=@S$%B
M 6ZD#K7CFE^(/B)JW[-%CXOT_P 77#^+)KKR8GEMK589F-_]G5'40\*5QDK@
MYYS6G>?$W5/$GP4U#7M)EN?"_BC2+ZWL=3LFCBDDM)_/C26,B16!1E<E6QZ>
MA% 'HWAGP#X+\(W5U=>%_#-AI$UU_KI+:(*SC.<9[#/8<5?U+P[I.M3V=SJ-
MB)KBR9FMIU=HY82PPVUU(8 C@C//>N+CU#Q,O[0L?AH^);I]$7P]_:36;6]O
M\T_VGR\EQ&&V[>P/7O73^,+?Q!>>&;B+PWJ5WINJ;E:&6UBAD8D'[K"8;=A[
MGKCISP0!FH>!_"NJ:/8Z/=:+"VF6#K):VD1:**%U.5950@9!Y!ZC)QUK:FT^
MUN-,DT^ZA%U9R1&&2*?,@D0C:5;=DMD=<YS7-ZU\0-%\/:E=Z7>1WUU>6.G_
M -J7<=E:M+Y%ON9?,./4HV%&6P"<8&:W-1U5K/PY<:O;6LEULMS.D*E59QMR
M!\Q 'YU,FE%M[ M6NYDQ?#_PI ^E26^D^2VD*4L3#<2H;8%0I"888RH"GU4
M= !4$GPU\"S:%=>'[CPS;7.F7=Q]KFMIRTJ-.>3+\Q.'.3EAR>]<'\/_ !=
MOA?PQXY\27^N?VSXJ1;6/3_M1FMKVX?+AH82[+!M5",CRQ@G<"2#7?:?\0M
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>V%K=/$72[MRK*A=79 'VE"0V-KG)'->E9K)OM7L]/N+*&\DD5KZ<6T 2%Y
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MK[9IVM_!O2O$6DZUINK>*?$4MKK9MY;V-);=!)/"(PL^%A #D1("!\AQG;D
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M%@E\'S/9007<*E;Z>&(22F7@$*V=J["N,%N00!TGB_P&OC"^TNZD\5:WI/\
M9=PMY;Q:>;8)YZA@LC>;"Y8X8C&=N.U1:A\.=+U'4KJ^_MC5;1=3@2WU6VMG
MBCBU95&,S#R\ABI*EHC&2O&< 8-;"TO<Y'P[XZ\6>,O&MC96.I6VF:;JOA>#
MQ!:I_9^^6V=Y%0QNQDQ(/O<@)PP],UW/CS6KK0=*T^XM[V*QBFOXH+B4QM--
MY3!LK!$JL9)20H50K=2<<54M/AW9V/Q&3QE9Z_JEO+'9KIJ:;&MLMHEJIRL*
MKY.\*&^;(?.>,XXK8\4>%X?$\6G,VJ7VEW>F78O+6[L3&)8Y C(1^\1U*E78
M$%3D&EKIZB[GE'A?XOZYK%I:Z+?*(=7N_%EUX=CNO("%(8%\QI&0DCS2GRX^
MZ&.<8&#TFL>+/&GA^_TCPWJ#6/VO7-?;3[#4<;C]B$9E,CH %\[ * <+G#8Q
MP9E^"?A)?#FO:$U]JS)J^J-K NC<J+BQNR0?-MY @*-D=3N)Y!)'%6+KX0^%
M]2\"IX7U:^UO57BF6ZCUB]U!Y=1CG7.R59S]UER0  %'/')S5_(=AE]JWC;1
M8[+1KYHKV[U/7)+.RNK6)#(UD('GW,K%(Q+B-T_N]&VGH>2U#Q;\6]&U/0[/
M6(K'3K;4?%"Z3!+-:QRS75G(I=)3Y<Y5'78RD;<'((QC![.;X3Z%>> 3X/U/
M6O$&H_OQ=)J]WJ+2ZC',OW9%F(^4@9  &,$\<FN,\<> ;C3],\$Z+H]]XHU:
M2T\10:A>:I/-)>W<<:QNIE,C*PRI*X0+CK\I&:AW7GJ-:_<S,\>^,/$W]F?$
M_P 'W&JO'-H,=E/::A;11K)/;7)"M%*"I7(RPW(%)'ISGI/B%XQ\6^&-0U#3
M]+UJW?['H$NI6J>2MQ>7%PC$L9T50L=N$&-_R98@ D\'KF^&6@W7AG7]'O[B
M^O;GQ!@ZAJL[1B[G9<>6V50(NS VJ$"C'W>3FIJ'PHT75-:OM4NM<UQ9]2TL
MZ3J"QW"*M[%EB&?"9# N<;"JX^7;MRM#\AIQML<K9W6K>(OC7H>HV=^NF7%_
MX'6YD=81*4+SJV%#' PQ'4'(!'!.X87B+7M2\00_"FXUKR3J=GXWDT^ZDMT*
M12R0-/$70$G ;8#C/!)':O2I/A;I:2:+<:?X@UW3=0TBQ_LU;ZVND\VXMNIC
MD#QLA&>0552I^Z5P,,UKX4Z'JT7A6VM]6U;2(/#%R+NRCLI(COF!SYDK2QNS
ML<MDD_,78G).:N^QE;1]V85CXZ\<>(HUU[PMH-Q=V,>MO926CM;1QM9QR&*6
M3<\BR"4%2X_AQA<'[QZ+XG:WXC\.>%K75O#M[96SKJ%I;SK=6K3F1)KB.+Y2
M)%VD;\\ALXQQUIL?PLT&'QU-XJL]4UFTCN)//N-&M[XQZ=//CF9X ,,Y."<G
M!(R035;XQ:?>:Q\/VT?3[._NKBXO[*3;8QN76..ZBDD8,H^4A%)'(.1QDU/9
M>>I3ZO[C$\0?$#Q'X(\4^)M+U*6+5H$T:+5-,9+?8\<K3BW,<F" R>8Z,#P0
MN02<9J#Q9XF^*WAO2O%E_!9)%I.GZ/\ VC::GJ45N[BXC.9;<Q0S#*LO*OCY
M>0=W%=I:?#_0WL]7DU:ZU#7Y]<M1:75SJI7S3;X.V)55$6,#<3@*"6Y;+<UA
M6_P7TF'P?J_A>3QAXKNX=4C^SR7=YJ2W,\5N>L$7F(R1H>^%W'UX%%NE]2DU
MIIH97BY?$6H?"[2-8U+Q+(WV^^T.80VUK'$(R]U;;P20Q8;B67ICH=U:]OXB
M\1:]XI\9^']#U9;67PI#!%'-<PH[7EU)$9<R@  1 ;5P@4D[CD8%:&J?#-=6
M\&Z/X5F\:>(8;32VC=98#:)+.8G5X?,/V<CY"BXVA<X^;<>:FNOAS:7&J#5X
M_$>L66IW%JMGJ5W:_9XWU2)>GGCR=H8#(#QK&P!(!'&'W]="5W\CSW0?B=XP
M\=>*O"5KH]]::'8>)/#UQJ #V/G2VUQ$WEGYF?$B;\D#"Y7ODY$VI>._B%IN
ME_%6:XUC39;CP:L4UFT&GF-)PT(FVR*SL<8.TX(.>01TKN5^%ND0^/-'\7:?
MJVI:;+H]I]@M=.M5MUM$M^-T>TPEL' R0P/H169??!NPOW\7)-XT\2^7XNP-
M1C#6>"  H"?Z/E0$&SKTZY.#0[WNBE9:#+/QEXD_MK1DDNK2<:UX8N-82&5!
M%%;7$?DE5WYR(R)L'<2?ESD=*Y?P_P#$KQAK'C7_ (1BSU>SG2[\+?VQ#J%Q
MIC^6ETLH23REW1F6 Y.UCUX(9AUZB3X-V,K6/VSQMXENH+#39-&CMY&L]CVD
MBJLD;[;8,=P1<MG<,9!%3Q_!RQCU6TUF/QIXG_M:UTLZ.EZ\ULTAMRP8 @P%
M"1C&=O/4Y;YJ?<2T>IS&F_$KQ5!=_".XU6ZM+JV\964\M_%':^7Y12V656C.
MXG.20<D@CH!72>&_%'B[Q-H_AOQQI;6\VAZH\TU]93 *UK:_/Y31D#+2#:H8
M$D$DX"TRS^"^FV=YX/N6\8>([A?")(TN*5K3:J%0K(^VW!8%1MZYQT(/-:&B
M?"7P[H7BRZUJQU37!;33-<)H1U!O[,MY6.XNEN %SNRP#9 )R ,#!U\A=%WZ
MF%X+\9^/?%5CX6\51:.YT?6)I#>6_P#HXCM;9@_DR(YE\QG!5 X*G=N;:%P!
M7LW:O-O#_P )?#WA;Q9-KFBZIK=O9NSRQZ$+YO[,MY&^])';XP&SDC)(!/ &
M!CK/#^A_V!8SVO\ ;&IZJ9KF6Y\W4KCSY$WMN\M3@81>BKV%&G0.IO4444#"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** .6\9W]Y8^'GM=*D,>KZFXL+!@,[)I 0)"
M.XC4-(?9#7'^$_B)J#_ E_%VN:/=7FKZ)%+;ZM9P-&LOG6[%)6^=E4<+YF,Y
MP> 3@'7U?PWJ'BGQLL?BKPSX;U;PC:PM]F2[<W,_GMMS(T+P^6,8*C#Y ).3
MNP."USPGXF\'Z3\2_P"R],\.:=X"U'2;J>*QLY72:WG6UV&18Q"L:A]B[D#<
M'Y@2<@PVTFQI)M(Z>^^+UGI=M9SZMX?O8FU+1I-;T^**:-VN(XD#RQ$DJJR*
MC!\9(*YYS\M6]'^*%C?6^@:EJNFR:58:]I<FJ64\DRR?+&BR/&X ^5MA+C!(
M(4]",5YU>>$]6UKX26GB[Q1]@@'A[P;=0Z7'83O)YQGL]KS2[T78=B@!%+C)
M8[CP*TOAWX/U+QC\,/!$GBB.R@TBQ\/&WL#97#O-,;BV$1DD#(HC*QE@%4OD
MMG(QBM-/N)Z>IT.H?&:UTR.\D;PS>7RV^E-JP:PNK>=1&A'F1R/O"I(JG=MR
MV0#M+'BMNR^)&F-=&/6K5M*C.B#Q")9)1($M>C[\#Y67(X&00>N<BN1_X0[X
MRW7PYU_P=K6N>&=5BFT^33;"9(Y[:65779YL[[752JY.Q$.XXRXYS#-\+?%V
MN:O90:Y%H]OH[>$W\-7CVFH2R3J6VDS1JUNJG#(  6'!SVP5U?8?1=^IH-XJ
MU34/B+X3U2'2]6MM/U'0[^^BLOMGRW:J(6B#1%@D<P#'KP/,'S<':>%OBII\
MW@OPAKD&CW5GX:UZ>6U&H:GJAE:RD5Y !.\A9CO*$*=Q&2%..,NM?!_Q034/
M"]W<7GAIG\.V-SIY/[]C?HZQA7.%40,WE*#CS G)&_.T8OA'X4>*[/X7:1\,
M?&6GZ#J/AJWAN1??9=1N!+<RM*TD./W*[54MD\YR%(Z%6K1+0E)]=V>R:'?W
M>J:1;W]Y8_8))UWK!YOF$*?NDG Y(YQVKS?XE>,-?T'7](U#0Y&;1]"O;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ltbr_ex102img2.jpg
<TEXT>
begin 644 ltbr_ex102img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MI:+J=KJ=C(3Y=U:3+-$^"0<,I(."".O45K4 %%?,W_#:OPM_Z 'BK_P%MO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9YH[WZC>KNC\>:*]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9__'J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGT5^O^=@M=OY?D?6GC?XI:;X3\>>&/!L=K<7&IZW<8?%M*RQ6X5BSJ5'SMD
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MRWMK@%)%B+R$#:><=6^C U.ZOZ?B5:SL?1WQ'^)FG_\ "K_&5[X!\86O]O\
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M-%\96%PJ)I[:*(FA0@G>S.D,9W?=&,G'.><5[+3>@D[A1110,**** "BBB@
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MB*/X7W]]<^-?%\?]G:AI.E2Q/9LK$B2>ZS&WDX!/.]"2>^6SV&C^#[G0]?\
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MS?P;^,FA^(O GANQ\6>-M-G\9Z@LGF6[O'#)(WG.$7:H"ABH7"X!/''->.>
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MQDG:P/<D$5"OS*_5_A8IZ)^2/H1?B/X-N/!&H>-=-UM=3T/3P_VBXL4><H5
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M)9IG")&H&2S,>  .YI@7Z*Y+3?'GA76-9BT?3]<MIM1FMQ=PVY)5IX3TDCW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "5Y5\?[NTMO@#XNCN;J*%Y[%DC61PID;(X
M4'J?85ZL:.U)Z@M#X)E\.W]S^S3\/_'OAF\;6)O"LSW6J:+)<M<PA/M#E9#
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MY7MX+8[GECWS[M@'+ KQQZCUKZK_ .%K_"W_ **5X5_\'-M_\71_PM?X6?\
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M<"OLKO2]ZKOY@^A\-RZUILW_  3WCTN.[5KFUN5CEC((P[7[N$ST+;1NV@Y
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M#P_'?1Q6$=U:2B\@\IBRQGYE&3P?P([@&OR[J@"BBBD 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ!HNH:/=R:Y-,L%_;/;R,AMX &"N 2,JPSTR#Z5]$44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:2B@D9 ./85?TO1M)T.Q^PZ)I=IIEIN+^19P+#'N)R3M4 9)ZFM>B@ HHHH
M**** .3U'P#X%US4'U+7/!>AZK?2 *]S>Z;#-*P P 6923@<5H:+X3\*^&Q*
M/#OAG2M'$_\ K?L%E';^9_O;%&?QK<HH YS1O!OA'P[//-X?\*Z1I$MPNR:2
MQL8H&E7.<,449'L:J:?\._A_I5]!J&F^ _#MC>V[;X;BWTN".2-O565 0?<5
MUU)0!BZUX;\.^(K9;?Q%H.G:Q ARL=]:QSJI]@X('041^'?#\?A]O#L>AV$>
MC-&8FT]+5!;E#U7R\;<'TQ6W10!R>E_#_P ":+=-=:/X)T'3KAXVB::UTV&)
MV1AAE)50<$=1T--L?AS\/M)U"WU#3/ OAZPO+=M\-Q;:7!')&WJK*H(/TKKJ
M* ,+7/#/AOQ-!%!XBT'3M9AA8M''?VL=PJ,>,@.#@T6/AGP_IFB2:+IN@Z=9
M:7,K+)96]K''"X888%% 4@CKQS6[10!R.G_#OX?Z3J$&H:5X%\/6%Y VZ*YM
MM+@BDC/JK*H(/TJS'X-\(Q>(SXBC\,:4FMEBYU);&(7)8C:3YNW=DCCKTKI:
M* .?UKP?X1\221R>(O"^D:S)$,(U_8Q7!0>@+J<5J6UM;V=K%:VENEO;Q*%C
MBB4*J*.@ ' %7** .?UCPCX3\0W4-SX@\,Z5J]Q!Q%+?644[1]_E+J2/PJQJ
MFAZ+KFF'2];T>RU.PRI-K=VZ31$KT^1@1QVXK8HH R=)T71O#^G+I^@Z39Z5
M9*Q9;:R@2&,$\DA5 &3576/"WAKQ!;Q6VO\ AW3-6@BD:6.*]LXYU1V^\P#@
M@$Y.3WS7044;@<MI/@#P+H>H+J.A^"]"TN]0%5N+/3889%!Z@,J@UU-%% '/
M6OA/PO8Z]-KUAX9TJTUBX+&74(;*-+B0L<MND"[CD]<GFLV;X;_#V^OIM0OO
M /AVYO)Y#++/-I4#R2.3DLS%,DD\Y/-=G10!SNC^#_"?AV]FO-!\+:1I%S.-
MLLUC8Q0/(,YPS(H)&>>>]:EQ:V]P6$UO',&1HF#H&RC?>7GL<#([XJ]10!QG
M_"I_A;_T33PK_P"":V_^(KI[>WM[2UCMK6!(((U"QQ1J%5%'0 #@"KE% &#K
M7A?PSXF,*^(O#NF:TD!+1+J%G'<",GJ5W@XS@=/2I-'T#0O#]@;'P_HMCH]F
MSF0V]C;I!&7. 6VH ,\#GV%;5% &5JVAZ+X@L#8Z]I%GJMF2&-O>VZ3QDCH=
MK BFV&BZ/I>E#2-+TFSL=."E1:6T"1P@'J-B@#!^E:]% '&6GPU^'-C>17UA
MX#\.VEW;N)(9X-*@22-P<AE8)D$'N*M:AX#\#ZQJLNK:KX-T._U"8;9+NYTZ
M&65QMVX+LI)&WCKTXKJ:* .2TWX?> ]%U*+4]$\%:#I=[%GR[FSTV&&5,C!P
MRJ",@D?C76T44 <U%X%\$PZX->@\'Z)%JP?S!?)I\*S[O[WF!=V??-:MQ:V]
MT +JWCG #* ZAL!A@CGU!(/M6A14@8FB^%O#/AM)4\.^'=,T993ND%A9QVX<
M^IV 9K';X4_"UB6;X;>%B3U)T>WY_P#'*[.BJ Y[0_"7A3PS).WAKPSI6BM<
M "8Z?91VYD SC=L49QDXSZFNAHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ1/(9VD,:L1O\P(SC:&*8Y!Z'-5;GXO:'::?XJOKC0]:6#PK<BWU)O+A_=Y
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M>Q(]Z\JU#1_#'BKXY:;K&A>(+>^N;2W:VUZQLYEFB*PR"2W$Q4_)(LX& W)
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MX(:I3O8IZ)OL?0O>J-I?V=]]I6UN%E-M,;>7;_!( "5^HR*\>\!WLWCW3_\
MA*KCQAJMGKNF:U/9:A917#BW1%F9%M3;@A.49,2XW[N=W&*X[3YI/!.E.NCW
M>HVMIK'Q GT.^N7U"XF\FV:9QE?,=@CL0JF4#?SG=G!%).]B;V5SZ@[4=#BO
MGKQGJ'B;PP?B+X;T/6=671],\,IK5K>S7DEQ<6=T7D'E">4L[*PC+8+$C! (
M!Q5^^L?$T>E>#I-"U;4M6DU*W74=4TF;6IX+F]1(8@6MIRP$6UW5FCW(KYYX
MS2ZC/=C7*ZEX?\%^,&W:SX?T;7C82/ &O;.*Y\A^"Z@NIP>F<=QSTIO@W4H?
M$/@>SU"&XU"6*Z$JLUZ/*N5(D=65]APK*05RIQQD=J\*^'9A\+?#NW73[^_T
M^TU7QE/H]U/]NE<00>=,$V"1F6-F8(A=0&.[).<$&\DAO2+?8^G(XTC18XU"
MHHPJ@8 'I4U>=^&[?4-#^(.J^&8;[4+S1$T^VOXFU&ZDNI+>:269&C$LA+LI
M6,$!F."#C@XKF?&VJ:YIOC35M7DNK^]\-:581K,-(O6@N-&D(9GGE@+*ETC(
M5.26*[#M7.23L)'H&IZ;9>)+RYT3Q)X/M=2TF!(YH)K](;B&:0[@5$39*LH
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MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWD $@CJ"!N7'C#P_;7^IV5U=RP2:88UN'FM)DBW. 41)"FR1SN7"H6;)QC-
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M4JH.T\DX!P"02 <GQQ\2+'P3KGAS2KG3=2NY-<NC"LMK937"1*HW-Q&K,SD
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M7V>:>.SC5Y8L8V,P7++CC!XJ?1?#?AWPW;/;^'= T[1X96W/'86L=NKGU(0
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MP^*DVIKH]UI.E7W@ZYT-KJ6X@WV]Q([,-RI(Q*XQDKGK77>$V\3-I&B_V_\
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M !%<K\/_ (9^*_A_XFT'7_LO]J1?V5=Z=>6-I.@-FTMVUTAC\QE#*-VQN<Y
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MDCF],:[A<1EB5CRHY3:<,3S@8KUO4]0U3P5\+]1U;5=0;Q!J.D:?-<R7!@6
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MI&0REB%*H'W<MEMVW!]'LOAOH]G-X9N(=3U7/A>%[?3 TL;"*-D",I^3Y\H
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M/BDOA?P_X^\2?\*]GCN/#U_%!=1+<0I)=AHHRD\C+D!=K1@8+L!C@8(&ROQ
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MR?#_ ,;M)\0^'[F:QMK637TU3^QH-.@U!)H;NY(W*T5PJX:$KEB^W("M\N<
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M9D91)O)R5)4 @URO@#XC>)+KPKJVJ^*+.REO[OQ!-I>EVMO?,?.F$A3R?FC
M1$";MV6) =BH/!0'N5%>-Z_\8-0\,:7K\>L^"YSKVA1QW4]E:7\;P26LA*K<
M1S.$9D#+M(\O>&(^4CFO2=%O-6O$NI-7T9=*=)RD"K=+/YT6U2') &TY)4KS
M@J<$@@E[AL;E%>8^'?B5-XEUV:VL=!6XTZ&_N+&6YM;P3369A63)N8 H:$NT
M>$&6R&Y*G"LW0/B7?ZQXQB\/WV@Q:3<W^G2ZEI\,]\?M.U&5=EU 8@ULQ#JP
M^^,;N21BEY >GT5\W^'_ !;]CT_Q%XZ^(FA:1YFF>)+FVLKR+43YZ7(<0) &
MDCC580I/SNX& 24';0U;XR:KK7@?Q+)X8M]&_M;2+RTM;B6SUO[5;F&XD5$E
MAFCB^9B25(95*8)YP 6M4GW!Z7\CZ I:\TT_QMXK_P"$_F\*^)O">G:.BZ:^
MH6]_'K+3Q76PJ'5 ;="-I8;B<$ @@$&NC\'ZSK6N^%+76-<T./1+JZ!D2U2Y
M-QMC)^1BQC0@L,':5R,C/.0%NK@/U[P[#KESI=U)?WEE<Z9<&ZMY+5U&'*-&
M=RNK*PVNPY'&<C!K1M;!K>19+B^GOIE4HLLX0$*2"1\BJ.<#MVKSOXXV=O-\
M,+FZ=<3PWMBD<Z$K)&KWD*.%88(#*2#@\UZ$T<>GZ4R:?8;DMXV,5I;A4W8&
M0BY(4$GCD@<\TMDWYA>[L:M%>.>#/B-9WOPMT#6?#'@RVTN76]2GT_3]%2=(
M(1())2[NZ1X0;8I)&PC'/ W$\\SXX\;6_CCX5^)%F\,W%AJ7AK6[&RN/.:&5
M%NA>0AQ X;<1M/WV2/(?_> I*]D)NQ]$XYI.]>/ZQ\4->BB^(&CV_ANVLM=\
M,Z:NI0BXOR\4T#QLP<E(R5D7:08^02  ^#NKD8[KQ,?C!\/-2;1=/EUZY\,W
M99!J#>5,!Y6UY9S#OS@G@1O@M@9&32W'8^CZ.]>*1_' W1T2VLO"-R]_>ZS)
MX?O8I+R-(]/O4ZQLP!9U(!8,JXP/7Y:V=+\=2R>/CI_BOP.OAO4;;0I-1FU"
M6ZAN L*R()(T=!N* G)+;.5'RG@T70['J)I:\)OO$%]XH\:?#37IO"*Z;8WN
MK/)I^H23I)<20&RN2%E0+F+?\KJH9Q@?-M88K7D^,4[7)U#3O!EYJ?A[^UVT
M%+RVO(5N)+L-L&(9"B"(O\H=I0<_P@$$LGJ>O]J.U>+^)/CUH?A_Q!-8O%8/
M:V-]'87XEUB"*]B=L!FCM>6E1"P#'<IX)4, 379_$;7(?#/PYUK6[OPZ?$-G
M:V[-<Z?F,++%_'N\S@J%R2,$GT-)Z*XUO8V]<T>WU_0[O2+B6:&&Z3RV>%@K
MKSG(R".W<$'N"*@AT1HW@DU#5+S53!()4^U+"NUP" W[N-,GD]>._85QNI?$
MB;3)],TO1]#L[FYFT=-4733J M[B1"K;8K6+RSY[#8=P!7:,8!) KM?$5WJE
MEX=U&^TF&":\A@:2*.YE:*,D#/+!&(_[Y.>G'6GL@WT-VDKYU^%,WV;X?>"O
M$EQX=L;SQOJUO):V$XU%TDOHCF666Z<Q\8VDGY92,C:<N17H%K\4$-EJ%IJF
MBOIOB>QOX=,.D&X5Q//,,PF*7 #1LN6W%00$;*@C%)Z-J^PEJDSTREKR'7OB
MEXD\.:+<WFJ> 6BN+#4[?3KL-?.MNZ3LJI/;3& >>H+ ,-J%3D4FN_&(^&?$
MGC#2-9\/[8/#UE;WT=U#>[_M*S2"--ZF-1$ Q^8Y8  GFC?09Z]CFBO)O$GC
M^:U^'-WKFK^ X]8LHY[:-DAO8;BRG21D*SI*RCS(U9E (3=N'W0!NI-2^*FK
MV_C#Q;X;TWP7YTWANQ747FN]16!+B$@GY-B2$$A3M! SCG;UH?F"/6NU+7FT
MOQ*COHO#$'A6QBU35/$MF=2L[:\N6M(TMU169GD$<A!RRJ %.2>P!-:?@?QL
MOCCPX->M=%OM,A,CPA+QX6+NC%7V^7(W <,OS;3QG&*=M_(5]O,[:BO ]<^(
MM]:Z1\6+GPOX-L=*UCP[,D=W=W-PL<EX#$=MP?*C;<P7;M5FZ$9*XVUTVI?$
MO6-)\1+X8N/"]G<^(8M-.IS6%IJVYYTW2*B6OF0H;A_W>6&$V@\%CP9&>JT=
MZP?$'B'3_#/A:]\1:PSQ6=C%YTNT98^B@<98D@ >I%>7#5[Y?C3HNN>)O"\/
MAMD\/:E<R2I<K<-)"KVI D954AT&<J-RC=\K-DU76PKZ7/;Z*\6T+XX6_B7Q
M-;Z#HVFZ1=7>J6<EWI:1:]%,SL@W&&Z$2.;9]N6&/,'!&<@@:F@_$C7->\(:
M%K$/AO3!>ZGJ3V,NGMK#EK4)N\TEA;\N@1RR8 P.&.0*0SU2BO&=/^/'AG4/
M&&E:3]JTF;3M:NGL;*>UU5)[H2@X3S[8*#"DA!VG<QY7<%SQ1^'^M6WA/P_X
MJCL]-:ZEG\9WVGZ?80,L?F2%AM0%B%5556)]%4X!X%+JEW'LG?H>PZA9W5]I
MLUG;ZQ=:9,Y&V[M%B:6/!!X$J.G/3E3P?7FC2]/CTO3H[..:28H69I92"\CL
MQ9F;  R68G@ <\ #BO-=>^*VI>%?#7B:\U[P:R:YH$*7;:?:ZBDD5S;.Q5;A
M)F5#LW*P8>7N! ^4Y!J\WQ(U:TU"2UU3PBUL]UI<FJ:2MOJ$<SWXC56DA(8(
M(Y%#J<;F4@D@G!%5YBZV/3^U+7CV@_%K6=:L?!^H_P#"#^78^*XI!:2)J2O)
M'<*C2;'4HH"%48[PV?E/R=,K9_&S2_\ A%]6O]<M;31=4TS6W\/O;76H*ML]
MT.0?M#(N(]N6+% 0%/RDX!6S:?0-U='L&.:2O"&_:$T\:'->6>BQ:O?6>L0Z
M3>1Z7JD4]M&9CB*:.<A?-1^<80$%6#;<9,WCKXK>(M%\&>/X[32;&S\1^&(H
M)"/M;SQ&"X&$F4^4I+@YRA  (^\1U.C?8=M4NY[E17.:/J%U;^#(-5\1+!93
M16WGW7EW#3QHH7);>R(3\HR?E'.>O4^?^'?CEH7B3Q58:)92Z/(NM0ROI30:
MNLT[.@W".ZA5-UL67)'+]"#AOEH\NHD>Q4HKY4OM5\8WWPQ^('C*]\/Z+_:N
MCZEJ(MM435)A<V3(##MB MQN5$)VY=0QY*K7HOAW4KK0TTVRT7P1IC>+M6TR
M.[N8K74VBM?LT7"2S2F$'S&:0J L3$G@MM7(47<;5OOL>RXYI:\>U7XT/96G
MA?[-X1FN+_6-8;0KJU>]C0:;=J<-&[ -O[D%1@KSD9 .;HOCWQ]??':/0=<\
M-VNBV-MX<.I75@FH&XEB+2A=V4C*RN#'M51CY7)W9.RJL3<]SI<5PG@7QO<>
M,[+^T!I]BEE+"L]O<V&HB\C;<3^Z<[$V3+@;DY R,,W..[S1:VX!1110,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH \[F\%ZQ8_%.^\;Z#J5JB:KI\=E>
MV5U$Q'F1%O*G5E.3@,04XR/XA7%:#\(/%FC^(?AW?WFN:3>V_@U;N-1#!+ \
MT<Z;"#EG!9>6S\H;.,+C<?>#UHIIM"MOYGBGB7X2ZUX@G\0M)JEC.^H:I;7U
MG=W<4CSVL$3QN;13G")NCR"OKRI/(O7_ (!\67=_\09UN=((\6Z?%8H2\J_9
MBD+1;R-IW9WEMN1C &3UKT6&ZU1]<NK>;38HM-CC1H+P7.YYG.=ZF/:-H7 Y
MW'.>@Q6OSFIT::Z,=W=/JCP_5?A;XNU/4O!E]:ZW9Z5<>'-%N=)\^!I'D+RP
M>2)X\J-I7"N >IXR/O5K^&?AGK&B:GH-]/>Z89++2)].O9(H7,EY+*\+27+.
M3EW?RCG=R"V<MTKUNBF!X=IWPE\2:7\+O!_@N'4M-N'\.ZM#J/VAA)&)UBF:
M4+C!P6W8)[8_BSQIZ9\.O&'AGQ=KLWA/Q)I]KX<\0WYU&]M+JTDEN+69QB8V
M\@=5RV,@NI"G'!QSZ%<76KQZW';P:8L^G&!Y)+H7(61901MC$9&#N&?FW#&.
MG.:R? /BZ3QMX)M?$IT\Z<;B2>/[,TPE*>7,\?+  '.S/MG&3UIWD]2;*)P?
MB#X1ZYKEYJ%PVK:=+<3:[;ZI;WUS%(]PEM&ZN+/.?E12IQC@]USS6Q)X'\4C
MQ1X[UB.?2W7Q+I\%E"I>13 T<;Q[V^4Y!\PMM'3 &3UKU3N*7O4VT:[E=CQO
MQ%I$,/PLT#X=7/B#3K3QG90V2Z2T$P>=9H62-;J.-L-M&&+<$!=X)(S7J&D:
M=#H^D6FE6[.\=M$L0=SEGP.6)[DGDGU-:E'K3$>,>*OAGXH\3:'\0M+6[TNV
M'BZ>WDCE,DC_ &58HXH\$;!N)$6>HP6[XYVH_"7BB/XDZ=XO7^RV2TT)M':V
M,\@+L75_,#>7P,KC&#QSGM6I\2O';?#WP3/XF_LA]52*:*%H5F$./,<(&+$'
MC+#H#7;!NE"[_(?E\SYG;1=2\!>)?@QX3N=4T>74M.N]2PS3,J2I)&S#((#(
M3N* _,,@'!^[7<:Y\,]=U73UD^W:<VK7/B2W\07LN'CC(@V+% @PQ(V1JN\]
M\G;S@>Q\4=J+[-;H35[WZG!W_A[7K?X@1>+M#O+.,W-@MAJ5A<AMD^QF>*1)
M%&0R&1QROS!L<'!%74?A[%J7PNNO"\MU'_:4LLNH1Z@D140W[RM.)T7)("RM
MD#)^48R:]%QTI>])V8SS?Q%\/]1G\%Z-IOA/7ETK7M#NA>6NI3P"82S,KK,9
M5[^:)9"WNV:@U3P+XM\0:?H^J:WK^F2>*=&U%-0LI+6S>*SC 78\)4NSD.I;
M+[L@D8&!@^G;JQM)US3-<EU*/3+H7']G7;65P5Z+,JJS+GOC< ??([4;L-CC
M/"7@;7M%^+'C#QIJ.I6+P>)([4?8H(G+P-"FQ?WA(!&"V?DY.#\N,&SIO@S6
M+/XTZUXZFN+-K/4K"&P6!7;S(Q&20Y^7!R3TSQZFO0P>:S9M2L[74+&QGG"W
M-\SI#'W?:I=OP '7W'K1>U@>NYP/@[P?\0O"=Y#H<GBS3;WPC9S,;2$Z>RWL
M<'/EV_F!]FU>/F*EB!C(SQB0_"35X]7\,ZI-J&FW%_H^J3WMYJ,D#&YU175T
M0RL.C(KA=N2,+P5'%>IZ3>:M<B]_M?2XM.:*Z>.W$=UY_GPC&R4_*NPMS\G.
M,=36S3V:8MTT>2^!OAWXP\"S#PSIOB>PD\$074ES;0/9R?;X49_,^SB7S-FS
M<3EBI8@D<9!%.Q^%&I:?X9GTU-2M&U&S\12>(-)O/*<B.1I2Y25<C(*,R'!Z
M'(YP*]FK)O[C4X;BP6PT^.\BEG"7+O<>4;>+:3Y@&T[SD ;>.N<\4KC/./&/
MPTU[Q;9>)KB:]T^+5-<L(-*C4;_*LK>-VD8YQF5V=B>B #:.<$MZG:_:FM4:
M\BCBGQ\Z12&10?9BJD_D*I:?K>GZI?ZI8V,WFSZ9.MM= #A)#&LFW/?Y77\Z
MU\T[6"]SQ^Z^%>K7OBJR\1#6+'2-8MH[J.?6-+M6AN;]9(F2-9ESM;RR5;<2
MVXH,!*?X=^&OB#0]4\+:K)?:5->Z19W-M>SB*3S=2EF,1:XD<G)=O*YSG!8G
M+#Y:]=I:2TV!ZGB,/PI\27'@K6M!N-9L]-O[G79/$5AJEDK2FTN3,)%4Q.H#
M <C.[D'I6[J/@_QSXD^'^HZ/XK\0:3-JD\EL\+6%I)# HAF67Y@SLQ9RN"1@
M#C ZY]/JEINHV>K:7;ZG83":UN4$D4@Z,IZ&B.B2703U>O4\J^(UG:^,-?\
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MM:T?5/!FJI_:L^M)HTK745T93(653"D_E)/@J 3$2&P3N;)/M6K>*I-+\?\
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M4 "#=C+?,<C'JM%/NA=4SQOP[\.?%N@Z!\/M)^T:3<#PA-)([^9*OVL-#+$
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M&WC[Q.>,%WT%L<9X3\!MX<\67NOPQZ?IKW=FEO=VVEQF*&^G#EC=.F %<Y(
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MAQ\/[J>ZNKKP/X=FGNW,ES))I4#-.Q;<6<E,L<\Y/?FI+/X>^!-,U"VU#3/
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MRVJ]-L8*_(/9<5L6=C9Z?8QV5E:0VMM&-J0PQA$4>@4<"B6J:6EQ)6:OK8\
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MM[+[1<2".)$WN[G 4 9))-<<?B1X>686_D:AY\VG-JUG +?,E[;+]YXE!R2
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M89'OV6/8A2+;OB+X&\LZ\$CFA[:=AI7W[GH]OX]T6YTD:LJWD5E)8G4[>:6
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M'N>I[YQ70T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>1QN;HQQEN^<53T_X3_#_2]#U#0K/PS --U%#%<03R23 H2#L4NQ*+D A5(
M(!&"*[^CM1N!R%M\/_"=M<FY72VN)6L1ILAN[F:Y$MN"V$D$CL),;V&6R<$C
M..*B\/\ PW\%^%[&^LM#T46]M?HT4T3SRRKY;<&-0['8G^RN![5VE% '$?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR%063=NVG'(SWJP: %HHHH **** "BLV34+.WO[2SGF2.YO&988R?FD*J6;
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MTE]:U/[!?>&)KBYMH[Z9(Y9%*!9"JL!NY/(YKD]*\::[_P *Q\"ZQK7B2?\
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MFTD[?E')%^I/H>KGH:X70_$GAE+76-0M==U*^C?5VM9([F*=Y+>YV(#;Q1E
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '*+XV\._P#"?_\
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MG3"W\X-"4^9XN&R'9CCG?Q@@'LE9NH:A:Z7I]QJ%XT@@MXVED\J)I7VKUPB
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <??>!?#NJ>+?
M^$LO[>:?4CI[Z6=TS>6UL^=T93.T@DDYZ^]9&E_"/PGI.NZ%K,4VL3W6@QR0
MV'VC4II%@B90OE@$_= 4 #OWS77ZMX@T'P_' VN:Y8:4EQ)Y4+7MRD(E?^ZN
MXC)]A6==>-/!MCJESI-]XOT>UU&VC,T]I-J$22Q($WEF0ME5"_,21C'/2@#(
MTGX7^$]-MM-L8[>ZGTS2;@76G:==7#2V]E*"2KHK<D@DE=Q;;GC%"?"SPC']
MILULY?['N;H7TNC^:?L33A@WF>5_O*&VYV9&=N:W!XN\)M9P7Z^*M(-E<Q/-
M!<"^B\N6-,[W5MV&5<')' P<U:_X2/P\?#W_  D0US3_ .Q=GF?VA]J3[/MS
MC=YF=N,]\T 8R?#_ ,-_;/$MU-#<S_\ "41^5JJ37#,EROE^4!C/RX3Y1MQQ
M5+1_A3X3T:;29+5M5E&D6\EI9K<:I<2)%"^S,04OC9B-!MQ@A1G-=(OB3P[_
M &;::D->T\V5YC[-<_:H_+GSP-C9PWX5RUC\7/A[J?C:/PGI_BW3+N]^S^>'
MBO(VC<DC;&C9P[D9;"DD <]:.M@&V/PF\*:3X5TSP[IO]I0V^E71O-.G%ZYG
MLG.[(B<GA2&8%>00QR#5Z\^&OAB_T2_TNZCO'34[B*[OI_M<GG7<L>SRV>3.
M?E\M,*,*-H  '%2Z7XBTW2_"2:IXB\<Z-?V_VAX3JXDBM;=V\Q@(_OLNY<;#
M\V25/ Z5L:EXB\/Z/I2:IJVN:?I^GN0JW5U=)%$2>@#L0#GZT!Y'(>.+#6O$
MDT'@$^$5U+0+U(9;W6;VXC\F)4F#.GEXWM+M0;2  "P.?E->DU5BFBN(4FAD
M62-U#(Z'*L#R"".HKS7QYXZFT?Q-X:T?0/$6CM=3:S:V.J:8P66[6&9N&XD!
MB&/5#G<,$8Y+7:0F[)OL='_PKWPV]_KUU=1W-Z/$,8BU**YG:2*Y4(44%3PN
M%.!MQ2Z+\/M!T-;!;7[7/_9D+6^G?:KAIO[/C9=I6+=T^7Y=QRV.,XXJ_;^*
MO"]UJYTFW\3:3/J!=XQ:1WL;2ED4,Z[ V<J&!(QP"">M0Q^.O!<VGW^H1^+M
M&DM-.8)>3KJ$)CM6)P!(V["'/'..:!B^$?!^B>!M!_L/P]'/#8"5YEBEF:7:
MSL6;!;)Y))IFH>#=+U#QC!XL^T7UKJD5H;$O:W+1K)%N+A74<-AB2,^M/L_&
M_@_4=1L]/T_Q=HMW>7L?FVMO!J$4DEPG/S(H;+#Y6Y&1\I]*6'QIX.FMUNH/
M%VC2V[77V)94U")D-QQ^Y!#8W\CY>O(XH Q8?A3X/@T?PUHT=K=K8^&KH7FE
MQ_:G_<2@D@YSEL9/#9')INF_"?P?HNL_;M+AOK6T^TB]72DO)/L"W (82BWS
ML#!@&'& P! R!CKYM4TVUTJ36+K4+>'3HXC,]W),JPK&!G>7)P%QSG.*S[?Q
MGX1O+[3[.S\5:1<76I1F:RACOHG>Z09RT:ALN/E;E<CY3Z4 6->T/2?$VA7F
M@ZY:I?:;?1F*>!R0)%/N""#W!!!!&169#X)TWSK,ZCJ&HZO'92)-;0ZE/YR1
M2(<I)T!=U/(9RQ!YZ\U:A\9>$;C48--M_%ND2WUS(\,-NE]$TDKI]]54-DE>
MX'([U<O/$GA_3]9M=%O]>TZTU.[_ ./>SGNHTFG_ -Q"=S?@* ,C6_ FC>((
M];M]8GU&ZM-:MX[6YM&O)/(5$.?W:9PA/<CDU%'X"TG^UM/U+4+S4M5?2I&E
ML(KZ[:6.U<J5W@<;F"D@,Y8C)YSS6EJ7B[PMH\MQ'JWBC2M/DMU1YDNKV*(Q
M*YPA8,PP&/ )Z]JV_.B\CSO,7R]N_?NXQUSGTH\P,_3-*CTM;M8KJ\N/M5U)
M=-]JN&FV,YR43<?D0=E' [5@_P#"N]#7Q;J'BN&XU*#6=0B6"XN(KQUW1K]U
M .@ ]A6K'XJ\,SZA;V<'B33);FZ1Y8(4O(R\R(2'95!RP4@@D=,'/2JS>._!
M*Z&FN_\ "8:&-)DF^S)?'4(?(:7&?+$F[:6P#\N<\4 4K3X<^#;/0M:T./0T
MDL]=9GU/SY9)9+UFZM)(S%R>3SG@],5RFO?#_3_"OPO\36/AV'7]:N[K1[C2
MK"UFNY;TVZ21E5BB5VQ&F0F3Z*N2<"NVU#Q'8WUKK>E^&?$FDR>(-/MV9X?,
M6X:U?'RF6)7# 9[$BN \-_&K28? _@"\\::I9VVL>*D+,3(L$4( <F0[CA5R
MJH,GDL/>DG=V7D&RN;OA+P1I-UX4TBXUJWU:ZFCTXV?V/6)G8V@>/RY452>X
MRNXDG:>&P>9+#X2^%]/U32M1AOM=>ZTF"2ULI)=4F;R(G"C8N3]T!!@?GGBN
MC_MJQLWUN\U#Q-IQL[.50X=TB&GC8N4E<MU)RWS;>& [9J.Z\26&K:1K,?A'
MQ'I-SJEC$VXI(MTMM)M)7S41P1TZ$BDVE=OH-*YG-\,_";?#A?A_);W)T"+9
MY$9N&,D!1PZ%)/O A@".3Z=.*FM_A_H-KXLE\56\VHC69K$:<]T]X\C& ,&"
M_,2,[AG/7D]N*H_#_P <+JGP8T'QMXPU*QTYKNU$UU<RNMO C%B.K'"CZFNV
MM+RTU"RBO;.ZBN[690\<T+AT=3W##@BJVN2<?;_"_P *VT/AB&(7OE^%WWZ4
MK7;D6_R[<?[0V\?-G@U!:_"OPC8ZS+?VHU%+=KK[<NE_;Y?L,5QNW^:MONV!
MM_S#@@-R!D#$7Q"\93Z%-I]KH?B32(M22_LDO-,F4374EO/<Q0[E D!C WD[
MBC \#CK72PZ@L?BK5EF\46$EM;6T<CZ:%19;+[Q:61]^=K#&,J -IY/9)WU'
MY&"WPI\(R^%I_#+17K:;/J']JR1_:W#&YW[R^[.X?/\ -C.,BMC3O!NBZ3XK
MU3Q/8F[BOM4\LW:BY<0RNB>6)#&#MW;0 3CMGKS6AI_B'0=4TEM6TO7+"_TY
M06:ZMKE)(@!U)=21V/>LV^\2:+JG@N[UCP_XTT>UM "JZQYL5S:P," =QWA3
MZ8W#K5>0":KX+TG4_$47B!6N;'6$A-HUY9R^5)- 3N\I_P"\H/([CG!&35.X
M^&_A272-&T>WM;BRT_1;E;RR@M+AXECG#,PE)!R[99B2Q.223DUKZEXO\*Z-
M))'K'BC2-/DB"F075[%$4W?=)#,,9[>M<_K^O^(-/^*7@O2[.[M6T'6C<QSP
M_9R9M\<#RJPEWXVG"\;<\=3G FXUJ=9K6CV^MZ!>:+?-,;2\A:WF\N0H[(PP
MPW#D9&1QZU@V?@'1['PS;>&K.\U2/2+:);>.T%XX7REX"$_>*XX(SR.#5C3=
M8LX#JLVI>,M*U"/^TOL\0C,</V,L%V6KG>=TF3GG:3N'R^NII^N:/JT5U)I.
ML6.H+:2-#<&VN$E$+CJK[2=I'<'FF(YS4/AOX?U6T\16FH->S6_B5D;4XS=,
M!.5547&/NX6-%^7&0.:KZA\*?"VH:W9:O'-K&GW]M:+827&G:E-:O=6Z_=CF
M:-@7 ['K[\#'3Z7XD\/:YILVHZ/KNGZE90%EEN+2Y2:.,@9(9E) ('7-6--U
MC2]:M%O-&U*TU*V=0RS6DRRHP)(R&4D$9!_(T 8>E^ _#^D^(TUS2X9K6YBL
M(]+CB68^4EM&24B"= %+$@CGGK7BFA^&?B-C4=)&F^,?#OB.YO+F];4;?6H9
M-'C>21V1OWAD=U"E 5V%CCG;G(]ZNO%7ABSU0:9>^)M*MKYI(X1:S7D:2EWS
ML386SN;:<#&3@XZ59@\1:#=:[<:#:ZYI\^KVR[YK".Y1IXEXY:,'<HY')'>@
M#A=/T?4O%GQ(LO$GB;PG_9 \)M=6VG332I(]\\FU?/4+]R/8K84Y.9.VSGT/
M5M-M=:T2_P!'OD\RTOK>2VF7^\CJ58?D36=_PE7ALZE<:5_PD>E_VA;%1-:B
M[C\V(DX&Y,Y7)X&15;_A/O [6-MJ"^--#-C<SFVAN!J,/ERRCK&K;L,W(^4<
MT;[!L<G:_#G_ (2#X86OPY^(B3:A;:6L5O\ :;>=H8]1CCQY4AVG<& 4;E/\
M0)R00:Z2;P#X?OM7T[5M6CN]6N]+E$]D;Z[DE2WD'218\[-X[,5)'8U;;5(;
M;Q1J:WGBK3_LUO:PR-IK;$EL\ELRR/OSM?@#*@#:>3GB6+Q9X9DM+W4%\3:6
MUI8JKW<ZWL9CME90RF1MV$!4@@G&0<T 5]2\'Z3J6OKKZ>?IVM+#]F_M"RD\
MN9XMV[RWZJZYY 8''.,9HT_PCIFF_;I[5KG^TM1VB[U)Y=UU,%^Z"YZ*!D!0
M !DX ))K177M#DT$>((]8LGT<QF;[>MPAM_+'5_,SMV\=<XKC_ ?BK4O$?B7
MQ9:7&LZ;J]AIUS;_ &&[TV+9$\,L E'.]]Y&[&X-@XS@=*$KW\A7M;S-#3_A
MMX?T?P@/">FW6J6VBB-XEMH[^085R2P#YW#)8]^]10^'_P"T/'&EZI=Z/%8:
M9X9BGM]*C:0%I)'5$,P1>$18U9%R22)"2%P,S6_Q"\(W'Q N/ L.O6/]LVT2
M,T!N4#O(V[]TJDY9U5-S 9(!&>M;>G^)/#^L:C>:?I.NZ?J%W8MMNK:VNDDD
MMSDC#JI)4Y!ZXZ4;ZCV;#0-#A\.Z0FFVU[?WL:R/)YNH73W,Q+,6.7<DD9/'
MH*R+?P#H=KJNOZK;W&H17GB':-1D%VV9MJ;$Q_=PO VXXK>U;6M'T#3WU+7-
M5L]+LD(5KF\G6&-23@ LQ &336U[1A:V=X=9L1:7VT6LQN$V7&[&W8V<-G(Q
MC.<T 4;?PGH=KX'A\%M9_:M"CL_L'V:X8R9@"[0A)Y("\>O K+E^'&@S:1X:
MTMIK];;PP(/[-1+EE\IX8S&CG'WFV$CG(Y/%;UKXB\/WVCS:O8Z]I]UIL&_S
M;R&Z1X8]GW]S@[1M[Y/'>N!^*'Q$GTGX):OXZ^'>N:1J+6+1[;A"MW"X,BQL
MH*/@,-P/?IC'.0F[#2OH=O9>';.SUW^W&EO+N_%NUJDMU<-)Y4;,K,JKT7<4
M0D@9.U<]*;KWAJU\036,DUY?V5Q83&>">RN#$ZL5*G/9@02,$$?D*AL/&W@^
M[NI].7Q=H\NI6D32W=JE_$9;<(/WA= V4"]\@8[U6F^)'P_MX+:ZN?'WAVW@
MNU,EO+)JL"K,H8J2A+X8!@02.X(IO02U-70?#^D^%],?2])MS!!)-+<R,7+O
M)+(Q>21BQ))+$GT'0   5@V/PQ\,Z?H\NDV9OH;2XU-=8E473$O=K*DHD)//
M^LC1L=,CI6Q)XT\'P^'X/$+^+-'CT:X?RHM0:_B%O(^2-JR;MI.5(P#V/I70
M)(LB+)&P96&58'((]: //=2^$_A'5-4U[4)(]0CD\16XMM4C@U"6*.[ C,:N
MZ*P!8*2/3DD@FI+[X5^$[SQ6GB3_ (FUIJ9MQ:SW%GJUU ]U$/NK*RR!FQQS
MG/ R< "NQU+5-/T?3IM1U:^MM.LXANDN+J58HXQZLS$ ?G7$_#_Q9?:AIGBB
M\\2ZWI=U#I.JO;)J%K&+:V:#R(90_P TCX'[P\ES2NKV';2YJW'P[\+W6LR:
ME<V;S&73#HSV[R$P-9GGR?+Z8SSGK[UDZ/\ "#P;H>GW6FV\>HW6F36\MI%9
M7FHS3P6<,H*R) K,?+W*Q&1SCC/)SU2^*O#+:"WB-/$>F/H@&6U%;R,VRC.,
MF3.WJ0.M4=6U>WD@T2ZTWQAIFFV]W?1*LDNR9=00DCR(B74;V)&&7<>.AIB,
M33_A/X;TW6K'6X;[6I-4L;-K"&ZFU.5W6 L&V<GH,<#IUSD\UU?A_0;+PSX?
ML]#TMY_L-C$L%NDTID,4:J%5 QY(  QG-/F\0:#;Z]!H-QK=C#J]PADAL'N4
M6XE49RRQD[B.#R!V-1ZAXG\-Z2;G^U?$6FV'V79YXN;J.+R=YPF[<1MW'IGK
MVH Y?4OA)X1U3Q9=^)E74;&]U%0FHI8:A-;PZBH& LZ(P#C'';()SG-7KSX;
M^&[YO$WVMKUD\3HL>IK]J;;.JIL  _@P@V_+CBNPCD26-9(V#HP#*RG((/<5
M4U35M+T/3I-2UC4K;3;*/'F7-W,L4:9.!EF( Y-&P;GC'BKP[K6F>-K=M/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^ O@Y87WAW5XKK1=2G&H(^F3DVRF"Y3+?)]TLZ#<,CD<XKZ2JG-'))"RI</
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M=Y-K@E>8E0, PY)!%=EH^FR:/I45E<:E=:G<<M->76WS)W)R6(4!1Z!5
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M\-]<\"ZAJTU[8ZM<3737$48AFADE?S"RG+#*O@KQQ@9S6O\ \(;?W-MNU3Q
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M6WX%\*_\(3X+TWPO'?F^@TV/R8IFC\MF7.1N )&>>HQ]*++5^@7>QUM%%%,
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M$-"@8';&0Q!4<$'%+J5;2Y]=45\SZU%I>B_$&[UJRCTO6O#D6J:9I_EZ=/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIN(/<]@.2<<US=Q\4M!N?#%EJUYH7B>VTK4)+![6YCM7C6;[0X,9\R-_D4,
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M^'/Q,GTWP'\/=,US3]<UK4/$9EABU0R0O&9%EDRLLDLRMN"+D#!R!A=Q&*]
MN?''V>XO;7_A%]8DN+>_73K:-&M<ZA*8S*?))G  $8W$R%/3D@BF-Z.S-Z+P
M_H<#1^3HMC$8B6CV6R#83P2,#C.!FE;P_H#20,VB6#&W 6'-LA\H9SA>..3G
MBN<;XA::ME8S6>E:K?:A?R7$=MI,,*"[D\ARDK$.ZHBJ5ZLP'*C[S %L'Q&T
MJ^T71]2TO2-5U)]469Q9P1QK<6ZPL%G,BR2+@QL0I52S9.%#4/3<1UECI.DZ
M87;3=+M+)I,!S;P+&6^N ,UI5F:/JEOKFA6&L6JNL%];QW,0E7:X5U##(['!
MK+\2>*+'P])96KVUUJ.J:BYCL],L@AN+DJ,N5WLJJJCDLS*HXYR0"; M32_L
M31=VY=)L]WF&7/V=,[SU;IU/K4?_  B_AGRC%_PCNF;,[MOV2/&?7&*\M^'?
MC:.R\.^*M0UJYU64?\)1<:?I]C>R/-=EBL?EVJ!V/S [N-VT?,20H+5KZM\9
M-)T;PW<:U>^%_$ ^Q:@-,O[/R[83V$S;?+,N9@FQ]Z%75F4[AR*'T%<]"FT?
M2;J5)+G2[.=XT\I6D@5BJ?W02.![5/):VTEHUG);QO;LNPQ,@*%>F,=,>U<W
MJ'C*WTG4+NWU+1=2AM;.R2]FOML3Q#>Q5(0JR&1I2RD!50@G&#R*Y;7?'5KX
M@\'^.M'BM=:\.>(-&TF2\,%R1;SJIB=HIHWB=@5W+V;((PP'2D]$QGH,>AZ+
M%%%##I-E''$YEC1;= $?^\!C@^]1_P#"/:")XIQHUB)HCNCD%LFY#G.0<<<\
M_6N0TOQJNG>%/#%G]CU'Q%KUWI,-XUC8F-[EHQ&N^9VED10-QQEFRQ. "<U7
MF^,WA<:CX9TW3K/5M6N_$:RFRBM+<##Q*QDBD:1E5)%*[64G*D@MM'--JSL2
MG=)]T:Z^"6.O:CJ%U)I%^E]<>?\ Z?I7G3QC:%$8D\P J O V\>_6MNP\+Z'
MI^BV&CQZ;;RVEB,0)+"K",]<@8PISZ8KD+SXT>%=-T6SU"^L-8BFN=5&C2V(
MM \]G=;@NR;:Q1>"&&&.Y>5W4Z\^+6FV=MXA\_PSK_V[P[B34+!((6EB@*;Q
M<;A+Y90KD@!]_!^7@TMEZ%6/3:SH=-T^UN9+JUT^W@GD4*\L<2JS = 2!DBN
M6UOXC:5I&G0ZA:Z7JFMQ-8C4Y/[.A5S;VA&1,^]EX(#849<[6PIP:H0_%OPW
MJ&JQZ7HMAK6LW$^E?VO;FULBD=S#\GW))2B$_.,Y(4$%20WREL-SO(=/T^VN
M9KFVL+>&>?\ ULD<2JTG^\0,G\:JKH.B1JJQZ/8J%#*H6W08#<,!QW[^M><R
M_%Y=1'@J^\(^&=4U[2_$TDI6:![:-OW<4I:';+*F'5H\G)"X4X9B<5Z)K.LV
MFA:/+J%X)66-E1(HEWR2R,P5(T4=69B ![^E)Z 2PZ+HMK:36EOH]E#;S_ZV
M*.W14D_W@!@_C5JWM[>UMD@M8(X(4&%CB4*JCV X%</#\1H+JUUZWB\/ZM;^
M(-%MQ<3:+=+#'<%&!V2(_FF%T.#RLAQ@@\\5SGP7DU3Q1X(T#QMKEYK\>HS6
M;1S)<7JO:7Y9MWGK"KN$QRHXC/4%2-M-:W8MK(]7.G:>U^NH-8V[7BKM6X,2
MF0#T#8SBJK^']!D@:WDT2Q>!I/.,;6Z%2^,;L8QG'?K7#:%\:/#?B"\NTM=%
MUV#3[&ZNK2]U2ZLA%:V3P1B1_.8MNC!!P-RCD$''&=/3O'VF:YJ$6C7&EZMI
M U2V>;3;F]18$U",#DQ%7+HX4AMKA'QR!P<+I<HK:3\/5L?B+KWBJ\NM.OK?
M58[5(K'^S=OV3R%*H5<R,.C<X4=L8KN;K3;"_P!GVZRM[KRFW1^=$K[#ZC(X
M->#_  3^)D\?PF\*/XP76;@ZE=3VO]OWKK+;F<W$HCB=VD\P$@*H8ILSA=V>
M!U\'QGT6X\,7OB%?#>OK:Z;K1T.^5H[;?:SAT3<P\_E-\BKE2QZ\8YJVG<EV
MBV>@OHFCO?#46TNT:]!#"Y,"&0$# .[&>*B/A?PVV_=X?TT^8<OFTC^8YSSQ
MS6!<_$+2[?7[G2UTO4[F*VO8=-DOH(4:!;J4IMB)W[A@.I+%0@Z;MV%-3P)X
MZU/Q=J6O1W7A74=)ATW4);-99Y+=T!C6,&,^7*S;\EF^Z5P<!B:G<?F=4WAG
MPVQW-X?TTL!LR;2/.W&,=.F./I4JZ!H<=B]BNBV"VCMO: 6R"-F]2N,9]ZY#
M5/BEH^F:EXCTU="\07]WX?M5O+F.#3RGF1'?EHFE*!P/+?G.&QA2QXJ32?B=
MH.L:GH%M;V>H0VOB*W:XTO4+B-$ANRJ!WC W^8K!23\R*IP<$T+78'IN=3<:
M%HMS+%/=:193RQ*%C>2W1F0#H 2. *2+0]#M[::VAT:RB@GQYL:6Z*LF.1N
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M>652 Q'L-R_F*;NR4K'%^&[[QAI%UX=\,>*(;;5+B33=UUK$%R SW*??'D;
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M<0R[#\A8./*(/&.<@GI7T+VH]Z?-+N#29XK?> ?$UWXXM/&&GZ7:>'/$TE_
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MQB\N4"D(=GE;ED.1N<R>O!SFO>:2EIWN(**** "BBB@ HHHH **** "BBB@
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MJ45MHK^98I%K-\GV=L$!@5F!) )4$YPORC XIW7XIDM-]?(YU)M5TGQ)XO\
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MUL>3:E<7VL1? KQ7J&J7%Y>ZOJ27=RA?]UYDEL[@(F<($R4 &,C[V3S6_P"
M?$'CKQIH/A[QS'J5E;>?JDR:E9SZ@X06YD>,6P@$1"RI^[*G<&8@[CAL#LS\
M'_AW)<6LDWAU9TM+IKRVMIKF>2WMI2228H6<QQ@DY*JH4G!QP*N6GPR\#V?Q
M#F\?6OANWA\23*P>]5GY+##-LW; Q'!8+DY//)H^1/<X'3O$&M?\)[IOA7Q7
M=ZMIMQJ$-[+#/%="6QUM-I9&@EC(:!XUY" +QR2QVD\-H^I:]I/PK^"C:3XD
MU.R&N:U'9Z@BS^8+A'=R>7#%3\O\) ^8D@G!'T#I?@'PKHNLQ:MINC"*YA5T
M@W322);A_OF*-F*1%OXB@!;OFL:X^$7P_NH]-B?1;F--+N&N[)8-3NX?L\I;
M=N39*,8).T=%R0N 326]_O*^RTCD[%];L?C+XC\%2^*M:O\ 3+?PM%>H]U=?
MO5G,S#S R!<'"@< #CD')S6\)>)-6\3R^!?#>J^)[NQ?4?"*ZFTT4BQRWUTV
MU,[^I,8R^U<9W?-D#%>GZMX%\*ZYXCB\0:II"W&IQ6[6?G"61/,@)W>7(JL%
MD7/(#@@'D8-8-]\$_A;J7A>Q\,WG@NQ;3;!VDMXH]\;1LV-Q\Q6#DMM7.6.<
M#.<52\Q6ZW,";2-2A^)'PRM/$6O2ZOJ<5CJ275W;320)/)&(@'\M&"J>2&XY
MY!XXK.\KQYK7PV^(%GI/BW4[GQ#HFNS)I]TS)'+-'%'"_D,(U5?F#.HPHY8&
MO4/^$(\,R0:'"NE"WCT%2FGK:S20"!2H5DPC#<I  *MD''(H\,>"=!\'MJ#:
M#!>Q'4)OM%S]IU&YNQ+*>LG[Z1\,>[#!.!G.!4O79] 6GWG!:YXV^V> =8\>
M>%]3GBCM=-M8+=GN,P033;6>1P<JS1I,A)8'!#9'%=+X1L?%EKXMN;N\UZWO
M?#5[I\;V]N=0-W*MPK8:5&,2?NW4@D9(#=  <#I+'PSH.G^''\-V>EP)H\@E
M5[-EWQN)&9I 0V<ABS9!]:R_!GPW\%> 1>MX1\/PZ4U^P>X9&=V?&<#+DD*,
MG"C &>E,9QNH:AK<W[45KX3;Q!J T&Z\-R7[6,4BQ(LHF\O(9%#CIG[V<YYQ
MQ7(^'_&WBG5-4^"4]UK5SC6VU.VU) ^$NQ K"-F XW9&<C'/X5Z[J/PW\)ZI
MXP;QA=6U^-=:U-E]LM]5NX&6$@@HHCE55')/ 'S?-][FJUI\)_ MAHMAHMKI
M%Q'9Z?=&\L_^)C=-):RGJ8I#(7C!YRJL%.3D')H6B5Q[NYYA_P )]K^EV<^E
MS:U<);7?Q"DT ZA</O>SLQA@BNW0G&P,V2-Q/7!JS\=]/O\ 2OV?O&]K>:X=
M3B:_LY[2.5BTMI"UQ!B-V))8;Q(03S@XR<5Z3_PJOX>+I&MZ7'X0L%M-;;?J
M">7S<')8$MG(VDDK@C:>F*K_ /"F_AO_ ,(!_P (&OAORO#WVC[4UG#>7$?F
MR_WG=9 []N&8CY5_NC#3LT^PCE+W6_''BO7/'.G>'+ZST>_\/7$%O8-=WSPI
M&HC25II8EC<2))N*Y;@*O&#DGG/''B[Q=:S^*=2TOQ)/<OHUQIAVV V6>F[V
MC$UN[./])>3S,_=.Q<9*D[3ZMJWPK\!:]KVBZYK?AR+4=2T6-(K.YN)I79%0
MY4/EOWN#SF3<<DGN:75?A;X'UC4=5O\ 4M#\ZXUGRS>G[3,BRM'C9)M5PJR*
M!@.H#8R,X)J>P=3E=&;Q!J7QX\::%=>,-7&F:7'IU[:V\9A14+[V:/B/E"%V
MD'D@]<@$>RCM7&Z-\._"NA^*;OQ-I-G>0:G=J(YW.I7+QR*!A5,32&/"CA1M
M^7MBNQ[T[Z(5M6QU%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** .5N/''A6SU^X\.RZY;G6;>'[1+81$RSI'@'<44%NC ].G/3FFVOCC
MPG?7&FPV?B*SN&U3BS:.3<D[;=^Q6'R[]O.W.['.*\TU*XGT_P#:S?Q!<:#K
MDFDP^%#8/?VVCW5Q"9_/\[8&CC8,=GIGGY?O<5Q&EW&HQ>!_A'I[>%?$T-SH
M>O&XU")O#]Z#;0_OAO)$6",2+T)[^APNB8^K1]#_ /"8>&Y-:CT4:Q"MY-+)
M;Q(00)I8QF2-&(VNZ]U!)&#D5F:+\1O#^K0:_>2S2:=9:->/9RW5]!);QY58
M]V6D50#O<J%ZG ..:\:UBQ\1W7BKPGJ \/Z\CZ?XTFFN-/M=*=;2RA9IOWR2
M! 9O-R':4L5!8@^7T.QJ7AWQ.V@^,+&S\.W]Y=6OC :^MJI:V74+96A<)%,<
M N0"1M)PT>#@XR+H(]3F^(W@FSTZZOK[Q-8V4%K<?9)_M4GDO',1N$91L,&(
MY QDCFJMUXP\.WWB'0[+3_&UM:W$MY+%]@C$;MJ!5#NC^8%E RK;EQGCG!KR
M7Q<MOKGP9\6:IHWPZ\9:;JVO26=LT&I6EU<W=VT,H;<8@TIC14W .VW=TY^7
M/6?$*\DU#QQ\++[3]%UNZM;?47NYY(]'NC]FB:%HU,H\O,9W,,JP! Y( %4D
MNI+OT['H=KXQ\,W6N1:1:ZQ;S74SRQQ*N2LKQ?ZU4?&UF3^( DC!SC%</\.?
M&^K:D/'LGBW5$N(]&\33:7:-';A,1@1K&BJ@+,Q9N/O,2V/05Q?A2TU^/4O!
M>IWG@W6=)DL/$%_]ITJTL&2TT]7@N578< RB1F1C,24RV,H,+4/A6UNY-+^(
M5OJ/AOQ99I?^,9-2MKNUT^XM[F"%AF.[A#Q_O-IB.4 )((&TE@IA7W\OU-++
M9'T+IVH6>IVOVBQG$\2LT;,,@JZG:RD'D,"""#R""#7F'QP^(%UX/^&.NWGA
M?6X[7Q!I[P)G[-YX0R.OR$L"BOL;> V3@9Q@YKI/AC_;R^$77Q!)+<S_ &R?
MR+NXLS9SWD._Y)I8" 8W/.00"< D G%>*^.-)\51_!7QY\.KK0-;USQ%=ZM]
MOM[VVTZ6:"\BDNHY%<2@%0RJ-A0G<NW@%1D-Z-(F.NK[GT-?>*-%TEDBU;4D
MMG"Q&1W!V1>8=J&1@-L89L@;B,D''2LJR^(&EWWQ&UOP7'#<1S:/:Q7%S<R0
MR+&K/N.-Q7  50=Q.#G S@UY9>Z9=1>*=>T7Q9\/O%7B33O&DD%S UA.ZP6B
M^3'&;:\,<JI%L*9W98$'@G%7;GPCXB_X6'\3--L]-O(D\0>&K:TT^^^=H%>.
M"2-E:9N^XJ.27.[=C&2$WLQI;GK.G^,?"^J7LEG8ZW;RW4=N+PQ%MC& \"90
MV-T9_OC*^]4[SQ]X;L]$U/5OMS3Q:99?VC-'%"YD:WP2LJ+C+HVTX<97@\\5
MXWJ7AZY^*'A;7UTOX>^*/"7BN/2Y--2_UVZE$)4NK-;1%I3YB/M(W[ H!Z]J
MZ(W6H>/O ?BI8OAKK&@^(%\/7&CFXU6W2W,S-&<0P'<3(F_G=A5Z8SGA_P"0
M*VE^K.KTGQ[IOB+3O FHR>)!H-YKL:W2:0\:E[X-#N,8WKNVJ2#O3 ..N#72
MW'BSP_9ZDMA<:I%#,URMIN?(C\]AN6$R8V"0@@A,[CD<<UX;"NIPZ7\!K>;P
MOKZ2:,8Q?XT>X?[*!:^22^U#L'F''S8.!NQMP3+<>%?$5Q\)]?\ A#J&FZA?
M>)+O499K?6)+67[),LESYXNVN=NQ60$Y0G?N7"@@@U6B>FQ.^^AZ\WQ&\"J^
MIK_PE.GR'26VW_E2^8+0[MI\PKG8 1@DX [XKIS<6ZVANVF06X3S#*6&S;C.
M[/3&.<U\W>(FU"X_X7?9Q^'_ !+.^L:?;6VGN-"O"+Z2.W,+[&\K!^=ASW&6
M&5!->J:#]N;X!V*_V--<ZA'H*PG3+Z&2%Y95M]IA=' 898%>G(.1US4]&Q]5
MYFM'\0O!,BW$DGB>QA2VM5OI&N)/) MV.%F&_&Z,D@!QD$D8/-3V'CCPIJE_
MIEGI_B&TN9-5C:6Q"2<72J-S>6>C%002 <@=17@OA^'6--^)VF>*+W1?%-WI
M[>"Y-/DE.@S0^1/YP(MDMXX]R*HX4$$D#=N8?-5>WM]<O!\"K.ST/Q'8W6AV
MEQ9W]Q)H=XBZ?*]JL*,Y:,#&_OG&!DD#FAZ7LK@NEW8]%^)WQ&O-'U'P=9^%
M]:C1[WQ1;:3?J+;S!)&7Q*BR,"N5(VMMRP+?PD5ZEJ6I6.DV+7NI726T(*IO
M8]69@JJ .2Q)  '))P*^:=8L/$Z^ ?AUX5;P;XAU'7O"OBBUGU!HK!S'.D;2
M,T\<[8C=7SG.X8)^?:2,^[?$&QAU#PL+6XT_5[I3<12!]&DV7=HRG<)X_4H5
M!V\YZ ,2%+V7S_#0;W^1H+XLT"2SEO(]7A>&*Z%DX3+.+@X_<[ -WF?,/DQN
M!XQP:PO%GQ&T_1/AAJ7BW26_M+R0T,)BA=U6</Y9$@ RFU^H;!XQUKS6UC\<
MKX6M6UK1KS44;Q4)(]?71BFI16HB")>FSV$B7@Q[F3(7YBAK/U:+6K+X,>/M
M ;PQXHNKZ_\ $,TEI$--GN))D::.0.2BD8(5F+#Y<\9R<4M[^0MK>;/7+/Q)
M8^%8KMO%7CJ2_A=?M</]HV2VUU:0 [&:41H@\K?T=HT S@LW!K>U+QCX;T7R
M_P"TM:MH!+ UVIW;OW"XW3';G$8R,N<*,]:\A\0W4UOXZU/Q#=^ _%_B7P[X
MJL;>RC_LF.XMKBV,?F(\4]N[0NJ-O+!WP.3ZU0^(-[J?@_Q)96?ASP-XAU:W
MG\)C1IK73[%M12T3<PBW,)-VY?FR&_U@_B&":; ]FT_QQX5U:Z@M=)UVUU&6
MYADN(39MYZ3I&0)"CIE7*D@$*202!18^./"^IZ+;ZQINL1WMI<W#6L+0*\C2
MRKDLBH!N9@%8D <!2>@KROPNZZ5:_"?4[/1_$=SINF:;>Z+<";2Y/M=M.1"J
M^?"NXQ M"XR257*Y;'-<]X'L_%6E^%-"LM2\*Z[HJCQ+J$LFIQ:<+B[M$D$A
M1HH@LA59-QC:5DP 3CJ'">FP1U5V>XR?$+P3';:3/)XKTU$UABEA^_7==,&"
MD(.I(8@$8X/!IVH>,M#70FNK+6(UDN+>:6W<0O*5$?RO(R 9"HV Q; !X)%?
M/FFPZQI7@7P;I-]X5\3"?3?'$FI3J-&NIS%;+/*Q<F-&SPZD8SNR=N<''I6H
M1ZQX?^+^OZ]J&GZKJ^C>(](@M=.:SL9;C[')&&W02*JDQAR^X,P"YR&(Q2UU
M&K=2U\)_B VL?"/PQKWC'64DUC4H+B>1A&%+)',RL^Q!A44; 6P ,C)YKT6Y
MU;3[?0Y-::9GL4A^T>9#&TI:/;NW*J@EN.> :^8_"6B^)=.^$GA6W;0O%WA#
MQ'I.G3QP:Q:::;SF2=G^SRV8#%D?"G+*"I7YMH(W?1-C:ZE<?#:VLKRSBMM2
MDTM(YK>/ 2*8Q89![!N*<M+OML)+5)F=X;^(>AZYX+TOQ1-*]C%JA/V:":-Q
M)*>6"HNW,AV#)V ]#Z&M>W\6^&[K1+/6K'6(;ZQO7,=M):9G,[C=N5%0%F8;
M6R ,C:<]#7ANCP>(/#?PQ^'6JW/@?Q)J:>'[.?3=1TW3Q)!>QN_E_OHT!5I%
M4QLO! ._(R.:NOI]]X)U/PS\1/#_ ,/_ !&^B(M['=^'(@UUJ,$MRZM]J\LR
M.,L4PRA_E# _W@#KIL'37<Z3Q=\0KRS^(OPQC\/Z[;2>&O$4UTMP88EE,XCB
MRH5N3]Y@-J@-D8]J[2X^(7@W3["SOM0\36%G#>7#6</VB7RV>96V/'M;#!E;
M@@C([XKR77+5HOB)\(K_ $KP#K.BZ5:75_=W%M#ILDWV);A,*TWDJZ1NSEB5
MW':.3CMQ>O-J]]I$EO;^$_%<K_\ "R%UY1_PCU\/]!SGSN8O_'?O>U-=?4'T
M]#Z=7Q3X?^P:E?3:O!;6^F-LO6NB8?LQVAAO#X*Y#*1GJ",5F:MXIM+SPOXA
MD\.ZI&FJ:9:/(RRPMOMF,9=&>)]IP0,C/!]Z\=UZS\1:YXW\?7&BZ!J\ZKJ&
MC:I;P7>FW%K#J:6>//B225%3=D#:"?FV@C(YKJ=7:XU[5=<\=:?I>N6]C%X9
MFTQK2;2[B*ZO)W8LBK R!V\OD;@,9E."0&-)K1V8HOWE='3> _&GV[X2^$M<
M\3:DKZIK%BDIVQ_O+B39N;9'&,G !)"C@5T:>,/"TGAJ/Q-'X@L9-&D8(EXD
MP:-G+; @(ZMN^7;USQC->/\ @.36O"WA3X;ZYJ/A_7Y;&RT271+^RBTN8W-A
M.SQ,)C!M\QD/E%254_PD9!-,\6:=JFC_  YN_$%AX<U9+JY\70ZYIVDVEH)[
MA "F=\"N"=_ER2%0=R^9DX(;!]K71#Z>9Z/JOQ"\%W&@ZR;3X@Z;I-Q91,MQ
M<>;$9]-8ML#/#)RI#D#:Z\G Q6PWB?1=+T6RNM2UM9XY+,77VH1DF2)54M.P
M0?*GS EL!1N'2O %U2ZU[X9_&!I?"'BO3O$'B.,W,6D7>BS1LP:)8$$*KN,N
M"H+OA<;AD #-:GDZEH-WHVO:MX-\7>)-&UKPY9Z0;'28YXKG3Y8E82)-#NC*
MQOO/S,< J>Q!I]!:'MNH>,/#.EL3?:]:0(+9;UI"^4C@8D+*S#A48@@,2 3P
M,FNE4AE#*V0>AKYS\:>%]0T73?LO@O0]?T/4H=*AT^VA@C;5M/U*(;R+&Y5R
MVS:'8><Q55#GYS@"O<-,U*XN-5N=)N-+N[::SMX)'N&CQ;2LX;*1/GYRI7YN
M!C<OK1IK8.B-^BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7-S>&K=O$4NOV>H7VGWMQ$D-QY$BF.=
M4)*[D=67(R1N !P>M=)10!2M;>.SMEMX]Y1<G+L68DG)))Y)))-7:** "BBB
M@ HHHH **** "BBB@ HHHH *Y_6M M==-B;BXNK6>QG^TVT]I*8I(GVLA/H0
M5=@0P(.>E=!10!F6=A]CWR274]Y.X"M-,5W$#H,*%4=3T K3HHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** $HKRWQ3J7B&+XR^#M!L?$EY9:9J]M?2W%M%#;L-T*1E"K/$S#ES
MGG\JY&Q^)7B3P?\ %36-+\:WDNH^#)]472;+6)8X4;3KDPQ2!)O+1%\M_-X<
MC(*\\<U$7S;>?X#:L>_T5X_JVJ>*;7P?\3M4@\7:@MQH#7!L";>T(C$=E',H
M(\GYAO<]><8KT#PJ]Y+X2TJYU#4)K^YGM8YI)IEC5BS(">(U5<9/I5V)OT.A
MHKG]=\0:=X=2S>_=C+?7*6=I!& 7N)FSM1<D#. 3DD  ')KS;XG^+Y-0^%2Z
M]X9U;4-+GM-<MK&X6-O)D5Q=+#-#)WQR>AP>#DBI*/:J*Y6^\6Z;9ZBUI-#=
ME([N"QDN$BW1)/-L\N,\YY$B'.-HW#)SQ5*[^(7AVS>[DDDN7L+"]73KS4$B
MS;VMP2!L=NN 64,P!52<,00<,1VM'>N+^)DU];_"?Q7>V&I7.GW=KI=S<Q3V
MKA)%9(F88.#CD#IS[U4\*^.-+O)]&\,W+WJ:S<:1'J$9NX'47,8"H[AF[ACR
M&P3G(R#FFM;^0GT/0:*XB#X@>'YM5T6Q=KRU&N[CI4\]NRQ7NU=Q"MSM)7Y@
M'"EARN:M0^+]/N"ZV]G>S!H[B2!U1=ET(&VR;"6P/FX&_;NZC(R:3=AG69HK
MR[X=_$JX\5?#S0_$=]I,ZWFMS3K:VD'EY=%>0@@EP %1,$L5R1P.1GN++58=
M1T:'5[&.:6&>'SHH]FR1QC(&'(P?8X]\4VK7OT!:FR:!7G4GQ4\*Q:-X:UJ1
M;Y+/Q%J']EV;&WY6X\QHPCC.5^9&YY'R_2FR?&#PA#I&HZY-_:=OINF7RZ?>
MW%QITT MI6*@;ED56QEU!P"1D$@ @TEKL#TW/1Z!7$P^)/#7_";Z[:R:A?VU
MUI%A%->+>++#:1P;I")DW@(W\0,BY&$ S\O$5K\2M#O=3T2RAM=1W:]#)<:4
M[V^U+V-$+LRDGY?EQ@/M)W XQS36H'=\4<5YUI_Q8\-ZIX?\/>(+1;]M-U_4
M/[,M9F@"[;C>R!77.Y<E&YP1Q[BKS?$#PXNI1VJR74D#:E_9!O4@)MUO,X\D
MMZ[L+N V[OESG(H [BBBN#U+XB:+I5KXHN+NTOU/A<1MJ*+&K,B.F]77#89=
MO/'(],Y%+;4#NZ*X+_A97A^3Q':^'K6'4KG4KO31JL,4=BX62 A3D.P"$_,/
MXL \$YXJO;_%;PG=R>&X;/\ M*YD\31/)IPCL)=LFP'<I<C:K#:<@GY>IP.:
M0'HM%<-;_$7P[>:4E]&MX)FU,Z.+&2 QW'VP<^458@ [1NR3MQSFJ/\ PM[P
M:;2TO%DU%EN=3;1ML>G3.8;M7"&*0JI5#N88R?FYVYP::UV!Z'H]%<)J'Q&T
M/34N!=6>H+/9V<NHWEKY&);6VCD9&F=21E258C;N+ 9 (YK!UC5+Z3X\>"[?
M3]>O5TG5M'OIFMHY,0L4$9CD"XP6Q(3\V>W%*][6'8]9HKQ[X5^*'M_A+HEY
MKVI7FJ:E?:A=V<'G2>;<7<@N9@J L1T1">2%55/0"J/Q+\927_@G1]5\-ZS?
MZ;+!XHM-,O88I/)D5O/"2PRXY_(X((/(-#T=O-+[Q+4]P[4=:XK7/B%H/ATS
MR:I)<165K=165U?>5F"VFD"E$<YSSO3+ %5W#)%<W\6/& T_X;^-+71+C4(M
M3TO3&FDO-/P/L3LI,09LY!. 2%!*J03M!!I[(:5SU@=**XSP?JC_ /"IM!U?
M4IKFY<:-;W-Q* \TTA\A69L#+.QYZ9)/O7->$_B5X*C\-^$[72[[Q#JMOKCS
M1:;<WMO<7$D[J\F5>=Q@-\CX#-D* 3@#--JSL2M5<]9HK@M-^)6AZKK4^C6E
MCKJZA;);RSV\^E3PO$DS[%<AU&5!SDC( 5CR%)%C3?'OAW5]8TW3[=I]NK-<
MC3[ED'DWA@.)0A!)&,'[P7< 2,B@9VM%>(^-O'$>I2^"KKPQJ6J1:?<^*;:Q
M-W;#9:WRB1EECW#YF7*D=D;#8W8KI--\=>$(6\8:HNIZLRZ5>Q6^H17B3 0S
M$*B)!&X&T,2OW0 2V>^:%J#T=CTFBO+]>^*VG6/A'QA?Z?I]Y/JWAE=M[82(
MB/;NR;HV8E]K(>#E&8XZ"M)O%&BS_$S1=!O&UO3]>>QGN(;)]ZVTL>0&9RA,
M4C# Q@DKN[9I=;!TN=\:!7%P_$+P^][ID;1W\=KJMTUE8W\EJRV]Q,N?E#=1
MNVG:S *^/E)K+7XO>$I+/5+X1ZJMGI.H+IM]/+821"VE9E4;@X#8RZ] 2,Y(
M P:8'I-%8.OZ]I_A?P_>Z_KEVMIIMC&99YF!.U1[#))Z  <DFL"7XD^';73?
M$%]?P:C9KX?@BNKR)[1GD6&52R2*(]VY2%;)'W=K;L8-*Z'8[SO17%:+\0-#
MUZ;25M5NK>/5]/;4[&6ZB\M;B!=F\CG(*^8G# 9!R,CFN0U3QM#KGB[X=W.@
MZAK$6FZIJ4JH3"T-M?P+:SDMR Q&Y4(W8!'S*".:?6Q-]&^Q[+17)^)O&VB^
M$;G2H=86_+:K<K:6QMK&6=3*Q "LR*54G/ )!.#@'!J&'XA>&Y)/$-O<33V5
MWX>V'4;6XA(DB#KF,J!D.''W=I.3QUXH&=C17%?\+#\.0:EJNEZM--H]_I5C
M_:ES;7D>&%KSF92I974$$':20>" :R/&WQ"D\/\ P[\2>(;'1[PW^E6*W26]
MRJJ )-PB<G=AERI) )88Q@&@9Z;28YK-TRXFO-+MKF>WDMY9$#-')MW*<?[)
M(_(UPMU\0O".BZQXSOKJ\UQGT)+;^TX&M;B2*W4A]KQ1[>%(!+.HVD $G'-&
MU_(E.]K=3TVBO.YOBQX;M[W2;2YL=;A?6Y(H].=]-E$5TTB!T"RXV D'H6!&
M#D#!J&X^+WA6U^VBXCU*)M-6W;4T>S97TX3MMB\Y3R,]?E#8&"< BE<JQZ32
MUY]XS\6Z?96.M:';W.I)?V>G&\N9].A+FRC.X*[.00"2IX&7P"V !FN=\+^*
MM)F/PGTW6M:UP^)-3T);J!$DF^S7I-JK2M.?N2,-I(R25+ \;@2+5V$]%<]B
M[T5Q&G_$#0=0U33[&SDN'_M7[2-.GV#RKTVYQ*$;/!&#C<%! )&1S7$/\5-)
MUKX?7VN^*+;7?#VG#73IL$NGN1+NCFVJK/"Q*@LA#9PIW;06SR;M+N#T3?8]
MNHKD-=\;:/H*ZD]\MW-#I,"W6HS6T/F+9Q-DAG .3PI8A0Q &2 ",UE^(WAN
M7Q);:'IZW]_=WUE_:%HUM92&&YAPIW),0(V^^N3NP,@$@\4PV.YHKG/"?BK1
M_&OABT\2:#</-I]UO",\91@58HP*GD$,I%9+_$3P[_:MG:AKM[:[U!])BOA;
M-]G>[4D&+?ZY!4-C:6! ;((I/0#N**\YA^*6@27=W91Z?J9OK75$T:2T$*&4
M7#J7 "A^4VC=O'RXR<X!(T+[XA:#I^IFSO&N!$FI1:1)=I'NABNY%5DB8@[L
MD.GS;=H+ $@T^R[@]#MJ,5YU-\7/"<4/B28QZF8O#+A-49K"2/[,#_%AP"PQ
MS\H)(Y (YK8M?&VBW>HK8HMX&FL'U2U<VS$7=NA4,\8&6)!=/E(#'<" 0:7F
M!UM%>2^%_B=X)M?"7AR33;[Q%JECKEU/;V-U>6MS=R22"1\H\A4XY5MJDYVK
MP,"NAM_B-X=N=.UB_62YA;1]072[JWEBQ*ERS(J1@9PVXR( 0<<]>M('H=S1
M7EGB3XM:?I?@[7M4TG3;RZU#1[V/3;NT=41K2>1E5"^6PR_.IRA;.?J1H6_B
M;0[KXP1Z%)=ZO::^FCM<-ILS.+00&1?WA )B>3)QN4G R,\$4^H=+GHE)BN'
MC^(GAUM0TBUF%]:KKBNVEW$ML_EWNU=Y"$9()494,%+#[H-4;?XN>$9M/BU'
M_B:0V<VJ#1VGN-/EA$-T7*!'5P&7Y@0>/E/WMN11N!Z-17)>//%UOX'\":GX
MGN(6N#:JJPP+UFF=@D:>V7903V&37(^,IO$OAF#P6MKXJOX+G6-?MK+46"PR
M)()$;>$$D;>6,H,!<#J3DDDK89ZW1UKP,^-/%S>+OBGX;M?$TMY8^&M,2]M-
M0CM[?S;>X,+,;>0^7Y;\C/W<C&">M6;[Q1K6D>"OAOXAU7X@3V$.MW%M'J=U
M=)911!)+264G<T("?.J@'\.]42W9V/=**\]T/4K+Q1>:A_PC_P 0?^$@TV.%
M8Y)K*>W<VT^[<I22&,*3MSE6)'3(()K3\&^(3KFGZC9W5U]HU'1;^;3;QP@3
M<Z'*O@<#=&R-QP"2.U%@N=?1110,**** "BBB@ HHHH **** "BBB@ HHHH
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MVSPB3X9^,I--^)MI9^&IK6'5[W3;_34N-0BFDN%@,;/&SF1CYGR-DNV-W\3
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MC*>Y-B/QEXBL_&*V/B2XNK6TU/6OLNDW5E%#<:?+""%\B215,D4^0X.[ W#
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M#)\.O"#?V1MTN2-](B%O:2PWD\4BQ?\ /-W5PTJ'NKE@>X-8>J^&;K0]'M?
M/@GP39MX<U9+B'4;V6^"+8J_!8QL&>=F#-@9 RH!(!H>X+J=)X3U"XUBSO=<
M-]<7&G7MR[6$<J1J$@7Y0R[5!*N59P6).UEKB/\ A,/$6G^,_P"S_$=U=6MI
MJ6MFTTF\LH8;BPEA#;?(D<*9(I\AP0W&X8!X./58+>"QM(K6VA2&"%1'''&N
MU44#   Z "N?7P+X;BUA-6ATV07"7#W>P74WD-.S%S,T._RVDRQPY4L. " !
M@MJ%]'W/(-+U;7/#NA7_ /9_BQX)[WQW<:>R74"W$UQ&9VW) %C/[Y@!@O\
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M2%!3.#D5JZ7XH\7>-+OQW#H.M0:+>^'-7&GVEO<PHT+QH$9I)\J7P^9 "I7
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M&:F[U'IMV.AD\1>)K7XS>#-!'B*VU'0=6T:XN)/*M5!GEB5/WV\$C:V\$!<
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M'B/7]%?2K?1QIEK'>O*)]1U$F5;;8FY52V1TDN&<_* C9'7!Z5PTGQ,\:2^
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M=+O(["[TF;PT^N0Q6MK(ERDB-&IC+&1E<$NQ&%4\@<XR44>D231PQ/+*X2-
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MA^%/C>[^(7PXL?%5]IL>G3W,L\;6\4A=5\N5H_O$#/W:[S^*GJA6Z=AU%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Q_Q_XGU*/XJ^$_"/_")W^KZ5>Q7=
MQ-'#); 792,  "29.$\PL=V.=I7<1Q-X=^('AVQDT;P=!;^()=/FN)=$L]<O
M-K1W-S"&#QE]_F[AL8!R@4E3@\5I^(/#/B;4/BUX6\4:?!IC:=HMO=PR+/=R
M1S2&=4'"B)AA=G][G/:N4?X9^,KW5O"^L:S/INHZQH>O2ZA)J$M[,SS6K>8%
MB13%B' :/*+\IV9R34QVUZE:#/!?C"W\%Z#KRZE8ZY>:/9^([^VDU(N;I+&)
M9MJ&5Y)#*R@=6 ?'\1%=W9?$#3]1\1ZIH=CHVLS2Z5=+:WDHM0$A+1&57P6#
M%2, 84G++Q@YKE[CP#XEN?"OBSP@9--73?$.J7%V][YTC2QP3R[Y$\KR\;PN
M5!WXR<]L5O>&/#OB32?''C36KRWTS[-K<T$UJD-W(SIY5ND05\Q #.W.03CT
M-5>^_;\3-*WWLH^&_B!X3C\&Z--H-CJ3_P!K7%U'IFDR,&O+J2.1S-CS9,
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M@HK&/;\H&XUL?\+&TF35(;>ST_4[S3FU#^RWUB"%&M(;K?L\ILN)/OX3>J%
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M.:2TSO,C //Y2X ^[&YS_"#7?:M\5O#MC#:2:79:CXA>YTO^VQ'ID2%DL?\
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MBEOKL0^MCTGQ%K\>@K9QQ:7?:K>W\Q@M;*Q$?F2L$9V^:5TC4!$8Y9ATP,G
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M3Y@]UZ#J***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 F*6BN7\7>+M)\%:!+K>M32+"IVQPPQF6:X?!(CC0<LQP?H 2< $T
MF[ =/2UYS\-_BYX1^*FGW4_AN:YM[FS?;<6%^BQW$0[,55F!4^H)]#@UZ-3
M**** "BBB@!**\O\??%W2_AUKNF:7K?AO7KC^U)!#9W-DMLT,\AP-F7F5E(+
M#[P ]":N>'?BMH.N>,9_!M]9ZGX<\20KYBZ9K$2127"?WXF1W21>#]UB>">@
M)I+4'H>BT5Y[J'Q/T>/QC/X/\/Z;J'BK7;5#)>6ND+"19CMYLDTD<:D]-NXM
M[59\*?$3P_XN:_M=/2[M-:T[(N]#OT6"^@( (S&6P0<C#@E3G[U/S [FBO&/
M#?QTTOQ5XYU#P;I/@WQ4^L:8SB]BECLT6WV-M;+&YP?FP.,YSQQ5OPW\</"/
MB+XCWOP_N+'5?#_B"TW*;?5E@C61P0#&C1RN&;!R,<$9()I=O,._D>MT5P%Y
M\1H=/\7ZMX?N?">OC^R[%M1FOQ';FU, #D,K>=N)8HRA=H.1R .:Y?4_CSI>
MBZCX<T_5? /BVSN_$K!=+AE2Q#3DE5 (^U?NSEU^_MZ_6FM0V/:**\SM?BQH
MPD\2+X@TG6/"\GAY('N4U:.$>=YV_P L0F*202DE" %/)P!DYQHV?Q"ADUO3
M=%U?POX@T&]U-BMF+^VC:.7",YS)#)(B':K?*[*W'2CR!Z'=T5!)*D,;22,J
M(H+,S'  '4DUYM#\7M)U2XU7_A$_#>O>*[+2F*76H:3% UMN RRQM+*AF(](
MPWZC(!ZA17%:/X^T?Q3X+/BKP;'<^)+<-L^R6?EQW <$!D*SO&%9>I#,,CIG
M(SR?A+XZV/CK1KS5O"/P_P#%FIV=E*8)W1;%&5PH8J%>Z#,<$= :/(#V&BN?
M\,^((_$_ANTUJ/3;[35N-X-IJ$0BN(F5V1E=02 <J>,UB>*/B1X?\-ZO;^'E
MAO-=\17.&CT;2(A/=;/^>C LJQH.NYV4>F:/(#NZ*X*S^(FFS^*M-\*ZGHNL
MZ)K>HK(\%I>VZD,B(69O.B=XC@ #"N6!89 YQ%J'Q/T>/QA/X/\ #^FZAXKU
MVU0R7EKI"PD68[>;)-)'&I/3;N+>U 'H5%<+X9^(V@^+#?6VGQ7EMK>G[A=:
M%>HL%]"0 0#&S8P<C#AMAS]ZN;\(_'CP?XP\?WO@5;75-"U^U9XS:ZM%%&97
M0D.B%)'!88)QW'(S@T+4'H>N4>M>?W'Q&6S\1:]H]QX0\0(-$LFU">\\NW,$
MD(5RIC(FW,7\M@HV@Y'S;:YO5?CQINA:[H>AZM\/_%ECJ.OE1I]M+'9!YB6"
M@'_2OW9R0,/MI;VMU#N>S45Q_A7Q@/%%WJMC+X;UK0+S2Y42:#58HD+[@2&C
M,<CJZ\'Y@<9%30^,M#NOB%>>!X;@OK%E9)?S1C&U8V;:!G.=W0D8Z,OK2 ZJ
MBLW5=7TS1-,GU36+^WT^R@7=+/<R".-![L>*X73_ (L66J:=+KEEX.\4OX>3
MG^V#8((GCP#YB0^9]HD3GJL1[^E 'I?>BO-O^%J:?<-8?\(]X9U_Q!#>V!U1
M)K**"-$@WE0SFXEBVD[20O7';@@<MI?[0VAZWX+OO&^E>!_%UWH%A,8+FYB@
MM&,3 *3F/[3OP ZDL%P!WX-4M=@M;0]SHIJMN4,.A&:=0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZGC'[95]JD/@/PY:6_\ R"KJ_9KIQW=4_=KGT(,A_P" CTKZ<TM+6/2;.*S
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MW-O]E%I-+<V4<+@'<WG*&8@DYV@+UP>E4M7;^M0>F_\ 5CW/^S;S_H9M;_\
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M]FWG_0S:W_X&'_"I[;_C^OO]]?\ T 5;I#,W^S;S_H9M;_\  P_X4?V;>?\
M0S:W_P"!A_PK2HH S?[-O/\ H9M;_P# P_X4?V;>?]#-K?\ X&'_  K2HH S
M?[-O/^AFUO\ \##_ (4?V;>?]#-K?_@8?\*TJ* ,W^S;S_H9M;_\##_A1_9M
MY_T,VM_^!A_PK2HH S?[-O/^AFUO_P ##_A1_9MY_P!#-K?_ (&'_"M*B@#-
M_LV\_P"AFUO_ ,##_A1_9MY_T,VM_P#@8?\ "M*B@#-_LV\_Z&;6_P#P,/\
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MU-2W977]:C6]F?4D5C)<01SP>*-9EBD4.CI?%E93R"".HI_]FWG_ $,VM_\
M@8?\*@\*?\B3H7_7A!_Z+6MFM)+EDX]B(OFBI=S-_LV\_P"AFUO_ ,##_A1_
M9MY_T,VM_P#@8?\ "M*BI*,W^S;S_H9M;_\  P_X4?V;>?\ 0S:W_P"!A_PK
M2HH S?[-O/\ H9M;_P# P_X4?V;>?]#-K?\ X&'_  K2HH S?[-O/^AFUO\
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MPOS0O^B2Z5_X-+S_ .+H ^T?^$H\,_\ 0Q:9_P"!<?\ C1_PE'AG_H8M,_\
M N/_ !KXN_X7YH7_ $272O\ P:7G_P 71_POS0O^B2Z5_P"#2\_^+H ^O]=U
M+POKVA7>D2>,+6RCND,;RVUW!Y@4]<;PP_2J?B!/ ?BKPK)X=\0^(-/U"VD
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MO7=4B$,U]<WT)=(P  J*H"J/E7^'G SFOEK_ (7YH7_1)=*_\&EY_P#%T?\
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M@XY#*1^F+-WX)^&EYI/B>QD\7*L_BB19-2O5O[?SI0IRJC*[%49[*#[UZO\
M\*?^'/\ T+O_ )-S_P#Q='_"G_AS_P!"[_Y-S_\ Q=/O?J"TU/*M+\'_  ]T
MKQ?I_BI?'!N;VQTU=*2.>^M3$\"KM 8*@)..X(J'P_X)^'OA?1M1T31_B!=0
MZ7>M)(MH=4MREL[H4+1G;G(!X#%AD XR,UZU_P *?^'/_0N_^3<__P 72_\
M"G_AS_T+O_DW/_\ %T=[]0VM8\V\3>'?A[XH\ 6O@>X\716&C6T<42I9WUN'
M98\; 6=6Z;1TQ5M+3PN+/2+&;XC/<66EO#(EN]W9A9C%CR_,*QAB 0#P1R!7
M>_\ "G_AS_T+O_DW/_\ %T?\*?\ AS_T+O\ Y-S_ /Q=%W^-_F+2QX[+\._A
MK-I_BZQ;QY-Y/BRX6ZU#%_:9#B0R#9^[^49/?/%7=.\'^ =-\166O0^/I7N;
M/2%T6-7O[4+]G48&=J [N^X$<UZM_P *>^'.?^1=_P#)N?\ ^+H_X4]\.?\
MH7?_ ";G_P#BZ!O4\6T+X9_"_P /7/AVYL?'-PTWAZ:66S:74K9N).71AL (
M.3T ;GKTPLOPU^&LNB^*-);Q]<"U\3WBWM\!J%IGS!(9/D/E_*-Q]^E>T?\
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M_P#&M3_A3OPY_P"A=_\ )R?_ .+H_P"%._#G_H7?_)R?_P"+H R_^$H\,_\
M0Q:9_P"!<?\ C1_PE'AG_H8M,_\  N/_ !K4_P"%._#G_H7?_)R?_P"+H_X4
M[\.?^A=_\G)__BZ ,O\ X2CPS_T,6F?^!<?^-'_"4>&?^ABTS_P+C_QK4_X4
M[\.?^A=_\G)__BZ/^%._#G_H7?\ R<G_ /BZ ,O_ (2CPS_T,6F?^!<?^-'_
M  E'AG_H8M,_\"X_\:U/^%._#G_H7?\ R<G_ /BZ/^%._#G_ *%W_P G)_\
MXN@#+_X2CPS_ -#%IG_@7'_C5K2]9T?4?$^D0Z?JEG=RK,[%()U=@/)D&< ]
M.1^=6O\ A3OPY_Z%W_R<G_\ BZ;9^ _"?A?Q'H^H:#I/V.YDN'A9_/EDRA@E
M)&&8CJH_*@#T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JIJ7_(*O/^N+_^@FK=5-2_Y!5Y_P!<7_\ 030!
MXA^T!_R9MJW_ %Y:;_Z4V]?G#7Z/?M ?\F;:M_UY:;_Z4V]?G#0 4444 %%%
M% !1110 5^C/[(?_ ";S:_\ 80N?_0A7YS5^C/[(?_)O-K_V$+G_ -"% 'O]
M%%% !1110 4444 %%%% !1110!E3_P#(UZ?_ ->5S_Z'!7PM^VI_R6W1O^Q?
MA_\ 2FXK[IG_ .1KT_\ Z\KG_P!#@KX6_;4_Y+;HW_8OP_\ I3<4 ?,M%%%
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MJU*R]4_Y"6A_]?K?^D\U &I1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+U3_D):'_U^
MM_Z3S5J5EZI_R$M#_P"OUO\ TGFH U**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFI?\@J\_P"N+_\ H)JW
M534O^05>?]<7_P#030!XA^T!_P F;:M_UY:;_P"E-O7YPU^CW[0'_)FVK?\
M7EIO_I3;U^<- !1110 4444 %%%% !1110![)\ ?B5H/PH^(M]XB\16M_=6M
MSI<EDJ6$:/(':6)P2'=1C$;=\YQQ7TW_ ,-J_"W_ * 'BK_P%MO_ (_7P!10
M!]__ /#:OPM_Z 'BK_P%MO\ X_1_PVK\+?\ H >*O_ 6V_\ C]? %% 'W_\
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MEM;6*!RA)4LJ!3C...*V*** .7T3_D?O%G_;I_Z*-?F)\5O^2W^//^Q@O_\
MTI>OT[T3_D?O%G_;I_Z*-?F)\5O^2W^//^Q@O_\ TI>@#BJ*** "OL_X9_M4
M?#WP;\+?#WA;5-&\0R7FFVH@EDMK>!HV8$GY2TP)'/<"OC"B@#[_ /\ AM7X
M6_\ 0 \5?^ MM_\ 'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\
M0 \5?^ MM_\ 'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5
M?^ MM_\ 'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ M
MM_\ 'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ MM_\
M'Z/^&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ MM_\ 'Z/^
M&U?A;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ MM_\ 'Z/^&U?A
M;_T /%7_ ("VW_Q^O@"B@#[_ /\ AM7X6_\ 0 \5?^ MM_\ 'Z/^&U?A;_T
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MZI_R$M#_ .OUO_2>:M2LO5/^0EH?_7ZW_I/-0!J4444 %%%% !1110 4444
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M\37Z^T4 <1\+89(?@YX)@FC>*6/0K%'1U*LK"W0$$'H17;T44 %%%% &5/\
M\C7I_P#UY7/_ *'!7PM^VI_R6W1O^Q?A_P#2FXK[IG_Y&O3_ /KRN?\ T."O
MA;]M3_DMNC?]B_#_ .E-Q0!\RT444 %>S_LM_P#)S?A'_M\_](YJ\8KH/"_B
MC7/!_B6T\2>';[[#JEGO\FX\I)-F]&1OE<%3E68<CO0!^O%%?F=_PU'\=?\
MH>O_ "F6?_QFC_AJ/XZ_]#U_Y3+/_P",T ?IC17YG?\ #4?QU_Z'K_RF6?\
M\9KTOX%_'3XJ>-/CAX=\,^)O%1O])N_M/G6_V&VCW[+:5U^9(PPPRJ>#VH ^
MYJ*** "BBB@ HHHH Y?1/^1^\6?]NG_HHU^8GQ6_Y+?X\_[&"_\ _2EZ_3O1
M/^1^\6?]NG_HHUQ6K?LZ_!_7-;O]:U3P;]HO]0N)+JXE_M"Z3S)78L[864 9
M))P !0!^8E%?IC_PRY\"_P#H1O\ RIWG_P >H_X9<^!?_0C?^5.\_P#CU 'Y
MG45^F/\ PRY\"_\ H1O_ "IWG_QZC_AESX%_]"-_Y4[S_P"/4 ?F=17Z8_\
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M]#@KX6_;4_Y+;HW_ &+\/_I3<4 ?,M%%% !1110 4444 %>S_LM_\G-^$?\
MM\_](YJ\8KU#X#^)-#\(?'#P_P")?$E]]ATJS^T^?<>6\FS?;2HORH"QRS*.
M!WH _4BBO&/^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QF@#V>BO&/
M^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\
ME,O/_C->ST <OHG_ "/WBS_MT_\ 11KJ*Y?1/^1^\6?]NG_HHUU% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !67JG_(2T/_ *_6_P#2>:M2LO5/^0EH?_7ZW_I/-0!J4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-2_Y!
M5Y_UQ?\ ]!-6ZJ:E_P @J\_ZXO\ ^@F@"KX;_P"14TC_ *\H?_0!6K65X;_Y
M%32/^O*'_P! %:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &5/_ ,C7I_\ UY7/_H<%?"W[:G_);=&_[%^'_P!*;BONF?\ Y&O3_P#K
MRN?_ $."OA;]M3_DMNC?]B_#_P"E-Q0!\RT444 %%%% !1110 4444 %%%%
M!1110 5^S%?C/7[,4 <OHG_(_>+/^W3_ -%&NHKE]$_Y'[Q9_P!NG_HHUU%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !67JG_(2T/\ Z_6_])YJU*R]4_Y"6A_]?K?^D\U &I1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M4U+_ )!5Y_UQ?_T$U;JIJ7_(*O/^N+_^@F@"KX;_ .14TC_KRA_] %:M97AO
M_D5-(_Z\H?\ T 5JT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 94_P#R->G_ /7E<_\ H<%?"W[:G_);=&_[%^'_ -*;BONF?_D:]/\
M^O*Y_P#0X*^%OVU/^2VZ-_V+\/\ Z4W% 'S+1110 4444 %??_\ PQ5\+?\
MH/\ BK_P*MO_ (Q7P!7[,4 ?,W_#%7PM_P"@_P"*O_ JV_\ C%'_  Q5\+?^
M@_XJ_P# JV_^,5],T4 ?,W_#%7PM_P"@_P"*O_ JV_\ C%'_  Q5\+?^@_XJ
M_P# JV_^,5],T4 ?,W_#%7PM_P"@_P"*O_ JV_\ C%'_  Q5\+?^@_XJ_P#
MJV_^,5],T4 ?,W_#%7PM_P"@_P"*O_ JV_\ C%?3-%% '+Z)_P C]XL_[=/_
M $4:ZBN7T3_D?O%G_;I_Z*-=10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5EZI_R$M#_P"OUO\ TGFK4K+U
M3_D):'_U^M_Z3S4 :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7/\ \11_PJ?XI?\ 1-/%7_@FN?\ XBOUDHH _)O_ (5/\4O^B:>*O_!-<_\
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MTW#8A4Y^?'7I@FM[_A(I_P#H6=9_[]1__%UO44 8/_"13_\ 0LZS_P!^H_\
MXNC_ (2*?_H6=9_[]1__ !=;U% &#_PD4_\ T+.L_P#?J/\ ^+H_X2*?_H6=
M9_[]1_\ Q=;U% &#_P )%/\ ]"SK/_?J/_XNC_A(I_\ H6=9_P"_4?\ \76]
M10!@_P#"13_]"SK/_?J/_P"+H_X2*?\ Z%G6?^_4?_Q=;U% &#_PD4__ $+.
ML_\ ?J/_ .+H_P"$BG_Z%G6?^_4?_P 76]10!@_\)%/_ -"SK/\ WZC_ /BZ
M/^$BG_Z%G6?^_4?_ ,76]10!@_\ "13_ /0LZS_WZC_^+H_X2*?_ *%G6?\
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M/_XNC_A(I_\ H6=9_P"_4?\ \76]10!@_P#"13_]"SK/_?J/_P"+H_X2*?\
MZ%G6?^_4?_Q=;U% &#_PD4__ $+.L_\ ?J/_ .+H_P"$BG_Z%G6?^_4?_P 7
M6]10!@_\)%/_ -"SK/\ WZC_ /BZ/^$BG_Z%G6?^_4?_ ,76]10!@_\ "13_
M /0LZS_WZC_^+H_X2*?_ *%G6?\ OU'_ /%UO44 8/\ PD4__0LZS_WZC_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO_PD48&0\-R3&O/8Q\2,.,!D.<5UO@V'QY8^"%L_%RZ1=Z[:(8X9+.[E,5R
MOR&5FB!1CT8A6'\0'.T<I+\,+7Q#X3UN;QAX)\(W7B[4/M&+M/WP8N"(C]H>
M 21[1M485L! 1R<"'H[KH4MK/T/8>M+7&?#VT\::;X-L=-\>3:;<ZS:KY+7.
MG2N\<Z* %=MZ(0_8@ CC.><#LZ8D%%%% PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN*.&7[%#\L3F08V#!R57G';''O74=JIZ,B-VKL6BBB@H**** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ltbr_ex102img1.jpg
<TEXT>
begin 644 ltbr_ex102img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M_@+;?_'Z /IFBOF;_AM7X6_] #Q5_P" MM_\?H_X;5^%O_0 \5?^ MM_\?H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(GBSPW:+>VVJ?\)1I]_X>_MMKRY@B":8Y=%!_<JF8<.QPV7_ '3?,><>Q?\
M"+^&O^$D_P"$F_X1_3?[=^[_ &E]CC^TXV[<>;C=]WY>O3BC3_#7A[1TO(=(
MT'3=.CO6+W2VMI'$)V/4N% W$Y/)SUH3V\A2U\CRWP;/&O[1&O6[^*$\033>
M&K*:.Z8PAY4,TK9 B"J5 =<$#[K+DDG)V?B%>7"W^C7.EV]AK<5CKEHMYID8
M/VL3-PKJZO@,BLLFQEY1220M=QH_A?PWX?=FT'P]INDDQB+-E:1P$H&+;?E
MXW,QQZDGO3T\.>'X?$4OB./0].3694\N345M4%RZX VF3&XC  QGL*%I8'K?
MS5C='2BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX]!N<@9/I2VT\[A>^OE8\#\,2S>#/VBM1L_$4;^(;37[<2Z'XKG0RM;Q'/\
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MV_8ET"Q@74)=:\](WL%FG=D(G=FS!DA<+@YVCJ#W&?2/BYJ5CJ'Q$^#M[8W
MN[:TU0W-U- "Z6\>8AND(X09#=<=#Z&H_P#AM+X6_P#0!\5?^ MM_P#'Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!XII-U-KG[4/C&/4;B7[-X:
MTBTM[&,L=D9G4R23 = _\.[K@8KAM"NO&7PUU?PKX%\;>';+Q+X/DU."+1_%
M-HH\R!GDS#Y@P<,6V@GC(8_,U>R2^!VM_BO_ ,)UIMTJ+J%A_9NJV4F0LZJ<
MQ3*1GYUY7!X(;J".=*+P-X;MQIJBTN9(M,=)+.&:^N)8H6080B-G*Y7^'CCM
MBEV_$._X'SK:Z'K7B;XW_'#PSHEGI<B:K#;6MS<:E,ZBU5XB/,CC6-O,<9)
M+)R!S6KKOA_4/!GQI^"GA[1#%KFH:;INH6T<FHW#6RW $!R6=4E*@ M@;6[#
MWKW#1?A]X3\/^*]3\4:5I\\.L:J1]LN'O9Y?/QTRKN5X[<<=J75/ /A;6O%E
MAXLU*SN9-:TU62TN8[^XB\A6&&"JD@7D'!XY[T;6\MP[^>QXKJGP[U#X5_ W
MQKXADU&WE\0?VC_PD-L;2(B'3IA*A\N(MR5(!5CA=RG!&*]K^W+XD^%/]I75
MJH75-'\^2!AE1YD&XK@]N<<U'XZ\-7/C#18_#,GDIHUY-&=2+LWF20HZN8D
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M%% 'E_B+XM6?AGX@V?@67PAXAU#5]0B>XLOL:VACND12SE2]PI! 5N&"DD<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)"^/XE8$>_!Z&NFI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*(@+.2.@4$GL*YSP[\3/!GB[3M8U#P[K#ZA'HQ(OHELYUG@(!./)9!(3\K8
M4Y((&2,4[V^6H?KH?.7Q>T?Q!??%WXBW=CX5\07UOJ/A>+3;2>VT>ZECFN/-
M@<HK+&1]U6YSC@C.>*ZG2])UG3O'O@/6-<\(ZIK/AK4O!\/AZ\A?2Y)38S+@
MN)X63<J,5 )88YST%>^^&_$FD>+-"M]?T&::?3[G)AFEM98#(/[P6558KZ'&
M#VK?H6C!NZ/F:'P#)'\</%4/B[PGJMSX7\56%H+ :=YP@MV@5 MM,;8@1;2.
M"Q"?+P:]C\->-UUWQ?XE\+R^']3TJZT.2/\ >WD8$=Y$Y8++&03E24;_ /7D
M!OBKXE^#_ ^IV-CXGU"[LIM0(6U":;=7"SL3@(K11LI?/\.=W(XY%+X;\4>#
M=4CUR^\-W;2W$4S3:G;FWG6\20*!\\#J)@=J@*NWD !123!_G8\FU*^N(?VO
M8?%C^&?$K:#9Z(^F27\.@WLL9G$CG"[8B67D8905/4$CFLKX\:IX@\??#1K+
M1O _B60IX@C^R1#1+H32V\467G=2F44O)A0P!.#QPV/4X?CK\,[O3;_4K75]
M3GL=.8I>7,6@Z@T5JPZB1A!A"/<BO1K6ZANK.&ZADWQ3()(VP1N4C(.#STIV
MT7E_G<.K\SC(_&EMXBUJT\.Z=H/B/[/>QRBZOKO1;NQAMT$;<;YHT^<MM  S
MWKS;X-VVN?"'0M1^'_BKP[J]P\-[+<:??Z78RW5O?1/@ ;XU(B;(/$I0#(YK
MW.ZU;3[+4-/L+NZ6*YU"5H;6-LYE=8VD8#Z*C'GT]Q4VJ:KIVAZ7<:IJ]Y#9
M6%LADFN)W"I&H[DFI3LW;J*VWD8^MP:AKG@?4[2.TDL+Z_L)HTAD=6>)WC(4
M$J2N02,X)&>A/6OFC5(=0UC]A72/#>D:'JVHZPSI:-96>GS3RPR0W1,@D5%.
MS 4_>QG(]:^A]*^)/@O6IK*.SU26,Z@P2R^U6-Q;"])[P&5%$PQR2FX <DXI
M=+\1>"6\;ZEI.FWJ_P!MW3$7.V*413R0J P60CRGE164,%)< *&^Z,5T:[V_
M ?5/L>.:3IVM+\;?#/B;PGX?UW3M&LM)\OQ)>ZG87,;7(6,E8HTG7SI&! XC
M7&<=<5SW@"UBTWXD>._%GB+PCXT@)\0OK&C+%X?U!OM:D3J1L$>T$K*,&3&-
MW;FO9;'X^?"74O%,'AFQ\6&;6)[H6<=N+"Z&Z8MMV[C%MZ]\X]\5Z1>7-O96
M<U[=S)!;01M++(YPJ(HR6)[  9HNUJ*R>AY/<:]XI\8>(](T:#1[CP\R6'V^
MYDUC0KF[LY))HB/LV]7B7>D;L&R^-QVA20<<A^SO-KOA$^(?A_K^BZ[#IUM?
MS7&DZE<:3=6]I)#SN :1?W0XW@,?XB,D]?;_  ]XLT#Q1:7%UHM\\J0,OFK/
M!);R1AE#*QCE56"LI!5L88<@FN'@^,GPA\<:9K6EV^M/K-E:6;W.H0)IMXP%
MNK .6 B^9>1D#.1G(QFCJ_0.BOW%^"-C=1Z;XQUQI=^GZ[XFO]0T_'1H#)L#
MCV8H2/48/>O7*\F@^.GPKM?"T6MVVK7<7A^)A;1WB:'?+;*1P$5A!MXQC Z<
M"NGT'XA>$_$>LOHNGZHZ:K'&)C87MK-9W!C."'$4Z([+R/F (J=?R0;?.[.T
MHKF&\9^&5\80^#_[:M6U^:-Y%L4;?(%49)8#.S_@6,]LU-KGB31_#*6,FN:@
MEFNH7D5A:[PS&:>1L(@"@G)/?H!DG %/MYC.AHKS7QA\9_AKX!\0#0?%GB86
M&I&)9_)%G<3?(Q(!S'&P'0\9S^==%>>-/"]CXATSP[=:Y;Q:QJ?_ !Z6)8F:
M0;2V=@Y48!Y; XI@=117EGB7X[?"OP;XDNO#_B7Q5]AU6VV^=!]AN9=FY0Z_
M,D;*?E8'@]Z]!L;Z'5-.MM1LV9[>XC6:)G1D)1AD$JP!'!Z$ T+570/0TJ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.#G]U\F,IR?E.1R>.:FA\(Z#;^,)O%,-B$UF:/R9+L2/N>,=$(W8*CC"XP"
M>M6WJF96M&WH>/?M5KJB_#+1?L_VC^R%UB#^U6CSCR=K >9C^#<1G/&=OM7M
M5]#H=YHUI'="UDT]I;=K?+ 1EPZM#L([[@FW'M5^\LK34;*?3[ZUCNK6X0QS
M03('21",%6!X(([5DZ3X/\/Z&MK'I>F+;169)MH?,=HK8D$'RD8E8\AB/E X
M)%2M+EOH?,NC_$#QI>:I:^,YM;U ZA-\01X:.C"=A:_8B@S'Y/W=ZDY\S&[/
M4FN;\7>*O%FC^*/B5>6/C3Q%$-#\4:;'90?VK.\4<<C3EXRC,04.T?*>. ,8
MKZZ7P'X/7Q"OB!/#MDFHBX:[$RQXQ.PPTVW[OF$<%\;O>LN]^$_P[U"XU"2]
M\+P7$FHSK=79>20_:)5SM=_FY(W-@GIDXH7^0V[GEND:5;W7[;?BN.:XO]L?
MAZ.5 E].@!8Q CY7'R_,2%^Z#R " :QOA/-KVK?"J_\ &^L_%'7=+'AZYU2
MS74SWD)0QJ$DF1R3*8B=RKGJ,#J<_0H\)>'!XG_X29=)B&M?9OLAO@6$S1?W
M2V<GZGGWJIIO@'P?I'AW4/#>GZ%;PZ/J!9KJR^9HIBPPQ()/)&,^N!3O9678
MGKKWO^!\[_#_ .(7B>T\8>,6M=<U/7+"'P8=<M$U&XDE,\\8 698G9O($N2_
ME*Q #+T^ZMZWL]6U;]F76/'TWQ U_5)-3\.S2SVLMZPC6\1V9I(RI!C"[2AC
M7"$#D')KW[2_A_X-T.ZBNM)\.6=G/%9_V>LD2X)M\Y\IO[RY['-)I?@?PCHN
ME3Z1IOAVRM]-N!(DEH(]T163'F*$.0%; R  #@9Z4OLM=64G:5^B,CX/Z7;Z
M;\&?"GV>6[D-UI5I<2?:;R:?:S0)D)YC-Y:^B+A1V KR+QQX7USX>ZU#\;OA
MO9R74[22IXCTN(CR[NV#MNFV]=PVC)&><-C[V?H33O#^EZ/HHT72[/[%8+'Y
M:QP.R%5"A0 P.X84 #!X  &,"ETOP_I.CZ.-'T^S$>G#<!;L[2* WWA\Q/!R
M>.G)]:6[N):*S/$9=:U;5O%GPG^'PNKW3/#^IZ!]ON+FPNI+6:XD2V.V(2QL
M&4+\KD \Y&>.#TGP5^(4WB;X;:%-XLU2UBUF[FN+2S,TJQRZFL+8\Q$)!<X'
MS;0>03Q7H5UX4\.W]EI]C<:5&8=/7;9E,QM;+LV81E(904^4X/(X-0CP-X0^
MUZ+=KX?LEFT%#'IK+$%^QJ1@A,=.E5U?F)W:7D>.?M-?\A7X5?\ 8T0_^A+4
M-X)7_;XT\Z7DI'X</]I^7T Q)MW_ (F'K[5[3XA\$>%_%ES:7GB+25U&6Q8/
M;&21P('SG>@# *W3YASP.>*LZ7X7T/1S?2:=IR6]SJ!W7=RK,9[@XP"\I.]B
M!T)/';%"T_'\1[GSA\ X?$$NK>+A8&S.AGQ==#5HID/F&+R9,8.=I7?LR".G
M>OHRQ\0:3-#9IIHN)K::.,V\MM93- R, 4*R*FS;@CG. *Q[7X5^ K/3K[3[
M70!;V>HL6O+>*YF2.Z)ZF10^'S[YKJ+?3[*UTB#2K.U%O900K;Q11Y4)&%VA
M1CD8'%+8;U=SYM_: :YGA_X61X>N-0DU+P?J,(LFC@E:U$2$BX8N!L),C!&R
M>D..YS+\9M:?7=5^"^O,[-X*O]2@NM0=CFV!=H6B$W;&-^-WHU>[0>"?"]MX
M1?PG;Z2(=#GW[[)9I A#G+K][.UB22O0Y.1R:99> _".G^%)O"=MX?M!H4V=
M^G2J98#DY^XQ('(SQWYZT+\G<6[OY6+FL6^EW$-FEVMNURLWF:>)& ;[0J,R
M^7SUVAC@=L]LU\K?#>'6/^%;?!V&V64:JGC.Y^U@Y\P*!-Y^[//W-V:^J]+\
M,Z)HYA_L^Q\O[-&88-\KR^1&<92/>3L7Y5X7 X'I3;?POX=M=<;6;728([\O
M)()57[KR8$CJO16;:-S  MCDFC9ATLSA[[PCI5Q\6?#5II>E65A8^&[=]6N#
M;VZJTDKAH;="0,XP)W[\H*SOCQJ5UJ?P$\6PZ';WXF2"-IO,LYX/W E3S<%U
M7/R;L@=LUZY'96L.H7-]'"JW-RJ+++W<)G:/H-Q_,TMW:V]U:36EU"DUO.AC
MDBD4,KJ1@J0>H(XQ2:NK#B[.Y\V:_8MJ7[0'CRTN/$)\-Z!<>$;:WO=6:18X
M[<O*@3+,0H9E\Q1D]SBM+PIX?\5?#[6O$'@G4-0B\2:+=>'Y=0L]9^S+%<0[
M?D\F5AG>#G())S@GUQ[&W@?PG)H=[H=QH=M<V%^$6YAN%,HF" ! Q8DD*%4*
M,_+@8Q4L/A/0;?09= AL-NFRPBU>'S7),(R!%NW;@@!("@XP2,<FF]4TNJL3
MM:_>Y\D7'_*.6T_Z^_\ W(-7HGQ@CNIOB1\%X?#0W>)%NQ)B'_6"T C\POCG
MR\!\YXQN]Z]=;X3_  ^;PX/#1\-Q'11)YPTXS2_9P^2=PCW;0<DGI6OIO@WP
MSI>L?VM9Z1$NIB$6PO92TLZQ#I&)')8)Q]T'%&WWW_"P6_7\3R36+>"#]MGP
MIY,$<7F>&YW;8H7<QDER3CJ?>N*^.&M_;?B7\/[J\36(VL/%44$=M)I-U%"D
M4<P!>-VC"W#R8#?NRWRA0!U+?13^"/#,WBZ#Q9-I?F:Y "L5\\\IDC4DDHI+
M<)\S?*/EY/'-7-:\,^'_ !%<:;/K6E07\FF7"W=FTH),$HY#K[\"JOMY E:Y
MX#\3O"^N>']9\1_%[PKXLM?$DEC<HNH>'+N".>W55"(8Q\Q*2*I0XP&/X@'1
M^(T<?_#4_P ';G[*+>>X2\>4!0&)\H<,>^.E>Q6_@?PK;Z]>:];Z#:Q:A?2+
M-<NJD">12&5W7.UF! (8C(//6G:IX)\,ZUX@M?$>J:5]IU:R_P"/6Y,T@>W_
M .N>&&S/?&,]Z2Z>0][^9R/Q*T'1YK*RT'3_  ]83:MXJU)+2:Z-NC2K#@O<
M3%B,_+$C*.>,J!V%>J *JA5& . !VJK)8V<VH6]]+ C75LKI#(1R@?&['UVC
M\JNT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!S'C'5KKP_P""=:URSMOM-S864MQ''QAF
M5"03EAP,9/.<9QS7E?@?XG:A:Z5X2N/%^J:CK6L>,[6*33=*ALK:-HV2/=-(
MLBLJ^6VY<!R&&WOFO4?&VG:MK/@;7-&T.*TDOM0M)+6/[9.T,2^8I0L65'/
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MD\/Z?K,,+%XX[^UCN%C8C&0'!P<>E;U% &)'X?T&&XL+B'0[".;3E9+.1;9
MUJK##",XR@(Z@8S6W110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 )17S#\2/B'JGA;XX^$
MO%D>M0-H$-]+X?NM,CE4N%?;YD[C.1\Z\ @?Z@<_,:[#XS?"V'QY?Z5+HLT.
MD>*[>.2YLM85-DJO$T916D7YMOS-CKM)R!V*VBFQI7=CVVBOF_X<:IX;^+NO
M./&_@>Q?Q?X?T^33=674+2.5G<,@$@W+P&_>8!'RY8#@Y/FGP_\ #&CC]D7Q
M#XPLH8],\3:3<75Q::S:#R;J,QLK*GF+ABIQC:21STS03O\ ?8^VEIW>N%^%
M/B#4?%7PE\->(M7C,=_>6://E=N]QE2^.P;&[\:[KO3:M<2%HHHH*"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\Z<*8H<]M[+GCUH [.BJUO<0W5K#=0R"2&91)&XZ,I&0?RJS0 4444 %%%%
M!165#J=E<ZK?:7%<9O;,(TT)4JRJXRK#(^93@C(R,JPZ@@:M !1110 4444
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MGEW,0&=VT#=PN1G XSGU-)+X#\)S6NG6IT.W:'3+9K.U&6!B@9=K0YSDQD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]#)F'4(GC$J1A""ER,L<Q+E\$8ZBGT3[;B5FV>L0^))+KP"OBJUTV6,R:?\
M;TL[IO*=?W>_RW(#;6['@X/K5;P1XRM?&GA'2-8C$-G=W]G'>/8BX$KP!QD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2Q RS'DGD^F -JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME>5_#7Q]'K'@_P -?\)1J1;7]7>Z6)FMVBCN&CED^5&"A,A%Z9S@'KS72_\
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M'H[&QVHKR_Q9\3M/L/AYKVO^';AKN]TV8631O:S;K:=F5<2QE0RX#AOFP#P
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MG&% X'(?%SP;XT\5?\)?IND^'Y[R.[33Y=.E@N[>WAD,,JM*DH+J[R]=N\%
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M^ZQ%:5)5+16 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY;K#L2=5DWM&\T>><@ 8KT'2/"/B34/%OC>^\2:7I]KHGBZSAMFBMM0DDNH
MD)C*LODA,D.Q)#G:1@;LYHZ-]>@:778OK\6M"CEF-]'Y=HNEOJR7-K,MP@C7
M[T4A7 CFP00N2#SACBJ.I?&"+38-7F;PK>7_ /9EBFHLVG7=O/'Y))#[GWA0
MZ$#<@W'D%=PYJOIO@/XA:IX&UCP-\0/$6CRZ*]BVG6$^DV\@NI$QM26<N=H9
M0%.U!@G.6P.:MYX8^-&K?#77_"VO:GX5U*ZN[8Z?:3Q?:+;=&PPT\YV/^\QC
M"(H7D_-T%-[: M]3H[KXC2V_BG5?"T?AZ=M7T_2QK"QO<QJDEN2PP6&=LFY<
M;<%>1\V.0S5?BIIMGH$.L6EI]J5M)BUEK0W,<=P\,@)1(HSDR2$*WR\#C&<D
M5@7G@OXC7'Q1U7QM#IWAL"^\-KHHM6U:X^23?O+[OLO*@E@.,D 'C.!'IW@C
MXL>'XO#EYX9U+PS9WL>E6NCZS;7OGW5O(EMN$4\)58WW[7?*':.0,G&:6H&R
MOQ<BGO=;AM/#-\8](T>/76ENI8X?/MG0L-J@LP?"L-KA>5.=O&;.G^.-1U3X
MS1>%[*UMSHIT&/5Q.92))/-DVH=NSC&TC&>C9SQBN?U;P'X^NO%WC;5H5T&Y
MBUSP^FBP/->S0OO4,#-(JP,%!\QSM4M]T#/)(GT'P3XUT'Q/I_BIVT836_A9
M-#N+=)IYP)H'9HG3$2EU;(W# *\@;NM-=V*5]H^1[-BO'/'WC?7/#_C+1+W2
M][^'-*U&&RU_ &T_:E*H<]O)_=NWKYJ^]>@Z;<>))?"-O<7]G9#Q#]D#26ZS
M.ELT^WH'*LZH6[E20#T)%>?WWPKA\0>!=7/B;P5X0N?&NH1SAKV-=R^8Y.QQ
M<-!YJ;01CY6(V@ ]Z3T8U9KU.IU?QQ)IOQ$TOP3!H-Q<7>I6LMU;W;SQQVY$
M>-ZG!9P1E?X/XAC/..?L_C+8:IKGAG0],T&\DOM?-Y"OG31QI:7%KD3PR$$L
M"I Y"D$,",]*XJ?_ (679_%CX:PZW#X?U+Q5!I>IQR&*]FBMKI!Y(WE_)+1O
MW(","1VS\N=K7A?4_!OQC^$MGHPLK_7+J;7-1NOM4S003W$T:O+AE1F1>2%^
M5C@#(/-5"SW\P=UL>MV_Q(L;C3;63[/%9ZC-/=6TME?WL< MY+=]DH9SG/S%
M-NT'(=3@#)&5H_Q@CUS5/#>GV/A'58)/$-O<36[W[1P)$\!(D1P&9^/E.X*0
M0P(SSBCJ'P]\=:?8Z;KW@S5M'M?%\=U>7-\E]'(UC="Z='EB^4;P%,405@,D
M)SC)JW>>%_B)=_$'PAXFNO[ OSHEG=QW3+<36GFRSJ!MCC\J3:B;%&6<ELDX
M&,%=OQ!=;FC9?$JPU[3] 32=/NKG4M?2X:*T\P1_9U@)69I)!]U0^%!&22RX
MQR1R'A_QPNF^'/!<.L6.O7L^K>)=0T^WFEU)@UJZW4ZQQW!$FZ4!!C:0Z_)G
MJ%R>$?A?X^\+Q>'=6CET$ZUH[7MK+:_:YFM[RSN9O./[SR0T4B/TPC!@.2,\
M,NOAG\2)'\-*UUX;O8]'\47&O']Y<6I,<DLC^7]R3<Q,SG^$+M ^?):GIS)]
M"=6FON.YTGQY=:MJEUH<N@K9:W::D;*>QEO5+K!Y7F?:AA<F(@@*<<DX.#D5
MZ"S!5+$@ =2>U>.R>#_B$/$6E>.H;/P\/&*S2VVHXU*Y6UFTXG*6Z_N"=P.U
MMQ PP8_,&VCMO&UGX@U7PK-I/AVSTZZ>](@NEO[R2V7[.W$@5DBD.YERH.!C
M=NYQ@SV*Z^1R7@_Q'XAF^+&KVFK7WVK0?$%BNJ>'QM"K%%$_E2(O]XLK12_1
MZ];KQ7Q9\*[JUU'PIK_PK\->%/#FN:5>?:+J3;]F2:$QE'@S% 3(K;C\S;=N
M 0,GCT/1;OQ--KVLPZQ8V,.GQ-#]AEMY)"[9C!E1]ZC.U^C+P0P& 0::6F^P
MF]?4Y_7/B!I_AWQAK]MJ.EZG'_9&A'5FN/.4PW$*N01''OP&W9!9@IXZ[<&N
MET'6YM:65I-/\F-$C>.YBG6>WN0X)S%(OW@,8.0.?48)Y'4O#7C:3XP77BC3
MX=#CTV31O[*CDN;F624'S#+YC0B(*1N.W;Y@XYW?PU-\-O 5YX-U#Q'>216&
MF6>KW$<T.C:9(\EI:,JD/(A=5VF0D$JJA5V@#/6FK6%K=G+ZAXTU+PK\4OB9
M?R17^JZ/I&D6%^UH;S]W ,2F0QJY(#, #@  [>2.,];X@^*&CZ+;W$T,27PM
M+>&ZN+>.X476R7D+%#UD<+\Q7*\$8))Q7(>+OA[X_P!6\0_$2XTN#P^UEXKT
MJ'2[=[G4)TD@\M64NZK;L.1(QP&_A'//&E;^#/B=HFO6>J>%=3\.V<>J6MK#
MKT%\LUR(I88Q&);4J$W$H -K[1E0>YI-W:[%66IHZ;\6(M3U3Q'&OAV^@T[P
M[,R7U]/-"@1! 9ED"[LD, !CJ-ZY YQP_P 7OB9-+\-_%VFZ7-?:7K%A8V^H
M6VH:7>EXMK7"1LGGQ$8D&[#)Z$$$]:ZC1OAOX@DO?B7:>(I+"/3?%SLT,]E=
M/)/#^Z$0+HT**#@!^&(SQ@CFJ^H>!?B?XX^&.O\ @_XA>)-!62\B6&TN-)LY
M,L5D5Q+-O8#)V8VH !DG)XP/R[+[^H1T:OW.CG^(-UIL.J6=UX?GEU?3M)35
MX+6*X#M?V_(?8<?ZQ2,%2.K+@D'-;&A^+O[>C\.7%A9Q/;ZSIYU%I%N-WD)\
MF!]WYB3(!V^ZWI6-I>F7.DZM+X\\?76CZ5<66G+IJ/;W;&V@@WAWD>658^7<
M+QC"A0,MDFH_ACH-G8VFJ:YIVH"]T^_N9$TMD(,<5DLTCHJ$<%2\DK!N<J4[
M 4V&QNZWXG@C\00>$;&TDU#6+NTDO&MTG\CRK=2%+F0<J2S!5QU.>0 2//?
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M*>N02>.E8/Q4A^($/PJT=O&VH:!+K;>(].6&+2H94M8R)N"S2$NQ/!. H &
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MWQ/\.>.KS^R]<\/W'A#4[QM0NH;JVF^UVTLGS3+!M.TJS[F!<G&<8..6>!O
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M$4'S -HW@9X4@^E<[XJM]%U'7?C=)_97VFVU+1;*;3YGLF:&>Y2)QF)BNWS
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MTI@G<UZ7O7@7A>3Q]KWQ)\?^'?\ A96K^5X:N+-+(RV-@1,)(O,<3;;8$\\
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M$ZQX=\8>)/#]CX>C\$_V9J6E^([37;P_VI%=)<J9'DD?S=L?[TD'Y-H !7!
MQ78WUA\3-!^)VJZKX5TK2=9T'7(H9)H;Z^:UDL[E$$>_*QON0HJ9 !)(ZC'/
MIMK:6MC +>SM8K:)>B0H$4?@*M>M5ML'J>/Z!X=^(7@WQOKMII5CINJ^'/$.
MI_VH]]-=F*;3I) HG'E;")1E<H 5Z\GK7/:WX#\::AX9\0Z;#H6);_Q=%KD!
M:YAV_9EDB8@_-P^(SQTY'/7'T!WS2]ZE;">KN>'>*/ OC;7-9\9WVC6\>F7E
MU=:9J6CW-W*C1F:TQE)50E@K<XQGWQT.OK=K\1/%'@N&WUCPK966HKJ-A<"V
MLM16==D%S'-([.ZI@L$(51NQW;GCUJBFW?\  +'SWJWPU\7:IXK^(FK1:?%%
M#KFHZ+?V*RW";G6S9#(K8)VLP!V]O4BO0?BAH.N>+/@]KGA_3;.-M5U*U$*Q
M><!&C$@G+MC(&#SC/M7H5+4]_,J[3N>1:UX&U34M4T+7+72VT_Q%I=O:06VJ
MV]WM\J,,#<0W$8;$J8W;0 V2Q^[U.E\6O#FM>)O!UEINBV?VJY74[2Z<-*L8
M6.*99&Y8CDA< >I[5Z92=Z5OSN(\.\2^"_'>IZQXLU3P]:P6&H2:EI^JZ/-?
M3*897MHUC>.54)90PW8QU[[:N:YIWQ$\4S>#K[5O"MG83:3KD6HS6]GJ*W&(
MDC=6.YUC^9C(,* 0 O+9.*]C-.JGK9,2TV/)$T/XB>%_B9XBU+PUI^E:SH'B
M66*Z<7=ZUM+IUPL:Q.^!&WF(513M&#D8R.IA\1>#_%E]-\1=*TVUM/LWC'R5
MBOY9_EM4^S1V\V^/&XL%1F7;D$D E>37L% -&^X]G='DGB;PW-#\2/ =GHMZ
MJQO;O8:E:R#<9["#9*K^VV543/\ TW(KIOB1X:O/%G@"]TG39DAOA)#=VWF$
MB-Y895E17QSM8H 3VSGM706FAZ-I^H7NI:?I-E:7U\0UU<P0(DEP1T+L!EC]
M<UK4/568+1W1\]^,OACXW\>>-->U:.SM=#M]0T&VL[>6>[#207<%S]H0E45@
MR%U )R#M.<9^6MWQ-IGQ,\;_  =\0Z!KGAW3M/UB[@BMH([341,DKA@TDK%E
M7RUX&%!8^M>ST=ZKF%;6YXY'H/Q$\._$K6?$GAC2-/U32_%$-L]U:W]]]GET
MVYBC$6\%4<2)L RH.21U'=_B[P+XGU[3?&FG:3+#9W5_J=IK&EWLLGR":"*V
M"HZ@$C+V[9.,88$9Y%>OTM3KOU!*QY-J6F_$;Q5X:TZ^UKP_INE:WHNIVFH6
MUE;ZD9H[PQDB4,_ECRPRNVT?-@@9-/\ !?AGQ1IWQA\>>*M3TV"TTKQ$MDUL
M#=!YT:"+859%!7G).0W&,<YR/5LTE-:7MU'NK'BOB#P;XIO-6^*LUKHYDB\4
M:1!I]A(9XAF1(I(R7!;*KF0$=3@'C. =#P_X7\1V?Q,\.ZU=:4T5C8>%QH]P
MYFC)6?>CY #$E?D(SUR1QCFO7*3BB^HFKJQYYK&CZS??%*TU6'3'_LV+1KS3
M7N3)& ))GA=3MW;BH\H@\9R1@$<UQ-K\.=:N/A=X3\-Z]X=!O_#]FT=MJ&F:
MEY%Y:72@*DD4HQB-ANW G/"_*QX'O-%):*P^MSA/$WAG6_$7PFN?#4FI1#7Y
MK!$^V'B,W2!6#G R%,B@G Z'I7*ZY:_%3Q5\)=>\.^(O#.E6NJW5G]CC:PU#
MS$N)3]Z4AU7RDXX7<['=VQS[-3:'K=/J"TL^QX#XZ^&_B[Q=XL\9WUGIT=K;
M:WX7BTJV:XN$RMPDOFX8*3A>=N1GD>G-:GB3POXOU+Q;/J\.@_NI?"5UH@5;
MN([9Y&#(3DCY< !CV)XW 9/M.:=1?2P'AP\"^/-.^&/P['AZ.SB\4^#?+\RS
MO9OW%VGDM#*@=,XW Y4GIWQ75W%GXRU:;PKKVIZ'9VFH:;J$T\VGPW_FK'&]
MK+"O[THNX[W4G"\ G&XCGT:EIO7<25CRRS\(K'\;-0U*UNECTL1PZK<6:=6U
M%TDMQ(?;R5.1_>PU:OCG3?$VJ-HUGHI9M*-Y_P 3BWBN/L\T]L48!4DZ@;]I
M;!4D9&>2*Z;2=#T70;9[;0])L],MW<R-%9VZ0HSGJQ"@ D^M:PZTDK)+L/4\
M#\$> /%GA>'P5I]QH4 M]!UG4;R5[2ZC9!#<+.D80-M/'FKD8' /?BJ?A?X8
M^,M$\0:1XHDL8OM.E>(M5OFL3<(3/9WH RC [1*FT':Q //S5]%44UIL#U/.
MO .B^)-%N/%/]N:?:6UOJ.KSZC:M#=F:1ED/W778 I 5>C-G)Z8YY";X<^(-
M<^'GCKP[,AT:_P!8UJ36-.N))$=%;?')$'V%B/FB&[@X!X)KW*BIZI]4"T5O
M.YX;XWO_ !]=?""]E\6>'=,TV_BO]*2&&TU SI<R"^AW.3Y8\M2<8'SD<YSQ
M5CQ5X+\5>)!X[UC^S(XKO6]#CT+3;/[0A9%'F,\LS9V@%Y, *6.%SU.!ZGJV
MAZ+KUI';ZUI%GJ<".'6.[@2958'((# C.0.:O10QPQ)##&L:(H5508"@= !V
M%-V=TP5T[H\*^*'@#QUX\TC6;5;,R K92:/#/?B.*U*.K7 D125:4E3M<[@%
M8@%>0>DTG0_'GA'X@:_+H>CZ?JF@^);Q-2FFN;XQ2Z9.8PDHV[#YR?(I4 KW
M&1UKUJEIW!*QY5H>G_$[0_%6JZ+'INCWGA6[U"6]M=1>\>.XM8II3+-&8@A\
MQMSOMY4#C)/2N6T[X>^.-!^'OA?P;I]C8ZA)X8UY;Z&[FO?(BNK97D=<D([+
M)^\PPV$<9!.:]^I*%IL)JZ:[G+^.-'U+7O VIZ?I#1IJH1;BQ,A^1;F)UEAW
M'T\Q%S[5PWAWX7W>F_$BS\:WDT7FW=F+K5K>$_(VJ*'59$S_  ;+B=1_NI7L
M5%+9W0^ECP^;P7XIN-+UC;I CGD\96_B""&2XCS+;HT)9<AB ^(VX/'(YZXJ
M:_X'\8ZI:?%%(=%"S>*9K)K%3=1;1Y4:*^\YX&4)'!)!' Y ]ZI::]VUN@K;
M^9Q_C#2]0\2_#36M(M;<6]_J%A)%'%,XPLC)PK,N1UXR,UQ5UX9\63?'";QS
M_8/_ !+G\,R:0L2W$1D\XSF1<@L!C;@'G@Y R.3[+2=ZFR=_,I-I61XAI.@_
M%+PF/"M]H>AZ7J"Q:#::+J^G7M_Y!5[?=Y<T4JJXVYD?.021C@'IZ5K%OJU[
MX"O[.2VCN=5N+%X6BMG C,KH5(5GQ\H)ZGG Z9XKIZ*IZJPEH>)>'_ _B+1Y
MOA_XD_LUCJ?A_1_[!U*P\^,^;"47]["V=N1(@X8KE2>F!FL/ACKFDZ?HOV*Q
M^V74OC)_%6IA)D"0JQ?]TFXC<P5D'H2K'(R!7N6ZC=2>HEI^1X)<_#/Q5J46
MM7D=JEEJ=OXQ3Q5I:SS(8KA554,,FTMM8J'YP0"5YZXZZ;X<V_B35/&NI>(+
M62W3Q-8PZ6+5I%9HH8T;YSM)4.7=B,$X"J>I('J%%-NZL-:;'B6D_#7Q=9>,
M?"_B2ZU"VDN+N''BHACB5XMDEL(AZ(\83_=R>I-8?B+X>^-+S6?BQ):Z2LL?
MBR33?L#?:(E %N ',F6RH..,9/(SBOHFBGN"T/!/&6CZU8Z]\1/%%YI-H-.U
MS0K72[--1E1DDN=S(L<BJQ.&>55&._H.:VO!TGC#1=9EAUOP&\.HW6GB"TN3
MKJ7@=;96,<+XA3RES(?WF')9_F)XKU6^L;/4;*2SOK2&\MY1M>&>,2(X]U/!
MIMCI.EZ9&8]-TZULE;J+>%8P?^^0*0#-/EO+C3K6;4K%+2\>-6FMXY?-6%R/
MF4/@;@#D9P,^E:5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M==1U&;4MUOI[6ICDF8M(O,TF5SC'0CN34+FZCT%NO%^K:AJ>O6?A'3[?5)-
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MZ8;LKKS)5W9LVX_$GC+4/']A:PPVUAO\,G4FTF]5TVW+2*#')*I.-I&-P1L
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M/F+C'GOE>^%Y&"#S>F_"77K&U\+Z;>>+-/OM)T/29]%FMO['='O;>;8),O\
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MHX++PY*DXS1V%KJ=7XH^)=FJ>&=4\(^*-)NM,EUJVT_582GF3PK*3PWS@P.
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M[N@)I$^)'A^?XA:=X+M([VZNKW3O[2BNH;662W,1*A#YBJ1M;)^<D*" "=Q
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M+*KGC>0%R",\&O-?#NB>+)/&?@_Q!JWA.[TV6UO]22[TZQ6.*QL5=)%C9$#
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ME<5R,=HUKXX\*75CX1O-#TRTT3487M(+'Y+-II('CC(A!3<1&Y(0D!N,\C/
M?"#PGXP\(GP#JVO:3J"6MEH]_H]W:>4SR6$SW9G278,EE= JY4'&!GC.'N@/
M0O _Q*AN/A+IGBCQEJ4;W=U-=Q@Z?9R2&=8II%W1PQAW*A$!) .!R3WK;\0>
M/M%L?!2:QI.L(\FIV<ESIUQ'9S7D> H/FR+$,K$I9=S,55<@$BO&O#^A^-/#
M</AC5]1^%][K.G6)U.QOM,=;:2:-)[H3Q7$"&0ANR$':>#VP:[6TT35-%\3:
MOJEOX/GL]%UKPZMG8Z;;0QG^SID>4_9VCB)1/,\T,6!V!@P)Z$GIU_ %Y_\
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M;XI>"?L5M?2:K<Q6]SJAT5&ETZZ0K>9 \EP8P8SDXRP Z\\&O*?#NB^(-/\
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M(YTMJ3MOV/7**.U%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <VOA?18]4N]3ABNK>YO91-<>1>SQ)*X4+N9%<*3M51G'.!6U#
M%';PI#"BQQHH5448"@<  >E6J* "BBB@ HHHH **** "BBB@")EW(5.>1CK@
M_F*QM%\/Z;X?MYH--CF'GOYDTUQ<27,TK;0H+R2LSL0  ,DX  K>HH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHK,74].DTMM4CU""2Q6-I3<I(&CV#.6W#C P>?:@#
M3H[5PVG_ !.\"ZQ#HCZ=XDM[@:]/+;Z:H5PUR\1(DVJ5SM!4_,1MZ<\C/<T
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MJTVZ=M=$(U$_VE= W7E+MCW$2=AQ[]\TMXM/J"T:\CE--_Y.^U[_ +%2U_\
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MT/$O!=]XFL/A[\,O"OAN^\S5]=TF6[CO;N:WM7M(8EB)MX7^QS @EMQ#QNV
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ.ZL'#[ H$;9)8;20#C(JEH/Q8\/>)K:>\TG3=6EM+?4UTBXG\A-L%R65=K
M/NVY=<L 5YZU5M2;Z7/2:2O-M'^*VD^(-0\0Z?HNB:S>W?AZ7R-2A2",/"_S
M#: 9 9#\C8V;LX]Q1K'Q@\+Z%9>&;R^L]5$/B<HFFE;89DD?&(V4L"C?,/O
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M 'H%%<\WB*%?&2>%S87IN7M3>"X\H>1Y8(4_/GKN(&W&><].:Z&EY@%%%%,
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M]O\ _$4UI)ONK">L4GWN:%EXJ\/ZAXINO#5KJUL^MV<"3W%AO'G0HP!!9?\
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M9D<*!XEB8DG& 'CR:]>F^'?P]N9XKBY\!>'IIH42..1]+@9HT0 (JDID!0
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M<W/_ ,77Z8?%;_DB'CS_ +%^_P#_ $F>OR;H&=I_PMCXI?\ 12_%7_@YN?\
MXNC_ (6Q\4O^BE^*O_!S<_\ Q=<710!VG_"V/BE_T4OQ5_X.;G_XNC_A;'Q2
M_P"BE^*O_!S<_P#Q=<710!VG_"V/BE_T4OQ5_P"#FY_^+H_X6Q\4O^BE^*O_
M  <W/_Q=<710!VG_  MCXI?]%+\5?^#FY_\ BZ/^%L?%+_HI?BK_ ,'-S_\
M%UQ=% ':?\+8^*7_ $4OQ5_X.;G_ .+H_P"%L?%+_HI?BK_P<W/_ ,77%T4
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MS_H4[O\ []/_ /$T?\,Z_%S_ *%.[_[]/_\ $U^G]% 'Y@?\,Z_%S_H4[O\
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M;K_Y=UG_ /$T?\+#^.W_ $;K_P"7=9__ !->S44 >,_\+#^.W_1NO_EW6?\
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M/^%A_';_ *-U_P#+NL__ (FO9J* /&?^%A_';_HW7_R[K/\ ^)H_X6'\=O\
MHW7_ ,NZS_\ B:]FHH \9_X6'\=O^C=?_+NL_P#XFC_A8?QV_P"C=?\ R[K/
M_P")KV:B@#QG_A8?QV_Z-U_\NZS_ /B:/^%A_';_ *-U_P#+NL__ (FO9J*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%>8T4 >G?\+^^,G_ $4+5?\ OM?\*/\ A?WQD_Z*%JO_ 'VO^%>8T4 >G?\
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M .BUH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"DH#MSCKQ@XKN_AGJ6BV?PR\%V/]K0+<7FF6_DPS7F^25Q C.J!F). 0=HZ
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M_0_^*O\ PW&J_P"%'_#,?AW_ *'_ ,5?^&XU7_"OO^B@#X _X9C\._\ 0_\
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M*_\  */_ .)K;HH Q/\ A$_"O_0LZ5_X!1__ !-'_")^%?\ H6=*_P# */\
M^)K;HH Q/^$3\*_]"SI7_@%'_P#$T?\ ")^%?^A9TK_P"C_^)K;HH Q/^$3\
M*_\ 0LZ5_P" 4?\ \31_PB?A7_H6=*_\ H__ (FMNB@#$_X1/PK_ -"SI7_@
M%'_\31_PB?A7_H6=*_\  */_ .)K;HH Q/\ A$_"O_0LZ5_X!1__ !-'_")^
M%?\ H6=*_P# */\ ^)K;HH Q/^$3\*_]"SI7_@%'_P#$T?\ ")^%?^A9TK_P
M"C_^)K;HH Q/^$3\*_\ 0LZ5_P" 4?\ \31_PB?A7_H6=*_\ H__ (FMNB@#
M$_X1/PK_ -"SI7_@%'_\31_PB?A7_H6=*_\  */_ .)K;HH Q/\ A$_"O_0L
MZ5_X!1__ !-'_")^%?\ H6=*_P# */\ ^)K;HH Q/^$3\*_]"SI7_@%'_P#$
MT?\ ")^%?^A9TK_P"C_^)K;HH Q/^$3\*_\ 0LZ5_P" 4?\ \31_PB?A7_H6
M=*_\ H__ (FMNB@#$_X1/PK_ -"SI7_@%'_\31_PB?A7_H6=*_\  */_ .)K
M;HH Q/\ A$_"O_0LZ5_X!1__ !-'_")^%?\ H6=*_P# */\ ^)K;HH Q/^$3
M\*_]"SI7_@%'_P#$T?\ ")^%?^A9TK_P"C_^)K;HH Q/^$3\*_\ 0LZ5_P"
M4?\ \31_PB?A7_H6=*_\ H__ (FMNB@#$_X1/PK_ -"SI7_@%'_\31_PB?A7
M_H6=*_\  */_ .)K;HH Q/\ A$_"O_0LZ5_X!1__ !-'_")^%?\ H6=*_P#
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M=&S*BEF8!0,DG@ 4 2451L;NUU#3[>_L;A+FUN8UEAEC;<LB,,A@>X(.:O4
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M2% #RO!PQ# 'IUKZ!JFK!>XM%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,-L>/\ _H5?#_Y3?_'*3_AMCQ__ -"KX?\ RF_^.4-7"Y[EJ>A_%KPI\/\
MP?X)\(Z3/J*QJTFOZEIMW;0R?,Q=X8#.ZE2S.W[S&5&".>G0:?:>.%^'T^C>
M"_!L?PXO-.FBELH+VXMKJ&]7S"TT;&(R%=PSER-V6SGJ:^;O^&V/'W_0J^'_
M ,IO_CE'_#:_C[_H5?#_ .4W_P <IK03UW/I"/0?%WCCXF^&/%WB3PW_ ,(I
M9^%?M31V\UY%=37LLT8CRIB)"(H&>3DG'R]Z]A%?!W_#;'C[_H5/#_Y3?_'*
M/^&V/'W_ $*GA_\ *;_XY0!]XT5\'?\ #;'C[_H5?#_Y3?\ QRC_ (;8\??]
M"KX?_*;_ ..4 ?>-%?!W_#;'C[_H5?#_ .4W_P <H_X;8\??]"KX?_*;_P".
M4 ?>-%?!W_#;'C[_ *%7P_\ E-_\<H_X;8\??]"KX?\ RF_^.4 ?>-%?!W_#
M;'C[_H5?#_Y3?_'*/^&V/'W_ $*OA_\ *;_XY0!]XT5\'?\ #;'C[_H5?#_Y
M3?\ QRC_ (;8\??]"KX?_*;_ ..4 ?>-%?!W_#;'C[_H5?#_ .4W_P <H_X;
M8\??]"KX?_*;_P".4 ?>-%?!W_#;'C[_ *%7P_\ E-_\<H_X;8\??]"KX?\
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M45\ _P##:GQ2_P"@!X5_\!;G_P"/T?\ #:GQ2_Z 'A7_ ,!;G_X_2&??U%?
M/_#:GQ2_Z 'A7_P%N?\ X_1_PVI\4O\ H >%?_ 6Y_\ C] 'W]17P#_PVI\4
MO^@!X5_\!;G_ ./T?\-J?%+_ * 'A7_P%N?_ (_0!]_45\ _\-J?%+_H >%?
M_ 6Y_P#C]'_#:GQ2_P"@!X5_\!;G_P"/T ??U%? /_#:GQ2_Z 'A7_P%N?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^LGPI_P"2(> _^Q?L/_29*_)NOUD^%/\ R1#P
M'_V+]A_Z3)0!VE%%% !1110 4444 %%%% !1110 5^3GQ6_Y+=X\_P"Q@O\
M_P!*7K]8Z_)SXK?\EO\ 'G_8P7__ *4O0!Q5%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[]J3_DYOQ=_VY_\ I'#0!XQ1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.ORU^*'AOQ'<?&;QM/!X?U*6*37;YT=+21E93<.000.0: /,:*V_^$3\4_\
M0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B: ,2BMO_A$_%/\ T+.J_P#@')_\
M31_PB?BG_H6=5_\  .3_ .)H Q**V_\ A$_%/_0LZK_X!R?_ !-'_")^*?\
MH6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\ ")^*?^A9U7_P#D_^
M)H Q**V_^$3\4_\ 0LZK_P" <G_Q-'_")^*?^A9U7_P#D_\ B: ,2BMO_A$_
M%/\ T+.J_P#@')_\31_PB?BG_H6=5_\  .3_ .)H Q**V_\ A$_%/_0LZK_X
M!R?_ !-'_")^*?\ H6=5_P# .3_XF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\
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MF@#$HK;_ .$3\4_]"SJO_@')_P#$T?\ ")^*?^A9U7_P#D_^)H ]_P#V*_\
MDMNL_P#8OS?^E-O7W]7PA^Q_H>LZ;\9M7FU'2;VRB;0ID#W%N\:EOM%N<9('
M/!_*ON^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3%+17G_P 2O%VN
M>"O#MOKFC:.NLJEP!<V8!$K0A6>1XV!QE41C@@Y_G('H%%>?^,/'2Z'H6EW6
M@PQ:C=ZQ-;K:YR8U@DEC1IVQSL7S4],LZCO6M<^-/#NEWZZ3JWB&QBU!'B@F
M&2J)+(/W:MR1&7_A5FR>V:H5SJJ*\Q^)GQ$D\&Z$)=)DM)M334+2UFBN(9)(
MU6:15(+*5"OM;< 3G S@CFI=8^(EE8^'M>U;3=7L=;^Q:A'IZ)8V\DHM)&:.
M,I,49MS!F+<;.R]>26NKA<])HKA=%\46]QJFM6]_XNT>[.EPI-<VT%E):2V*
MMN;,_F2OC*XX*J1@GO@:R^*M!:V>87AS'<"T:$P2"83% XC\K;OW%"&QM^[S
MTYH&=)17!7'Q&\-6_B#P]I=O=?:HM;@GNH[N)6,,<,(^=F8+@88@')&WDMCO
M>M_&GAUM%LM6EU^TO[:^,S6UQ91LRSHC-N*JI<D(H^9NG!/ .  =?17(K\0/
M!LEY:V=OXFL;NZO+7[;;P6DGGR30<_O%5,EEX/('8^AKH;&\M=2T^VU"QN$N
M+2YC6:&6,Y61&&58'N""#0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]6L;BQNTU&^D,4\91MLES)(AYZ@JRG].H(KT_N:*,TMM"GJ[BT444Q!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Oct. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGHTBRIDGE CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001084554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,371,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1975651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">11710 Plaza America Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Reston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">20190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">730-1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LTBR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 153,330,134<span></span>
</td>
<td class="nump">$ 39,990,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,293,501<span></span>
</td>
<td class="nump">324,378<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">154,623,635<span></span>
</td>
<td class="nump">40,315,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="nump">327,148<span></span>
</td>
<td class="nump">528,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Trademarks</a></td>
<td class="nump">114,982<span></span>
</td>
<td class="nump">108,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">155,065,765<span></span>
</td>
<td class="nump">40,952,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,560,097<span></span>
</td>
<td class="nump">424,585<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">1,560,097<span></span>
</td>
<td class="nump">424,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 authorized shares, no shares issued and outstanding at September 30, 2025 and December 31, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 100,000,000 authorized, 30,384,981 shares and 18,783,912 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively</a></td>
<td class="nump">30,385<span></span>
</td>
<td class="nump">18,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">330,050,816<span></span>
</td>
<td class="nump">204,694,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(176,575,533)<span></span>
</td>
<td class="num">(164,184,842)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">153,505,668<span></span>
</td>
<td class="nump">40,528,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 155,065,765<span></span>
</td>
<td class="nump">$ 40,952,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">30,384,981<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">30,384,981<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 3,164,343<span></span>
</td>
<td class="nump">$ 1,676,209<span></span>
</td>
<td class="nump">$ 9,146,989<span></span>
</td>
<td class="nump">$ 5,626,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,039,857<span></span>
</td>
<td class="nump">1,298,601<span></span>
</td>
<td class="nump">5,345,635<span></span>
</td>
<td class="nump">3,232,036<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">5,204,200<span></span>
</td>
<td class="nump">2,974,810<span></span>
</td>
<td class="nump">14,492,624<span></span>
</td>
<td class="nump">8,858,603<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="num">(5,204,200)<span></span>
</td>
<td class="num">(2,974,810)<span></span>
</td>
<td class="num">(14,492,624)<span></span>
</td>
<td class="num">(8,858,603)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">1,104,955<span></span>
</td>
<td class="nump">318,649<span></span>
</td>
<td class="nump">2,101,933<span></span>
</td>
<td class="nump">1,008,224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total Other Income</a></td>
<td class="nump">1,104,955<span></span>
</td>
<td class="nump">318,649<span></span>
</td>
<td class="nump">2,101,933<span></span>
</td>
<td class="nump">1,008,224<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Loss Before Income Taxes</a></td>
<td class="num">(4,099,245)<span></span>
</td>
<td class="num">(2,656,161)<span></span>
</td>
<td class="num">(12,390,691)<span></span>
</td>
<td class="num">(7,850,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (4,099,245)<span></span>
</td>
<td class="num">$ (2,656,161)<span></span>
</td>
<td class="num">$ (12,390,691)<span></span>
</td>
<td class="num">$ (7,850,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Basic and diluted</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted Average Number of Common Shares Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Basic and diluted</a></td>
<td class="nump">25,624,598<span></span>
</td>
<td class="nump">14,189,787<span></span>
</td>
<td class="nump">22,498,638<span></span>
</td>
<td class="nump">13,871,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2023</a></td>
<td class="nump">$ 28,911,047<span></span>
</td>
<td class="nump">$ 13,698<span></span>
</td>
<td class="nump">$ 181,295,125<span></span>
</td>
<td class="num">$ (152,397,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,436,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings, amount</a></td>
<td class="nump">3,716,365<span></span>
</td>
<td class="nump">$ 1,437<span></span>
</td>
<td class="nump">3,714,928<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultants and directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultants and directors for services, amount</a></td>
<td class="nump">465,000<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">464,855<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares', window );">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount', window );">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, amount</a></td>
<td class="num">(10,583)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">(10,579)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,229,597<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,229,597<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(7,850,379)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,850,379)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,276,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Sep. 30, 2024</a></td>
<td class="nump">26,461,047<span></span>
</td>
<td class="nump">$ 15,276<span></span>
</td>
<td class="nump">186,693,926<span></span>
</td>
<td class="num">(160,248,155)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,591,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2024</a></td>
<td class="nump">27,021,990<span></span>
</td>
<td class="nump">$ 14,591<span></span>
</td>
<td class="nump">184,599,393<span></span>
</td>
<td class="num">(157,591,994)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings, amount</a></td>
<td class="nump">1,511,741<span></span>
</td>
<td class="nump">$ 609<span></span>
</td>
<td class="nump">1,511,132<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultants and directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultants and directors for services, amount</a></td>
<td class="nump">195,000<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">194,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">388,477<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">388,477<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,656,161)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,656,161)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,276,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Sep. 30, 2024</a></td>
<td class="nump">26,461,047<span></span>
</td>
<td class="nump">$ 15,276<span></span>
</td>
<td class="nump">186,693,926<span></span>
</td>
<td class="num">(160,248,155)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2024</a></td>
<td class="nump">40,528,290<span></span>
</td>
<td class="nump">$ 18,784<span></span>
</td>
<td class="nump">204,694,348<span></span>
</td>
<td class="num">(164,184,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,854,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings, amount</a></td>
<td class="nump">120,451,448<span></span>
</td>
<td class="nump">$ 9,854<span></span>
</td>
<td class="nump">120,441,594<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultants and directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultants and directors for services, amount</a></td>
<td class="nump">345,000<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">344,888<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares', window );">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount', window );">Net share settlement for withholding taxes paid upon vesting of restricted stock awards, amount</a></td>
<td class="num">(234,621)<span></span>
</td>
<td class="num">$ (29)<span></span>
</td>
<td class="num">(234,592)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,562,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,562,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,390,691)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,390,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IssuanceOfRestrictedShareAwardsShares', window );">Issuance of restricted share awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,467,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IssuanceOfRestrictedShareAwardsAmount', window );">Issuance of restricted share awards, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,468<span></span>
</td>
<td class="num">(1,468)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued through the exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares issued through the exercise of options, amount</a></td>
<td class="nump">1,243,794<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">1,243,598<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Sep. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,384,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Sep. 30, 2025</a></td>
<td class="nump">153,505,668<span></span>
</td>
<td class="nump">$ 30,385<span></span>
</td>
<td class="nump">330,050,816<span></span>
</td>
<td class="num">(176,575,533)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,545,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2025</a></td>
<td class="nump">97,774,593<span></span>
</td>
<td class="nump">$ 25,545<span></span>
</td>
<td class="nump">270,225,336<span></span>
</td>
<td class="num">(172,476,288)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares', window );">Shares issued - registered offerings, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,612,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount', window );">Shares issued - registered offerings, amount</a></td>
<td class="nump">57,328,526<span></span>
</td>
<td class="nump">$ 3,613<span></span>
</td>
<td class="nump">57,324,913<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to consultants and directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to consultants and directors for services, amount</a></td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">314,979<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,576,375<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,576,375<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(4,099,245)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,099,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IssuanceOfRestrictedShareAwardsShares', window );">Issuance of restricted share awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IssuanceOfRestrictedShareAwardsAmount', window );">Issuance of restricted share awards, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,110<span></span>
</td>
<td class="num">(1,110)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued through the exercise of options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares issued through the exercise of options, amount</a></td>
<td class="nump">610,419<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">610,323<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Sep. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,384,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Sep. 30, 2025</a></td>
<td class="nump">$ 153,505,668<span></span>
</td>
<td class="nump">$ 30,385<span></span>
</td>
<td class="nump">$ 330,050,816<span></span>
</td>
<td class="num">$ (176,575,533)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IssuanceOfRestrictedShareAwardsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IssuanceOfRestrictedShareAwardsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IssuanceOfRestrictedShareAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IssuanceOfRestrictedShareAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProfitAndLoss', window );">Net Loss</a></td>
<td class="num">$ (12,390,691)<span></span>
</td>
<td class="num">$ (7,850,379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,746,642<span></span>
</td>
<td class="nump">1,280,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(808,317)<span></span>
</td>
<td class="num">(37,665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="nump">201,657<span></span>
</td>
<td class="nump">10,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,135,512<span></span>
</td>
<td class="nump">928,240<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used in Operating Activities</a></td>
<td class="num">(8,115,197)<span></span>
</td>
<td class="num">(5,669,276)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Trademarks</a></td>
<td class="num">(6,117)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(6,117)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from the issuances of common stock under the ATM program</a></td>
<td class="nump">124,659,368<span></span>
</td>
<td class="nump">4,138,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Payment of offering costs and commissions</a></td>
<td class="num">(4,207,920)<span></span>
</td>
<td class="num">(421,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from the exercise of stock options</a></td>
<td class="nump">1,243,794<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(234,621)<span></span>
</td>
<td class="num">(10,583)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">121,460,621<span></span>
</td>
<td class="nump">3,705,782<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Increase (Decrease) in Cash and Cash Equivalents</a></td>
<td class="nump">113,339,307<span></span>
</td>
<td class="num">(1,963,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, Beginning of Period</a></td>
<td class="nump">39,990,827<span></span>
</td>
<td class="nump">28,598,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, End of Period</a></td>
<td class="nump">153,330,134<span></span>
</td>
<td class="nump">26,634,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CashPaidDuringThePeriodAbstract', window );"><strong>Cash paid during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock', window );">Payment of accrued liabilities with common stock</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockIssuedForConsultingServices', window );">Common stock issued for prepaid consulting services</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CashPaidDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CashPaidDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockIssuedForConsultingServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockIssuedForConsultingServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PaymentOfAccruedLiabilitiesWithCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProfitAndLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProfitAndLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September 30, 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (&#8220;Rule 10b5-1 Plan&#8221;) and was adopted during an open insider trading window and no sales will commence under the plan until completion of the required cooling off period under Rule 10b5-1, were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Title</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Action</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Date Adopted</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Expiration Date</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate # of Securities to be Purchased/Sold</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Seth Grae<sup style="vertical-align:super">(1)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer and Chairman of the Board</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">9/30/2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">12/30/2026</p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">98,711</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Andrey Mushakov<sup style="vertical-align:super">(2)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Executive Vice President of Fuel Operations</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">9/30/2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">12/31/2026</p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">180,593</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:13%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mark Tobin<sup style="vertical-align:super">(3)</sup></p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adoption</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">9/30/2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">12/31/2026</p></td><td style="width:19%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">15,000</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1) Seth Grae, the Chief Executive Officer and Chairman of the Board, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Grae&#8217;s plan provides for the sale, subject to certain price limits, of up to 98,711 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 30, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2) Andrey Mushakov, the Executive Vice President of Fuel Operations, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Mushakov&#8217;s plan provides for the sale, subject to certain price limits, of up to 180,593 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="6" style="width:85%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3) Mark Tobin, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Tobin&#8217;s plan provides for the sale at market price, of up to 15,000 shares of the Company&#8217;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended September 30, 2025, no other director or officer of the Company adopted, modified or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as each term is defined in Item&#160;408(a)&#160;of&#160;Regulation S-K.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Trading Arrangement, Individual Name</a></td>
<td class="text">Seth Grae<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Trading Arrangement, Individual Title</a></td>
<td class="text">Chief Executive Officer and Chairman of the Board<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Trading Arrangement Adoption Date</a></td>
<td class="text">9/30/2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Trading Arrangement Expiration Date</a></td>
<td class="text">12/30/2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Trading Arrangement, Securities Aggregate Available Amount</a></td>
<td class="nump">98,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameSecond', window );">Trading Arrangement, Individual Name</a></td>
<td class="text">Andrey Mushakov<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedFlagSecond', window );">Rule 10b5-1 Arrangement Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleSecond', window );">Trading Arrangement, Individual Title</a></td>
<td class="text">Executive Vice President of Fuel Operations<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateSecond', window );">Trading Arrangement Adoption Date</a></td>
<td class="text">9/30/2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateSecond', window );">Trading Arrangement Expiration Date</a></td>
<td class="text">12/31/2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrSecuritiesAggAvailAmtTwo', window );">Trading Arrangement, Securities Aggregate Available Amount</a></td>
<td class="nump">180,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndNameThird', window );">Trading Arrangement, Individual Name</a></td>
<td class="text">Mark Tobin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_Rule10b51ArrAdoptedFlagThird', window );">Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrIndTitleThird', window );">Trading Arrangement, Individual Title</a></td>
<td class="text">Director<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrAdoptionDateThird', window );">Trading Arrangement Adoption Date</a></td>
<td class="text">9/30/2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrExpirationDateThird', window );">Trading Arrangement Expiration Date</a></td>
<td class="text">12/31/2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TrdArrSecuritiesAggAvailAmtThird', window );">Trading Arrangement, Securities Aggregate Available Amount</a></td>
<td class="nump">15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedFlagSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedFlagSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_Rule10b51ArrAdoptedFlagThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_Rule10b51ArrAdoptedFlagThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrAdoptionDateThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrAdoptionDateThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrExpirationDateThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrExpirationDateThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndNameThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndNameThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleSecond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleSecond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrIndTitleThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrIndTitleThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrSecuritiesAggAvailAmtThird">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrSecuritiesAggAvailAmtThird</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TrdArrSecuritiesAggAvailAmtTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TrdArrSecuritiesAggAvailAmtTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#8217;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine-month periods have been made. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At period-end, the Company evaluates U.S. Treasury instruments held to determine whether they are:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;On-the-run&#8221;: Securities from the most recent auction with active market pricing, classified as Level 1</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;Off-the-run&#8221;: Securities from prior auctions with observable inputs but less liquidity, classified as Level 2</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although U.S. Treasury instruments held as cash equivalents have short maturities (typically 30&#8211;90 days) and cost closely approximates fair value, fair value disclosures are presented in accordance with ASC 820 and ASC 320 guidance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of U.S. Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $116.7 million of U.S. Treasury instruments during the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at September 30, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s cash and cash equivalents are sufficient to pay for the Company&#8217;s research and development (R&amp;D) and operations for the next year. However, given the long-term nature of the R&amp;D activities that are expected to be necessary prior to commercialization, the Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future R&amp;D activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant R&amp;D activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three and nine months ended September 30, 2025, R&amp;D expenses associated with activities conducted at INL accounted for 41% and 45% of the Company&#8217;s total R&amp;D expenditure, respectively. For the three and nine months ended September 30, 2024, R&amp;D expenses associated with activities conducted at the INL accounted for 32% and 36% of the Company&#8217;s total R&amp;D expenditure, respectively. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Recent Accounting Pronouncements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Update (ASU) No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the Financial Accounting Standards Board (FASB) in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (ASU 2024-03), which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three and nine months ended September 30, 2025 and 2024, as they would have been anti-dilutive due to the Company&#8217;s losses at September 30, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three and Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">547,362</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards (RSAs) outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,113,036</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">545,992</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,376,666</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,093,354</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Longterm Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract', window );"><strong>Prepaid Project Costs and Other Longterm Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsDisclosureTextBlock', window );">Prepaid Project Costs and Other Long-term Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-Term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with INL, in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advance payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $0.1 million to a total of $0.5 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, and December 31, 2024, the Company&#8217;s prepaid project costs were $0.3 million and $0.5 million, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidProjectCostsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidProjectCostsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consist of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued professional and consulting fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Operating Leases</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a 12-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $24,000. Total rent expense for the three and nine months ended September 30, 2025 was approximately $25,000 and $75,000, respectively. Total rent expense for the three and nine months ended September 30, 2024 was approximately $24,000 and $73,000, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development Costs</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>INL Project</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Throughout the duration of these umbrella agreements, all R&amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three and nine months ended September 30, 2025, the Company recorded $0.8 million and $2.4 million in R&amp;D expenses associated with INL, respectively. For the three and nine months ended September 30, 2024, the Company recorded $0.4 million and $1.1 million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>INL Modifications to the CRADA and SPPA Project Task Statements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;D activities were increased by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; CRADA to $4.2 million. This modification also required that a $600,000 advance payment be made, which was due and paid on January 16, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $2.6 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 6, 2025, the Company and BEA entered into Modification No. 3 to the SPPA extending the duration of this umbrella agreement from 7 years to 12 years. On November 5, 2025, the Company and BEA entered into Modification No. 1 to the CRADA with INL, extending the period of performance from September 27, 2029 to September 27, 2032.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods. The balance of the PTS obligations as of September 30, 2025 was $2.0 million. These PTS obligations are generally cancellable with 30 days&#8217; notice and therefore, are not considered firm commitments. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Romania Feasibility Study</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $0.2 million was payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $0 million in R&amp;D expenses associated with RATEN ICN feasibility study. For the three and nine months ended September 30, 2024, the Company recorded zero and $0.1 million, respectively in R&amp;D expenses associated with RATEN ICN feasibility study.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study that was completed in 2024 and has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $0 million in R&amp;D expenses associated with this FEED study. For the three and nine months ended September 30, 2024, the Company recorded $0.1 million and $0.3 million, respectively in R&amp;D expenses associated with this FEED study.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity and Stock-Based Compensation</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Increase in Authorized Common Shares </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 8, 2025, the Company held the 2025 annual meeting of stockholders (the Annual Meeting) at which the Company&#8217;s stockholders approved increasing the authorized common shares from 25,000,000 shares to 100,000,000 shares. The Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada on May 8, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock and Common Stock Equivalents Outstanding</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At September 30, 2025, the Company had a total of 30,648,611 shares of common stock and common stock equivalents outstanding, comprised of 30,384,981 common shares outstanding (including outstanding RSAs totaling 2,113,036 shares) and stock options to purchase 263,630 shares of common stock (of which 250,547 stock options were vested).&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, the Company had a total of 19,248,852 shares of common stock and common stock equivalents outstanding, comprised of 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares) and stock options to purchase 464,940 shares of common stock (of which 445,275 stock options were vested).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Issuance and Redemption of Series X Preferred Stock&#160;</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee, an independent member of the Board (the Purchaser), pursuant to which the Company agreed to issue and sell one (1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the Series X Preferred Stock), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was received by the Company. The Company redeemed the Series X Preferred Stock for $100 cash after the Annual Meeting and filed the Certificate of Withdrawal with the Secretary of State of Nevada on May 8, 2025. The Series X Preferred Stock did not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock was entitled to 25,000,000 votes on such proposal, voting together with the holders of the Company&#8217;s common stock. The votes by the holder of Series X Preferred Stock were cast at the Annual Meeting automatically in the same &#8220;mirrored&#8221; proportion as the aggregate votes cast &#8220;for&#8221; and &#8220;against&#8221; the proposal by the holders of the common stock who voted on such proposal (excluding abstentions, broker non-votes and shares of common stock that were not voted &#8220;for&#8221; or &#8220;against&#8221; such proposal). The voting power attributable to the Series X Preferred Stock was disregarded for purposes of determining whether a quorum is present at the Annual Meeting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Common Stock Equity Offerings</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>At-the-Market (ATM) Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024, pursuant to which the Company issued and sold shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. Under this amended agreement, the Company paid Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. This agreement was terminated on May 30, 2025. Sales of the Company&#8217;s common stock through Stifel, were made by any method that is deemed to be an at-the-market (ATM) equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the First Prospectus Supplement), pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $12.6 million from time to time through an ATM offering. The Company exhausted all capacity under the First Prospectus Supplement. On November 22, 2024, the Company filed a prospectus supplement (the Second Prospectus Supplement) pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $45.0 million from time to time through an ATM offering. The Company exhausted all capacity under the Second Prospectus Supplement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company filed a shelf registration statement on Form S-3 (File No. 333-287563) on May 23, 2025 registering the sale of up to $150.0 million of the Company&#8217;s securities that was declared effective on June 4, 2025. On June 5, 2025, the Company filed a prospectus supplement (the June Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $75.0 million of&#160;its shares of common stock through the Company&#8217;s new sales agent, Jefferies LLC (Jefferies).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 5, 2025, the Company entered into an Open Market Sale Agreement<sup style="vertical-align:super">SM</sup> (the Sales Agreement) with Jefferies pursuant to which the Company may issue and sell from time to time shares of its common stock through Jefferies as the Company&#8217;s sales agent. Sales of the Company&#8217;s common stock through Jefferies, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-287563) , and the base prospectus filed as part of such registration statement and a prospectus supplement. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 26, 2025, the Company filed a prospectus supplement (the September Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $75.0 million of&#160;its shares of common stock through Jefferies. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold 9,854,669 shares under the ATM for the nine months ended September 30, 2025 resulting in net proceeds of $120.4 million (stock issuance costs were approximately $4.2 million). The Company sold 1,436,821 shares under the ATM for the nine months ended September 30, 2024 resulting in net proceeds of $3.7 million (stock issuance costs were approximately $0.4 million). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended September 30, 2025, the Company sold 3,612,403 shares under the ATM, resulting in net proceeds of $57.3 million (stock issuance costs were approximately $2.0 million). For the three months ended September 30, 2024, the Company sold 608,690 shares under the ATM, resulting in net proceeds of $1.5 million (stock issuance costs were approximately $0.1 million).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Stock-Based Compensation</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2020 Omnibus Incentive Plan </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (as subsequently amended, the 2020 Plan). On September 3, 2020, the stockholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the annual meeting of stockholders on April 19, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 26, 2025, the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000. This increase was approved by the stockholders at the annual meeting of stockholders on May 8, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total number of shares of common stock available for future issuance under the 2020 Plan was 2,008,361 shares and 1,471,026 shares at September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock options issued to the Company&#8217;s employees, directors and consultants are summarized as follows for the nine months ended September 30, 2025:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16.24</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.07</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">184,818</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,418</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.33</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(195,855 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,834,474</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17,873 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">75.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">19.28</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.35</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,045,064</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">19.28</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.35</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,045,064</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">250,547</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">20.04</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.01</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,829,575</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company issued 12,418 and 71,330 stock options, respectively, to two consultants. The 12,418 stock options and the 71,330 stock options were assigned a fair value of $6.85 per share and $1.19 per share, respectively (total fair value of $85,000 for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the nine months ended September 30, 2025 and 2024, was $10.33 and $2.91, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The intrinsic value is calculated as the difference between the fair value of the Company&#8217;s common stock and the exercise price of the stock options. The fair value of the Company&#8217;s common stock was $21.21 per share and $2.80 per share at September 30, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#8217;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#8217;s expected holding term or option life determined by using the simplified method. The Company recognizes forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the nine months ended September 30, 2025 and 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">109.24% - 117.44%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">75.36% - 92.89%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3.80% - 3.95%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3.76% - 4.54%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2-6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2-6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$9.42 - $15.13</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$2.49 - $2.62</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, total unrecognized compensation cost related to option awards was $47,813, which is expected to be recognized over a remaining weighted-average vesting period of 2.26 years. As of September 30, 2024, total unrecognized compensation cost related to option awards was $47,853, which was expected to be recognized over a remaining weighted-average vesting period of 2.26 years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Exercise of Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three and nine months ended September 30, 2025, the Company received approximately $0.6 million and $1.2 million in net proceeds from the exercise of 96,141 and 195,855 stock options by employees and consultants, respectively. There were no options exercised for the nine months ended September 30, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company issued 6,302 shares (with an average stock price of $7.14 per share) and 13,201 shares (with an average stock price of $3.41&#160;per share) of common stock, respectively, to its investor relations firm for services provided during the period, which were recorded as stock-based compensation expense. These shares vested immediately upon issuance. The expense recorded for these share issuances was $15,000 for each quarter. The shares were valued based on the closing market price of the Company&#8217;s common stock on the date of grant. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 19, 2024, the Company issued an equity grant valued at $180,000 to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant 71,713 shares of common stock on the grant date, valued at $2.51 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $180,000 began to be recognized on a straight-line basis over the requisite service period and fully amortized to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 29, 2025, the Company issued an equity grant valued at $300,000 to the same consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, which resulted in issuing the consultant 19,828 shares of common stock on the grant date, valued at $15.13 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $300,000 began to be recognized on a straight-line basis over the requisite service period. Approximately $25,000 was recorded to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, the unrecognized compensation cost of approximately $275,000 was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of 0.92 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Restricted Stock Awards (RSAs) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">RSAs are awards of common stock that are legally issued and outstanding. RSAs are subject to time-based restrictions on transfer and unvested portions are generally subject to a risk of forfeiture if the award recipient ceases providing services to the Company prior to the lapse of the restrictions or does not meet certain performance conditions. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">RSAs were included in common stock issued and outstanding and were considered contingently issuable in the calculation of weighted-average shares outstanding for purposes of calculating diluted loss per share. The grantees receiving RSAs have all rights as a shareholder with respect to these shares, whether vested or unvested, including, without limitation, rights to vote the shares, receive dividends, etc.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following summarizes the Company&#8217;s restricted stock award activity and the RSAs outstanding: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">781,864</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,698,217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted (including performance-based RSAs of 1,125,000 shares)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,467,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,821,822</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(136,768 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,346,731</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,113,036</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10.91</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">44,817,494</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The aggregate fair value was calculated as the fair value of the Company&#8217;s common stock. The fair value of the Company&#8217;s common stock was $21.21 per share and $2.80 per share at September 30, 2025 and 2024, respectively. The fair value of the RSAs vested for the&#160;nine months ended September 30, 2025 and 2024 was $1.3 million and $0 million, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025, total unrecognized compensation cost related to RSAs was $20.5 million, which is expected to be recognized over a remaining weighted-average vesting period of 2.57 years. As of September 30, 2024, total unrecognized compensation cost related to RSAs was $1.45 million, which is expected to be recognized over a remaining weighted-average vesting period of 1.64 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">August 28, 2025 &#8211; Equity Grant of 1,800,000 shares of Restricted Stock Awards Program</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 28, 2025, the Board of Directors approved an aggregate restricted stock award program of 1.8 million shares of common stock. Pursuant to this approval, on August 28, 2025, the Company granted 1.1 million restricted stock awards with an aggregate grant-date fair value of approximately $17.1 million to its executives, directors, and employees. These awards consisted of 275,000 RSAs and 825,000 performance-based restricted stock awards (PSAs). The total value of approximately $17.1 million was based on the Company&#8217;s closing stock price of $15.54 per share on the grant date. The remaining portion of the Board-approved program has been authorized for future issuance by management, subject to applicable conditions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The first tranche of 275,000 RSAs are subject to service-based vesting, with the shares vesting in three equal installments on the first, second and third anniversaries of the date of grant. These shares were included in the total outstanding common shares as of September 30, 2025 due to their voting rights. These awards were valued at approximately $4.3 million. The Company recognized $0.1 million in stock-based compensation expense for the three and nine months ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The second tranche of 825,000 PSAs are subject to both service-based and performance-based vesting conditions. The PSAs have three specific R&amp;D fuel milestones relating to key technical development and commercialization objectives of the Company&#8217;s R&amp;D fuel program and one specific financial milestone vesting in unequal tranches based on which milestone is certified. Each milestone applies only to a separate portion of the 825,00 PSAs. The respective portions of each tranche will vest upon the later of achievement and Board or Compensation Committee certification of operational milestones and is subject to (i) the grantee&#8217;s continued service through the certification date and (ii) the grantee having completed at least twelve months of continuous service with Lightbridge as of the operational milestone achievement date. The performance period for achieving these operational milestones extend from the grant date to December 31, 2028. Any unvested shares will be forfeited if the corresponding operational and financial milestones are not achieved by December 31, 2028 or if the grantee&#8217;s service with the Company ends prior to vesting. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of the grant date and September 30, 2025, management concluded that the performance conditions associated with these performance milestones were probable of achievement. In accordance with ASC 718, the Company applied the graded vesting attribution amortization to the related RSAs from the grant date through each milestone&#8217;s estimated achievement date. These awards were valued at approximately $12.8 million. The Company recognized $0.4 million in stock-based compensation expense for the three and nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">April 3, 2025 &#8211; Equity Grant of 300,000 Performance-Based Restricted Stock Awards</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 3, 2025, the Company granted 300,000 PSAs to certain executives, key employees, and consultants under the 2020 Equity Incentive Plan. These awards were valued at approximately $2.1 million in total, based on the Company&#8217;s closing stock price of $6.99 per share on April 7, 2025, which was the final date of communication with the certain executives, key employees and consultants regarding the awards.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These PSAs are subject to both service-based and performance-based vesting conditions. The performance condition requires the successful insertion of the Company&#8217;s coupon fuel samples into the Advanced Test Reactor at INL by December 31, 2026 and is subject to the grantees continuous service over a three-year period from the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of the grant date and September 30, 2025, management concluded that the performance condition was probable of achievement. The Company recognized $0.4 million in stock-based compensation expense for the three months ended September 30, 2025, and $0.6 million for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Director Compensation - Equity-Settled Awards</span></em><span style="text-decoration:underline">&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 12, 2025, the Board of Directors granted 57,940 RSAs to its five independent directors for their service during the year ending December 31, 2025. The awards were valued at $0.5 million, based on the Company&#8217;s closing stock price of $8.63 per share on the grant date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These RSAs vest in four equal quarterly installments, beginning March 31, 2025. As of September 30, 2025, a total of 43,455 shares had vested. The Company recognized $0.1 million in stock-based compensation expense for the three months ended September 30, 2025, and $0.4 million for the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 4, 2024, the Board of Directors approved an equity grant valued at $500,000 in total to its five independent directors for the service period and year ended December 31, 2024, which resulted in granting a total of 85,915 shares of common stock, valued on the grant date at $5.82 per share on December 4, 2024, which shares vested on January 2, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six independent directors for the service period and year ended December 31, 2023, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share on November 20, 2023, which shares vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the shares granted was determined based on the closing market price of the Company&#8217;s common stock on the grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In March 2025, the Company accelerated the vesting of 70,710 RSAs in connection with a separation agreement with a former employee, resulting in approximately $0.5 million of stock-based compensation expense, including $0.3 million of incremental fair value. This expense was recognized in the first quarter of 2025 and is included in the results for the nine-month period ended September 30, 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">RSAs Summary - 2025 and 2024</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2025 and December 31, 2024, the Company had 2,113,036 shares (including performance-based RSAs of 1,125,000 shares) and 781,864 shares (including performance-based RSAs of 0 share) of RSAs, respectively, included in its total issued and outstanding common stock </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2025 and 2024, the Company recorded $3.2 million and $1.1 million, respectively, in stock-based compensation expense related to RSAs granted. For the three months ended September 30, 2025 and 2024, the Company recorded $1.6 million and $0.4 million, respectively, in stock-based compensation expense related to RSAs granted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options and RSAs included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2025 and 2024 are as follows (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Segment Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (CODM), or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#8217;s CODM is the chief executive officer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. R&amp;D expenses, general and administrative (G&amp;A) expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while R&amp;D milestones scorecard results and scorecard G&amp;A budgeted results are used in establishing management&#8217;s incentive compensation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the significant expense categories regularly provided to the CODM for the three and nine months ended September 30, 2025 and 2024 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">9.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">INL project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Allocated employee compensation and stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1.1 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.3 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.1 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.1 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.7 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(12.4 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 13.5pt; text-align:justify;">(1) Other segment items include interest income.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>ATM Sales</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the Company&#8217;s ATM from October 1, 2025 to November 6, 2025 amounted to 1,891,613 shares, which resulted in total net proceeds of approximately $42.0 million, stock issuance costs were approximately $1.3 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Safety Analysis Code Development Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 27, 2025, Lightbridge Corporation entered into an Agreement for Safety Analysis Codes and Services for Lightbridge Fuel Designs with Numerical Advisory Solutions, LLC (&#8220;NAS&#8221;). Under the agreement, NAS will develop customized safety-analysis computer codes, models, and documentation to evaluate Lightbridge&#8217;s proprietary metallic uranium-zirconium fuel designs for water-cooled reactors. The firm-fixed-price contract totals approximately $0.8 million and will commence in the fourth quarter of 2025. All deliverables, including related intellectual-property rights, will be owned by Lightbridge.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#8220;on-the-run&#8221;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#8220;off-the-run&#8221; and is classified as level 2. The three levels of the fair value hierarchy were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may have affected the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At period-end, the Company evaluates U.S. Treasury instruments held to determine whether they are:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;On-the-run&#8221;: Securities from the most recent auction with active market pricing, classified as Level 1</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;Off-the-run&#8221;: Securities from prior auctions with observable inputs but less liquidity, classified as Level 2</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Although U.S. Treasury instruments held as cash equivalents have short maturities (typically 30&#8211;90 days) and cost closely approximates fair value, fair value disclosures are presented in accordance with ASC 820 and ASC 320 guidance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of U.S. Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $116.7 million of U.S. Treasury instruments during the nine months ended September 30, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at September 30, 2025: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarized the valuation of the Company&#8217;s financial instruments that fell within the fair value hierarchy (rounded in millions) at December 31, 2024: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Certain Risks and Uncertainties</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s cash and cash equivalents are sufficient to pay for the Company&#8217;s research and development (R&amp;D) and operations for the next year. However, given the long-term nature of the R&amp;D activities that are expected to be necessary prior to commercialization, the Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future R&amp;D activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of the Lightbridge Fuel&#8482;, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is engaged in significant R&amp;D activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three and nine months ended September 30, 2025, R&amp;D expenses associated with activities conducted at INL accounted for 41% and 45% of the Company&#8217;s total R&amp;D expenditure, respectively. For the three and nine months ended September 30, 2024, R&amp;D expenses associated with activities conducted at the INL accounted for 32% and 36% of the Company&#8217;s total R&amp;D expenditure, respectively. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#8217;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#8217;s current ability to advance its R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Adopted Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Update (ASU) No. 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</em>, was issued by the Financial Accounting Standards Board (FASB) in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2024, the FASB issued ASU No. 2024-03, <em>Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</em> (Subtopic 220-40): <em>Disaggregation of Income Statement Expenses</em> (ASU 2024-03), which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of fair value of financial instruments</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40.0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 182<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480401/815-10-55-182<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of outstanding securities excluded from diluted weighted shares outstanding</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three and Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">547,362</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards (RSAs) outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,113,036</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">545,992</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,376,666</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,093,354</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued professional and consulting fees </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule Of stock option</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Term (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16.24</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.07</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">184,818</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,418</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.33</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(195,855 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,834,474</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17,873 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">75.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">19.28</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.35</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,045,064</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested and expected to vest, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">263,630</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">19.28</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.35</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,045,064</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options exercisable, end of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">250,547</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">20.04</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2.01</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,829,575</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule Of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">109.24% - 117.44%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">75.36% - 92.89%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3.80% - 3.95%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3.76% - 4.54%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2-6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2-6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share - common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$9.42 - $15.13</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">$2.49 - $2.62</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ScheduleOfOutstandingRSATableTextBlock', window );">Schedule Of outstanding RSA</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted- </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">781,864</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,698,217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards granted (including performance-based RSAs of 1,125,000 shares)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,467,940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,821,822</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(136,768 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,346,731</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Awards forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding, September 30, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,113,036</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10.91</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">44,817,494</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of stock based compensation expense</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ScheduleOfOutstandingRSATableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ScheduleOfOutstandingRSATableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarizes the expense categories Segment Reporting</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">9.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">INL project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Romania feasibility study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Centrus Energy FEED study</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Allocated employee compensation and stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other segments items<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1.1 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(0.3 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.1 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(4.1 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.7 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(12.4 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(7.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 153,330,134<span></span>
</td>
<td class="nump">$ 39,990,827<span></span>
</td>
<td class="nump">$ 26,634,951<span></span>
</td>
<td class="nump">$ 28,598,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember', window );">Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">56,600,000<span></span>
</td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember', window );">Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">96,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember', window );">Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InvestmentsInDebtSecuritiesPurchased', window );">US Treasury instruments purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_INLMember', window );">Idaho National Laboratory (INL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentPercentage', window );">Percentage of research and development expense</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InvestmentsInDebtSecuritiesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InvestmentsInDebtSecuritiesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_INLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_INLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Stock options outstanding</a></td>
<td class="nump">263,630<span></span>
</td>
<td class="nump">547,362<span></span>
</td>
<td class="nump">263,630<span></span>
</td>
<td class="nump">547,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted stock awards outstanding</a></td>
<td class="nump">2,113,036<span></span>
</td>
<td class="nump">545,992<span></span>
</td>
<td class="nump">2,113,036<span></span>
</td>
<td class="nump">545,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Total</a></td>
<td class="nump">2,376,666<span></span>
</td>
<td class="nump">1,093,354<span></span>
</td>
<td class="nump">2,376,666<span></span>
</td>
<td class="nump">1,093,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Long-term Assets (Details Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>May 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember', window );">Battelle Energy Alliance, LLC (BEA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProjectAbandonmentCosts', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProjectAbandonmentCosts', window );">Prepaid project costs</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProjectAbandonmentCosts', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses And Other Current Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProjectAbandonmentCosts', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProjectAbandonmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProjectAbandonmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade payables</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AccruedResearchAndDevelopmentExpensesCurrent', window );">Accrued research and development expenses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued bonus</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued professional and consulting fees</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Total</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AccruedResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AccruedResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total rent expense</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease monthly payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases', window );">Future minimum lease payments required under the non-cancellable operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LesseeOperatingLeaseTerm', window );">Operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LeasePaymentUnderNonCancellableOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LesseeOperatingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LesseeOperatingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 18, 2025</div></th>
<th class="th"><div>Jan. 16, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Oct. 16, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InvestmentCompanyExcessCostReimbursable', window );">Cost reimbursable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InvestmentCompanyExcessProjectTaskObligations', window );">Project task obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance payment made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 324,378<span></span>
</td>
<td class="nump">1,293,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,293,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,039,857<span></span>
</td>
<td class="nump">$ 1,298,601<span></span>
</td>
<td class="nump">5,345,635<span></span>
</td>
<td class="nump">$ 3,232,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember', window );">Strategic Partnership Project Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember', window );">Battelle Energy Alliance, LLC (BEA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentArrangementExpense', window );">Increase in estimated cost under R&amp;D agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_INLMember', window );">Idaho National Laboratory (INL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_CRADAMember', window );">CRADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_CANDUMember', window );">Canada Deuterium Uranium (CANDU)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance payment made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentExpensePayable', window );">Payable amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PaymentsToResearchAndDevelopmentCost', window );">Final payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ltbr_FEEdMember', window );">Front-end engineering and design (FEED)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InvestmentCompanyExcessCostReimbursable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InvestmentCompanyExcessCostReimbursable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InvestmentCompanyExcessProjectTaskObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InvestmentCompanyExcessProjectTaskObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PaymentsToResearchAndDevelopmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PaymentsToResearchAndDevelopmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentArrangementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentArrangementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentExpensePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentExpensePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_INLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_INLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_CRADAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_CRADAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_CANDUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_CANDUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ltbr_FEEdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ltbr_FEEdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and StockBased Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, Beginning of the period</a></td>
<td class="nump">464,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options outstanding, Granted</a></td>
<td class="nump">12,418<span></span>
</td>
<td class="nump">71,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options outstanding, Exercised</a></td>
<td class="num">(195,855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options outstanding, Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options outstanding, Expired</a></td>
<td class="num">(17,873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, End of the period</a></td>
<td class="nump">263,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and expected to vest, End of the period</a></td>
<td class="nump">263,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options outstanding options, exercisable</a></td>
<td class="nump">250,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning of the period</a></td>
<td class="nump">$ 16.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Granted</a></td>
<td class="nump">10.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Exercised</a></td>
<td class="nump">6.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Stock Options, Expired</a></td>
<td class="nump">75.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, End of the period</a></td>
<td class="nump">19.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and expected to vest, End of the period</a></td>
<td class="nump">19.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Options, exercisable</a></td>
<td class="nump">$ 20.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life - Years Beginning</a></td>
<td class="text">3 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF', window );">Weighted Average Remaining Contractual Life - Years Ending</a></td>
<td class="text">2 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested', window );">Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest</a></td>
<td class="text">2 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable', window );">Weighted Average Remaining Contractual Life - (Years) exercisable</a></td>
<td class="text">2 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 184,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised', window );">Options aggregate intrinsic value, Outstanding exercised</a></td>
<td class="nump">1,834,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding', window );">Options aggregate intrinsic value, Outstanding ending</a></td>
<td class="nump">2,045,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest', window );">Options aggregate intrinsic value, Vested and expected to vest</a></td>
<td class="nump">2,045,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable', window );">Options aggregate intrinsic value, Options exercisable</a></td>
<td class="nump">$ 1,829,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TopMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">109.24%<span></span>
</td>
<td class="nump">75.36%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price per share - common stock</a></td>
<td class="nump">$ 9.42<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_BottomMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">117.44%<span></span>
</td>
<td class="nump">92.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price per share - common stock</a></td>
<td class="nump">$ 15.13<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, vested</a></td>
<td class="nump">$ 10.33<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 184,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember', window );">Restricted Stock Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="nump">1,467,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Shares, vested</a></td>
<td class="num">(136,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Shares, forfieted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94', window );">Outstanding at end of period</a></td>
<td class="nump">2,113,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding', window );">Outstanding at beginning of period</a></td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, beginning</a></td>
<td class="nump">$ 5.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, granted</a></td>
<td class="nump">13.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, vested</a></td>
<td class="nump">6.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, ending</a></td>
<td class="nump">$ 10.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding', window );">Options aggregate intrinsic value, Outstanding beginning</a></td>
<td class="nump">$ 3,698,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted', window );">Options aggregate intrinsic value, granted</a></td>
<td class="nump">19,821,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested', window );">Options aggregate intrinsic value, vested</a></td>
<td class="nump">1,346,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited', window );">Options aggregate intrinsic value, forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings', window );">Options aggregate intrinsic value, Outstanding ending</a></td>
<td class="nump">$ 44,817,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research And Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General And Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="12">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 05, 2025</div></th>
<th class="th"><div>Apr. 03, 2025</div></th>
<th class="th"><div>Mar. 12, 2025</div></th>
<th class="th"><div>Dec. 04, 2024</div></th>
<th class="th"><div>Sep. 26, 2025</div></th>
<th class="th"><div>Aug. 29, 2025</div></th>
<th class="th"><div>Aug. 28, 2025</div></th>
<th class="th"><div>May 23, 2025</div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
<th class="th"><div>Nov. 22, 2024</div></th>
<th class="th"><div>Aug. 19, 2024</div></th>
<th class="th"><div>Mar. 29, 2024</div></th>
<th class="th"><div>Feb. 27, 2024</div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>May 28, 2019</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options outstanding, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,418<span></span>
</td>
<td class="nump">71,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price lower range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.85<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.33<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,746,642<span></span>
</td>
<td class="nump">$ 1,280,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,384,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,384,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,783,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,813<span></span>
</td>
<td class="nump">$ 47,853<span></span>
</td>
<td class="nump">$ 47,813<span></span>
</td>
<td class="nump">$ 47,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 3 days<span></span>
</td>
<td class="text">2 years 3 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,243,794<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding', window );">Description of common Stock and common stock equivalents outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company had a total of 30,648,611 shares of common stock and common stock equivalents outstanding, comprised of 30,384,981 common shares outstanding (including outstanding RSAs totaling 2,113,036 shares) and stock options to purchase 263,630 shares of common stock (of which 250,547 stock options were vested).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company had a total of 19,248,852 shares of common stock and common stock equivalents outstanding, comprised of 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares) and stock options to purchase 464,940 shares of common stock (of which 445,275 stock options were vested).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntercompanyAgreementsDescription', window );">ATM agreement amendment, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Under this amended agreement, the Company paid Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares of common stock issued</a></td>
<td class="nump">75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Consulting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,204,200<span></span>
</td>
<td class="nump">$ 2,974,810<span></span>
</td>
<td class="nump">$ 14,492,624<span></span>
</td>
<td class="nump">$ 8,858,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.21<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="nump">$ 21.21<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the Company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering', window );">Offering price, ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_MarketOfferingsDisclosureDescription', window );">Description related to ATM offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#8217;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the First Prospectus Supplement), pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $12.6 million from time to time through an ATM offering. The Company exhausted all capacity under the First Prospectus Supplement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember', window );">Series X Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement', window );">Description of subscription and investment representation agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1) share of the Company&#8217;s Series X Preferred Stock, par value $0.001 per share (the Series X Preferred Stock), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was received by the Company. The Company redeemed the Series X Preferred Stock for $100 cash after the Annual Meeting and filed the Certificate of Withdrawal with the Secretary of State of Nevada on May 8, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PreferredStockVotingRightsShares', window );">Preferred stock voting rights shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesIssuancesEquityGrant', window );">Common shares issuances equity grant value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted', window );">Number of shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesEquityGrantPricePerShares', window );">Common shares equity grant price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Consulting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockValuedGrantDatePricePerShare', window );">Common stock, valued grant date price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember', window );">Prepaid Expenses And Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember', window );">Common Share Issuances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.14<span></span>
</td>
<td class="nump">$ 3.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,302<span></span>
</td>
<td class="nump">13,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Proceeds from stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember', window );">Restricted Stock Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,467,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Shares, vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember', window );">Restricted Stock Award [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockUnitsRSAMember', window );">Restricted Stock Units R S A [Member] | Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross', window );">Shares, vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock awards shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value grant date, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="nump">$ 1,450,000<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="nump">$ 1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Unrecognized compensation cost related to option awards vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months 25 days<span></span>
</td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSAs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Fair value of the Company's common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsProgramMember', window );">Restricted Stock Awards Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options outstanding, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber', window );">Share-Based compensation arrangement, restricted stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod', window );">Share-Based compensation arrangement, restricted stock grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced', window );">Performance-based restricted stock awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based compensation arrangement by share-based payment award, grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember', window );">2025 Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Shares, vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember', window );">RSA Summary 2025 and 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,113,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,113,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockShareOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,113,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,113,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RSAFairValue', window );">Fair value of the RSAs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_FirstTrancheMember', window );">First Tranche [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of shares granted under share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited', window );">Fair value of share-based awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_SecondTrancheMember', window );">Second Tranche [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of shares granted under share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total number of common stock available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,008,361<span></span>
</td>
<td class="nump">1,471,026<span></span>
</td>
<td class="nump">2,008,361<span></span>
</td>
<td class="nump">1,471,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_DescriptionOfEquityIncentivePlan', window );">Description of equity incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company&#8217;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_BottomMember', window );">Maximum [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TopMember', window );">Minimum [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember', window );">Available for sale Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Proceeds from sale of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,612,403<span></span>
</td>
<td class="nump">608,690<span></span>
</td>
<td class="nump">9,854,669<span></span>
</td>
<td class="nump">1,436,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedsFromStockIssuances', window );">Net proceeds from stock issuance under ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,300,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 120,400,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issuence cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesEquityGrantPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesEquityGrantPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesIssuancesEquityGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesIssuancesEquityGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockValuedGrantDatePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockValuedGrantDatePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfEquityIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfEquityIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_MarketOfferingsDisclosureDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_MarketOfferingsDisclosureDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PreferredStockVotingRightsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PreferredStockVotingRightsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedsFromStockIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedsFromStockIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RSAFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RSAFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480459/718-40-55-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyAgreementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of product support, consulting, business, or other advisory service agreements entered into between the managing member or general partner and the LLC or LP, affiliate of the managing member or general partner, or affiliate of the LLC or LP. Includes a description of the key provisions of such agreements and the amount of compensation for such services during the accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyAgreementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_SeriesXPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=ltbr_PrepaidExpenseAndOtherCurrentAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ltbr_CommonShareIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_RestrictedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ltbr_RestrictedStockUnitsRSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ltbr_RestrictedStockUnitsRSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TwentyTwentyFiveTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardsSummaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_FirstTrancheMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_FirstTrancheMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_SecondTrancheMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_SecondTrancheMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated employee compensation and stock-based compensation</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=ltbr_CODMMember', window );">CODM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InlProject', window );">INL Project</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RomaniaFeasibilityStudy', window );">Romania feasibility study</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CentrusEnergyFeedStudy', window );">Centrus Energy FEED study</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated employee compensation and stock-based compensation</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other outside R&amp;D expenses</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentExpenseNet', window );">Total research and development</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OtherSegmentsItem', window );">Other segments item (1)</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated', window );">Net loss</a></td>
<td class="num">$ (4.1)<span></span>
</td>
<td class="num">$ (2.7)<span></span>
</td>
<td class="num">$ (12.4)<span></span>
</td>
<td class="num">$ (7.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CentrusEnergyFeedStudy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CentrusEnergyFeedStudy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InlProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InlProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OtherSegmentsItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OtherSegmentsItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RomaniaFeasibilityStudy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RomaniaFeasibilityStudy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=ltbr_CODMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=ltbr_CODMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 06, 2025</div></th>
<th class="th"><div>Oct. 27, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,659,368<span></span>
</td>
<td class="nump">$ 4,138,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sales of common stock</a></td>
<td class="nump">1,891,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of stocks</a></td>
<td class="nump">$ 42,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentArrangementObligationAmount', window );">Research and development arrangement total contract amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentArrangementObligationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentArrangementObligationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>149</ContextCount>
  <ElementCount>244</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>36</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets</Role>
      <ShortName>Prepaid Project Costs and Other Longterm Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995449 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995450 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995451 - Disclosure - Research and Development Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCosts</Role>
      <ShortName>Research and Development Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995452 - Disclosure - Stockholders Equity and StockBased Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation</Role>
      <ShortName>Stockholders Equity and StockBased Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995453 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995454 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShare</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995460 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/SegmentReporting</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995463 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShareTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative</Role>
      <ShortName>Prepaid Project Costs and Other Long-term Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995466 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Research and Development Costs (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative</Role>
      <ShortName>Research and Development Costs (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/ResearchAndDevelopmentCosts</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995473 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/SegmentReportingTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995474 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/SubsequentEvents</ParentRole>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ltbr-20250930.xsd</File>
    <File>ltbr-20250930_cal.xml</File>
    <File>ltbr-20250930_def.xml</File>
    <File>ltbr-20250930_lab.xml</File>
    <File>ltbr-20250930_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="ltbr_10q.htm">ltbr_10q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="438">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>59
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ltbr_10q.htm": {
   "nsprefix": "ltbr",
   "nsuri": "http://ltbr.com/20250930",
   "dts": {
    "schema": {
     "local": [
      "ltbr-20250930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ltbr-20250930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ltbr-20250930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ltbr-20250930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ltbr-20250930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ltbr_10q.htm"
     ]
    }
   },
   "keyStandard": 168,
   "keyCustom": 76,
   "axisStandard": 13,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 26,
   "hidden": {
    "total": 33,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://ltbr.com/20250930": 6,
    "http://xbrl.sec.gov/ecd/2025": 4,
    "http://fasb.org/us-gaap/2025": 18
   },
   "contextCount": 149,
   "entityCount": 1,
   "segmentCount": 36,
   "elementCount": 336,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 438,
    "http://xbrl.sec.gov/dei/2025": 30,
    "http://xbrl.sec.gov/ecd/2025": 10
   },
   "report": {
    "R1": {
     "role": "http://ltbr.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
     "longName": "110200 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "110201 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
     "longName": "124100 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity",
     "longName": "148600 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "longName": "170000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:ProfitAndLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:ProfitAndLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements",
     "longName": "995446 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://ltbr.com/role/NetLossPerShare",
     "longName": "995447 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets",
     "longName": "995448 - Disclosure - Prepaid Project Costs and Other Longterm Assets",
     "shortName": "Prepaid Project Costs and Other Longterm Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "995449 - Disclosure - Accounts Payable and Accrued Liabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://ltbr.com/role/CommitmentsAndContingencies",
     "longName": "995450 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCosts",
     "longName": "995451 - Disclosure - Research and Development Costs",
     "shortName": "Research and Development Costs",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation",
     "longName": "995452 - Disclosure - Stockholders Equity and StockBased Compensation",
     "shortName": "Stockholders Equity and StockBased Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://ltbr.com/role/SegmentReporting",
     "longName": "995453 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://ltbr.com/role/SubsequentEvents",
     "longName": "995454 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies",
     "longName": "995455 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables",
     "longName": "995456 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://ltbr.com/role/NetLossPerShareTables",
     "longName": "995457 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "995458 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables",
     "longName": "995459 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)",
     "shortName": "Stockholders Equity and StockBased Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://ltbr.com/role/SegmentReportingTables",
     "longName": "995460 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
     "longName": "995461 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
     "longName": "995462 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:InvestmentsInDebtSecuritiesPurchased",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "ltbr:InvestmentsInDebtSecuritiesPurchased",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://ltbr.com/role/NetLossPerShareDetails",
     "longName": "995463 - Disclosure - Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
     "longName": "995464 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "shortName": "Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember",
      "name": "ltbr:ProjectAbandonmentCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember",
      "name": "ltbr:ProjectAbandonmentCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
     "longName": "995465 - Disclosure - Accounts Payable and Accrued Liabilities (Details)",
     "shortName": "Accounts Payable and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995466 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
     "longName": "995467 - Disclosure - Research and Development Costs (Details Narrative)",
     "shortName": "Research and Development Costs (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "ltbr:InvestmentCompanyExcessCostReimbursable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-01-16",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
     "longName": "995468 - Disclosure - Stockholders Equity and StockBased Compensation (Details)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
     "longName": "995469 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
     "longName": "995470 - Disclosure - Stockholders Equity and StockBased Compensation (Details 2)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ltbr:ScheduleOfOutstandingRSATableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
     "longName": "995471 - Disclosure - Stockholders Equity and StockBased Compensation (Details 3)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
     "longName": "995472 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://ltbr.com/role/SegmentReportingDetails",
     "longName": "995473 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2025-07-01to2025-09-30",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-01to2025-09-30_ltbr_CODMMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
     "longName": "995474 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-09-30",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Payable and Accrued Liabilities",
        "label": "[Accounts Payable and Accrued Liabilities]",
        "terseLabel": "Total",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Payable and Accrued Liabilities",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r19",
      "r21",
      "r678"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccruedBonusesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedBonusesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued professional and consulting fees",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AccruedResearchAndDevelopmentExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "AccruedResearchAndDevelopmentExpensesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r535",
      "r732"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r624",
      "r625",
      "r626",
      "r627",
      "r683",
      "r735"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stock-based compensation expense",
        "verboseLabel": "Allocated employee compensation and stock-based compensation",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r265",
      "r266"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "[Assets]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r56",
      "r66",
      "r85",
      "r86",
      "r87",
      "r118",
      "r126",
      "r134",
      "r137",
      "r175",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r284",
      "r286",
      "r329",
      "r383",
      "r384",
      "r387",
      "r451",
      "r504",
      "r505",
      "r511",
      "r535",
      "r541",
      "r542",
      "r554",
      "r646",
      "r647",
      "r697"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "[Assets, Current]",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r70",
      "r85",
      "r86",
      "r87",
      "r175",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r284",
      "r286",
      "r329",
      "r535",
      "r646",
      "r647",
      "r697"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AvailableForSaleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "AvailableForSaleSecuritiesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available for sale Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r288",
      "r291",
      "r292",
      "r293",
      "r294",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r328",
      "r521",
      "r522",
      "r569",
      "r701"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r288",
      "r291",
      "r292",
      "r293",
      "r294",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r328",
      "r521",
      "r522",
      "r569",
      "r701"
     ]
    },
    "ltbr_BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "BasisOfPresentationSummaryOfSignificantAccountingPoliciesAndNatureOfOperations",
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_BattelleEnergyAllianceLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "BattelleEnergyAllianceLLCMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Battelle Energy Alliance, LLC (BEA) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "ltbr_BoardOfDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "BoardOfDirectorsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_BottomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "BottomMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CANDUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CANDUMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada Deuterium Uranium (CANDU)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CODMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CODMMember",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CODM"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CRADAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CRADAMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CRADA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodStartLabel": "Cash and Cash Equivalents, Beginning of Period",
        "periodEndLabel": "Cash and Cash Equivalents, End of Period",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r36",
      "r84"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Increase (Decrease) in Cash and Cash Equivalents",
        "label": "[Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation]",
        "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r36"
     ]
    },
    "ltbr_CashPaidDuringThePeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CashPaidDuringThePeriodAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid during the period:"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CentrusEnergyFeedStudy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CentrusEnergyFeedStudy",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centrus Energy FEED study"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r67",
      "r68",
      "r69",
      "r85",
      "r87",
      "r108",
      "r109",
      "r111",
      "r113",
      "r120",
      "r121",
      "r175",
      "r194",
      "r196",
      "r197",
      "r198",
      "r201",
      "r202",
      "r206",
      "r207",
      "r209",
      "r210",
      "r212",
      "r215",
      "r218",
      "r219",
      "r221",
      "r224",
      "r231",
      "r329",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r439",
      "r459",
      "r477",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r567",
      "r621",
      "r622",
      "r628"
     ]
    },
    "ltbr_CommitmentsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommitmentsAndContingenciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies - Note 5"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r192",
      "r193",
      "r489",
      "r642",
      "r643"
     ]
    },
    "ltbr_CommonShareIssuancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonShareIssuancesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Share Issuances [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesEquityGrantPricePerShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonSharesEquityGrantPricePerShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares equity grant price per shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesIssuancesEquityGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonSharesIssuancesEquityGrant",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issuances equity grant value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of common stock available for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ltbr_CommonStockIssuedForConsultingServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonStockIssuedForConsultingServices",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for prepaid consulting services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r545",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551",
      "r624",
      "r625",
      "r627",
      "r683",
      "r731",
      "r735"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Par Value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ltbr_CommonStockShareOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonStockShareOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r439"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Issued",
        "verboseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r23",
      "r439",
      "r457",
      "r735",
      "r736"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.001 par value, 100,000,000 authorized, 30,384,981 shares and 18,783,912 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r207",
      "r214",
      "r390",
      "r535"
     ]
    },
    "ltbr_CommonStockValuedGrantDatePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "CommonStockValuedGrantDatePricePerShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, valued grant date price per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certain Risks and Uncertainties",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of common Stock and common stock equivalents outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfEquityIncentivePlan": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "DescriptionOfEquityIncentivePlan",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of equity incentive plan"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_DescriptionOfSubscriptionAndInvestmentRepresentationAgreement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "DescriptionOfSubscriptionAndInvestmentRepresentationAgreement",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of subscription and investment representation agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Common Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r77",
      "r95",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r108",
      "r111",
      "r112",
      "r113",
      "r117",
      "r205",
      "r264",
      "r280",
      "r283",
      "r320",
      "r321",
      "r382",
      "r398",
      "r499"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r114",
      "r115",
      "r116"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to option awards",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation cost recognized",
        "documentation": "The amount of plan compensation cost recognized during the period."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r515",
      "r516"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity and StockBased Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r60",
      "r61",
      "r62",
      "r73",
      "r74",
      "r75",
      "r90",
      "r91",
      "r92",
      "r94",
      "r101",
      "r103",
      "r105",
      "r119",
      "r176",
      "r177",
      "r188",
      "r204",
      "r232",
      "r264",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r341",
      "r344",
      "r396",
      "r409",
      "r410",
      "r411",
      "r420",
      "r477"
     ]
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Interest Type [Axis]",
        "documentation": "Information by type of equity interest issued or issuable by acquirer as part of consideration transferred in business combination."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682"
     ]
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of equity interest issued or issuable by acquirer as part of consideration transferred in business combination."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r682"
     ]
    },
    "ltbr_FEEdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "FEEdMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Front-end engineering and design (FEED)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument Axis",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r203",
      "r229",
      "r306",
      "r317",
      "r325",
      "r328",
      "r331",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r386",
      "r397",
      "r509",
      "r524",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r636",
      "r637",
      "r638",
      "r639",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r691",
      "r692"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r641"
     ]
    },
    "ltbr_FirstTrancheMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "FirstTrancheMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Tranche [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r461"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General And Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "ltbr_INLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "INLMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Idaho National Laboratory (INL)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss Before Income Taxes",
        "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r51",
      "r55",
      "r383",
      "r385",
      "r394",
      "r495",
      "r497",
      "r498",
      "r500",
      "r504",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location Axis",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r289",
      "r295",
      "r296",
      "r305",
      "r322",
      "r323",
      "r324",
      "r330",
      "r331",
      "r332",
      "r407",
      "r408",
      "r462",
      "r491",
      "r492",
      "r518",
      "r519",
      "r522",
      "r523",
      "r526",
      "r534",
      "r679",
      "r680",
      "r702"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r289",
      "r295",
      "r296",
      "r305",
      "r322",
      "r323",
      "r324",
      "r330",
      "r331",
      "r332",
      "r407",
      "r408",
      "r462",
      "r491",
      "r492",
      "r518",
      "r519",
      "r522",
      "r523",
      "r526",
      "r534",
      "r679",
      "r680",
      "r702"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r85",
      "r104",
      "r105",
      "r118",
      "r129",
      "r137",
      "r270",
      "r271",
      "r276",
      "r399",
      "r495",
      "r497",
      "r498",
      "r517"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r83",
      "r272",
      "r273"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "[Increase (Decrease) in Prepaid Expenses, Other]",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid project costs and other long-term assets",
        "label": "[Prepaid project costs and other long-term assets]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_InlProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "InlProject",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INL Project"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_IntercompanyAgreementsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntercompanyAgreementsDescription",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM agreement amendment, description",
        "documentation": "Description of product support, consulting, business, or other advisory service agreements entered into between the managing member or general partner and the LLC or LP, affiliate of the managing member or general partner, or affiliate of the LLC or LP. Includes a description of the key provisions of such agreements and the amount of compensation for such services during the accounting period."
       }
      }
     },
     "auth_ref": [
      "r695"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r81",
      "r82"
     ]
    },
    "ltbr_InvestmentCompanyExcessCostReimbursable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "InvestmentCompanyExcessCostReimbursable",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost reimbursable"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_InvestmentCompanyExcessProjectTaskObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "InvestmentCompanyExcessProjectTaskObligations",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Project task obligations"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_InvestmentsInDebtSecuritiesPurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "InvestmentsInDebtSecuritiesPurchased",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury instruments purchased"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_IssuanceOfRestrictedShareAwardsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "IssuanceOfRestrictedShareAwardsAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted share awards, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_IssuanceOfRestrictedShareAwardsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "IssuanceOfRestrictedShareAwardsShares",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of restricted share awards, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LeasePaymentUnderNonCancellableOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "LeasePaymentUnderNonCancellableOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future minimum lease payments required under the non-cancellable operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LesseeOperatingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "LesseeOperatingLeaseTerm",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "[Liabilities and Equity]",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r50",
      "r392",
      "r535",
      "r541",
      "r542",
      "r620",
      "r623",
      "r640",
      "r693"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "[Liabilities, Current]",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r65",
      "r85",
      "r86",
      "r87",
      "r175",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r285",
      "r286",
      "r287",
      "r329",
      "r535",
      "r646",
      "r697",
      "r698"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_MarketOfferingsDisclosureDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "MarketOfferingsDisclosureDescription",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description related to ATM offerings"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Financing Activities",
        "label": "[Cash Provided by (Used in) Financing Activity, Including Discontinued Operation]",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Investing Activities",
        "label": "[Cash Provided by (Used in) Investing Activity, Including Discontinued Operation]",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Operating Activities",
        "label": "[Cash Provided by (Used in) Operating Activity, Including Discontinued Operation]",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "[Net Income (Loss) Attributable to Parent]",
        "verboseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r38",
      "r52",
      "r62",
      "r63",
      "r71",
      "r72",
      "r75",
      "r85",
      "r86",
      "r87",
      "r89",
      "r93",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r104",
      "r105",
      "r110",
      "r175",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r205",
      "r208",
      "r211",
      "r216",
      "r264",
      "r280",
      "r283",
      "r321",
      "r329",
      "r395",
      "r458",
      "r475",
      "r476",
      "r495",
      "r497",
      "r498",
      "r552",
      "r646"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Adopted Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "[Operating Expenses]",
        "verboseLabel": "Consulting expense",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss",
        "label": "[Operating Income (Loss)]",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r495",
      "r498",
      "r500",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total rent expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r694"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease monthly payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343"
     ]
    },
    "ltbr_OperatingNetIncomeLossFromSegmentsToConsolidated": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "OperatingNetIncomeLossFromSegmentsToConsolidated",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss",
        "label": "[Net loss]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_OptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "OptionsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r46",
      "r619"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other outside R&amp;D expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r541",
      "r542"
     ]
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "[Other General and Administrative Expense]",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r734"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Income",
        "label": "[Other Nonoperating Income (Expense)]",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r520"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_OtherSegmentsItem": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "OtherSegmentsItem",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other segments item (1)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PaymentOfAccruedLiabilitiesWithCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PaymentOfAccruedLiabilitiesWithCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of accrued liabilities with common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of offering costs and commissions",
        "label": "[Payment of Financing and Stock Issuance Costs]",
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering price, ATM",
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issuance costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for taxes related to net share settlement of equity awards",
        "label": "[Payment, Tax Withholding, Share-Based Payment Arrangement]",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trademarks",
        "label": "[Payments to Acquire Intangible Assets]",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ltbr_PaymentsToResearchAndDevelopmentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PaymentsToResearchAndDevelopmentCost",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Par Value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r218"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r439"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r218"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r439",
      "r457",
      "r735",
      "r736"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, $0.001 par value, 10,000,000 authorized shares, no shares issued and outstanding at September 30, 2025 and December 31, 2024",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r207",
      "r213",
      "r389",
      "r535"
     ]
    },
    "ltbr_PreferredStockVotingRightsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PreferredStockVotingRightsShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock voting rights shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs and other long-term assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "verboseLabel": "Advance payment made",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ltbr_PrepaidExpenseAndOtherCurrentAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PrepaidExpenseAndOtherCurrentAssetMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid Expenses And Other Current Assets [Member]",
        "label": "[Prepaid Expenses And Other Current Assets [Member]]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses And Other Current Assets [Member]",
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PrepaidExpensesCurrentAndLongTermAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Project Costs and Other Longterm Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidProjectCostsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "PrepaidProjectCostsDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongtermAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Project Costs and Other Long-term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds from the issuances of common stock under the ATM program",
        "verboseLabel": "Net proceeds from sale of stocks",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ltbr_ProceedsFromStockIssuances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ProceedsFromStockIssuances",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from stock issuance under ATM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from the exercise of stock options",
        "verboseLabel": "Proceeds from stock option exercise",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service Axis"
       }
      }
     },
     "auth_ref": [
      "r140",
      "r380",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r493",
      "r494",
      "r497",
      "r498",
      "r512",
      "r513",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r568",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r644",
      "r645",
      "r700",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "auth_ref": [
      "r140",
      "r380",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r493",
      "r494",
      "r497",
      "r498",
      "r512",
      "r513",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r568",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r644",
      "r645",
      "r700",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730"
     ]
    },
    "ltbr_ProfitAndLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ProfitAndLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Loss",
        "label": "[Net Loss]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ProjectAbandonmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ProjectAbandonmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RSAFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RSAFairValue",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the RSAs vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r88",
      "r89",
      "r144",
      "r233",
      "r234",
      "r345",
      "r346",
      "r388",
      "r393",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r456",
      "r482",
      "r733"
     ]
    },
    "ltbr_RelatedPartyTransactionAmountsResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RelatedPartyTransactionAmountsResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development expenses",
        "label": "[Research and development expenses]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions By Related Party Axis",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r88",
      "r89",
      "r144",
      "r233",
      "r234",
      "r345",
      "r346",
      "r388",
      "r393",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r456",
      "r482",
      "r696",
      "r733"
     ]
    },
    "us-gaap_ReportingUnitAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReportingUnitAxis",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Unit Axis",
        "documentation": "Information by reporting unit."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187",
      "r510"
     ]
    },
    "us-gaap_ReportingUnitDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReportingUnitDomain",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187",
      "r510"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentArrangementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementExpense",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in estimated cost under R&amp;D agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentArrangementObligationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementObligationAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development arrangement total contract amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Research and development expenses",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r491",
      "r495",
      "r496",
      "r504",
      "r699"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research And Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ResearchAndDevelopmentExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total research and development"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpensePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ResearchAndDevelopmentExpensePayable",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ResearchAndDevelopmentPercentage",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of research and development expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCosts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and Development Costs",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r490"
     ]
    },
    "ltbr_RestrictedStockAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RestrictedStockAwardMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Award [Member]",
        "verboseLabel": "Restricted Stock Award [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedStockAwardsProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RestrictedStockAwardsProgramMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Awards Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RestrictedStockAwardsSummaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RestrictedStockAwardsSummaryMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSA Summary 2025 and 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards outstanding",
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r677"
     ]
    },
    "ltbr_RestrictedStockUnitsRSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RestrictedStockUnitsRSAMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units R S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r43",
      "r391",
      "r412",
      "r413",
      "r419",
      "r440",
      "r535"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r90",
      "r91",
      "r92",
      "r94",
      "r101",
      "r103",
      "r105",
      "r176",
      "r177",
      "r188",
      "r204",
      "r264",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r307",
      "r309",
      "r310",
      "r312",
      "r319",
      "r340",
      "r341",
      "r409",
      "r411",
      "r420",
      "r735"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r76",
      "r85",
      "r86",
      "r87",
      "r118",
      "r127",
      "r128",
      "r133",
      "r137",
      "r140",
      "r142",
      "r143",
      "r175",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r329",
      "r383",
      "r385",
      "r504",
      "r520",
      "r541",
      "r542",
      "r646"
     ]
    },
    "ltbr_RomaniaFeasibilityStudy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "RomaniaFeasibilityStudy",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Romania feasibility study"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ltbr_Rule10b51ArrAdoptedFlagSecond": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "Rule10b51ArrAdoptedFlagSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_Rule10b51ArrAdoptedFlagThird": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "Rule10b51ArrAdoptedFlagThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Rule 10b5-1 Arragement Adopted [Flag]",
        "label": "[Rule 10b5-1 Arragement Adopted [Flag]]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of common stock, shares",
        "verboseLabel": "Sales of common stock",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of outstanding securities excluded from diluted weighted shares outstanding",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of financial instruments",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r290",
      "r297",
      "r522"
     ]
    },
    "ltbr_ScheduleOfOutstandingRSATableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ScheduleOfOutstandingRSATableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of outstanding RSA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://ltbr.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarizes the expense categories Segment Reporting",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock based compensation expense",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r45"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share-based Compensation, Stock Options, Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r44"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of stock option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "ltbr_SecondTrancheMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SecondTrancheMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Tranche [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r118",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r130",
      "r131",
      "r132",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r143",
      "r501",
      "r502",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508"
     ]
    },
    "ltbr_SeriesXPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SeriesXPreferredStockMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series X Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "[Share-Based Payment Arrangement, Noncash Expense]",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to option awards vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based compensation arrangement, restricted stock authorized"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period",
        "label": "[Outstanding at beginning of period]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of period",
        "label": "[Outstanding at end of period]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSAs vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares granted under share-based payment arrangement",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options outstanding options, exercisable",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price Options, exercisable",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options outstanding, Expired",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period]",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding, Forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding, Granted",
        "verboseLabel": "Options outstanding, granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Granted",
        "verboseLabel": "Shares, granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, granted",
        "verboseLabel": "Weighted average fair value grant date, granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Options outstanding, Beginning of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]",
        "periodEndLabel": "Options outstanding, End of the period",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options outstanding",
        "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Beginning of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted Average Exercise Price, End of the period",
        "verboseLabel": "Fair value of the Company's common stock per share",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options vested and expected to vest, End of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number]",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares, vested",
        "label": "[Shares, vested]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based compensation arrangement, restricted stock grant-date fair value"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, vested and expected to vest, End of the period",
        "label": "[Weighted Average Exercise Price, vested and expected to vest, End of the period]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of the company's common stock per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Stock Options, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price lower range limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing price per share - common stock",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation arrangement by share-based payment award, grant-date fair value",
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected Life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, forfieted",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, forfeited",
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average fair value grant date, beginning",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted average fair value grant date, ending",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total fair value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, vested",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares]",
        "verboseLabel": "Shares, vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value grant date, vested",
        "verboseLabel": "Weighted average fair value per share at grant date",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - Years Beginning"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - Years Ending"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - (Years) exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life - (Years) Vested and expected to vest"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Outstanding exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, forfeited"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, granted"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Options exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Options aggregate intrinsic value, Outstanding beginning",
        "label": "[Options aggregate intrinsic value, Outstanding beginning]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options aggregate intrinsic value, Outstanding ending",
        "label": "[Options aggregate intrinsic value, Outstanding ending 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, vested"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options aggregate intrinsic value, Vested and expected to vest"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options aggregate intrinsic value, Outstanding ending",
        "label": "[Options aggregate intrinsic value, Outstanding ending]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssued",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "label": "[Shares, Issued]",
        "periodEndLabel": "Balance, shares",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net share settlement for withholding taxes paid upon vesting of restricted stock awards, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net share settlement for withholding taxes paid upon vesting of restricted stock awards, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r67",
      "r68",
      "r69",
      "r85",
      "r87",
      "r108",
      "r109",
      "r111",
      "r113",
      "r120",
      "r121",
      "r175",
      "r194",
      "r196",
      "r197",
      "r198",
      "r201",
      "r202",
      "r206",
      "r207",
      "r209",
      "r210",
      "r212",
      "r215",
      "r218",
      "r219",
      "r221",
      "r224",
      "r231",
      "r329",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r439",
      "r459",
      "r477",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r567",
      "r621",
      "r622",
      "r628"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r23",
      "r26",
      "r27",
      "r60",
      "r61",
      "r62",
      "r73",
      "r74",
      "r75",
      "r90",
      "r91",
      "r92",
      "r94",
      "r101",
      "r103",
      "r105",
      "r119",
      "r176",
      "r177",
      "r188",
      "r204",
      "r232",
      "r264",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r341",
      "r344",
      "r396",
      "r409",
      "r410",
      "r411",
      "r420",
      "r477"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r119",
      "r206",
      "r207",
      "r209",
      "r212",
      "r341",
      "r380",
      "r414",
      "r421",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r497",
      "r498",
      "r547",
      "r733"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/SegmentReportingDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails2",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails3",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r119",
      "r144",
      "r206",
      "r207",
      "r209",
      "r212",
      "r341",
      "r380",
      "r414",
      "r421",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r497",
      "r498",
      "r547",
      "r733"
     ]
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of share-based awards granted",
        "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultants and directors for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares of common stock issued",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards granted",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r43"
     ]
    },
    "ltbr_StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance-based restricted stock awards granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued through the exercise of options, shares",
        "verboseLabel": "Proceeds from stock options, shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r22",
      "r23",
      "r43"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options outstanding, Exercised",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r22",
      "r23",
      "r43",
      "r244"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultants and directors for services, amount",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issuence cost",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r22",
      "r23",
      "r43",
      "r420",
      "r477",
      "r484",
      "r553"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards shares value",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r22",
      "r23",
      "r43"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued through the exercise of options, amount",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r22",
      "r23",
      "r43"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "label": "[Equity, Attributable to Parent]",
        "periodStartLabel": "Balance, amount",
        "periodEndLabel": "Balance, amount",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r26",
      "r27",
      "r40",
      "r441",
      "r457",
      "r478",
      "r479",
      "r535",
      "r554",
      "r620",
      "r622",
      "r623",
      "r640",
      "r693",
      "r735"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity and Stock-Based Compensation",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r217",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r232",
      "r306",
      "r318",
      "r480",
      "r481",
      "r488"
     ]
    },
    "ltbr_StrategicPartnershipProjectAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "StrategicPartnershipProjectAgreementMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strategic Partnership Project Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r348"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type Axis",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r348"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r348"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://ltbr.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r349"
     ]
    },
    "ltbr_TopMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TopMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r203",
      "r229",
      "r306",
      "r317",
      "r325",
      "r328",
      "r331",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r386",
      "r397",
      "r524",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r536",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r636",
      "r637",
      "r638",
      "r639",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r691",
      "r692"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement Adoption Date",
        "label": "[Trading Arrangement Adoption Date]"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "ltbr_TrdArrAdoptionDateSecond": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrAdoptionDateSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement Adoption Date",
        "label": "[Trading Arrangement Adoption Date 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrAdoptionDateThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrAdoptionDateThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "ltbr_TrdArrExpirationDateSecond": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrExpirationDateSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement Expiration Date",
        "label": "[Trading Arrangement Expiration Date]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrExpirationDateThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrExpirationDateThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement Expiration Date",
        "label": "[Trading Arrangement Expiration Date 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "ltbr_TrdArrIndNameSecond": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrIndNameSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Individual Name",
        "label": "[Trading Arrangement, Individual Name]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndNameThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrIndNameThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Individual Name",
        "label": "[Trading Arrangement, Individual Name 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "ltbr_TrdArrIndTitleSecond": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrIndTitleSecond",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Individual Title",
        "label": "[Trading Arrangement, Individual Title]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrIndTitleThird": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrIndTitleThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Individual Title",
        "label": "[Trading Arrangement, Individual Title 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ltbr_TrdArrSecuritiesAggAvailAmtThird": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrSecuritiesAggAvailAmtThird",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Securities Aggregate Available Amount",
        "label": "[Trading Arrangement, Securities Aggregate Available Amount 1]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TrdArrSecuritiesAggAvailAmtTwo": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TrdArrSecuritiesAggAvailAmtTwo",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading Arrangement, Securities Aggregate Available Amount",
        "label": "[Trading Arrangement, Securities Aggregate Available Amount]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TreasuryBillsLevelOneMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level I"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TreasuryBillsLevelThreeMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level III"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TreasuryBillsLevelTwoMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level II"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwentyTwentyFiveTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TwentyTwentyFiveTransactionsMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 Transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20250930",
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic and diluted",
        "label": "[Weighted Average Number of Shares Outstanding, Diluted]",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r113"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Common Shares Outstanding"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/250/tableOfContent"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480459/718-40-55-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480459/718-40-55-9"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "SubTopic": "310",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>60
<FILENAME>0001477932-25-007949-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-25-007949-xbrl.zip
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MAO5L7JATV^(?M 848A(PVB(;$Z_N&KQ!DSND?=-K<ZW_/&EDO>T@-IF^W1E
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M1W2F&I0!#OB+ XC_2Q3OD#XB&Q1_Z(?U$;G ^ <^:.@= /+ V3>:./!./@X
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M1:)!4QVNI>I2WZ"I'L=L3@5JWF+_O(S$,S.2Q\V)>&Y.Y'%S*IZ;4WG<<-L
M 4V+GOWROOCL:J+]&;4%RUF?3B<RS3&I9473W5-V"^--2+Q-^)90M4%->$9P
M#PY-"TD/$D=4U%%:%KM6+,<_0D6/HC)'I0UT3?6NJT/3W>I639*+M3NGE_1S
MN 7;>[QQ6HO8;-6N*=5MNQY]I$+75#FN/ZY+6%RG1UT$*SVP_<;*&%=/4XQ^
MM!P+6]MK]#5#-?CA \<$9DPW;HYG5]^W?%SP./QOI!TF(2>'&BFIW>IKH,V<
ME>MM0]\TH2BFR7:-#"$V#F-PO:+\8,PX!,:;M?MX9 *+!)O@#\0ZAA($UI^D
MW_$]]#W=\..6;/T>V*3]/U&9B(E(.D<EXA$NMR8!!:%T1Z-CI"%(H+M=4?3Y
MZ\WXZ^7L;GJI3>8WE].;9?AI.;^>78[QSQ?CZ_'-9*HM?YM.[Y9=:$+KN((4
M>Z-V[&D_97KXN7]V*T(.(E9/SD;UD5S>H7^^3&\0F_,K;7X[78SO9JB 7"9Y
MP@XBKL\^O&O+]>2W\<WGZ5*;W: '\\F_?IM?7TX72VWZOU]G=_]N:U-6.KPG
M%C6 AVM=?P@-"[!]&/^26)CHAS]WS"!Q@QGZ"$M,352XK.R13)J).Y>#WJA<
MEM9$T\9>EFHT$,6-1F,2YZ ?UEEY[K92;E%_+I-@UT/:^.D F<UC5(.,LA\-
MU_'1FS"U24$T4H=S_.2Y[2)U_W3@>T&!Y9[A"5\CO#YR'>+_^6'Q:%=YM2[!
M*YVQ5X&943X:D.6\1+CB$4,.1#FR+J-)/PT:2O$N(2FN2*KP8&E;#AX*/SM8
M3A6&Y<]1@?C.D(FGYUU#0WC:H7/&80QEH(<]W6XXC_@2K4UIR)44[12R[(J9
M A=3^W(PE3"0&+61'/F/39-(3+=O=<N<.1/]P?)UNPJ+BFIJX5+!3(+1B1R,
M%MC%YP!SJGN.Y:QA%3BT\FJA0N,B@>-4TE0-[^G"&81!LJPJF9EE2LD7/?]\
M.D-X+&U9LV+:^K)L*EPLJY+82\B/ES*-A%_<.L"_9+1W =86/@L&S/EJ!3S\
MEMT ?[Z*OY$MV_DJK%(B>=Q@B_940*<EBQ&"S2R5. 3'6QP,(0[!N+T7C&#,
M8H3@F40#&-)]&6#J;A&-KIGFY\KUEL![M(S25S1M76JTHP*P#5F+ 'T[*$"_
MZ78 VN-):T9].&F<16B^Z\K $M- ?E@"WP^7S(B WRU_@P=K$A[[ T"\</B*
M)K7? ,0Q _/5 GWP+(,XSA%#XR?=,R'W0-I)KRHH02^"B'3FO1(ZPSUT=]+K
MJ]>9W#3@@RPOS5\!#.-![UR*NX)P7 BN6@"TEH"6#R*3&5K3!3#<=8@D,:PL
M1T_7/:N@8KT)(U*S<SEJAMZ<F6.X6X"CU^DZD2NF$( YRG>N))$C 39"./HA
M8U"P4G#, 3CKJB#Q&NS$,#1S,C6#@3FL<M9](3#DAKB1)"\W<QU'_E[0SCK7
M7._2&E,!SS;\Q0#+\ILS5G:"\&6VI3Z\3/9B='>>JB'$-K*3N40Q8N]Q &G+
M&+'Q\C?MZGK^>R>1<5(RM83".3]_>W;V#@?76A!'*2$ZT)>0()R#+2'I%XT0
MA7],D_6+%A&&'Z1(TQ("M)@XDI8M)"_S.$=@!P*FY(E)R>!]00; UW E#=72
MHFKB*:N?(29%\X<\S5%K6M2<1MHC4B<M:G&36MRF>(9J98])\7*>YR5N2(M:
M(FQ$;6F9QKH(1*_.+9/0_O8X3WNJ/B$[UX)X@GG2S:0('N4)CNL3:E,M:%$3
MXBENDG(FQ<%)GH-T>UK8(&&&_![FFBP;KH6R1$M1DZ+[M$!W6$E+U>J ,EK2
MFA1E9P7*=I6TN);:0U\AQ4R*^[=#&@*UG^+BG9PVD)B()B7Q04TZM)]"0KN1
M-S,33DHD''.03@EMD LG17UA-L([@G?*4_/D."G6"I.3FJ--MQRR\^DD;+PK
MS%,*@T^W[X'$/#@I*10F/W(-3T3IS_N#1ON#1B_IH-'$UB&.5"-[G7R'C(I5
MU#Q@5.1#^N&B-$E51UC*R@[K6!%-M_('(DH8D7Z>J!T20SQ)U!B-7HX04?;O
M[CR@H_'_^<*R;7B-/1YS!U!//N JS!KRG?]TO4KOU3&9:'M:B%O4=T]N35&G
M:J@KZA03;0_]\(L:E:^KUYDZ"HL[S8;T8SUX>PK_CU>+C[J-)__)=CE^0-8T
MZ1]2)1E#1+MFY:/+/3]NR:G<DT8\KI5)X.%$(^C9C>L8X1=&Y%SC%A7"O#F3
M^;--_>Q6#R(G;<K74=@F&82O0]O1O/=Z[+T>@_5Z0,]/08.^);"@+W\BY38#
MPY_'IT4H3@Y4M+RD&KX-*OG=N#3X9(Z-8WQ&A[J&3B@O*R[7H4&5*DWX92QT
MX\KH"8$A.#($H"#3A3&[N68N[%+/)4[YV#I<7,>EJ.[('U$>+'.+#":>^JS+
M1E=<K[J:"A-K/DY:+99HZNH\@NATR\RY!/?^$J#9.IG"WP:(&KQK2M-DKJJJ
MB)^/&TD+&/;5$JFE12&2J2Q88;>YV7_H),=U$BEN"M%//*&4AZE8ROWB9K^X
M46EQ4P.>=+K=Z^@N:/:.+KV&&HN>2C:D[^>6D5:UF\BJ,XC]W2I%XX!G,-N\
M8@$:PFI)-$AJ)) D9QCO4 =LBY<KII29R]&>@41: KS"";0QFE4YZ]"3?/&<
ME+G5G_%OA(F$$\>\17IWHV]!U4O736^#L*>ENEN6CD\X^SL=>KO7H8:]#<CD
MR]*C[ CQ;J CQ +8^"CJK>[YSW>(7:@;X<[?<_H)>_BHTX928TL=QC)(RT:R
MZI4O*SL(HU]?'1F0%>SY>R6A&9 M[0">K)G\,% S&3G4IC_PX !VKKHX>H,X
MT:HR3]=I0[XWN'H)F(.V#GN)L13JI+]P?=_=,K>5LD7DB[G+J5[:;9_E.Y&_
MT #."]WW@6V#J0.\]?/8MBVL0M?7$S8D5;7DHT0WX!D95S&2B%UHSN,[]X$=
M(YL\ER_*OA0^Q70B]F:)BBEBCS97QO>Z8[I.(65!#@1JZ0% PK7Q1V4@O]W:
MSUY?DSO,4UMFA2/S_.=]N]P6;'*W>8JKPK%T9BZ/TEV_?O-[\#!5.%C.SO>Q
MW\O<[V6JM)>Y#]3D"M1LF(=T'Z@I+%!3Q5#9(?A.A =JG@[42;+W)8OV)<L*
MT-C[DBM]R;)",_:^9%Y?\E"#,F+?!=L09DLI9>JRI$N/R.#=!Q]D%$29LE#$
M/9CPA68"'Y!IJBWT7O;Z7_U!FC.QFT7[S0J^S8HSH7M$D\7X<LP4<::$0BJ;
MH3N1GMCK+7T/8;NV#(PN0@YNK(?8,;_V +$R3.'6:4"^*E=O\]3A)\%$Z#[0
M9'QS^96MT>D2*FETFNY$>LUNAZ1([VHZ-9G"2Q=02'9ILA/1";V*,3F*A[=2
M=>=Y^@.1!/$NR )8V_O @Q0W?O8@7T5M^6:@[LG$"H:Z/1^:Z3PR17<Z_#Z_
MMZUUF+.D'B*T-A3'A<96JWN]!0=ZQ4%,8?32I"JK$5=E%6"KPT\7MWB7[QBG
M@D0BDB@O$G]U%<"HQU&K*[FI<)2ZZL*[T6 Y;54(M6A1'=!:,"GW)NZZF.Z6
MGLH#Q\=)%S=K,[N,HI)J&;Q\517$S\]-%Q=51^&&\,ZEQRQ1(."KJ@H$?-SD
M[WWN)_*OQJ48C # PH4?M6_%Z#(.L#Z/HS(FVU_]$<?2C?8Q=/L8NL'&T.UW
M7RMW7X7&S^UW7ZMW7V7%[KSVW=>.HN->PMF;9J=FQ%X]K^ 9O<:GZZ3=%E]U
MQHIVQ.I*MSQRC_88PF#[0#RR>-V%<])_<VW4C(UFC LT"C'F-7UT+E\I^*=-
M?<A#[OT 0EE<6/#[E0? #-EN#T"_1VTK[_JUZEJY-.1NSW3R,EU:CY:)5N82
M[%JVZ]>J:>72:+6Q)$;3;CW+J%*)J(QJV$5DM]HN$B/D@D>KJ$7W=;0(Y\X=
M58#649^J*4%'8LCO70W5+WQ2XC-]7[QGN*G/]&3O,]W[3%^"S_05IQ&5Y395
M/P7D0%RX T@C*LL3K+X.#<@K/8PTHOTZMY,+*</KD3&13,\MJ\( YL8]I9YB
M2:&M5UV>!V4>3O4_HX+XZI=;X%FN^=ES(6M^V45G U"DSKTD+/X'X.MMLFZ,
M6/J&7@Y@W@18P/,5*5JE0,)[4TV#A M@ $[<%CS=N.1$ 8B_7[G>"E@]:A4W
M :](T;AETL5Y@<9V-G3GS!PT8 =D!D!..-QM="=B8Q[XT-<=TW+6YV>464]O
MO:N@3KT*I(O##KT0+U.3]GJ4$X?<HQ;"#._OP%IOT+_C1^#I:T#FCI=(S#N'
M?0\#(@<-*BB?!+&T.E$RL%5A6TWLDQ#5U+%/V;0Z8B/=,'Z3;16Y"5!-!_N0
M2?YLD5JZ1UT-#6&0;D#3*]+0-F**E/9<^'JDP$^XFHY('*_7'E@C4F:.[UD.
MM Q"#^=ZHWW;*FB'0'9C!ZS0N/CFM!%%I-X^+Z#=EP_OCM486J$ISYK3%8Z6
MPI&-FWWYP,:<QKB*]SHV(FLWI@B'-M7RRT<WQ6P,L'A78-OQ@I;M253C+Q_F
M++\QTH./+CTMBRX="8LN/=U'E^ZC2U]"=.G,02\92)B.+IMDQYHR*RD5><KD
M1'H,(86ZJF# BFJ#B SET#L^J 9S-T078 TH!%,P8&K<%L%,AE5UY3!79?D3
M2"Z]K9.@K1!M>2(I6NXS<("GV_AV2G.+Y K]\$9"3OPXJZN)("=S"8:2PM7&
M-FD7F.7[;Y5)$7GKRT>1>^+)RY*<JV'K+]58]X^^/Q&V9-M?2+I?NKVHI=N5
MY>B.8>EV$FK%7K91*RBU9*-R(7VY1M(,KY!=VMU18#GK^:J$8(B/L\#R1U4+
M!K&]#&(Q6*').040*P#IZT;UM&9 JU)YFJ/& O:U)MR4]3*_VH2;:MTO.2 +
MUC+AYMN!&IY7G+5"UJN@?L:!@=C! 62MD'5[K/HZ-"#3/HRL%1U=B-M:U7!T
M&)I^L\>'3"&E1H<,Y1DP) J[ZH7,%1N$-2[1DW)1%XSH>X6$/2"S55/@66OS
M8:#6)CZ4&F;3G4$8 '/NX7_Q.WSQ7#U5Y6]!*3O%SU8&X^%AB FM>N7X6QB$
MZ:NKM+6@37.[@_;\Q4,[($/;$[P9 SWBV>*2$VI3>E\CFOZFG[!-=)TVE#+2
M=1B3_BZG2:IZ:\O*#L+TUE='!F1Y,TM>0O6@&9#I[ ">K)D<#=1,[LS%Q-8A
MG*_")(=,J\BHHI019/ A_<5*DU3U8I65'83-J]2M'"!EC&1>(/60&)"):X]&
MUJ*=])J]=ORH6S9^F:]<;ZG;8 F,P$-2!)"9P[:ZFOQ S2X"-M)G]:IED)@[
MH:?@RU+GPEO/77LZ^\XXGHKR<6N6.SC/1R)[H<?4HT.83#'GRLB7:%\YG7.,
M)Q (/5&.>-A&9V+)(MHQ*HP5JX)\<$J]T&FILLA/1"ST3/>M!QYTRXQ"U!'V
M)#7@)/ \K!@0 I\I</[J\L5?UZ.5N0">F\\$IV8)%&D7JSZACI[#OU?6(T@O
ML=@WKG)4E(\-QU6L''PDLF^6-[#.*+P,MEO=>ZX_"N<JJB!['CX2V3?+CT>1
M_97E01]C;6SHQ\-PR;*"*LBVC.Y$ELWRO='R=P"TS#!YA%E:4@5IEA*>B%-H
M)K+]=2"=70?2U%=!O60;Y[-;75H>,% =]H!)*RP?(;JO.'OY=CG]B6Q%'OZ%
MGI_R :%OB?\'?2E(?K+1+6^K.U0$4*6J.BH P<%&@H?09>O=DWNW<0.H(S-(
M)DOQM-= 7]"\";^@%1-&_@;D0\$S<>3G)\%$Z#HV9_*^(B'!Q7)<9[#(UY$O
M>4GC15X0"61B<YT!SP+P#[3N6P&TR O[KI@S,6K(AXONA<_.GQA,)*(6NK2]
M<'W?9;LSLT7D"[-::[,4)Y(3NC"]<Q_8ICQYKH+,4N0F I.9;7U_+YR*F?R'
M<R^<,);Z4IU7K#6#N 6NP$V8#W0<^!O7L_X/F%\=1",9E$,FL%&%TQ_ ,RP(
M;M$T"2PP]]?N$_#"3];6\NNJCZA>E5<F48)H=<F;]-L;]C>'#/!>AKHWAS1;
M'75DUNH:)/60+6%![7O50GV+1\N=?HVZ?NO+>E1-&3H10JL;TGJ_[#$90\,+
M4&E.E!X)4$&+^I9)JRO.1"M5./LB^AY&:S"60ZT$Q>CHQ2L)@W?)=X[A:79(
MTF7@6<XZ)"NDMVP3L<K)TK ]%32@)8N=W--5EQ;T?.7B#3*#?@],NS950%(
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MAY#'M0= >#Z_="K9LDT5=$  FS&<0MV.V<C5;RX^<+O F@6I$[CH?&=%-55
MJ>9D=[=.1T>UX>[L<NA-(J\R1>[5U521>S4GL=PE>= B K%6)%2RG&/4"BI
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M'S:^7?Q#CE+0)D>6J0Z(O2B?!^Q1!5+4V,LQ7&P- ':/JE0& "9F2?;(#^C
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MUXJ3Q.R;+S"T(SG#?) J-5@Z S8=UQX:H#Z6[Q<NEUN=;YFHUY07.TZ7%#P
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MA=JNYM"$K LMQ>5MMJLK9C[! ELIDS0+6EVP#XB^Z/04/,&ON624)*6S]#6
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M;UT?T5F]U")-Q,-C3TY< K=Z2F9&.;/U2.?\UD;&JJE'^4#"F(]>B,"OI!!
M2^DS*+$92A_CT"/IC:)[YRFTL4Q/Z&O\P:NNKDW$:J#4+&X*)3$ENQAG66ME
M;C 1E&1E+$/I(\3;2Q=Z@#*3!9(#*O K*0W0XM1BZF'OH?%H.Q\3C<*=']O7
M'GSFZ"\B5(.E>C%3'/&IF)_(WMI3G2\\RLI7Q@_A 83I?$P1DP"&H F;^>0
MYU=2B%K4X*U&7I>-';QB203(J2-6@YYF<5,$B2G9^<;2FB"='JXV,G+VAT"
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M_I/,/.F=?_>"DER+)])#;_-\>"Z>8?2$TIOH(8O=WY_CT,.3Y]4_MT'V-A]
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M4JKEJP539>!"%;F"W**?@[N!L$O>]NO[*>]PYJ))D?OC4_SZ$;E>8;+>1&F
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MSW6[,_I/:9.<57FB!/P.&_FSP*X]#23.KH5A^KJ-=VM<8PWL?N%EJN^M]YM
MU7U9_]Y\X^QBJ;TEQ&U)V?6I/F3R1;#=O*>])E*?94>V"FQ5\Y$H(01CEI>I
MP*<]%L1O;UTO?A&GV2EVTXUO $FU3-2(I5B(NLPOAM,]/33A:.9PG]]EE4ZR
MW;N_!"!$LK8T#3FU,&I/%2W2K3O9ZU3L_N_\PC@\M>/O\&O 0+[E+76-.Z5
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M/N48KYQCC:'/P$DU36B6*]NBK4*'$J:ST82ROTK(BY*]8I&'I-;? @HCC:)
MAY*$1 NN9""D&\E^A(R\W#DO'\4+/8R,E&]?^V0U%8.3;CGWTW($9RHQ72=<
M=Y>_T!^LWQ< #D*:(\A6DR:JEH.J)HA*GIQ"X^[1*XJHIFU9 NBZ(1OB'OV4
M<WF'3A^!J!XKXG+J3L*R?D812F"XCKRUMPFB@%@4Q.W0&UK!4AO(GN8)8ST-
M9&L00&Y/_G3,93=1B+>[_T"M9CHI414 LHSL9C)0P4GJP##I,9NNJ&D\I48!
MO$8P#9P@#+*WAVSKO74(MJ,TT*"%FC&/"Y!R'Z#JL989EV+<MV2;7N'!]_1V
MC<CUZVZ)MQ<&AB'+KK@Y&+L%WH.G>D"%QZ*Q#O-VD==^:MR[;+#5Q])Q3$]<
MMR]UX1@(L7IP9&FGX?D*R1"R5R\&%,]"]D(-N'8DIWC%@YS,82C/V/"XQ%9C
M&+^0;NX^?8NZ5O6^:L#7/&F9JQ KLDGO972PD?.^\[ZEI*<=XF^4 S[29($S
MBW?+NQO**1ZDV,?!8B9O(C?>H,]Q6AS4[+KP&%_$41J'@0>[[VD,;09X)I*M
M)0Z'T4AK+TU,7V[.>)ZR=5+TSRT9\J\HOQV6'XC<PJ38C[4=K&B-@Y5](ZNB
ME?W!RFK?$)\CEB-T#$<L'36 KD$#-BX""GW$HNF^:XN29J%/KBQ'+"6@A1^Q
M(%OSH&C.FT,)LQZQE%"X'[$<Z=<C_A3]H*6C G UU_1%&31#R.G!P_W0I:6#
M?4<OG56 [.B&)0I+/9)GI>L(FFB$=9[@M"/:'85 6S>]ADM%&**.9,Y"U1$P
M[F<\'&('%<G63-%B!)J+4CN;8X!6YTE+<R758_/*L+R#1#G=*M%;%9BF(SOB
M)L>@Z@$[.FY'4+/=JMGI>PF3I&&E6$:T6D R%5/@2\%TREF G>2@J]7'5KL(
M=N>$P5,AO4V\[<Q#/K@=X#N>9HE[!-E.US2HQ\=FW;Z4W6_('^2!HW___U!+
M P04    "  DB&9;8Y \>C4" 0#C& T #    &QT8G)?,3!Q+FAT;>R];7?B
M2)(&^OW^"EW/]&[5.<)&XMU5[7LH&U>QZP*/H:9G]DN?!"5&W4*B)6$7\^MO
M1$H"@<2[!(G(/3M=-A;*S(@G(B,B(R,^_W\_1X;T1FU'M\Q?_UNYSO^W1,V^
MI>GFZZ__7>_<-YO__?_=_3^?ARX\!H^:SJW^\]>KH>N.;V]NWM_?KW_V;./:
MLE]OU+Q2N-%-0S?IO[Z\/%W-'G?CGY\_>N/:Q'0&ECTB+DP#WU3*Y=6<6@Z]
M).?0_L*+X/?K5^MMXWNJN8(2O*<_L6U8WG3V(C:;X$W!7^&+:LG_RL*0[P4V
M<Z56J]W\1)($[_WIZ'$/JOF\<O.O[T^=_I".2$XW'9>8?3K[%DS\S]4#X%^#
M1R-/ALB>+]S@GWO$F;\9_JJO>3XR$_BKYBY2Q7^X=./]<>%1/?;1LO>H'CRJ
M43V>T/"',(UOS<DH?K*::]^XTS&]@2>HK?=G7[#,+;YCF;FE[]ETL)(JY1OX
MZPQPCE54E<HZ$GI/S)!E34S77@4L[X\+:YZX]LJWUV[@K\&#CNWF<#US* Z(
MTV./SOZT\&8@P-(7XND#WU%S^4)(/.!]L8,L3MS)O1(RCC[H_V'A8=K7XDD"
M?UAX<#!8\2#\8>%!P^W-"8>_7/>M$7LB7RODK^X^#RG1[CZ[NFO0._S[[TK^
MKVL0UL\WWF>?_]]<[L'J S!,5[JW*7&I)O6F$FJ0[\1QJ9W+W7T>49=(.$J.
M_C71WWZ]NK=,%[Z1ZP+IKJ2^]]NO5R[]Z=XP57!S]_G&&[MG:5/)<:<&]?Z>
M(X;^:M[^,7%<?3#]-(#OWBKYL2NY^H@ZDDG?)=L:$1,FK^EOP3<UW1D;9(I8
MIY]V><VG$;%?=3-GT(%[6_DE^-767X?L]RM)!UKC<A^:_X0Q]9^W.&]J>S_J
MFD9-]B.,W/+D1S+)"*=$]=N&"62<WL/B;6(T38W^_%\Z]0GRTWU! 7N$:2!#
M<GD%_M^UO)]K.6 /&UK_^9:KELNEJ[L\*,A\M5@J%3_?+ RX>OPZ\$U#WCT:
MY'7[<;U= <=V;WN695!B#HB!&C,TH_+5'?MPZ\G<LQW#?=2=/C'^38G=,+4'
M -1>]*A<W>5RB@KRN/7X 8Z]"3S#7RWM$3YS]II ]>KN'X4]Q\;%[S]R[>H.
M_[)B[$>;]'%#]P?W]<SM,^AK"O37.J[5__.9V&V[XZ(T_Y,8$PK$Z R)O<2*
MNM,>P$A%C\Y7TL34O3_\Z#P\L^=A 1KMZR/ P:]7S=9C>)X5T"_Y:\!L,-%@
M9CO-U!NF/G&'EJW_AVI;SC ZNP4:5I2K.R7O_5\"TVLZSF3%U&8,W'IJ*I M
MW3GM3JY",G-J3UPTI=!>3FABQ>-,;'<NEG:?V+TU&EGF\>2SO)]\AJ:9DG!6
MYL)Y  W3@APH?J5:J19JBIKVY':''>P-A7RA6JQ55[)U<7,"T_+V96)0)=\K
M*77;[MHCT]5V,Q?FXU?SNQ@%.';+,L/#US5K#*#?>WSEP/$/7+ZZZ_!)KAV4
MM&M/MAL;;?U5@W<H#*[M-85B0E/H#G5[OQF4ULY@A6 RJ?I"'*J!B(ZIZ;"0
M"$R)F*\4S;8OT_DCSV2*']7?B:VUQ_A@6(X]L[)I]L%7<N@#]?Y=M91*9"G;
M2GH5M+=:+I0+NVK(TZRU&%IK<>>UPH90*E8*Y5T5[@MU7."^&V,8M:C;'G@?
M/%IVE_S\37>'0\O =:TTRP]@%^P:JJ* ;BZ?<@V'L:&&;"C5:KNRX3>*WC35
MZF_4)J\49+)'[0?=F."BEC?"NH8^.Z(N>2[48'M2"Q7P77?E0I)+.(@)->:Y
MU J%>11@PQ(\/4L--";!KG2G70S\>H_41QAL<P!CX)'VAW5PR.D;-:PQ3K[Q
M$]7#UO+\.XL?W==;#S^^4R3/HD&Z>D5[.#R[3S@&-]Z$'QL-;;?Y[N ,I4+[
ME4O9@_9[^$^';B!?X4'7:9K>[O'5MIRMPR#>,I<TX@]8J//2J7L+_]VQW=^_
M6#C<X$&W:=^U;.=^2'1[1,P(;38)&U@3I4JMN!.[EZW\+3V0V+4QNCF=R6A$
M[.G.LP<3H5)5JN6=-,6NTU_'FL.F7UFS9=XL!E^92T_-/G7N/N/QSJW##I%@
M&(F=#-UB#/_7*T<?C0T\QV&?#=D!!\X[%T3$KW\Z&HM-+[V3_>I8$YO]Q@Z,
M;GU:L!FO,4Z#QRD+!0>_Z1K^/M"I+;&ITMC3NOOF_RZ&?9>_?!=\M/CV,1.M
MX#=@G^UBH/5N/L7@>_._S::IA1[%%<R'\/X2_!X,<K- CK744?)SZL#/:N5W
M7ZG\WIGT'/K7!#7?&_S'QTK*M/-)0%]117F_:C#8S[&A]W5_#I*FPU_9@>]<
M RY.%@\YZC]UY^INQ0/>FS[?Q XP(^!L'KNSE-%U.Y8RLJ?%4D!66;#TZ"Q%
MLB?&TF)(ARU:=NV'[WPS\86.+=N%C0I- H]]WI8VFWEJ#"MNKU:+":O5U::X
M8-A:AE5.Q+"5AJU@&*^&RRJ'2S!L+<.VE;"D&;92)=;?B&Z0GD$?+;M##-JA
M_8FMNSIU^&;CHVX2LZ]C#@DX6"R3(,3,3:O*J!*-ETG!X@Q)<;PE*EB<%=MU
MI2DD6)PAXTD-L1@3U3T6=]^M[M":.,34NN^PDFGCKPFLIFGV<5EO]-F8!6PY
M93;.L$5&-,3A[1>5)J_5[7F-_$A28ZLAC:UBA$_P.EW5O2VO?7X<SNO9L45(
M70O^)L9?[[:)&[/;!G_9FV4EP;*T659*F&7L<#!?W.94DU,NK3C]=KY,PW_Q
M> BKO%V_RM0DC9'Y<+;--\)":",LY-0:;P>!_A2WW#IP!0F:"4K(L8.?594_
MZBC;^T1L!>D'K[8X7.=4!\1HZLV+N:BHE>!M=L-5@K>9C%,)DRR#02O?["ZP
M/5WP.&6SVR=SDF9W-:2"JSFE)EAXA!A4=7NUC#Q)4BU70VJY"DZ*X/<1U/*V
M_/9YDF3,4<CT,:(A"V)ZL%IFNW/8>E++O/G[_A2WMC62/319D7#I9>)CECS>
M]\(21)R??OX3G .\_Q3*,UJYADMQ$P0KS\L#F+.R'&(E_%SB4&>5MZ<.KB!)
MZI1"U"GEU *'U"EM3QU<05+446ISZG@_JU7.J!-,<0OJ!"M(7TF*.-GY:LWY
M"3/:_!X_EVU7_X*F=_ILC?EFZ2Z&.F-X_&I7,OD0;,V(EY+][W/Q</M_5U1\
ML5S7&@E@[ N,,/UXQT:L]^/58N)KK]S-H?!+$B:D3]>=(^U^[YU3B6)[X_S&
M9=SVN;C6PV7G7,(PR>02;3I\]@LSG!]*%B:>ICUU]#/E+8HK"/G/N/PGEDNX
M8X*" %86@<5]C/39IF.B:W[EH[JIM=TAM?VBT77'H9R7D A2C5UJ \:\"FUM
MFX5*>P;],ET"XK;+S6B80/#]B'Q/<5-9*<["J#P+Z1-!5ZZD:L^:<()%6WC3
M"Z&9!*QI15T(7(E;.L>P6Y7M[SLN7.DYV&XMA"ZMB/30(_&[L/TUG*5<TH3N
MK1="]];]N\P=>!-U_K781H)O;K-.$OB=>X,XL,-XJG>NE-<L*4T#".F[I0&4
MZ-5E>!]>:1/!CXL)?BR::L40[I)P@(HA!T@ ZZ* M:S2BMO[=&$4'C>I9O'(
M/>YT^HRQ%UKA<8&WSV'_.481]KG**A"7(<2=ZH+MMH@3.^TE[+0G1.'2G;-J
MX!=BVRPD&H"%;V#%Q.5B9I\F]W:[099H\G$\]QYUVW'/E7G1R5\4[V)CRL^V
M]6H3SI-)MPV0+RPFH[R-]U^\,E[>?Q_U-QK>E,Z.MYL7DU%/(:5&3IQR7MAM
M9XQ"L7N<)6\+(=X6<HHJ-,S%:IAMRQKZ2$D,A7'YM4$SK*_4I#8QZJ96UT:Z
MJ0.K"!8D]=/ ^$9;T^Q;(SH[1'RR^E[+QX4&65NM,,7$ *[Z+PFV'XWM/)5R
M%&P_#MM/&_Z+F)&"[4=C^ZDLS'5[^]H.SAE@^A;KN[1]7; \JWOZ2N4N6)Y)
MQ;[.C!,LSY8)M^WE"KY9FU!&RAX,3.,VQ;9WD@1/-O+D:%?[!'_.:)^+$[!S
MJ+-TLO)&*;;<XKWHV6EJC25\<U+@_ 2MY8H"YT<B^*;-66">K_UW4_$=P2]>
MHW_Q_!+*C3-.K4X=%)SB2P>NO,!Q7V\]_."35YC*\FQ;VJ3OMNT.M=_T?IA?
MH9EG*E2VB6./C0:G+O\&ALTGGE%^Q>M"P2]>->)2XF)PF0@/UNFKWL>L.I/:
MSE ? Y7^H'VW_FI3%M3GDY_K[AAMO:@T>;U;>F"B5QSB>?V%N"XU#-H DKQ.
MZX:A8V^5IZ=[OAF\^TW5]>O,*,_#^EC)*67?XGFI/]3YY.\FBV<^<TXT,E(U
M?;]/[*!<>G\KNZ4+?G&98A,IFQ<<Q L?,,G"=PGVH( -,3_?MP275H;X?4(E
M%N)?J=H$$[A5;JM:>0J.\6D^K R8"([Q&S*)=ZF$&\T3SY-QRN99-/@^#AJ#
M+6:N*(EL]^$N>6 -!]G'BXT"G+A. 6?7/.\+,1"LG2&E*W*2MU_U2J!O/9NX
MK,!CM=!+,'<V<*-V!\Y%P^0P)J:5 "V8>$0FII#M>9 *YSYC@7_]?93>N G*
MO1J.@0D3-DW6J0EW %GI.S9;3WPR;(/G.)LW)S[$<5)9!+<X3&19&?L4W#JG
MN*?@%D\QS]@[238ESL2>?M$-PWG"6\#=H4TYO]V\J9_-VD6=B2^Q<#@JN,2Y
MV[Z*2^]6YG@4+"DC<B0XQ+D,M<W,Z;G9DK(A0X)#IY.AK<K8N$0WJ=8@MJF;
MKYR'C6>\\OIJWUNCL67"K\YR[9JX1671%5['VKJFZ1AJ(\8ST;6F>4_&NDN,
M3'!X[=HNC=% I)%EGE.KT?7,C:PG4PR=&S9E>!]W:0OEA,^\RF*W2=AZ2Y5#
M8M,X+WX)W<\-7X1=S;6?*LSCU#5=JOP2FH[?RH]"ZV4E#6(E:X6ZO!!&"SU[
M3@Q=D>8M%#$W0?@5'!+Z]+SX)=0B'X=9ZSNO"*UWZ"9VVDS!E:P5ZO)"&"WT
M[#DQ=%[AF[_#K&+"(=ZB.,Q*ONYYJAP2F\9Y\4OH?F[X4N-1G:?2E4*H<^[:
M6*S@D%#GY\4OH<[Y: >SOC^QT'H).%X\=2(1ZO+"&"WT[#DQ=%XY%>/B?-G8
MA80/40KB6#+Y.K*I<DAL&N?%+Z'[3\R7U?LS!ZK]Y)O=Z@,?#JESJN.PF+M=
MO%'GA!>EBCP:2BE=<^=KD<EG="MY[CCI3VJ_14Y,W5OAC\[#;%DC=E^<WNF.
M5525RBW\+?AZ\*?@=_Q^Y%V=(;&I$WF=+WGLCSN]#\9_7GJGIK\!Q<)/MB8C
M:A/7LO=<1>3[^.$#-:V1;L:]=MO5++SB9G'VZQ;]#"]:0<(Q_+B>@#?ZSUN8
MES6Q^]3Q?AU2HC%PP>!WG\>2XTX-0.ACN]7-=9K_U[B5E/S8_22Q#Q[KWYM/
M_[Z57#"#',FD[Q(H>F)^DK[77[XV6[=2?OSSDX1 RA%#?S5O_Y@X@-[IIZN[
M__J;4LY_DC[?C.\^NZ1GT&"D 2 OY^C_H;<*?/E=U]SAK9+/_P*+='N6!D!W
M87JN%CS_I?WRT'C)?6EWN^WOMU)I_%-R+$/7/EW=P"K8L^N>5Z//W_CCW+!Y
MI4\$1H.D!^F#6J VC/'9<6W+?+W[T6IV&P]2IUOO-CJ?;_Q/CS-VIW'_XZ79
M;38Z4KWU(#7^=?^MWOK:D.[;W[\W.YUFNR4=>4:_U3O?FJVOW79+EAZN[Z\E
M-5\JUHXTB>.P?4S,&)FJCMTY%1[;+]^ESR#UIF4RQ:;W)9/@CJ11_?;!ZD_0
MY<#BLE>2OR.\T,&Z[/HKII3TGV^Y6E4M7MW!GO,/IE?F(]S-J!S0 :>:,LD_
M?"?VGU+;I!]#Q%_0.SW+!L67@[GT=?/U-O\I1#2<04@327UJ&&,"7K;Y^NM5
M/JR9@K<-J?XZ=&\54$=78>WCO:7XRZ<W:KMZGQC^1'NLXCKR;1S#-!R?_3H@
M(]V8WBZO?T3L5]V\S;/!-K'S'Q.P::EM3%_HV++=[3D[L.P1<9&[,"_:ASE;
M1H\8A@6K_[G ^!)BO%8IEC]%>3]&Q:J%:9(:*?[QH_[2;;P\_5MZ:3RW7[K2
M\X^7SH]ZJRMUVQ+HI"XJ'J4@M5\DI?1!^RBU'Z7NMX844E<S556_[^*?E5JA
M.%_#4;:+HZJ-1\N6W"&5_@I (GF&H03N#=5NI4!S+*@7]B*-]BV;U<(&XP(D
MR=!-N@4:G]GK&Y[SM!<6;S4,N,#WAAJ93BD86N8"&,M7=QTZ=KV 32$O2_B>
M&)WD*:$EU72D;> R-1$KD\TBE>FIHHJOBHJG547=EWJKTV0*1^BB'761.X-)
MH(P&\ KI]_#_2:ZU^,'Y6W 8(=8=#"Y+CSIH!\ M:+ $57"#!0[PW=ZK][+Q
MJABE4'*%8K%:V:14^52G,9Z9)[DY@P[<6S)QK> #FZE2]HFG/LN'Z> E7U29
M^Z)'<('6>PCK0?-"7W4'Y=+%[N9[ :=V=??4_/JM^^6E^<!<P1=0BW54@UO!
M:*[S5I,Y37^B\9/T7487R1I(]HP>$G$D9TS[&*/3)-V4=->1^D-F37WD0%L?
M332JI71$P[=;2A'#Q;7&QY&;]:+1-$$)CWT]S X#[ZV)Z=K3>TO;S\!E%HZ#
M;QK;UAN.MVCA8CB]1=^(1E9ZVG&V3F!&_I(&U6)C7$L3.%L6=\G/IA^'][K_
M[+]_XBE!3<DIM4JI7%*VX-\&E;?"D$V=<'1T]X&!70*CS<)F1](?$UMW-)UU
MP4$=^?D&'DHYZ 4CZ&'Y8[.Q7XFI_X?]_G$^"1^,IX'^*=C3O'ZY[EQ+C='8
ML*; GR/Q8U%2I)9UO<R$['DN"9OH=4VSJ>/X_SS!5Y2]=(UZ=:<H%24O/1OD
M/T2JL]&(]&#K;W19]<BKX\*K)J7N-:G"U5UGHH/B4//Y_+ZSN(<?VW;7>C?W
MFD/QZNZ%.JYE[CL^4WUM^QGV9] _>QG$A=+5W3_KRQ/8<OQG"^P#X__T\6Y&
M1FCT\M6=FE=J$0X<UX=CBLI?$^X98QO(J8^)(=&?M#]Q :CP,2@3ZGR4/L!Z
M)5SPQR.H,A[5QH>5X$!YJ-N4[ V'RM5=J1*Q1SZNAB,V0C2>AY9Y0#"A4+VZ
MJQ3R.46-:H(3X'#NY/[7WZJJ4OGDP+,&'>,B)9.M4@8/KV],T+^1"- ;%IT=
M.'9 XFS=U>%KGG]+;7!IQQ/;F:"CZUH2/,$V=47]T/N(\HKANGK?O>4STI-,
MX'R#VU+(;Q-23YHD7=TU6"2B0?I#B75XN%WM]!5^^23U2/_/5QM<4RW7MPS+
MOOW;@/T?I][@B<AJ$R;;G>FH9QD?G(^"J(<3M>4'S1A4&S_[0V*^P@>F]-M0
MAT]>9KKF]E"W]PB+V1@R\+7H5%%[3$CWVAAKWG$ T(AEC,O2W_/7^;PBC8DM
MO1%C$C'?MXC\\(A7#OGGJP!/ ^S#O"+L+D_=+R^"10>RJ O&Q48Q"_3);N<2
MR]%6"F^)!EJ+"BHO1R-_1=PT_XJ-A&E&U%T5M\M"D&..D::I852'2KVIU!_2
M_I_2").LWH>4Q?_0%@R=BWQ0/DI#XD@#W0 KDA@&_!$/_=&X_&NBHVD)%F6/
M^@_ .V?690'#>-ZIN&]CADS3V08"=B?^&4_%)0W^"MLV/CJV:9^R35Q1)98F
MXD@?X'W <LF9P'[C#"T\G G.EMTA<9?G_DX69XE3]+[LK^&C+!%3DSZHWAI[
M !SX>^\/6 $^SQZ%+^$L_/=@_H/#)L$F21Q7JN4EC4R=ZTT^O]]&WLN90-7D
M$G?B[*6:U*N[?V->\A*:_>0M#T5^IJ[W3\N29ND49^K?[ M@9"SP=*2[+J
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MIOBL-1H!!S=MN,5(/H7WQ7/<;8L1XR&TEJ-MM5OMM6L6$:UVN[R()MN54UH
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MBW*U&!-K2!N87!OHBU=YSB4;X:+D;+681>I8AOGG\2VM%EJE?$DNE\^C-X5
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M)7_FR #><2L1XYU,'7AN"^S[;Z.CN\]$&MIH.?P-K!' '&,"H.D>#1'6[YW
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M397+*G\%;2]TY/11%SD<VUK5)66@5N5J"<,%_)VNBCH,6?/N4B40#_Z3 (H
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ME:A@7)QLW B:\ SFKN7R@>/MC?GL@"3>)]JGX'# USGNRL= 3Y 2"][0GSR
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M;DJV*^84-5=0TNFM794KU8)<4U3N+BAR-7*2Q_%)HBF^^NWF0_>$,!5S'(^
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M+5XY]9BU8]7==5CKT5<TO%G!WO[$P?EH](T:UACU8] B ZLN V/^@Y^-J L
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M1 A",!T@%C6U( V3O5IBU0?@;_Y+:[+$P.K=P)R#2YO8"STK=-LFFG<5)+C
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M:,R9'SS:-/X"H)P,2!^BB3"RB"KB44L6!MC:S4_)N!^B$D)_MCY9=S$.9WP
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M9([93"&-\]B$/1CQH/!#9N1/:A*,+8< T9=U!TZHW&7"FB#N&/@KW699)O#
M?5K7&OMFR"J</[GH>HN]0.6YWBTU>5S**XH;8+X27+;!-MJ-L_RLSCV</8G4
MZ"K-7[(\-[+ "ADDGAWS;$4D+,<=#D'@XB#7OHB?A/#IXRRG+)KGF)T0*]67
M&2(O(FWF%&N^?QD]'[TX3A^5+9^XW6JT"\;*KBSWCPK"MZ\%D\U1[VF!*#)
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M_B&--"SX*>(VO7J>;)KA;=1N%J@T#U8PA0B&H:/?C?M./Y4'3S>D?P;G5WN
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M-T-6\BKX)KX*X53*;[DP8J]Q\>BYN+@K#V_Y./P[77D'^L9+&&.E^[ZCE7>
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MY/5SY[?=\>Q'*(1G/QO;4_T1:%D1K.'9(?9O ",X8K62C6*\:UZ*W00N]H
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M M!ICK$;BI_@5[XJ-I(C& 2FE +!6 \ +1F%EQRD+T:N#,.,!<!#\1/=Z9)
MI5] YS#[#P&% [53\!A(_#=S%@W $5_[%(2>HPE>;LP7PI$]QSQ2<*R'P/9
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ML6YZGZHA,[& K(UP3X7LF8?A"'I&%Z;%HF)..R-,ZS1!;$PCZ=C!)!'L)P\
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MDMZJ#AHO E4MC;MR4[7!(.$<Q:= NANY^ 46N2$\;-7H#?PN3LF5X$445@J
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MP_Y&K"-HYTVF253KU/P-.W5D:RPS!4\:]@8+ OL'N91,EY%>:F-WG-8BV1W
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M0$(F<CV7Y,K?PCM6JSR=G6JDTSZ9)CN3*YEM4U<8H"VT8>^/\.MA($*D!0X
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MRAO&9'0].ZJMI&G-W#)K6:6YGF7JM367I[YCA2<VL?K(KL#4GQ@5*WEP/[Z
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MVOGB^;;&\QD\SPJ0ZG?:^PY02P,$%     @ )(AF6^+[/=L6!P  *"(   X
M  !L=&)R7V5X,S$Q+FAT;=5:;6\3.1#^*[Z<0$5*:-/2XY2$2"T-)1)0*/W
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M:NY,>^9?F-B6N:<;>[E)-%;5Y#>I%,G=WQRQI5C_A71G?=&/HZ@*SL;W9QW
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MOU!+ 0(4 Q0    ( "2(9EOHSG9#'1$  )"W   1              "  0
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M+3(P,C4P.3,P7W!R92YX;6Q02P$"% ,4    "  DB&9;8Y \>C4" 0#C& T
M#               @ &FP   ;'1B<E\Q,'$N:'1M4$L! A0#%     @ )(AF
M6RY7I#\W @  K@\   X              ( !!<,! &QT8G)?97@Q,#(N:'1M
M4$L! A0#%     @ )(AF6^+[/=L6!P  *"(   X              ( !:,4!
M &QT8G)?97@S,3$N:'1M4$L! A0#%     @ )(AF6X(:X+PF!P  6"@   X
M             ( !JLP! &QT8G)?97@S,3(N:'1M4$L! A0#%     @ )(AF
M6V9H;=,M!   ,A,   T              ( !_-,! &QT8G)?97@S,BYH=&U0
52P4&      H "@!T @  5-@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>ltbr_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:ltbr="http://ltbr.com/20250930"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ltbr-20250930.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-10-01to2025-10-27_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-27</endDate>
        </period>
    </context>
    <context id="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-11-06</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_CODMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">ltbr:CODMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-04</instant>
        </period>
    </context>
    <context id="From2024-03-01to2024-03-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-29</endDate>
        </period>
    </context>
    <context id="From2024-11-01to2024-11-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-22</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-19</endDate>
        </period>
    </context>
    <context id="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-19</instant>
        </period>
    </context>
    <context id="From2025-09-01to2025-09-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-26</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-06-01to2025-06-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-05</endDate>
        </period>
    </context>
    <context id="From2025-05-01to2025-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-05-23</endDate>
        </period>
    </context>
    <context id="From2019-05-01to2019-05-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-28</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">ltbr:PrepaidExpenseAndOtherCurrentAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsSummaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:SeriesXPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-03</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-03</instant>
        </period>
    </context>
    <context id="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-03</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-08-01to2025-08-28_ltbr_SecondTrancheMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:SecondTrancheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:FirstTrancheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-28</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwentyTwentyFiveTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockUnitsRSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:RestrictedStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-18_ltbr_StrategicPartnershipProjectAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-18</endDate>
        </period>
    </context>
    <context id="From2025-03-01to2025-03-18_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-18</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-01-16_ltbr_CRADAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CRADAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_FEEdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:FEEdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-12-01to2024-12-31_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-16_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-16</instant>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_CANDUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:CANDUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-01-16_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-16</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:BottomMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ltbr:TopMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_ltbr_INLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ltbr:INLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2025-07-01to2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2025-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-09-30" id="ixv-8665">0001084554</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-09-30" id="ixv-8666">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-09-30" id="ixv-8667">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-09-30" id="ixv-8668">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-09-30" id="ixv-8669">2025</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-8670"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8671"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="ixv-8672"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8673"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8674"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="ixv-8675"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-8676"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8677"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8678"
      unitRef="Shares">18783912</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="ixv-8679"
      unitRef="Shares">30384981</us-gaap:CommonStockSharesOutstanding>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-09-30" id="ixv-8680">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-09-30" id="ixv-8681">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-09-30" id="ixv-8682">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-09-30" id="ixv-8683">true</ecd:Rule10b51ArrAdoptedFlag>
    <ltbr:Rule10b51ArrAdoptedFlagSecond contextRef="From2025-01-01to2025-09-30" id="ixv-8684">true</ltbr:Rule10b51ArrAdoptedFlagSecond>
    <ltbr:Rule10b51ArrAdoptedFlagThird contextRef="From2025-01-01to2025-09-30" id="ixv-8685">true</ltbr:Rule10b51ArrAdoptedFlagThird>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="ixv-8686"
      unitRef="Shares">263630</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="ixv-8687"
      unitRef="Shares">547362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="ixv-8688"
      unitRef="Shares">2113036</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="ixv-8689"
      unitRef="Shares">545992</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="ixv-8690"
      unitRef="Shares">2376666</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="ixv-8691"
      unitRef="Shares">1093354</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2024-09-30_ltbr_CANDUMember"
      decimals="0"
      id="ixv-8692"
      unitRef="USD">0</ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-07-01to2025-09-30_ltbr_FEEdMember"
      decimals="0"
      id="ixv-8693"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense
      contextRef="From2025-07-01to2025-09-30_ltbr_CANDUMember"
      decimals="0"
      id="ixv-8694"
      unitRef="USD">0</ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="ixv-8695"
      unitRef="Shares">57940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="ixv-8696"
      unitRef="Shares">781864</ltbr:CommonStockShareOutstanding>
    <ltbr:CommonStockShareOutstanding
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="ixv-8697"
      unitRef="Shares">2113036</ltbr:CommonStockShareOutstanding>
    <dei:DocumentType contextRef="From2025-01-01to2025-09-30" id="ixv-9824">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2025-01-01to2025-09-30" id="ixv-9825">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-09-30" id="ixv-9826">2025-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-09-30" id="ixv-9827">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-09-30" id="ixv-9828">001-34487</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-09-30" id="ixv-9829">LIGHTBRIDGE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-09-30" id="ixv-9830">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-01-01to2025-09-30" id="ixv-9831">91-1975651</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-09-30" id="ixv-9832">11710 Plaza America Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-09-30" id="ixv-9833">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-09-30" id="ixv-9834">Reston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-01-01to2025-09-30" id="ixv-9835">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-09-30" id="ixv-9836">20190</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-01-01to2025-09-30" id="ixv-9837">571</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-01-01to2025-09-30" id="ixv-9838">730-1200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-09-30" id="ixv-9839">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-01-01to2025-09-30" id="ixv-9840">LTBR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-01-01to2025-09-30" id="ixv-9841">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-09-30" id="ixv-9842">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-09-30" id="ixv-9843">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-09-30" id="ixv-9844">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-01-01to2025-09-30" id="ixv-9845">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-09-30" id="ixv-9846">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-09-30" id="ixv-9847">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-10-31"
      decimals="INF"
      id="ixv-9848"
      unitRef="Shares">32371338</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_808"
      unitRef="USD">153330134</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_809"
      unitRef="USD">39990827</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_810"
      unitRef="USD">1293501</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_811"
      unitRef="USD">324378</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_812"
      unitRef="USD">154623635</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_813"
      unitRef="USD">40315205</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_815"
      unitRef="USD">327148</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_816"
      unitRef="USD">528805</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_817"
      unitRef="USD">114982</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_818"
      unitRef="USD">108865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Assets
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_819"
      unitRef="USD">155065765</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_820"
      unitRef="USD">40952875</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_822"
      unitRef="USD">1560097</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_823"
      unitRef="USD">424585</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_824"
      unitRef="USD">1560097</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_825"
      unitRef="USD">424585</us-gaap:LiabilitiesCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_35"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_37"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_828"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_829"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_43"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_45"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_48"
      unitRef="Shares">30384981</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_47"
      unitRef="Shares">18783912</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_830"
      unitRef="USD">30385</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_831"
      unitRef="USD">18784</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_832"
      unitRef="USD">330050816</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_833"
      unitRef="USD">204694348</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_834"
      unitRef="USD">-176575533</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_835"
      unitRef="USD">-164184842</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_836"
      unitRef="USD">153505668</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_837"
      unitRef="USD">40528290</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_838"
      unitRef="USD">155065765</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_839"
      unitRef="USD">40952875</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_841"
      unitRef="USD">3164343</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_842"
      unitRef="USD">1676209</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_843"
      unitRef="USD">9146989</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_844"
      unitRef="USD">5626567</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_845"
      unitRef="USD">2039857</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_846"
      unitRef="USD">1298601</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_847"
      unitRef="USD">5345635</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_848"
      unitRef="USD">3232036</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_849"
      unitRef="USD">5204200</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_850"
      unitRef="USD">2974810</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_851"
      unitRef="USD">14492624</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_852"
      unitRef="USD">8858603</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_853"
      unitRef="USD">-5204200</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_854"
      unitRef="USD">-2974810</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_855"
      unitRef="USD">-14492624</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_856"
      unitRef="USD">-8858603</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_858"
      unitRef="USD">1104955</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_859"
      unitRef="USD">318649</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_860"
      unitRef="USD">2101933</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_861"
      unitRef="USD">1008224</us-gaap:InterestIncomeOther>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_862"
      unitRef="USD">1104955</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_863"
      unitRef="USD">318649</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_864"
      unitRef="USD">2101933</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_865"
      unitRef="USD">1008224</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_866"
      unitRef="USD">-4099245</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_867"
      unitRef="USD">-2656161</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_868"
      unitRef="USD">-12390691</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_869"
      unitRef="USD">-7850379</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_870"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_871"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_872"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_873"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_874"
      unitRef="USD">-4099245</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_875"
      unitRef="USD">-2656161</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_876"
      unitRef="USD">-12390691</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_877"
      unitRef="USD">-7850379</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-07-01to2025-09-30"
      decimals="INF"
      id="fid_879"
      unitRef="USDPShares">-0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="fid_880"
      unitRef="USDPShares">-0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_881"
      unitRef="USDPShares">-0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="fid_882"
      unitRef="USDPShares">-0.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_884"
      unitRef="Shares">25624598</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_885"
      unitRef="Shares">14189787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_886"
      unitRef="Shares">22498638</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_887"
      unitRef="Shares">13871756</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_888"
      unitRef="Shares">25545488</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_889"
      unitRef="USD">25545</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_890"
      unitRef="USD">270225336</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_891"
      unitRef="USD">-172476288</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="fid_892"
      unitRef="USD">97774593</us-gaap:StockholdersEquity>
    <ltbr:IssuanceOfRestrictedShareAwardsShares
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_893"
      unitRef="Shares">1110000</ltbr:IssuanceOfRestrictedShareAwardsShares>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_894"
      unitRef="USD">1110</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_895"
      unitRef="USD">-1110</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_896"
      unitRef="USD">0</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_897"
      unitRef="USD">0</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_898"
      unitRef="Shares">3612403</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_899"
      unitRef="USD">3613</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_900"
      unitRef="USD">57324913</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_901"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_902"
      unitRef="USD">57328526</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_903"
      unitRef="Shares">20949</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_904"
      unitRef="USD">21</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_905"
      unitRef="USD">314979</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_906"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_907"
      unitRef="USD">315000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_908"
      unitRef="Shares">96141</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_909"
      unitRef="USD">96</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_910"
      unitRef="USD">610323</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_911"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_912"
      unitRef="USD">610419</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_913"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_914"
      unitRef="USD">1576375</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_915"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_916"
      unitRef="USD">1576375</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_917"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_918"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1387"
      unitRef="USD">-4099245</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_920"
      unitRef="USD">-4099245</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_921"
      unitRef="Shares">30384981</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_922"
      unitRef="USD">30385</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_923"
      unitRef="USD">330050816</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_924"
      unitRef="USD">-176575533</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_925"
      unitRef="USD">153505668</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_926"
      unitRef="Shares">18783912</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_927"
      unitRef="USD">18784</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_928"
      unitRef="USD">204694348</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_929"
      unitRef="USD">-164184842</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_930"
      unitRef="USD">40528290</us-gaap:StockholdersEquity>
    <ltbr:IssuanceOfRestrictedShareAwardsShares
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_931"
      unitRef="Shares">1467940</ltbr:IssuanceOfRestrictedShareAwardsShares>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_932"
      unitRef="USD">1468</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_933"
      unitRef="USD">-1468</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_934"
      unitRef="USD">0</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:IssuanceOfRestrictedShareAwardsAmount
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_935"
      unitRef="USD">0</ltbr:IssuanceOfRestrictedShareAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_936"
      unitRef="Shares">-29440</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_937"
      unitRef="USD">-29</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1388"
      unitRef="USD">-234592</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_939"
      unitRef="USD">0</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_940"
      unitRef="USD">-234621</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_941"
      unitRef="Shares">9854669</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_942"
      unitRef="USD">9854</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_943"
      unitRef="USD">120441594</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_944"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_945"
      unitRef="USD">120451448</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_946"
      unitRef="Shares">112045</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_947"
      unitRef="USD">112</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_948"
      unitRef="USD">344888</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_949"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_950"
      unitRef="USD">345000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_951"
      unitRef="Shares">195855</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_952"
      unitRef="USD">196</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_953"
      unitRef="USD">1243598</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_954"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_955"
      unitRef="USD">1243794</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_956"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_957"
      unitRef="USD">3562448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_958"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_959"
      unitRef="USD">3562448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_960"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_961"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_962"
      unitRef="USD">-12390691</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_963"
      unitRef="USD">-12390691</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_964"
      unitRef="Shares">30384981</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_965"
      unitRef="USD">30385</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_966"
      unitRef="USD">330050816</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_967"
      unitRef="USD">-176575533</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_968"
      unitRef="USD">153505668</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_969"
      unitRef="Shares">14591477</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_970"
      unitRef="USD">14591</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_971"
      unitRef="USD">184599393</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_972"
      unitRef="USD">-157591994</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="fid_973"
      unitRef="USD">27021990</us-gaap:StockholdersEquity>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_974"
      unitRef="Shares">608690</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_975"
      unitRef="USD">609</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_976"
      unitRef="USD">1511132</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_977"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_978"
      unitRef="USD">1511741</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_979"
      unitRef="Shares">76164</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_980"
      unitRef="USD">76</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_981"
      unitRef="USD">194924</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_982"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_983"
      unitRef="USD">195000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_984"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_985"
      unitRef="USD">388477</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_986"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_987"
      unitRef="USD">388477</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_988"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_989"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_990"
      unitRef="USD">-2656161</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_991"
      unitRef="USD">-2656161</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_992"
      unitRef="Shares">15276331</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_993"
      unitRef="USD">15276</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_994"
      unitRef="USD">186693926</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_995"
      unitRef="USD">-160248155</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="fid_996"
      unitRef="USD">26461047</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_997"
      unitRef="Shares">13698274</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_998"
      unitRef="USD">13698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_999"
      unitRef="USD">181295125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1000"
      unitRef="USD">-152397776</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1001"
      unitRef="USD">28911047</us-gaap:StockholdersEquity>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1002"
      unitRef="Shares">1436821</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1003"
      unitRef="USD">1437</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1004"
      unitRef="USD">3714928</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1005"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1006"
      unitRef="USD">3716365</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsOfAmount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1007"
      unitRef="Shares">145370</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1008"
      unitRef="USD">145</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1009"
      unitRef="USD">464855</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1010"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1011"
      unitRef="USD">465000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1012"
      unitRef="Shares">-4134</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsShares>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1013"
      unitRef="USD">-4</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1014"
      unitRef="USD">-10579</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1015"
      unitRef="USD">0</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1016"
      unitRef="USD">-10583</ltbr:SharesIssuedNetOfShareSettlementForWithholdingTaxesPaidUponVestingOfRestrictedStockAwardsAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1017"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1018"
      unitRef="USD">1229597</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1019"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1020"
      unitRef="USD">1229597</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1021"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1022"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1023"
      unitRef="USD">-7850379</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1024"
      unitRef="USD">-7850379</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1025"
      unitRef="Shares">15276331</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1026"
      unitRef="USD">15276</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1027"
      unitRef="USD">186693926</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1028"
      unitRef="USD">-160248155</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="fid_1029"
      unitRef="USD">26461047</us-gaap:StockholdersEquity>
    <ltbr:ProfitAndLoss
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1031"
      unitRef="USD">12390691</ltbr:ProfitAndLoss>
    <ltbr:ProfitAndLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1032"
      unitRef="USD">7850379</ltbr:ProfitAndLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1034"
      unitRef="USD">3746642</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1035"
      unitRef="USD">1280403</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1037"
      unitRef="USD">808317</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1038"
      unitRef="USD">37665</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1039"
      unitRef="USD">-201657</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1040"
      unitRef="USD">-10125</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1041"
      unitRef="USD">1135512</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1042"
      unitRef="USD">928240</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1043"
      unitRef="USD">-8115197</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1044"
      unitRef="USD">-5669276</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1046"
      unitRef="USD">6117</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1047"
      unitRef="USD">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1048"
      unitRef="USD">-6117</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1049"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1051"
      unitRef="USD">124659368</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1052"
      unitRef="USD">4138022</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1053"
      unitRef="USD">4207920</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1054"
      unitRef="USD">421657</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1055"
      unitRef="USD">1243794</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1056"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1057"
      unitRef="USD">234621</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1058"
      unitRef="USD">10583</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1059"
      unitRef="USD">121460621</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1060"
      unitRef="USD">3705782</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1061"
      unitRef="USD">113339307</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1062"
      unitRef="USD">-1963494</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1063"
      unitRef="USD">39990827</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1064"
      unitRef="USD">28598445</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1065"
      unitRef="USD">153330134</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="fid_1066"
      unitRef="USD">26634951</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1068"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1069"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1070"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1071"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1073"
      unitRef="USD">15000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1074"
      unitRef="USD">15000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <ltbr:CommonStockIssuedForConsultingServices
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1075"
      unitRef="USD">300000</ltbr:CommonStockIssuedForConsultingServices>
    <ltbr:CommonStockIssuedForConsultingServices
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1076"
      unitRef="USD">180000</ltbr:CommonStockIssuedForConsultingServices>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_191">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Nature of Operations and Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;When used in these notes, the terms &#x201c;Lightbridge,&#x201d; &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its nuclear fuel. The Company views its operations and manages its business as one business segment, which is the development and commercialization of its nuclear fuel. These unaudited condensed consolidated financial statements include the accounts of the Company, and the Company&#x2019;s wholly-owned subsidiaries, TPI, a Delaware corporation, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accompanying unaudited condensed consolidated financial statements of Lightbridge and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (GAAP), including a summary of the Company&#x2019;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 3, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three and nine-month periods have been made. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Summary of Significant Accounting Policies&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Fair Value of Financial Instruments&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#x201c;on-the-run&#x201d;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#x201c;off-the-run&#x201d; and is classified as level 2. The three levels of the fair value hierarchy were as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment and may have affected the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At period-end, the Company evaluates U.S. Treasury instruments held to determine whether they are:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x201c;On-the-run&#x201d;: Securities from the most recent auction with active market pricing, classified as Level 1&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x201c;Off-the-run&#x201d;: Securities from prior auctions with observable inputs but less liquidity, classified as Level 2&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Although U.S. Treasury instruments held as cash equivalents have short maturities (typically 30&#x2013;90 days) and cost closely approximates fair value, fair value disclosures are presented in accordance with ASC 820 and ASC 320 guidance.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of U.S. Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $116.7 million of U.S. Treasury instruments during the nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (rounded in millions) at September 30, 2025: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;56.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;96.7&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (rounded in millions) at December 31, 2024: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Certain Risks and Uncertainties&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s cash and cash equivalents are sufficient to pay for the Company&#x2019;s research and development (R&amp;amp;D) and operations for the next year. However, given the long-term nature of the R&amp;amp;D activities that are expected to be necessary prior to commercialization, the Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future R&amp;amp;D activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;amp;D of the Lightbridge Fuel&#x2122;, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company is engaged in significant R&amp;amp;D activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three and nine months ended September 30, 2025, R&amp;amp;D expenses associated with activities conducted at INL accounted for 41% and 45% of the Company&#x2019;s total R&amp;amp;D expenditure, respectively. For the three and nine months ended September 30, 2024, R&amp;amp;D expenses associated with activities conducted at the INL accounted for 32% and 36% of the Company&#x2019;s total R&amp;amp;D expenditure, respectively. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#x2019;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#x2019;s current ability to advance its R&amp;amp;D activities.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Update (ASU) No. 2023-09, &lt;em&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/em&gt;, was issued by the Financial Accounting Standards Board (FASB) in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;em&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/em&gt; (Subtopic 220-40): &lt;em&gt;Disaggregation of Income Statement Expenses&lt;/em&gt; (ASU 2024-03), which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-01-01to2025-09-30" id="fid_202">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determined fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), established a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value were categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy was based on the lowest level of input that is significant to the fair value measurement. At the end of the reporting period, the Company reviews U.S. treasury instruments held to determine whether the securities are of the most recent issuance of that security with the same maturity (referred to as &#x201c;on-the-run&#x201d;, which is the most liquid version of the maturity band). If a U.S. treasury instrument held at the end of the reporting period was from the most recent issuance it is classified as level 1, otherwise it is referred to as &#x201c;off-the-run&#x201d; and is classified as level 2. The three levels of the fair value hierarchy were as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that were observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that were not active and inputs other than quoted prices that were observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities were classified in their entirety in the fair value hierarchy level based on the lowest level of input that was significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment and may have affected the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At period-end, the Company evaluates U.S. Treasury instruments held to determine whether they are:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x201c;On-the-run&#x201d;: Securities from the most recent auction with active market pricing, classified as Level 1&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="font-family:symbol"&gt;&#xb7;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x201c;Off-the-run&#x201d;: Securities from prior auctions with observable inputs but less liquidity, classified as Level 2&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Although U.S. Treasury instruments held as cash equivalents have short maturities (typically 30&#x2013;90 days) and cost closely approximates fair value, fair value disclosures are presented in accordance with ASC 820 and ASC 320 guidance.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consisted principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash, accounts payable and accrued liabilities are considered to be Level 1 measurements, because of the short-term nature of those instruments. Cash equivalents are primarily composed of U.S. Treasury instruments having maturity dates of 30 to 90 days. The Company purchased $116.7 million of U.S. Treasury instruments during the nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (rounded in millions) at September 30, 2025: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;56.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;96.7&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarized the valuation of the Company&#x2019;s financial instruments that fell within the fair value hierarchy (rounded in millions) at December 31, 2024: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <ltbr:InvestmentsInDebtSecuritiesPurchased
      contextRef="From2025-01-01to2025-09-30"
      decimals="-5"
      id="fid_1180"
      unitRef="USD">116700000</ltbr:InvestmentsInDebtSecuritiesPurchased>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_213">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;56.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;96.7&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40.0&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_1167"
      unitRef="USD">56600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-5"
      id="fid_1169"
      unitRef="USD">96700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_1170"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_1173"
      unitRef="USD">1600000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_1174"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-09-30_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_1175"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_1168"
      unitRef="USD">40000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_1171"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_1172"
      unitRef="USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_1176"
      unitRef="USD">400000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-6"
      id="fid_1177"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_1178"
      unitRef="USD">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-01-01to2025-09-30" id="fid_203">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s cash and cash equivalents are sufficient to pay for the Company&#x2019;s research and development (R&amp;amp;D) and operations for the next year. However, given the long-term nature of the R&amp;amp;D activities that are expected to be necessary prior to commercialization, the Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, commercial loans, further offerings of equity securities, or an offering of debt securities in order to support its future R&amp;amp;D activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;amp;D of the Lightbridge Fuel&#x2122;, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company is engaged in significant R&amp;amp;D activities to advance its nuclear fuel technology at Idaho National Laboratory (INL). For the three and nine months ended September 30, 2025, R&amp;amp;D expenses associated with activities conducted at INL accounted for 41% and 45% of the Company&#x2019;s total R&amp;amp;D expenditure, respectively. For the three and nine months ended September 30, 2024, R&amp;amp;D expenses associated with activities conducted at the INL accounted for 32% and 36% of the Company&#x2019;s total R&amp;amp;D expenditure, respectively. The Company currently relies on INL for developing, testing and evaluating its nuclear fuel. Any disruption in access to INL&#x2019;s resources, including changes in government policies, facility downtime, regulatory constraints, or unforeseen operational challenges could have a material adverse effect on the Company&#x2019;s current ability to advance its R&amp;amp;D activities.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <ltbr:ResearchAndDevelopmentPercentage
      contextRef="From2025-07-01to2025-09-30_ltbr_INLMember"
      decimals="2"
      id="fid_1383"
      unitRef="Pure">0.41</ltbr:ResearchAndDevelopmentPercentage>
    <ltbr:ResearchAndDevelopmentPercentage
      contextRef="From2025-01-01to2025-09-30_ltbr_INLMember"
      decimals="2"
      id="fid_1179"
      unitRef="Pure">0.45</ltbr:ResearchAndDevelopmentPercentage>
    <ltbr:ResearchAndDevelopmentPercentage
      contextRef="From2024-07-01to2024-09-30_ltbr_INLMember"
      decimals="2"
      id="fid_1382"
      unitRef="Pure">0.32</ltbr:ResearchAndDevelopmentPercentage>
    <ltbr:ResearchAndDevelopmentPercentage
      contextRef="From2024-01-01to2024-09-30_ltbr_INLMember"
      decimals="2"
      id="fid_1381"
      unitRef="Pure">0.36</ltbr:ResearchAndDevelopmentPercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_212">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Update (ASU) No. 2023-09, &lt;em&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/em&gt;, was issued by the Financial Accounting Standards Board (FASB) in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;em&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/em&gt; (Subtopic 220-40): &lt;em&gt;Disaggregation of Income Statement Expenses&lt;/em&gt; (ASU 2024-03), which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the consolidated financial statements. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements and related disclosures.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and does not believe the future adoption of any such standards will have a material impact on the consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_192">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 2. Net Loss Per Share&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three and nine months ended September 30, 2025 and 2024, as they would have been anti-dilutive due to the Company&#x2019;s losses at September 30, 2025 and 2024 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#x2019;s common stock.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three and Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;547,362&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards (RSAs) outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,113,036&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;545,992&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,376,666&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,093,354&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_214">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three and Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;547,362&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards (RSAs) outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,113,036&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;545,992&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,376,666&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,093,354&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1077"
      unitRef="Shares">263630</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1080"
      unitRef="Shares">547362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1078"
      unitRef="Shares">2113036</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1081"
      unitRef="Shares">545992</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1079"
      unitRef="Shares">2376666</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1082"
      unitRef="Shares">1093354</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <ltbr:PrepaidProjectCostsDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_193">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 3. Prepaid Project Costs and Other Long-Term Assets&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, the Company entered into two agreements with INL, in collaboration with the Department of Energy (DOE), to support the development of Lightbridge Fuel&#x2122;. At the time of signing, the Company made advance payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), the DOE&#x2019;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing, and increasing the advance payments by $0.1 million to a total of $0.5 million. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of September 30, 2025, and December 31, 2024, the Company&#x2019;s prepaid project costs were $0.3 million and $0.5 million, respectively.&lt;/p&gt;</ltbr:PrepaidProjectCostsDisclosureTextBlock>
    <ltbr:ProjectAbandonmentCosts
      contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_1089"
      unitRef="USD">400000</ltbr:ProjectAbandonmentCosts>
    <ltbr:ProjectAbandonmentCosts
      contextRef="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_TopMember"
      decimals="-5"
      id="fid_1091"
      unitRef="USD">100000</ltbr:ProjectAbandonmentCosts>
    <ltbr:ProjectAbandonmentCosts
      contextRef="AsOf2025-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ltbr_BottomMember"
      decimals="-5"
      id="fid_1090"
      unitRef="USD">500000</ltbr:ProjectAbandonmentCosts>
    <ltbr:ProjectAbandonmentCosts
      contextRef="AsOf2025-09-30_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="fid_1092"
      unitRef="USD">300000</ltbr:ProjectAbandonmentCosts>
    <ltbr:ProjectAbandonmentCosts
      contextRef="AsOf2024-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="fid_1093"
      unitRef="USD">500000</ltbr:ProjectAbandonmentCosts>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_194">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 4. Accounts Payable and Accrued Liabilities&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities consist of the following (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued professional and consulting fees &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_215">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued professional and consulting fees &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1181"
      unitRef="USD">500000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_1186"
      unitRef="USD">200000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <ltbr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="AsOf2025-09-30"
      decimals="-6"
      id="fid_1182"
      unitRef="USD">0</ltbr:AccruedResearchAndDevelopmentExpensesCurrent>
    <ltbr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_1187"
      unitRef="USD">100000</ltbr:AccruedResearchAndDevelopmentExpensesCurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1183"
      unitRef="USD">900000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-6"
      id="fid_1188"
      unitRef="USD">0</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1185"
      unitRef="USD">200000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_1189"
      unitRef="USD">100000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1184"
      unitRef="USD">1600000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="fid_1190"
      unitRef="USD">400000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_195">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 5. Commitments and Contingencies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Operating Leases&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company leased office space for a 12-month term from January 1, 2025 through December 31, 2025 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2025 total approximately $24,000. Total rent expense for the three and nine months ended September 30, 2025 was approximately $25,000 and $75,000, respectively. Total rent expense for the three and nine months ended September 30, 2024 was approximately $24,000 and $73,000, respectively.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ltbr:LesseeOperatingLeaseTerm contextRef="From2025-01-01to2025-09-30" id="fid_1195">P12M</ltbr:LesseeOperatingLeaseTerm>
    <us-gaap:OperatingLeasePayments
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1193"
      unitRef="USD">8000</us-gaap:OperatingLeasePayments>
    <ltbr:LeasePaymentUnderNonCancellableOperatingLeases
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1194"
      unitRef="USD">24000</ltbr:LeasePaymentUnderNonCancellableOperatingLeases>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2025-07-01to2025-09-30"
      decimals="0"
      id="fid_1196"
      unitRef="USD">25000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1192"
      unitRef="USD">75000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="0"
      id="fid_1191"
      unitRef="USD">24000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1197"
      unitRef="USD">73000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_196">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 6. Research and Development Costs&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;INL Project&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#x2122;. These framework agreements use an innovative structure that consists of an &#x201c;umbrella&#x201d; Strategic Partnership Project Agreement (SPPA) and an &#x201c;umbrella&#x201d; Cooperative Research and Development Agreement (CRADA), with an initial duration of seven years.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Throughout the duration of these umbrella agreements, all R&amp;amp;D work contracted with BEA is through the issuance of Project Task Statements (PTS). The initial phase of work under the two agreements is expected to culminate in future irradiation testing in the INL Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#x2019;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. Data gathered during future post-irradiation examination work are expected to support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#x2122;. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three and nine months ended September 30, 2025, the Company recorded $0.8 million and $2.4 million in R&amp;amp;D expenses associated with INL, respectively. For the three and nine months ended September 30, 2024, the Company recorded $0.4 million and $1.1 million in R&amp;amp;D expenses associated with INL, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;INL Modifications to the CRADA and SPPA Project Task Statements&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On January 16, 2025, the Company and BEA entered into Modification No. 3 to the PTS No. 1 under the CRADA, dated September 27, 2022, as amended on May 22, 2023 and May 30, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 3, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time associated with R&amp;amp;D activities were increased by approximately $1.6 million, bringing the total estimated cost for the work to be performed under the &#x201c;umbrella&#x201d; CRADA to $4.2 million. This modification also required that a $600,000 advance payment be made, which was due and paid on January 16, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 18, 2025, the Company and BEA entered into Modification No. 4 to the PTS No. 1 under the SPPA, dated December 9, 2022, as amended on May 23, 2023, March 26, 2024 and October 24, 2024, by and between the Company and BEA. Pursuant to the terms of Modification No. 4, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#x201c;umbrella&#x201d; SPPA to $2.6 million.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 6, 2025, the Company and BEA entered into Modification No. 3 to the SPPA extending the duration of this umbrella agreement from 7 years to 12 years. On November 5, 2025, the Company and BEA entered into Modification No. 1 to the CRADA with INL, extending the period of performance from September 27, 2029 to September 27, 2032.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;After accounting for Modification No. 4, cash payments from Lightbridge to BEA under both CRADA and SPPA are estimated at approximately $6.8 million on a cost reimbursable basis over the performance periods. The balance of the PTS obligations as of September 30, 2025 was $2.0 million. These PTS obligations are generally cancellable with 30 days&#x2019; notice and therefore, are not considered firm commitments. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Romania Feasibility Study&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 16, 2023, the Company engaged Institutul de Cercet&#x103;ri Nucleare Pite&#x219;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#x2122; for use in Canada Deuterium Uranium (CANDU) reactors. The total price of approximately $0.2 million was payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. The Company made its final payment in December 2024 when the study was completed. The Company has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $0 million in R&amp;amp;D expenses associated with RATEN ICN feasibility study. For the three and nine months ended September 30, 2024, the Company recorded zero and $0.1 million, respectively in R&amp;amp;D expenses associated with RATEN ICN feasibility study.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a front-end engineering and design (FEED) study to evaluate deployment of a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio. The Company made its final payment in December 2024 for the study that was completed in 2024 and has no further obligations under the agreement. For the three and nine months ended September 30, 2025, the Company recorded $0 million in R&amp;amp;D expenses associated with this FEED study. For the three and nine months ended September 30, 2024, the Company recorded $0.1 million and $0.3 million, respectively in R&amp;amp;D expenses associated with this FEED study.&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-07-01to2025-09-30_ltbr_INLMember"
      decimals="-5"
      id="fid_1102"
      unitRef="USD">800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-09-30_ltbr_INLMember"
      decimals="-5"
      id="fid_1103"
      unitRef="USD">2400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2024-09-30_ltbr_INLMember"
      decimals="-5"
      id="fid_1094"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30_ltbr_INLMember"
      decimals="-5"
      id="fid_1095"
      unitRef="USD">1100000</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:ResearchAndDevelopmentArrangementExpense
      contextRef="From2025-01-01to2025-01-16_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_1104"
      unitRef="USD">1600000</ltbr:ResearchAndDevelopmentArrangementExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-01-16_ltbr_CRADAMember"
      decimals="-5"
      id="fid_1105"
      unitRef="USD">4200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-01-16"
      decimals="0"
      id="fid_1096"
      unitRef="USD">600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-03-01to2025-03-18_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_1106"
      unitRef="USD">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-03-01to2025-03-18_ltbr_StrategicPartnershipProjectAgreementMember"
      decimals="-5"
      id="fid_1107"
      unitRef="USD">2600000</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:InvestmentCompanyExcessCostReimbursable
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1113"
      unitRef="USD">6800000</ltbr:InvestmentCompanyExcessCostReimbursable>
    <ltbr:InvestmentCompanyExcessProjectTaskObligations
      contextRef="AsOf2025-09-30"
      decimals="-5"
      id="fid_1114"
      unitRef="USD">2000000.0</ltbr:InvestmentCompanyExcessProjectTaskObligations>
    <ltbr:ResearchAndDevelopmentExpensePayable
      contextRef="AsOf2023-10-16_ltbr_CANDUMember"
      decimals="-5"
      id="fid_1097"
      unitRef="USD">200000</ltbr:ResearchAndDevelopmentExpensePayable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-10-16_ltbr_CANDUMember"
      decimals="-5"
      id="fid_1098"
      unitRef="USD">100000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <ltbr:PaymentsToResearchAndDevelopmentCost
      contextRef="From2024-12-01to2024-12-31_ltbr_CANDUMember"
      decimals="-5"
      id="fid_1099"
      unitRef="USD">100000</ltbr:PaymentsToResearchAndDevelopmentCost>
    <ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-09-30_ltbr_CANDUMember"
      decimals="-6"
      id="fid_1111"
      unitRef="USD">0</ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense>
    <ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30_ltbr_CANDUMember"
      decimals="-5"
      id="fid_1112"
      unitRef="USD">100000</ltbr:RelatedPartyTransactionAmountsResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-09-30_ltbr_FEEdMember"
      decimals="-6"
      id="fid_1108"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2024-09-30_ltbr_FEEdMember"
      decimals="-5"
      id="fid_1100"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30_ltbr_FEEdMember"
      decimals="-5"
      id="fid_1101"
      unitRef="USD">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_197">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 7. Stockholders&#x2019; Equity and Stock-Based Compensation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Increase in Authorized Common Shares &lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On May 8, 2025, the Company held the 2025 annual meeting of stockholders (the Annual Meeting) at which the Company&#x2019;s stockholders approved increasing the authorized common shares from 25,000,000 shares to 100,000,000 shares. The Amendment to the Articles of Incorporation became effective upon the filing of the Amended and Restated Certificate of Incorporation with the Secretary of State of Nevada on May 8, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Common Stock and Common Stock Equivalents Outstanding&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At September 30, 2025, the Company had a total of 30,648,611 shares of common stock and common stock equivalents outstanding, comprised of 30,384,981 common shares outstanding (including outstanding RSAs totaling 2,113,036 shares) and stock options to purchase 263,630 shares of common stock (of which 250,547 stock options were vested).&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2024, the Company had a total of 19,248,852 shares of common stock and common stock equivalents outstanding, comprised of 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares) and stock options to purchase 464,940 shares of common stock (of which 445,275 stock options were vested).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Issuance and Redemption of Series X Preferred Stock&#160;&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 27, 2025, the Company entered into a Subscription and Investment Representation Agreement with the chair of the Audit Committee, an independent member of the Board (the Purchaser), pursuant to which the Company agreed to issue and sell one (1) share of the Company&#x2019;s Series X Preferred Stock, par value $0.001 per share (the Series X Preferred Stock), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was received by the Company. The Company redeemed the Series X Preferred Stock for $100 cash after the Annual Meeting and filed the Certificate of Withdrawal with the Secretary of State of Nevada on May 8, 2025. The Series X Preferred Stock did not have any voting rights except with respect to any proposal to increase the number of authorized shares of common stock of the Company. Each share of Series X Preferred Stock was entitled to 25,000,000 votes on such proposal, voting together with the holders of the Company&#x2019;s common stock. The votes by the holder of Series X Preferred Stock were cast at the Annual Meeting automatically in the same &#x201c;mirrored&#x201d; proportion as the aggregate votes cast &#x201c;for&#x201d; and &#x201c;against&#x201d; the proposal by the holders of the common stock who voted on such proposal (excluding abstentions, broker non-votes and shares of common stock that were not voted &#x201c;for&#x201d; or &#x201c;against&#x201d; such proposal). The voting power attributable to the Series X Preferred Stock was disregarded for purposes of determining whether a quorum is present at the Annual Meeting.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Common Stock Equity Offerings&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;At-the-Market (ATM) Offerings&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024, pursuant to which the Company issued and sold shares of its common stock from time to time through Stifel as the Company&#x2019;s sales agent. Under this amended agreement, the Company paid Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. This agreement was terminated on May 30, 2025. Sales of the Company&#x2019;s common stock through Stifel, were made by any method that is deemed to be an at-the-market (ATM) equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#x2019;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the First Prospectus Supplement), pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $12.6 million from time to time through an ATM offering. The Company exhausted all capacity under the First Prospectus Supplement. On November 22, 2024, the Company filed a prospectus supplement (the Second Prospectus Supplement) pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $45.0 million from time to time through an ATM offering. The Company exhausted all capacity under the Second Prospectus Supplement.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company filed a shelf registration statement on Form S-3 (File No. 333-287563) on May 23, 2025 registering the sale of up to $150.0 million of the Company&#x2019;s securities that was declared effective on June 4, 2025. On June 5, 2025, the Company filed a prospectus supplement (the June Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $75.0 million of&#160;its shares of common stock through the Company&#x2019;s new sales agent, Jefferies LLC (Jefferies).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On June 5, 2025, the Company entered into an Open Market Sale Agreement&lt;sup style="vertical-align:super"&gt;SM&lt;/sup&gt; (the Sales Agreement) with Jefferies pursuant to which the Company may issue and sell from time to time shares of its common stock through Jefferies as the Company&#x2019;s sales agent. Sales of the Company&#x2019;s common stock through Jefferies, if any, will be made by any method that is deemed to be an &#x201c;at-the-market&#x201d; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to the Company&#x2019;s effective shelf registration statement on Form S-3 (File No. 333-287563) , and the base prospectus filed as part of such registration statement and a prospectus supplement. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On September 26, 2025, the Company filed a prospectus supplement (the September Prospectus Supplement) pursuant to which&#160;the Company may issue and sell from time to time up to $75.0 million of&#160;its shares of common stock through Jefferies. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company records its ATM sales on a settlement date basis. The Company sold 9,854,669 shares under the ATM for the nine months ended September 30, 2025 resulting in net proceeds of $120.4 million (stock issuance costs were approximately $4.2 million). The Company sold 1,436,821 shares under the ATM for the nine months ended September 30, 2024 resulting in net proceeds of $3.7 million (stock issuance costs were approximately $0.4 million). &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three months ended September 30, 2025, the Company sold 3,612,403 shares under the ATM, resulting in net proceeds of $57.3 million (stock issuance costs were approximately $2.0 million). For the three months ended September 30, 2024, the Company sold 608,690 shares under the ATM, resulting in net proceeds of $1.5 million (stock issuance costs were approximately $0.1 million).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Stock-Based Compensation&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;2020 Omnibus Incentive Plan &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 9, 2020, the Board of Directors adopted the Company&#x2019;s 2020 Omnibus Incentive Plan (as subsequently amended, the 2020 Plan). On September 3, 2020, the stockholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock Awards and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the annual meeting of stockholders on April 19, 2024. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 26, 2025, the Company&#x2019;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000. This increase was approved by the stockholders at the annual meeting of stockholders on May 8, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The total number of shares of common stock available for future issuance under the 2020 Plan was 2,008,361 shares and 1,471,026 shares at September 30, 2025 and 2024, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock Options&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Stock options issued to the Company&#x2019;s employees, directors and consultants are summarized as follows for the nine months ended September 30, 2025:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Term (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;464,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;16.24&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.07&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;184,818&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,418&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10.33&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(195,855 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;6.35&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,834,474&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Expired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(17,873 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;75.60&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, September 30, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;19.28&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.35&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,045,064&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested and expected to vest, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;19.28&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.35&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,045,064&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Options exercisable, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;250,547&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;20.04&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.01&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,829,575&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the nine months ended September 30, 2025 and 2024, the Company issued 12,418 and 71,330 stock options, respectively, to two consultants. The 12,418 stock options and the 71,330 stock options were assigned a fair value of $6.85 per share and $1.19 per share, respectively (total fair value of $85,000 for each grant). The weighted-average grant-date exercise price per share of the stock options granted for the nine months ended September 30, 2025 and 2024, was $10.33 and $2.91, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The intrinsic value is calculated as the difference between the fair value of the Company&#x2019;s common stock and the exercise price of the stock options. The fair value of the Company&#x2019;s common stock was $21.21 per share and $2.80 per share at September 30, 2025 and 2024, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The fair value was determined using the Black-Scholes pricing model. For expected volatility, the Company concluded that the historical volatility over the option&#x2019;s expected holding term provided the most reasonable basis for this estimate. For the risk-free interest rate, the Company used U.S. Treasury Note rates, which mature at approximately the same time as the option&#x2019;s expected holding term or option life determined by using the simplified method. The Company recognizes forfeitures of equity-based awards as a reduction to compensation costs in the period in which they occur. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted for the nine months ended September 30, 2025 and 2024:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;109.24% - 117.44%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;75.36% - 92.89%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;3.80% - 3.95%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;3.76% - 4.54%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;2-6 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;2-6 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share - common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;$9.42 - $15.13&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;$2.49 - $2.62&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of September 30, 2025, total unrecognized compensation cost related to option awards was $47,813, which is expected to be recognized over a remaining weighted-average vesting period of 2.26 years. As of September 30, 2024, total unrecognized compensation cost related to option awards was $47,853, which was expected to be recognized over a remaining weighted-average vesting period of 2.26 years. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Exercise of Options&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three and nine months ended September 30, 2025, the Company received approximately $0.6 million and $1.2 million in net proceeds from the exercise of 96,141 and 195,855 stock options by employees and consultants, respectively. There were no options exercised for the nine months ended September 30, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Common Stock&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Consultants&#x2019; Stock Issuances&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the nine months ended September 30, 2025 and 2024, the Company issued 6,302 shares (with an average stock price of $7.14 per share) and 13,201 shares (with an average stock price of $3.41&#160;per share) of common stock, respectively, to its investor relations firm for services provided during the period, which were recorded as stock-based compensation expense. These shares vested immediately upon issuance. The expense recorded for these share issuances was $15,000 for each quarter. The shares were valued based on the closing market price of the Company&#x2019;s common stock on the date of grant. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On August 19, 2024, the Company issued an equity grant valued at $180,000 to a consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, and preparation and dissemination of a report regarding the Company, which resulted in issuing the consultant 71,713 shares of common stock on the grant date, valued at $2.51 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $180,000 began to be recognized on a straight-line basis over the requisite service period and fully amortized to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On August 29, 2025, the Company issued an equity grant valued at $300,000 to the same consulting and investment research firm, for corporate advisory services to be provided over a twelve-month period, which resulted in issuing the consultant 19,828 shares of common stock on the grant date, valued at $15.13 per share. These shares vested immediately upon issuance and are not forfeitable. The compensation cost of $300,000 began to be recognized on a straight-line basis over the requisite service period. Approximately $25,000 was recorded to stock-based compensation expense in the condensed consolidated statement of operations for the nine months ended September 30, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of September 30, 2025, the unrecognized compensation cost of approximately $275,000 was recorded under prepaid expenses and other current assets on the accompanying condensed consolidated balance sheet, which is expected to be recognized over a remaining service period of 0.92 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Restricted Stock Awards (RSAs) &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;RSAs are awards of common stock that are legally issued and outstanding. RSAs are subject to time-based restrictions on transfer and unvested portions are generally subject to a risk of forfeiture if the award recipient ceases providing services to the Company prior to the lapse of the restrictions or does not meet certain performance conditions. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;RSAs were included in common stock issued and outstanding and were considered contingently issuable in the calculation of weighted-average shares outstanding for purposes of calculating diluted loss per share. The grantees receiving RSAs have all rights as a shareholder with respect to these shares, whether vested or unvested, including, without limitation, rights to vote the shares, receive dividends, etc.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following summarizes the Company&#x2019;s restricted stock award activity and the RSAs outstanding: &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted- &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;781,864&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,698,217&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards granted (including performance-based RSAs of 1,125,000 shares)&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,467,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;13.50&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,821,822&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(136,768 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;6.10&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,346,731&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, September 30, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,113,036&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;10.91&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;44,817,494&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The aggregate fair value was calculated as the fair value of the Company&#x2019;s common stock. The fair value of the Company&#x2019;s common stock was $21.21 per share and $2.80 per share at September 30, 2025 and 2024, respectively. The fair value of the RSAs vested for the&#160;nine months ended September 30, 2025 and 2024 was $1.3 million and $0 million, respectively. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of September 30, 2025, total unrecognized compensation cost related to RSAs was $20.5 million, which is expected to be recognized over a remaining weighted-average vesting period of 2.57 years. As of September 30, 2024, total unrecognized compensation cost related to RSAs was $1.45 million, which is expected to be recognized over a remaining weighted-average vesting period of 1.64 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;August 28, 2025 &#x2013; Equity Grant of 1,800,000 shares of Restricted Stock Awards Program&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On August 28, 2025, the Board of Directors approved an aggregate restricted stock award program of 1.8 million shares of common stock. Pursuant to this approval, on August 28, 2025, the Company granted 1.1 million restricted stock awards with an aggregate grant-date fair value of approximately $17.1 million to its executives, directors, and employees. These awards consisted of 275,000 RSAs and 825,000 performance-based restricted stock awards (PSAs). The total value of approximately $17.1 million was based on the Company&#x2019;s closing stock price of $15.54 per share on the grant date. The remaining portion of the Board-approved program has been authorized for future issuance by management, subject to applicable conditions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The first tranche of 275,000 RSAs are subject to service-based vesting, with the shares vesting in three equal installments on the first, second and third anniversaries of the date of grant. These shares were included in the total outstanding common shares as of September 30, 2025 due to their voting rights. These awards were valued at approximately $4.3 million. The Company recognized $0.1 million in stock-based compensation expense for the three and nine months ended September 30, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The second tranche of 825,000 PSAs are subject to both service-based and performance-based vesting conditions. The PSAs have three specific R&amp;amp;D fuel milestones relating to key technical development and commercialization objectives of the Company&#x2019;s R&amp;amp;D fuel program and one specific financial milestone vesting in unequal tranches based on which milestone is certified. Each milestone applies only to a separate portion of the 825,00 PSAs. The respective portions of each tranche will vest upon the later of achievement and Board or Compensation Committee certification of operational milestones and is subject to (i) the grantee&#x2019;s continued service through the certification date and (ii) the grantee having completed at least twelve months of continuous service with Lightbridge as of the operational milestone achievement date. The performance period for achieving these operational milestones extend from the grant date to December 31, 2028. Any unvested shares will be forfeited if the corresponding operational and financial milestones are not achieved by December 31, 2028 or if the grantee&#x2019;s service with the Company ends prior to vesting. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of the grant date and September 30, 2025, management concluded that the performance conditions associated with these performance milestones were probable of achievement. In accordance with ASC 718, the Company applied the graded vesting attribution amortization to the related RSAs from the grant date through each milestone&#x2019;s estimated achievement date. These awards were valued at approximately $12.8 million. The Company recognized $0.4 million in stock-based compensation expense for the three and nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;April 3, 2025 &#x2013; Equity Grant of 300,000 Performance-Based Restricted Stock Awards&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On April 3, 2025, the Company granted 300,000 PSAs to certain executives, key employees, and consultants under the 2020 Equity Incentive Plan. These awards were valued at approximately $2.1 million in total, based on the Company&#x2019;s closing stock price of $6.99 per share on April 7, 2025, which was the final date of communication with the certain executives, key employees and consultants regarding the awards.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;These PSAs are subject to both service-based and performance-based vesting conditions. The performance condition requires the successful insertion of the Company&#x2019;s coupon fuel samples into the Advanced Test Reactor at INL by December 31, 2026 and is subject to the grantees continuous service over a three-year period from the grant date. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of the grant date and September 30, 2025, management concluded that the performance condition was probable of achievement. The Company recognized $0.4 million in stock-based compensation expense for the three months ended September 30, 2025, and $0.6 million for the nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Director Compensation - Equity-Settled Awards&lt;/span&gt;&lt;/em&gt;&lt;span style="text-decoration:underline"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 12, 2025, the Board of Directors granted 57,940 RSAs to its five independent directors for their service during the year ending December 31, 2025. The awards were valued at $0.5 million, based on the Company&#x2019;s closing stock price of $8.63 per share on the grant date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;These RSAs vest in four equal quarterly installments, beginning March 31, 2025. As of September 30, 2025, a total of 43,455 shares had vested. The Company recognized $0.1 million in stock-based compensation expense for the three months ended September 30, 2025, and $0.4 million for the nine months ended September 30, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 4, 2024, the Board of Directors approved an equity grant valued at $500,000 in total to its five independent directors for the service period and year ended December 31, 2024, which resulted in granting a total of 85,915 shares of common stock, valued on the grant date at $5.82 per share on December 4, 2024, which shares vested on January 2, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six independent directors for the service period and year ended December 31, 2023, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share on November 20, 2023, which shares vested on January 2, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The fair value of the shares granted was determined based on the closing market price of the Company&#x2019;s common stock on the grant date. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Restricted Stock Awards Modification and Net Share Settlements for Payments of Withholding Taxes&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In March 2025, the Company accelerated the vesting of 70,710 RSAs in connection with a separation agreement with a former employee, resulting in approximately $0.5 million of stock-based compensation expense, including $0.3 million of incremental fair value. This expense was recognized in the first quarter of 2025 and is included in the results for the nine-month period ended September 30, 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;RSAs Summary - 2025 and 2024&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of September 30, 2025 and December 31, 2024, the Company had 2,113,036 shares (including performance-based RSAs of 1,125,000 shares) and 781,864 shares (including performance-based RSAs of 0 share) of RSAs, respectively, included in its total issued and outstanding common stock &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the nine months ended September 30, 2025 and 2024, the Company recorded $3.2 million and $1.1 million, respectively, in stock-based compensation expense related to RSAs granted. For the three months ended September 30, 2025 and 2024, the Company recorded $1.6 million and $0.4 million, respectively, in stock-based compensation expense related to RSAs granted.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock-Based Compensation Expense&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Total non-cash stock-based compensation expense recorded related to options and RSAs included in the Company&#x2019;s unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2025 and 2024 are as follows (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_BottomMember"
      decimals="0"
      id="fid_1289"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-05-08_ltbr_BoardOfDirectorsMember_ltbr_TopMember"
      decimals="0"
      id="fid_1290"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding contextRef="From2025-01-01to2025-09-30" id="fid_1291">the Company had a total of 30,648,611 shares of common stock and common stock equivalents outstanding, comprised of 30,384,981 common shares outstanding (including outstanding RSAs totaling 2,113,036 shares) and stock options to purchase 263,630 shares of common stock (of which 250,547 stock options were vested).</ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding>
    <ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding contextRef="From2024-01-01to2024-12-31" id="fid_1292">the Company had a total of 19,248,852 shares of common stock and common stock equivalents outstanding, comprised of 18,783,912 common shares outstanding (including outstanding RSAs totaling 781,864 shares) and stock options to purchase 464,940 shares of common stock (of which 445,275 stock options were vested).</ltbr:DescriptionOfCommonStockAndCommonStockEquivalentsOutstanding>
    <ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement
      contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"
      id="fid_1287">(1) share of the Company&#x2019;s Series X Preferred Stock, par value $0.001 per share (the Series X Preferred Stock), to the Purchaser for $100 in cash. The sale closed on February 27, 2025 and the $100 was received by the Company. The Company redeemed the Series X Preferred Stock for $100 cash after the Annual Meeting and filed the Certificate of Withdrawal with the Secretary of State of Nevada on May 8, 2025</ltbr:DescriptionOfSubscriptionAndInvestmentRepresentationAgreement>
    <ltbr:PreferredStockVotingRightsShares
      contextRef="From2025-02-03to2025-02-27_ltbr_SeriesXPreferredStockMember"
      decimals="0"
      id="fid_1288"
      unitRef="Shares">25000000</ltbr:PreferredStockVotingRightsShares>
    <us-gaap:IntercompanyAgreementsDescription contextRef="From2019-05-01to2019-05-28" id="fid_1278">Under this amended agreement, the Company paid Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement</us-gaap:IntercompanyAgreementsDescription>
    <ltbr:MarketOfferingsDisclosureDescription contextRef="From2024-03-01to2024-03-29" id="fid_1273">The Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) on March 29, 2024, registering the sale of up to $75.0 million of the Company&#x2019;s securities that was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement, which was further supplemented on July 19, 2024 and August 9, 2024 (collectively, the First Prospectus Supplement), pursuant to which the Company offered and sold shares of common stock having an aggregate offering price of up to $12.6 million from time to time through an ATM offering. The Company exhausted all capacity under the First Prospectus Supplement</ltbr:MarketOfferingsDisclosureDescription>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="From2024-11-01to2024-11-22"
      decimals="-5"
      id="fid_1284"
      unitRef="USD">45000000.0</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-05-01to2025-05-23"
      decimals="-5"
      id="fid_1293"
      unitRef="Shares">150000000.0</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-06-01to2025-06-05"
      decimals="-5"
      id="fid_1294"
      unitRef="Shares">75000000.0</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-09-01to2025-09-26"
      decimals="-5"
      id="fid_1348"
      unitRef="Shares">75000000.0</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1295"
      unitRef="Shares">9854669</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1296"
      unitRef="USD">120400000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1297"
      unitRef="USD">4200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1298"
      unitRef="Shares">1436821</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1299"
      unitRef="USD">3700000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1300"
      unitRef="USD">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1301"
      unitRef="Shares">3612403</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1302"
      unitRef="USD">57300000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-07-01to2025-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1303"
      unitRef="USD">2000000.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1304"
      unitRef="Shares">608690</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ltbr:ProceedsFromStockIssuances
      contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1305"
      unitRef="USD">1500000</ltbr:ProceedsFromStockIssuances>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-01to2024-09-30_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1306"
      unitRef="USD">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ltbr:DescriptionOfEquityIncentivePlan
      contextRef="From2024-02-01to2024-02-27_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      id="fid_1277">the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares</ltbr:DescriptionOfEquityIncentivePlan>
    <ltbr:DescriptionOfEquityIncentivePlan
      contextRef="From2025-02-01to2025-02-26_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      id="fid_1285">the Company&#x2019;s Board of Directors approved an increase of 2,500,000 shares to the authorized number of shares under the 2020 Plan, increasing the total authorized number of shares from 2,500,000 to 5,000,000</ltbr:DescriptionOfEquityIncentivePlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2025-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_1307"
      unitRef="Shares">2008361</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-09-30_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_1349"
      unitRef="Shares">1471026</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_216">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Term (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;464,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;16.24&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.07&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;184,818&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,418&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10.33&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(195,855 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;6.35&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,834,474&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Expired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(17,873 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;75.60&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, September 30, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;19.28&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.35&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,045,064&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested and expected to vest, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;263,630&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;19.28&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.35&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,045,064&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Options exercisable, end of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;250,547&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;20.04&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2.01&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,829,575&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1198"
      unitRef="Shares">464940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="fid_1203"
      unitRef="USDPShares">16.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm contextRef="From2025-01-01to2025-09-30" id="fid_1208">P3M2D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1216"
      unitRef="USD">184818</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1199"
      unitRef="Shares">12418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1204"
      unitRef="USDPShares">10.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1200"
      unitRef="Shares">195855</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1205"
      unitRef="USDPShares">6.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1222"
      unitRef="USD">1834474</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1201"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1206"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1202"
      unitRef="Shares">17873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1207"
      unitRef="USDPShares">75.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1221"
      unitRef="Shares">263630</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_1220"
      unitRef="USDPShares">19.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF contextRef="From2025-01-01to2025-09-30" id="fid_1209">P2M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermEndingFF>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1219"
      unitRef="USD">2045064</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicsValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1212"
      unitRef="Shares">263630</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_1214"
      unitRef="USDPShares">19.28</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested contextRef="From2025-01-01to2025-09-30" id="fid_1210">P2M10D</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermVested>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1217"
      unitRef="USD">2045064</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVestedAndExpectedToVest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1213"
      unitRef="Shares">250547</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_1215"
      unitRef="USDPShares">20.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable contextRef="From2025-01-01to2025-09-30" id="fid_1211">P2M</ltbr:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermOptionsExercisable>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1218"
      unitRef="USD">1829575</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOptionsExercisable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1308"
      unitRef="Shares">12418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1311"
      unitRef="Shares">71330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1309"
      unitRef="USDPShares">6.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="fid_1312"
      unitRef="USDPShares">1.19</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember"
      decimals="INF"
      id="fid_1310"
      unitRef="USDPShares">85000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30"
      decimals="INF"
      id="fid_1313"
      unitRef="USDPShares">10.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="fid_1314"
      unitRef="USDPShares">2.91</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-09-30"
      decimals="INF"
      id="fid_1315"
      unitRef="USDPShares">21.21</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="fid_1350"
      unitRef="USDPShares">2.80</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_217">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;109.24% - 117.44%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;75.36% - 92.89%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;3.80% - 3.95%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;3.76% - 4.54%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;2-6 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;2-6 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share - common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;$9.42 - $15.13&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;$2.49 - $2.62&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-01-01to2025-09-30_ltbr_TopMember"
      decimals="4"
      id="fid_1225"
      unitRef="Pure">1.0924</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember"
      decimals="4"
      id="fid_1243"
      unitRef="Pure">1.1744</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-09-30_ltbr_TopMember"
      decimals="4"
      id="fid_1226"
      unitRef="Pure">0.7536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember"
      decimals="4"
      id="fid_1244"
      unitRef="Pure">0.9289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-01-01to2025-09-30_ltbr_TopMember"
      decimals="3"
      id="fid_1233"
      unitRef="Pure">0.0380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember"
      decimals="4"
      id="fid_1241"
      unitRef="Pure">0.0395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-09-30_ltbr_TopMember"
      decimals="4"
      id="fid_1234"
      unitRef="Pure">0.0376</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember"
      decimals="4"
      id="fid_1242"
      unitRef="Pure">0.0454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2025-01-01to2025-09-30"
      decimals="0"
      id="fid_1384"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="fid_1385"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2025-01-01to2025-09-30_ltbr_BottomMember"
      id="fid_1235">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2025-01-01to2025-09-30_ltbr_TopMember"
      id="fid_1227">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-01to2024-09-30_ltbr_BottomMember"
      id="fid_1236">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-01to2024-09-30_ltbr_TopMember"
      id="fid_1228">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="AsOf2025-09-30_ltbr_TopMember"
      decimals="INF"
      id="fid_1229"
      unitRef="USDPShares">9.42</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-09-30_ltbr_BottomMember"
      decimals="INF"
      id="fid_1237"
      unitRef="USDPShares">15.13</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-30_ltbr_TopMember"
      decimals="INF"
      id="fid_1230"
      unitRef="USDPShares">2.49</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-30_ltbr_BottomMember"
      decimals="INF"
      id="fid_1238"
      unitRef="USDPShares">2.62</us-gaap:SharePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1316"
      unitRef="USD">47813</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2025-01-01to2025-09-30" id="fid_1317">P2Y3M3D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="fid_1351"
      unitRef="USD">47853</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2024-01-01to2024-09-30" id="fid_1318">P2Y3M3D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-07-01to2025-09-30_ltbr_OptionsMember"
      decimals="-5"
      id="fid_1352"
      unitRef="USD">600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-01-01to2025-09-30_ltbr_OptionsMember"
      decimals="-5"
      id="fid_1319"
      unitRef="USD">1200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_ltbr_OptionsMember"
      decimals="0"
      id="fid_1353"
      unitRef="Shares">96141</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_OptionsMember"
      decimals="0"
      id="fid_1320"
      unitRef="Shares">195855</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_1321"
      unitRef="Shares">6302</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_1323"
      unitRef="USDPShares">7.14</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_1324"
      unitRef="Shares">13201</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-09-30_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_1354"
      unitRef="USDPShares">3.41</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_1322"
      unitRef="USD">15000</us-gaap:ShareBasedCompensation>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1283"
      unitRef="USD">180000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1355"
      unitRef="Shares">71713</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonStockValuedGrantDatePricePerShare
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1279"
      unitRef="USDPShares">2.51</ltbr:CommonStockValuedGrantDatePricePerShare>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2024-08-01to2024-08-19_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1280"
      unitRef="USD">180000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1356"
      unitRef="USD">300000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:CommonStockValuedGrantDatePricePerShare
      contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1358"
      unitRef="USDPShares">15.13</ltbr:CommonStockValuedGrantDatePricePerShare>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="From2025-08-01to2025-08-29_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1357"
      unitRef="USD">300000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-09-30_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1325"
      unitRef="USD">25000</us-gaap:OperatingExpenses>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"
      decimals="0"
      id="fid_1326"
      unitRef="USD">275000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2025-01-01to2025-09-30_ltbr_PrepaidExpenseAndOtherCurrentAssetMember"
      id="fid_1327">P0Y11M1D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ltbr:ScheduleOfOutstandingRSATableTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_218">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Number of &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted- &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;781,864&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,698,217&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards granted (including performance-based RSAs of 1,125,000 shares)&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,467,940&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;13.50&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,821,822&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(136,768 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;6.10&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,346,731&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Awards forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding, September 30, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,113,036&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;10.91&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;44,817,494&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ltbr:ScheduleOfOutstandingRSATableTextBlock>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1256"
      unitRef="Shares">781864</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_1257"
      unitRef="USDPShares">5.19</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1258"
      unitRef="USD">3698217</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1245"
      unitRef="Shares">1467940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_1248"
      unitRef="USDPShares">13.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1252"
      unitRef="USD">19821822</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1246"
      unitRef="Shares">136768</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_1249"
      unitRef="USDPShares">6.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1253"
      unitRef="USD">1346731</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1247"
      unitRef="Shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_1250"
      unitRef="USDPShares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1254"
      unitRef="USD">0</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueForfeited>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1259"
      unitRef="Shares">2113036</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstanding94>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="INF"
      id="fid_1251"
      unitRef="USDPShares">10.91</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardMember"
      decimals="0"
      id="fid_1255"
      unitRef="USD">44817494</ltbr:SharebasedCompensationSharesOptionsAggregateIntrinsicValueOutstandings>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1328"
      unitRef="USDPShares">21.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_1329"
      unitRef="Shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-6"
      id="fid_1330"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_1331"
      unitRef="USD">20500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      id="fid_1332">P2Y6M25D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-4"
      id="fid_1359"
      unitRef="USD">1450000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      id="fid_1360">P1Y7M20D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="-5"
      id="fid_1362"
      unitRef="Shares">1800000</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAuthorizedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="-5"
      id="fid_1363"
      unitRef="Shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="-5"
      id="fid_1364"
      unitRef="USD">17100000</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesValueIssuedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="0"
      id="fid_1365"
      unitRef="Shares">275000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <ltbr:StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="0"
      id="fid_1366"
      unitRef="Shares">825000</ltbr:StockIssuedDuringPeriodSharesRestrictedStockAwardPerformanced>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="INF"
      id="fid_1367"
      unitRef="USDPShares">15.54</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember"
      decimals="0"
      id="fid_1368"
      unitRef="Shares">275000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited
      contextRef="From2025-08-01to2025-08-28_ltbr_FirstTrancheMember"
      decimals="-5"
      id="fid_1369"
      unitRef="USD">4300000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-08-01to2025-08-28_ltbr_SecondTrancheMember"
      decimals="0"
      id="fid_1371"
      unitRef="Shares">825000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="From2025-08-01to2025-08-28_ltbr_RestrictedStockAwardsProgramMember"
      decimals="-5"
      id="fid_1372"
      unitRef="USD">12800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsProgramMember"
      decimals="-5"
      id="fid_1386"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1333"
      unitRef="Shares">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2025-04-01to2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_1335"
      unitRef="USD">2100000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-04-03_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1334"
      unitRef="USDPShares">6.99</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_1374"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="-5"
      id="fid_1375"
      unitRef="USD">600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-03-01to2025-03-12_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1286"
      unitRef="Shares">57940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <ltbr:RSAFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_1346"
      unitRef="USD">500000</ltbr:RSAFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1337"
      unitRef="USDPShares">8.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockUnitsRSAMember_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1376"
      unitRef="Shares">43455</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember"
      decimals="-4"
      id="fid_1377"
      unitRef="USD">10000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardMember_ltbr_BoardOfDirectorsMember"
      decimals="-5"
      id="fid_1378"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1274"
      unitRef="USD">500000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1276"
      unitRef="Shares">85915</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2024-12-01to2024-12-04_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1275"
      unitRef="USDPShares">5.82</ltbr:CommonSharesEquityGrantPricePerShares>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1272"
      unitRef="USD">240000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted
      contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1281"
      unitRef="Shares">60456</ltbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGranted>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1282"
      unitRef="USDPShares">3.97</ltbr:CommonSharesEquityGrantPricePerShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="0"
      id="fid_1339"
      unitRef="Shares">70710</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="-5"
      id="fid_1338"
      unitRef="USD">500000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2025-01-01to2025-09-30_ltbr_TwentyTwentyFiveTransactionsMember"
      decimals="-5"
      id="fid_1340"
      unitRef="USD">300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="fid_1343"
      unitRef="Shares">2113036</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="0"
      id="fid_1341"
      unitRef="Shares">781864</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_1345"
      unitRef="USD">3200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_1347"
      unitRef="USD">1100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-07-01to2025-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_1379"
      unitRef="USD">1600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-07-01to2024-09-30_ltbr_RestrictedStockAwardsSummaryMember"
      decimals="-5"
      id="fid_1380"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_219">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-07-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1266"
      unitRef="USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1267"
      unitRef="USD">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1260"
      unitRef="USD">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1261"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-07-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_1268"
      unitRef="USD">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_1269"
      unitRef="USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_1262"
      unitRef="USD">2700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="fid_1263"
      unitRef="USD">1000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-07-01to2025-09-30"
      decimals="-5"
      id="fid_1270"
      unitRef="USD">1600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-5"
      id="fid_1271"
      unitRef="USD">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-09-30"
      decimals="-5"
      id="fid_1264"
      unitRef="USD">3600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-5"
      id="fid_1265"
      unitRef="USD">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_198">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 8. Segment Reporting&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (CODM), or decision-making group, in deciding how to allocate resources in assessing performance. The Company has one reportable business segment: nuclear fuel technology. This segment consists of the research and development and commercialization of its nuclear fuel. The Company&#x2019;s CODM is the chief executive officer.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss as reported on the condensed consolidated statement of operations. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future as it advances its nuclear fuel through all the stages of its development and commercialization. In addition, the measure of segment assets is reported on the condensed consolidated balance sheet as total assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The CODM uses segment net loss to allocate resources predominantly in the annual budget and forecasting process and uses that measure as a basis for evaluating progress toward R&amp;amp;D milestones. The CODM uses cash forecast models in deciding how to invest into the segment. R&amp;amp;D expenses, general and administrative (G&amp;amp;A) expenses are included in segment net loss and used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment, while R&amp;amp;D milestones scorecard results and scorecard G&amp;amp;A budgeted results are used in establishing management&#x2019;s incentive compensation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The table below summarizes the significant expense categories regularly provided to the CODM for the three and nine months ended September 30, 2025 and 2024 (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;9.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;INL project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Romania feasibility study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Centrus Energy FEED study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Allocated employee compensation and stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other segments items&lt;sup style="vertical-align:super"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.3 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1.0 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(4.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.7 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(12.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(7.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 13.5pt; text-align:justify;"&gt;(1) Other segment items include interest income.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_220">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Nine Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;September 30,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.7&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;9.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;INL project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.8&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Romania feasibility study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Centrus Energy FEED study&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt"&gt;Allocated employee compensation and stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.3&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:9pt"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other segments items&lt;sup style="vertical-align:super"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(0.3 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1.0 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(4.1 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(2.7 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(12.4 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;(7.8 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1136"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1137"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1116"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1117"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1138"
      unitRef="USD">3200000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1139"
      unitRef="USD">1700000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1118"
      unitRef="USD">9200000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1119"
      unitRef="USD">5600000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <ltbr:InlProject
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1140"
      unitRef="USD">800000</ltbr:InlProject>
    <ltbr:InlProject
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1141"
      unitRef="USD">400000</ltbr:InlProject>
    <ltbr:InlProject
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1120"
      unitRef="USD">2400000</ltbr:InlProject>
    <ltbr:InlProject
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1121"
      unitRef="USD">1100000</ltbr:InlProject>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1142"
      unitRef="USD">0</ltbr:RomaniaFeasibilityStudy>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1143"
      unitRef="USD">0</ltbr:RomaniaFeasibilityStudy>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1122"
      unitRef="USD">0</ltbr:RomaniaFeasibilityStudy>
    <ltbr:RomaniaFeasibilityStudy
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1123"
      unitRef="USD">100000</ltbr:RomaniaFeasibilityStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1144"
      unitRef="USD">0</ltbr:CentrusEnergyFeedStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1145"
      unitRef="USD">100000</ltbr:CentrusEnergyFeedStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-6"
      id="fid_1124"
      unitRef="USD">0</ltbr:CentrusEnergyFeedStudy>
    <ltbr:CentrusEnergyFeedStudy
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1125"
      unitRef="USD">300000</ltbr:CentrusEnergyFeedStudy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1146"
      unitRef="USD">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1147"
      unitRef="USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1126"
      unitRef="USD">2300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1127"
      unitRef="USD">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherExpenses
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1148"
      unitRef="USD">300000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1149"
      unitRef="USD">300000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1128"
      unitRef="USD">600000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1129"
      unitRef="USD">500000</us-gaap:OtherExpenses>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1150"
      unitRef="USD">2000000.0</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1151"
      unitRef="USD">1300000</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1130"
      unitRef="USD">5300000</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:ResearchAndDevelopmentExpenseNet
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1131"
      unitRef="USD">3200000</ltbr:ResearchAndDevelopmentExpenseNet>
    <ltbr:OtherSegmentsItem
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1152"
      unitRef="USD">-1100000</ltbr:OtherSegmentsItem>
    <ltbr:OtherSegmentsItem
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1153"
      unitRef="USD">-300000</ltbr:OtherSegmentsItem>
    <ltbr:OtherSegmentsItem
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1132"
      unitRef="USD">-2100000</ltbr:OtherSegmentsItem>
    <ltbr:OtherSegmentsItem
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1133"
      unitRef="USD">-1000000.0</ltbr:OtherSegmentsItem>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2025-07-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1154"
      unitRef="USD">-4100000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2024-07-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1155"
      unitRef="USD">-2700000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2025-01-01to2025-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1134"
      unitRef="USD">-12400000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated
      contextRef="From2024-01-01to2024-09-30_ltbr_CODMMember"
      decimals="-5"
      id="fid_1135"
      unitRef="USD">-7800000</ltbr:OperatingNetIncomeLossFromSegmentsToConsolidated>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_199">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 9. Subsequent Events&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;ATM Sales&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Sales of common stock under the Company&#x2019;s ATM from October 1, 2025 to November 6, 2025 amounted to 1,891,613 shares, which resulted in total net proceeds of approximately $42.0 million, stock issuance costs were approximately $1.3 million. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Safety Analysis Code Development Agreement&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 27, 2025, Lightbridge Corporation entered into an Agreement for Safety Analysis Codes and Services for Lightbridge Fuel Designs with Numerical Advisory Solutions, LLC (&#x201c;NAS&#x201d;). Under the agreement, NAS will develop customized safety-analysis computer codes, models, and documentation to evaluate Lightbridge&#x2019;s proprietary metallic uranium-zirconium fuel designs for water-cooled reactors. The firm-fixed-price contract totals approximately $0.8 million and will commence in the fourth quarter of 2025. All deliverables, including related intellectual-property rights, will be owned by Lightbridge.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_1156"
      unitRef="Shares">1891613</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_1157"
      unitRef="USD">42000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2025-10-01to2025-11-06_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_1158"
      unitRef="USD">1300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <ltbr:ResearchAndDevelopmentArrangementObligationAmount
      contextRef="From2025-10-01to2025-10-27_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_1159"
      unitRef="USD">800000</ltbr:ResearchAndDevelopmentArrangementObligationAmount>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="From2025-01-01to2025-09-30" id="fid_802">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September 30, 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (&#x201c;Rule 10b5-1 Plan&#x201d;) and was adopted during an open insider trading window and no sales will commence under the plan until completion of the required cooling off period under Rule 10b5-1, were as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Title&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Action&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Date Adopted&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Expiration Date&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:19%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Aggregate # of Securities to be Purchased/Sold&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Seth Grae&lt;sup style="vertical-align:super"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Chief Executive Officer and Chairman of the Board&lt;/p&gt;&lt;/td&gt;&lt;td style="width:7%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Adoption&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;9/30/2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;12/30/2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;98,711&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Andrey Mushakov&lt;sup style="vertical-align:super"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Executive Vice President of Fuel Operations&lt;/p&gt;&lt;/td&gt;&lt;td style="width:7%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Adoption&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;9/30/2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;12/31/2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;180,593&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Mark Tobin&lt;sup style="vertical-align:super"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Director&lt;/p&gt;&lt;/td&gt;&lt;td style="width:7%;vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Adoption&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;9/30/2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:13%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;12/31/2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:19%;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;15,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td colspan="6" style="width:85%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td colspan="6" style="width:85%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(1) Seth Grae, the Chief Executive Officer and Chairman of the Board, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Grae&#x2019;s plan provides for the sale, subject to certain price limits, of up to 98,711 shares of the Company&#x2019;s common stock in the aggregate. The plan terminates on December 30, 2026, unless terminated sooner in accordance with its terms.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td colspan="6" style="width:85%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(2) Andrey Mushakov, the Executive Vice President of Fuel Operations, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Mushakov&#x2019;s plan provides for the sale, subject to certain price limits, of up to 180,593 shares of the Company&#x2019;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td colspan="6" style="width:85%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(3) Mark Tobin, Director, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 30, 2025. Mr. Tobin&#x2019;s plan provides for the sale at market price, of up to 15,000 shares of the Company&#x2019;s common stock in the aggregate. The plan terminates on December 31, 2026, unless terminated sooner in accordance with its terms.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended September 30, 2025, no other director or officer of the Company adopted, modified or terminated a &#x201c;Rule 10b5-1 trading arrangement&#x201d; or &#x201c;non-Rule 10b5-1 trading arrangement,&#x201d; as each term is defined in Item&#160;408(a)&#160;of&#160;Regulation S-K.&lt;/p&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndName contextRef="From2025-01-01to2025-09-30" id="fid_463">Seth Grae</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="From2025-01-01to2025-09-30" id="fid_467">Chief Executive Officer and Chairman of the Board</ecd:TrdArrIndTitle>
    <ecd:TrdArrAdoptionDate contextRef="From2025-01-01to2025-09-30" id="fid_1164">9/30/2025</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrExpirationDate contextRef="From2025-01-01to2025-09-30" id="fid_479">12/30/2026</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_483"
      unitRef="Shares">98711</ecd:TrdArrSecuritiesAggAvailAmt>
    <ltbr:TrdArrIndNameSecond contextRef="From2025-01-01to2025-09-30" id="fid_803">Andrey Mushakov</ltbr:TrdArrIndNameSecond>
    <ltbr:TrdArrIndTitleSecond contextRef="From2025-01-01to2025-09-30" id="fid_1161">Executive Vice President of Fuel Operations</ltbr:TrdArrIndTitleSecond>
    <ltbr:TrdArrAdoptionDateSecond contextRef="From2025-01-01to2025-09-30" id="fid_476">9/30/2025</ltbr:TrdArrAdoptionDateSecond>
    <ltbr:TrdArrExpirationDateSecond contextRef="From2025-01-01to2025-09-30" id="fid_480">12/31/2026</ltbr:TrdArrExpirationDateSecond>
    <ltbr:TrdArrSecuritiesAggAvailAmtTwo
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_484"
      unitRef="Shares">180593</ltbr:TrdArrSecuritiesAggAvailAmtTwo>
    <ltbr:TrdArrIndNameThird contextRef="From2025-01-01to2025-09-30" id="fid_1160">Mark Tobin</ltbr:TrdArrIndNameThird>
    <ltbr:TrdArrIndTitleThird contextRef="From2025-01-01to2025-09-30" id="fid_1162">Director</ltbr:TrdArrIndTitleThird>
    <ltbr:TrdArrAdoptionDateThird contextRef="From2025-01-01to2025-09-30" id="fid_475">9/30/2025</ltbr:TrdArrAdoptionDateThird>
    <ltbr:TrdArrExpirationDateThird contextRef="From2025-01-01to2025-09-30" id="fid_1165">12/31/2026</ltbr:TrdArrExpirationDateThird>
    <ltbr:TrdArrSecuritiesAggAvailAmtThird
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="fid_1166"
      unitRef="Shares">15000</ltbr:TrdArrSecuritiesAggAvailAmtThird>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
